[
  {
    "model": "o3",
    "claim_id": "205",
    "claim": "CDK6 shows improved binding to loss-of-function variants of p18 INK4C.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers discuss p18 INK4C variants or their interaction/binding affinity with CDK6. The evidence therefore neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "3127341",
      "864491",
      "7548577",
      "36464673",
      "4418070"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the provided papers discuss CDK6, p18 INK4C, or the binding affinity between CDK6 and loss-of-function variants of p18. Therefore, they offer no relevant evidence to evaluate the claim."
    },
    "overthinking_doc_ids": [
      "1225513",
      "35684881",
      "4396105",
      "8219248",
      "11983390"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.31,
      "justification": "None of the provided papers discuss CDK6, p18 INK4C, or their binding interactions. The evidence is unrelated to the claim, so no conclusion can be drawn from these sources."
    },
    "posthoc_doc_ids": [
      "3127341",
      "7717468",
      "1225513",
      "22874817",
      "25827024"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1191",
    "claim": "The amount of publicly available DNA data doubles every 10 years.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers quantify temporal growth rates of publicly available DNA sequence data. They describe databases, bioinformatic tools, or unrelated biomedical studies, but do not report that DNA data doubles every 10 years or provide figures that can be used to infer such a trend."
    },
    "naive_doc_ids": [
      "30655442",
      "19854543",
      "4231060",
      "18654430",
      "991139"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the cited papers report on the quantity or historical growth rate of publicly available DNA sequence data. The articles discuss health metrics, clinical trials, environmental effects, genome\u2010analysis software, and microbial genome annotation platforms, but they do not provide statistics showing that public DNA data doubles every decade. Therefore, the evidence supplied is not relevant to confirming or refuting the claim."
    },
    "overthinking_doc_ids": [
      "581832",
      "11880289",
      "20606520",
      "21003930",
      "28633594"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address trends in the volume of publicly available DNA sequence data or its rate of increase over time. Therefore, they neither support nor contradict the claim."
    },
    "posthoc_doc_ids": [
      "2295434",
      "11880289",
      "25657127",
      "175735",
      "739734"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "649",
    "claim": "Integrating classroom-based collaborative learning with Web-based collaborative learning leads to subpar class performance",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers examine the academic effects of combining classroom\u2010based collaborative learning with Web\u2010based collaborative learning. The studies address topics such as antidepressant risks, perioperative fluids, immunology, integrated medical care, sex differences in angina, aerobic fitness and brain structure, fluid volume effects, computer-assisted learning in medicine (without performance data on integrated collaborative models), medical-school attrition, and neuroimaging in blindness. Therefore they supply no direct evidence to confirm or refute the specific claim about educational outcomes."
    },
    "naive_doc_ids": [
      "5691302",
      "8814634",
      "9278263",
      "15041758",
      "12561083"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the provided papers examine the impact of integrating classroom-based collaborative learning with Web-based collaborative learning on student or class performance. The cited studies cover topics ranging from neuroimaging, online health information, medical diagnostics, HIV models, and other biomedical issues, with only one paper (Paper 7) broadly discussing computer-assisted learning but without data addressing the specific claim. Hence, the evidence set does not speak to whether such integration leads to subpar performance."
    },
    "overthinking_doc_ids": [
      "313394",
      "4506702",
      "12122482",
      "13901073",
      "2424794"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the provided papers address classroom-based or Web-based collaborative learning, nor do they report on resultant class performance. The evidence is unrelated to the educational claim."
    },
    "posthoc_doc_ids": [
      "841371",
      "1191830",
      "1412089",
      "1456068",
      "1542437"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "828",
    "claim": "NAC inhibits the generation of angiotensin-converting enzyme.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers mention N-acetyl-cysteine (NAC) or examine its effects on the synthesis or activity of angiotensin-converting enzyme. The evidence therefore does not speak to whether NAC inhibits ACE generation."
    },
    "naive_doc_ids": [
      "6157837",
      "14584755",
      "6397191",
      "22036571",
      "23863551"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers mention N-acetylcysteine (NAC) or examine its effect on the generation or activity of angiotensin-converting enzyme. The evidence therefore provides no information relevant to the stated claim."
    },
    "overthinking_doc_ids": [
      "6157837",
      "14584755",
      "6397191",
      "38944245",
      "41133176"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the cited papers investigate N-acetylcysteine (NAC) or its effects on angiotensin-converting enzyme synthesis or activity. The articles focus on ACE inhibitors as drugs, endothelin-converting enzyme, and other unrelated molecular pathways. Therefore, they provide no evidence to confirm or refute the claim that NAC inhibits ACE generation."
    },
    "posthoc_doc_ids": [
      "6157837",
      "14584755",
      "6397191",
      "2272614",
      "6690087"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "715",
    "claim": "Low expression of miR7a does represses target genes and exerts a biological function in ovaries.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers mention miR7a expression levels, its effect on target-gene repression, or any biological role in ovaries. The evidence provided addresses other microRNAs (e.g., miR-192, miR-27) or general principles of miRNA function, but not the specific claim about miR7a in ovarian biology."
    },
    "naive_doc_ids": [
      "2000038",
      "2619579",
      "19828689",
      "153744",
      "12580014"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers investigate miR-7a expression or its functional impact in ovaries. The cited studies focus on other microRNAs (e.g., miR-192, miR-148a, miR-155, miR-199a-3p) and on different tissues or diseases (kidney, liver, hematopoietic cells, blood aging, breast carcinoma, mesothelioma, ovarian cancer stem cells, lupus). Consequently, they supply no evidence supporting or refuting the specific claim about low miR-7a expression repressing target genes and exerting biological effects in ovaries."
    },
    "overthinking_doc_ids": [
      "19828689",
      "5612738",
      "23727313",
      "663464",
      "13964633"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the provided papers discuss miR7a expression levels, its effects on target-gene repression, or its biological role in ovaries. Therefore they offer no information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "16550075",
      "23286603",
      "29429111",
      "19828689",
      "23727313"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "186",
    "claim": "British female students are bullied more than British male students.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers examine bullying among British students or compare bullying prevalence between female and male students. Therefore the claim is not addressed by the cited evidence."
    },
    "naive_doc_ids": [
      "38664102",
      "42291761",
      "2295434",
      "2488880",
      "5824985"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the provided papers discuss bullying among British students or compare bullying prevalence between British female and male students. Therefore they offer no relevant evidence to verify or refute the claim."
    },
    "overthinking_doc_ids": [
      "13900610",
      "24510595",
      "41380943",
      "43226130",
      "3828508"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.12,
      "justification": "None of the provided papers investigate bullying among British students or compare bullying prevalence between British female and male students. Therefore, the evidence set contains no information relevant to confirming or refuting the claim."
    },
    "posthoc_doc_ids": [
      "38664102",
      "41380943",
      "43226130",
      "3828508",
      "13900610"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "336",
    "claim": "Destination container port throughput(CPT) is negatively related to dengue virus (DENV-1) diffusion in air traffic shipments.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the supplied papers examine container-port throughput, air-cargo volumes, or their statistical relationship to the spread of DENV-1. The studies focus on local spatial clustering, phylogeography, importation routes, water supply, and other epidemiological factors, but not on port logistics variables. Therefore they provide no evidence for or against the stated claim."
    },
    "naive_doc_ids": [
      "18816720",
      "5114282",
      "8665891",
      "4928282",
      "15129362"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the cited papers examine any relationship between container port throughput (CPT) at destination ports and the spread or diffusion of DENV-1 in air-traffic shipments. The studies focus on local transmission dynamics, importation sources, population density, water supply, genetics, or are unrelated to dengue entirely. Consequently, they provide no evidence that either supports or contradicts the stated claim."
    },
    "overthinking_doc_ids": [
      "18816720",
      "8665891",
      "17454301",
      "22938539",
      "37677954"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided papers examine any relationship between destination container port throughput (CPT) and the diffusion of dengue virus (DENV-1) via air traffic shipments. The only dengue-related study (Paper 6) concerns spatial and temporal clustering of transmission within Thai villages and does not address shipping or air-traffic variables. Therefore the evidence set neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "12762485",
      "19685306",
      "20758340",
      "24148722",
      "4983"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "161",
    "claim": "Bacteriophagaes MS2 and Q\u03b2 are members of the Leviviridae.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.13,
      "justification": "None of the provided abstracts state the taxonomic family of bacteriophages MS2 or Q\u03b2, nor do they discuss the Leviviridae family. Therefore the evidence supplied does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "1153655",
      "1191830",
      "1398021",
      "1669173",
      "2042250"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Among the provided papers, only Paper 2 discusses bacteriophage MS2, and none of the abstracts reference the taxonomic family Leviviridae or mention bacteriophage Q\u03b2 at all. Consequently, the supplied evidence neither confirms nor refutes the claim that MS2 and Q\u03b2 belong to the Leviviridae family."
    },
    "overthinking_doc_ids": [
      "28707489",
      "6903077",
      "8577229",
      "17939443",
      "26996935"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the cited papers describe bacteriophage taxonomy or mention phages MS2, Q\u03b2, or the family Leviviridae. The evidence focuses on human diseases, genetic risk, immunological pathways, and healthcare classification systems, which are unrelated to viral classification. Therefore, the provided literature offers no information to verify or refute the claim."
    },
    "posthoc_doc_ids": [
      "1153655",
      "1398021",
      "1669173",
      "2042250",
      "2734421"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "484",
    "claim": "H4 G94P proteins induce chromatin assembly, which increases free histones.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers mention H4 G94P mutant proteins or discuss their effects on chromatin assembly or free-histone levels. The evidence therefore neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "24311787",
      "12588500",
      "29877890",
      "502591",
      "8267678"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers discuss the mutant histone H4 G94P, its effect on chromatin assembly, or resultant levels of free histones. The evidence concerns other chromatin remodelers, histone modifications, or RNA-mediated chromatin regulation, but does not address the specific claim."
    },
    "overthinking_doc_ids": [
      "24311787",
      "1354567",
      "7681810",
      "10189634",
      "12588500"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "None of the provided papers discuss histone H4 G94P proteins, their role in chromatin assembly, or changes in free histone levels caused by such proteins. Therefore, the evidence does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "24311787",
      "25041967",
      "7137057",
      "12588500",
      "29877890"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1033",
    "claim": "Reduction of purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpF in 2D BN-PAGE gels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the provided papers discuss 2-dimensional Blue Native-PAGE analysis of cytoplasmic-membrane preparations from overexpression strains, nor do they report changes in OmpF signal intensity as an indicator of membrane purity. Therefore, the evidence set contains no information relevant to confirming or refuting the stated claim."
    },
    "naive_doc_ids": [
      "5914739",
      "8903143",
      "26117607",
      "350542",
      "797114"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "None of the cited papers discuss 2-dimensional Blue-Native PAGE analyses of cytoplasmic-membrane preparations, nor do they report OmpF signal intensity as an indicator of membrane purity. The papers focus on unrelated topics such as mitochondrial lipid metabolism, T-cell receptor signaling, membrane-protein topology, \u03b2-cell proliferation, immunological synapses and outer-membrane biogenesis. Consequently, they provide no data that confirm or refute the stated claim."
    },
    "overthinking_doc_ids": [
      "797114",
      "5914739",
      "7643848",
      "24142891",
      "40094786"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "None of the provided papers examine purification of cytoplasmic membranes from over-expression strains, 2D BN-PAGE analyses, or the presence/absence of OmpF spots as a purity marker. Therefore they offer no evidence that stronger OmpF spots indicate reduced membrane purity in this context."
    },
    "posthoc_doc_ids": [
      "5914739",
      "8903143",
      "26117607",
      "38477436",
      "7643848"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "377",
    "claim": "Emodin forms hydrogen bonds with residues involved in PGAM1 substrate binding.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "None of the provided papers mention emodin or describe its interactions with PGAM1. Paper 1 deals with phosphorylation-dependent regulation of PGAM1 activity but does not study small-molecule binding; the remaining papers focus on unrelated proteins and processes. Therefore, the evidence set contains no data that confirms or refutes whether emodin forms hydrogen bonds with PGAM1 substrate-binding residues."
    },
    "naive_doc_ids": [
      "18810195",
      "23698769",
      "8331432",
      "10247314",
      "21557055"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "Among the supplied papers, only Paper 1 mentions emodin (Aloe-emodin) but it deals with gene-expression changes in glioblastoma cells and provides no structural or biochemical data on PGAM1. Paper 3 discusses PGAM1 structure and substrate binding, yet makes no reference to emodin or to docking interactions with small molecules. None of the other papers mention emodin or PGAM1 together. Consequently, the evidence set contains no information about emodin forming hydrogen bonds with PGAM1 substrate-binding residues."
    },
    "overthinking_doc_ids": [
      "14180565",
      "17518195",
      "18810195",
      "327319",
      "1635872"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.22,
      "justification": "Among the provided abstracts, only Paper 3 concerns PGAM1, and none of the papers mention Emodin or describe hydrogen-bond interactions between Emodin and PGAM1 substrate-binding residues. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "1225513",
      "12225214",
      "18810195",
      "1574014",
      "4740447"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "199",
    "claim": "CCL19 is predominantly present within dLNs.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "None of the cited papers discuss the chemokine CCL19 or compare its abundance in draining lymph nodes (dLNs) versus other sites. Therefore they provide no evidence that verifies or refutes the claim that CCL19 is predominantly present within dLNs."
    },
    "naive_doc_ids": [
      "22963769",
      "2389574",
      "10342807",
      "1071991",
      "11020556"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers present experimental data or conclusions about the abundance or distribution of the chemokine CCL19 in draining lymph nodes (dLNs). The articles that mention CCL19 (papers 6 and 7) discuss its biochemical properties, receptor interactions, or effects on cell migration, but do not quantify or compare its presence within dLNs versus other tissues. Therefore, the evidence set does not allow verification of the claim that CCL19 is predominantly present within dLNs."
    },
    "overthinking_doc_ids": [
      "1933281",
      "21719289",
      "37444589",
      "2389574",
      "25523969"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "None of the provided paper summaries mention the chemokine CCL19 or its distribution in draining lymph nodes (dLNs). Therefore, the evidence set does not address the claim."
    },
    "posthoc_doc_ids": [
      "1933281",
      "21719289",
      "37444589",
      "2389574",
      "25523969"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "577",
    "claim": "In mice, P. chabaudi parasites are able to proliferate faster early in infection when inoculated at lower numbers than when inoculated at high numbers.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "Among the supplied papers, only Paper 9 concerns Plasmodium chabaudi infections in mice, and it focuses on estimating transmission-stage investment, not on how initial parasite inoculum size affects early asexual proliferation rate. The remaining papers deal with unrelated topics (skeletogenesis, diabetic nephropathy, breast cancer, sickle-cell miRNA, gut microbiome, macrophage proliferation, HSV-2, malaria elimination modelling in Cambodia, and hematopoietic stem cells). None of the summaries provide experimental data comparing early parasite growth at low versus high inoculum sizes in mice. Therefore, the provided evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "15365719",
      "24640046",
      "1171121",
      "2460304",
      "6372244"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers examine Plasmodium chabaudi infections or compare parasite proliferation rates at different inoculum sizes in mice. The evidence therefore does not address the claim."
    },
    "overthinking_doc_ids": [
      "9513785",
      "24640046",
      "2242416",
      "3419802",
      "9160947"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided papers discuss Plasmodium chabaudi infections, parasite inoculum size, or early-infection proliferation rates in mice. Therefore, they do not supply evidence that confirms or refutes the stated claim."
    },
    "posthoc_doc_ids": [
      "9160947",
      "2837758",
      "9178310",
      "10559501",
      "13350374"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "92",
    "claim": "Aged patients are more susceptible to ischaemia/reperfusion injury.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers compare young vs. aged subjects (human or animal) in terms of susceptibility or severity of ischemia/reperfusion injury. They focus on molecular mechanisms, pharmacologic interventions, bone fractures, stem\u2010cell therapy, etc., without addressing age as a determinant of I/R vulnerability. Therefore the evidence set does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "22281684",
      "6580081",
      "9588931",
      "13380011",
      "27665523"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the cited papers examine or compare ischaemia/reperfusion injury specifically in aged versus young subjects or patients. They focus on molecular mechanisms, genetic knockouts, pharmacologic interventions, sex differences, or other conditions unrelated to age-dependent susceptibility. Therefore, the provided evidence does not address the claim about increased susceptibility of aged patients."
    },
    "overthinking_doc_ids": [
      "6580081",
      "22281684",
      "21868715",
      "18691097",
      "33884866"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers compare ischemia/reperfusion injury between aged and young subjects or report age-related differences in susceptibility. They discuss molecular mechanisms, pharmacologic interventions, or unrelated clinical outcomes, but do not address whether advanced age increases vulnerability to ischemia/reperfusion injury."
    },
    "posthoc_doc_ids": [
      "22281684",
      "6580081",
      "21868715",
      "21789744",
      "33884866"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "891",
    "claim": "Origin gross domestic product(GDP) is positively related to dengue virus (DENV-1) diffusion in air traffic shipments.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "None of the provided papers analyze or report on the relationship between origin GDP and dengue (DENV-1) diffusion through air-traffic shipments. The evidence focuses on local transmission patterns, risk factors (water supply, population density), and unrelated infectious diseases or medical topics. Therefore no relevant information is available to verify or refute the specific claim."
    },
    "naive_doc_ids": [
      "18816720",
      "7485455",
      "253672",
      "4231060",
      "7647224"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided papers analyze or report a relationship between the gross domestic product of a departure location and the diffusion of DENV-1 through air-traffic shipments. The cited studies address dengue transmission in villages, importation into China, outbreak descriptions, viral genetics, burden estimates, and other unrelated health issues, but do not examine GDP or air-traffic factors. Hence they offer no direct evidence for or against the specific claim."
    },
    "overthinking_doc_ids": [
      "18816720",
      "8665891",
      "17454301",
      "4983",
      "152245"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers analyze or report on the relationship between the gross domestic product (GDP) of an origin country and the diffusion of dengue virus (DENV-1) via air traffic shipments. The cited studies focus on local transmission patterns, phylogenetics, epidemiology in specific regions, and unrelated biomedical topics. Therefore, they neither confirm nor refute the stated claim."
    },
    "posthoc_doc_ids": [
      "18816720",
      "12762485",
      "3765739",
      "7485455",
      "8665891"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "679",
    "claim": "LSD1-positive promoters are associated with RNA polymerase II",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided paper summaries mention LSD1 (lysine-specific demethylase 1) or analyze whether promoters bound by LSD1 are associated with RNA polymerase II. Therefore the evidence set contains no direct data supporting or refuting the stated claim."
    },
    "naive_doc_ids": [
      "18276599",
      "23586085",
      "23269537",
      "23286603",
      "175735"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided papers mention LSD1 (lysine-specific demethylase 1) or analyze promoters categorized as LSD1-positive. Consequently, they supply no direct evidence about any association between LSD1-positive promoters and RNA polymerase II."
    },
    "overthinking_doc_ids": [
      "175735",
      "2452989",
      "13777706",
      "18694784",
      "1695604"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers discuss LSD1, LSD1-positive promoters, or their association with RNA polymerase II. The evidence focuses on unrelated topics such as viral lymphomas, sepsis genetics, BRCA-related breast cancer, trastuzumab, PD-1 in SLE, histone variants (H2A.Z, H2AZ), Polycomb complexes, and chromatin remodelers Isw2 and Rsc3. Therefore, the supplied literature offers no relevant information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "11238951",
      "2647374",
      "3285322",
      "3329824",
      "14938990"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1310",
    "claim": "Traditional reviews are biased in their interpretations.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "All cited articles are systematic or critical reviews/meta-analyses addressing diverse clinical questions (BMI and gestational diabetes, blood-pressure lowering in dialysis, ADHD and obesity, vitamin-D and pregnancy, TMAO and CVD, SSRI withdrawal, gastric lavage, ACE-I vs ARB, aromatase inhibitors, cost-effectiveness of COX-2 inhibitors). None of them compares traditional (narrative) reviews with other review types or presents data on interpretative bias within traditional reviews. Therefore the provided evidence does not speak to the claim that traditional reviews are biased in their interpretations."
    },
    "naive_doc_ids": [
      "439670",
      "202259",
      "1831916",
      "2425364",
      "6793674"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 8 recounts empirical work by Antman et al. showing that conventional narrative review articles failed to mention new, beneficial treatments that were identified by an updated systematic review, demonstrating that traditional (non-systematic) reviews can give a distorted\u2014i.e., biased\u2014picture of the evidence. Paper 6 further documents that many published meta-analyses (38 % of journal reviews examined) display funnel-plot asymmetry and consequently overestimate treatment effects when compared with subsequent large trials, illustrating interpretative bias within reviews. These findings collectively substantiate the claim that traditional reviews are prone to bias in their interpretations."
    },
    "overthinking_doc_ids": [
      "13770184",
      "13906581",
      "23862975",
      "6793674",
      "13097856"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "Paper 1 explicitly states that conventional narrative review articles missed important treatment advances that were detected by an updated systematic review (Antman et al.), and stresses the need for \u201cexplicit efforts to limit bias in the review of literature.\u201d This directly shows that the interpretations offered in traditional (non-systematic) reviews can be biased or incomplete. Paper 4 further demonstrates that many published meta-analyses display funnel-plot asymmetry, indicating bias that leads to exaggerated effects compared with large single trials. Together these papers provide empirical evidence that traditional or non-systematically conducted reviews are prone to biased interpretations, supporting the claim."
    },
    "posthoc_doc_ids": [
      "8042158",
      "13515165",
      "14464451",
      "22711954",
      "439670"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "229",
    "claim": "Carriers of HNF4A mutations are at reduced risk for diabetes.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the ten provided papers mention HNF4A (hepatocyte nuclear factor-4\u03b1) mutations or assess diabetes risk among their carriers. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "13940200",
      "27449472",
      "13282296",
      "21164071",
      "27166444"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the provided papers discuss HNF4A mutations or their relationship to diabetes risk. The evidence is therefore insufficient to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "439670",
      "1711571",
      "2138767",
      "3355397",
      "8868863"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "None of the provided papers mention HNF4A mutations or evaluate diabetes risk in carriers of HNF4A variants. Therefore, the supplied evidence offers no information relevant to verifying the claim."
    },
    "posthoc_doc_ids": [
      "8892905",
      "13619127",
      "15648443",
      "24144677",
      "27449472"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "660",
    "claim": "Ivermectin is used to treat onchocerciasis.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention ivermectin or onchocerciasis. Therefore, they neither confirm nor refute the claim that ivermectin is used to treat onchocerciasis."
    },
    "naive_doc_ids": [
      "341324",
      "21479231",
      "44048701",
      "3654468",
      "5912283"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.85,
      "justification": "None of the supplied article summaries mention ivermectin or its use in treating onchocerciasis; the papers focus on topics such as prostate cancer therapy, tuberculosis regimens, substance-abuse case management, acupuncture for post-stroke depression, aliskiren safety, ocular epidemiology, and diabetes complications. Therefore, the provided evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "308862",
      "341324",
      "485020",
      "1495563",
      "1759213"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the provided papers mention ivermectin or onchocerciasis. Therefore, they offer no information that confirms or refutes the claim that ivermectin is used to treat onchocerciasis."
    },
    "posthoc_doc_ids": [
      "308862",
      "341324",
      "485020",
      "1495563",
      "1759213"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "313",
    "claim": "De novo assembly of sequence data has shorter contigs than unassembled sequence data.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "None of the cited papers compare the length of contigs produced by de novo assembly to the length (or any other property) of the original unassembled sequencing reads. They discuss issues such as GC-bias effects on assembly, the performance of specific assemblers (e.g., Trinity), quantification tools, and genome characteristics, but they do not present data addressing whether de novo assembly yields shorter or longer contigs than unassembled sequence data. Therefore the provided evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "14464451",
      "32770503",
      "13123189",
      "14185503",
      "1544804"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "None of the cited papers compare contig lengths obtained from de novo assembly with the length of the original (unassembled) sequencing reads. They discuss assembly strategies, GC bias effects, transcriptome reconstruction efficiency, etc., but do not provide data showing that contigs are shorter (or longer) than unassembled sequence data. Therefore, they neither support nor contradict the specific claim."
    },
    "overthinking_doc_ids": [
      "32770503",
      "143251",
      "14464451",
      "11041152",
      "2576811"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Several cited papers describe results of de novo genome or transcriptome assemblies (e.g., numbers of contigs, total assembled size, sensitivity), but none compare contig lengths with the lengths of the original unassembled sequence reads. Consequently, the provided evidence neither confirms nor refutes the specific claim that de novo assembly yields shorter contigs than unassembled sequence data."
    },
    "posthoc_doc_ids": [
      "14464451",
      "32770503",
      "8989616",
      "14185503",
      "15478227"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "139",
    "claim": "At least 85% of patients exposed to radiation have activated markers of myofibroblasts.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the cited papers report data on the proportion of radiation-exposed patients who exhibit activation of myofibroblast markers. The articles focus on neutrophil activation, smooth-muscle differentiation, cytokine effects, endothelial\u2013mesenchymal transition, cancer exosomes, fibroblast activation, and radiation-induced FGF-2 expression in mice, but they do not quantify myofibroblast marker activation in irradiated patients. Therefore the provided evidence neither supports nor contradicts the stated claim."
    },
    "naive_doc_ids": [
      "9164724",
      "11840194",
      "6397191",
      "32797183",
      "34328964"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "None of the provided papers measure or report on the proportion of patients exposed to radiation who show activation of myofibroblast markers. The studies address outcomes such as survival, tumor control, bone density, thyroid dose-response, antiviral therapy completion, endothelin production, smooth-muscle cell biology, vascular calcification, and radiosensitization\u2014all unrelated to myofibroblast activation in irradiated patients. Therefore they provide no evidence to confirm or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "3944632",
      "10699587",
      "12236208",
      "37912677",
      "2048139"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.27,
      "justification": "None of the provided papers address the frequency of activated myofibroblast markers in patients exposed to radiation. The cited radiation-related studies discuss senescence markers in mice or clinical outcomes of radiotherapy, but they do not measure or report myofibroblast activation. Therefore, the evidence set contains no information relevant to confirming or refuting the specific claim."
    },
    "posthoc_doc_ids": [
      "24596228",
      "31293581",
      "5649538",
      "8037453",
      "9997636"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "703",
    "claim": "Localization of PIN1 in the roots of Arabidopsis requires VPS9a",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the provided papers discuss VPS9a or the localization of the auxin transporter PIN1 in Arabidopsis roots. Therefore, the evidence set contains no information relevant to confirming or refuting the claim."
    },
    "naive_doc_ids": [
      "1354567",
      "313394",
      "435529",
      "810480",
      "4324278"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention PIN1, VPS9a, or experiments analyzing their interaction or localization in Arabidopsis roots. Therefore they supply no evidence relevant to the stated claim."
    },
    "overthinking_doc_ids": [
      "1354567",
      "313394",
      "435529",
      "810480",
      "4324278"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.12,
      "justification": "None of the provided papers mention VPS9a or examine its effect on the localization of PIN1 in Arabidopsis roots. Therefore, they do not supply evidence either supporting or contradicting the claim."
    },
    "posthoc_doc_ids": [
      "1354567",
      "4324278",
      "10212612",
      "16557565",
      "313394"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "517",
    "claim": "High levels of copeptin decrease risk of diabetes.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers examine copeptin concentrations or their relationship to diabetes incidence. The studies focus on fruit consumption, sugar-sweetened beverages, cardiovascular risk algorithms, thiazolidinediones, endothelial biomarkers (E-selectin, ICAM-1, VCAM-1), added sugars, fructosamine, bone metrics, sleep/circadian factors, and bezafibrate. Therefore they neither support nor contradict the claim about copeptin and diabetes risk."
    },
    "naive_doc_ids": [
      "1974176",
      "9822397",
      "27466734",
      "31229233",
      "6176498"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the cited studies investigate copeptin or its relationship to incident diabetes. The papers focus on fruit intake, cardiovascular risk prediction, TMAO, diabetes drug safety, anthropometrics, insulin-sensitizing therapy, HPV, endothelial biomarkers, and sugar-sweetened beverage taxation. Therefore, they provide no evidence to confirm or refute the claim that high copeptin levels decrease diabetes risk."
    },
    "overthinking_doc_ids": [
      "1974176",
      "27466734",
      "6793674",
      "13619127",
      "13831842"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the cited papers investigate copeptin levels or their relationship with diabetes risk. The studies focus on vitamin D, drug anticoagulant levels, insulin-sensitizing drugs, C-peptide, BMI, folate, bone score, sugar-sweetened beverages, breast cancer, and corin. Therefore they provide no information relevant to whether high copeptin levels decrease diabetes risk."
    },
    "posthoc_doc_ids": [
      "25599283",
      "4910408",
      "27166444",
      "23577867",
      "439670"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "422",
    "claim": "Flexible molecules experience less steric hindrance in the tumor microenviroment than rigid molecules.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers discuss steric hindrance of molecules in the tumor microenvironment, nor do they compare flexible versus rigid molecular structures in that context. They focus on fibroblasts, drug-target prediction, thymic development, circulating tumor cells, stromal metabolism, extracellular vesicles, integrin redox regulation, hyaluronan-mediated vascular effects, skeletal muscle ECM, and acidic pH signaling. Therefore, the provided evidence does not address the stated claim."
    },
    "naive_doc_ids": [
      "952111",
      "2158516",
      "2734421",
      "21033230",
      "27647593"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers address or compare the steric hindrance encountered by flexible versus rigid molecules within the tumor microenvironment. The articles focus on circulating tumor cells, tumor dormancy, signaling pathways, stromal interactions, and other cellular or molecular mechanisms, but do not present data or discussion on molecular flexibility or steric hindrance. Therefore, the evidence does not support or contradict the claim."
    },
    "overthinking_doc_ids": [
      "21033230",
      "30919024",
      "33370",
      "1379127",
      "7028976"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the cited papers examine or compare the behaviour of flexible versus rigid molecules with respect to steric hindrance in the tumor microenvironment. The studies focus on fibroblast interactions, signaling pathways, metabolic coupling, targeted therapies, fatty-acid ratios, etc., but they do not provide experimental data or discussion on molecular flexibility or steric hindrance. Therefore the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "952111",
      "2734421",
      "27647593",
      "28334217",
      "207972"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "676",
    "claim": "LRBA prevents CTLA - 4 recycling.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers discuss LRBA or its effect on CTLA-4 trafficking or recycling. Therefore, they offer no evidence to confirm or refute the claim that LRBA prevents CTLA-4 recycling."
    },
    "naive_doc_ids": [
      "9680193",
      "2248870",
      "3078550",
      "8677721",
      "15128866"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers discuss LRBA or its effect on CTLA-4 trafficking or recycling. Therefore, they neither support nor contradict the claim."
    },
    "overthinking_doc_ids": [
      "2758012",
      "5389523",
      "11250124",
      "11822354",
      "13398997"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers discuss LRBA or its effect on CTLA-4 recycling (or CTLA-4 trafficking in general). Therefore they neither support nor contradict the claim."
    },
    "posthoc_doc_ids": [
      "11250124",
      "14893425",
      "797114",
      "1103795",
      "2140513"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "762",
    "claim": "Measuring routine outcomes is more beneficial to clinical practice than assessing treatment adherence.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "The cited studies report clinical effectiveness, safety, cost-effectiveness, or epidemiological outcomes of various interventions. None of them compare the usefulness of routinely measuring clinical outcomes with assessing patients\u2019 adherence to treatment, nor do they analyze the relative benefit of these two approaches in clinical practice. Therefore they provide no direct evidence for or against the claim."
    },
    "naive_doc_ids": [
      "5824985",
      "15048300",
      "3690068",
      "20746604",
      "5151024"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Although several papers measure clinical outcomes (e.g., weight loss after bariatric surgery, fluid balance and survival) and one paper measures treatment adherence (physician adherence to cardiovascular prevention guidelines), none of the cited studies directly compare the benefits of routine outcome measurement with the benefits of assessing treatment adherence. Therefore, the supplied evidence does not confirm or refute the stated claim."
    },
    "overthinking_doc_ids": [
      "5824985",
      "6137330",
      "32969964",
      "313403",
      "12030680"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "The cited studies report on clinical outcomes (weight loss after bariatric surgery, bone-density prediction of fractures, efficacy of drug regimens, ICU organizational impact, cost-effectiveness of radiosurgery, etc.), but none of them compare the value of measuring routine outcomes with the value of assessing patients\u2019 adherence to treatment. Therefore they neither confirm nor refute the statement that measuring routine outcomes is more beneficial to clinical practice than assessing treatment adherence."
    },
    "posthoc_doc_ids": [
      "5824985",
      "12030680",
      "24873253",
      "16812091",
      "19308127"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "126",
    "claim": "Approximately 250,000 people are infected with human T-cell lymphotropic virus type 1 in the United Kingdom.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.33,
      "justification": "None of the provided papers discuss the prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) in the United Kingdom or give any numerical estimate of HTLV-1 infections there. Therefore they neither confirm nor refute the claim that about 250,000 people in the UK are infected with HTLV-1."
    },
    "naive_doc_ids": [
      "20996244",
      "46202852",
      "601033",
      "8639034",
      "14530534"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers mention human T-cell lymphotropic virus type 1, its prevalence, or infection numbers in the United Kingdom. Therefore they supply no evidence that could confirm or refute the stated estimate of 250,000 infections."
    },
    "overthinking_doc_ids": [
      "27063470",
      "9547722",
      "5824985",
      "6876224",
      "21323587"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the cited papers address the prevalence of human T-cell lymphotropic virus type 1 infections in the United Kingdom or provide numerical estimates of infected individuals. The articles focus on HIV, treatment toxicity, Creutzfeldt-Jakob disease, bariatric surgery outcomes, etc., with only one paper mentioning HTLV-1 in the context of adult T-cell leukemia-lymphoma treatment, not population prevalence. Therefore the evidence neither supports nor contradicts the stated claim."
    },
    "posthoc_doc_ids": [
      "20471181",
      "46202852",
      "14806256",
      "601033",
      "20996244"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "323",
    "claim": "Deleting Raptor increases G-CSF levels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.13,
      "justification": "None of the provided papers examine the effect of Raptor deletion on granulocyte-colony stimulating factor (G-CSF) levels. Although several papers mention G-CSF and others discuss mTORC1 signaling (where Raptor functions), no study specifically reports G-CSF changes after Raptor deletion. Therefore the evidence is insufficient to verify or refute the claim."
    },
    "naive_doc_ids": [
      "188911",
      "24612804",
      "42465769",
      "6313547",
      "2316374"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "Among the provided papers only Paper 10 directly discusses raptor deletion, but it focuses on Th17 differentiation and does not report any measurements of granulocyte-colony-stimulating factor (G-CSF). None of the other papers mention either raptor deletion or G-CSF levels. Thus the cited evidence gives no information about whether deleting raptor affects G-CSF."
    },
    "overthinking_doc_ids": [
      "4658268",
      "10017612",
      "14188138",
      "16389141",
      "18188022"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.27,
      "justification": "None of the provided papers study Raptor deletion or report its effect on granulocyte-colony stimulating factor (G-CSF) levels. The evidence focuses on other genes or cytokines (e.g., Sirt1, Dicer, PPAR\u03b3, IL-18) and on GM-CSF or G-CSF in contexts unrelated to Raptor. Therefore, the supplied literature offers no information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "2481032",
      "5409325",
      "7165938",
      "11428884",
      "25050364"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1400",
    "claim": "p75 NTR - associated cell death executor (NADE) interacts with the p75 NTR death domain",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention p75 NTR, NADE (p75 NTR-associated cell death executor), or an interaction between NADE and the death domain of p75 NTR. The evidence focuses on unrelated receptors, signaling pathways, and cell-death regulators, so they neither support nor contradict the specific claim."
    },
    "naive_doc_ids": [
      "41913714",
      "8903143",
      "3701541",
      "4270992",
      "6163801"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "None of the provided papers discuss NADE or its interaction with the p75 NTR death domain. The references focus on unrelated proteins or general p75 NTR genetics without addressing the claimed interaction, so the supplied evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "8093935",
      "41913714",
      "207972",
      "1103795",
      "1546650"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers discuss the p75 neurotrophin receptor (p75 NTR), its death domain, or the protein NADE. Therefore they contain no information relevant to whether NADE interacts with the p75 NTR death domain."
    },
    "posthoc_doc_ids": [
      "8093935",
      "9486930",
      "11578459",
      "32170702",
      "41913714"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "198",
    "claim": "CCL19 is absent within dLNs.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers mention the chemokine CCL19 or analyze its presence or absence in draining lymph nodes (dLNs). Therefore, the evidence set does not address the claim."
    },
    "naive_doc_ids": [
      "2389574",
      "1071991",
      "11020556",
      "22963769",
      "35256900"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.34,
      "justification": "None of the provided paper summaries discuss measurements or observations of CCL19 levels or distribution in draining lymph nodes (dLNs). Therefore they neither confirm nor refute the claim that CCL19 is absent within dLNs."
    },
    "overthinking_doc_ids": [
      "11020556",
      "35256900",
      "1071991",
      "2389574",
      "21719289"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention CCL19 expression levels\u2014whether present or absent\u2014in draining lymph nodes (dLNs). Therefore, the evidence set does not contain information relevant to verifying the claim that CCL19 is absent within dLNs."
    },
    "posthoc_doc_ids": [
      "1933281",
      "37444589",
      "2389574",
      "72159",
      "1071991"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1168",
    "claim": "The HSV-2 infection is typically asymptomatic.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "The provided papers include one study involving experimental HSV-2 infection in mice, but it does not state whether HSV-2 infection is usually asymptomatic; it only describes laboratory outcomes (including lethal encephalitis) at specific inoculum doses. None of the other cited papers address clinical presentation or symptom frequency of HSV-2 infection. Thus the evidence set supplies no information relevant to assessing the claim that HSV-2 infection is typically asymptomatic."
    },
    "naive_doc_ids": [
      "40584205",
      "5835149",
      "12885341",
      "20996244",
      "23915841"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.41,
      "justification": "None of the cited papers discuss herpes simplex virus type 2 (HSV-2) or the frequency of symptomatic versus asymptomatic infection; therefore they provide no information relevant to evaluating whether HSV-2 infection is typically asymptomatic."
    },
    "overthinking_doc_ids": [
      "5548081",
      "26873988",
      "37269418",
      "92308",
      "437924"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "Among the supplied abstracts, only Paper 6 specifically mentions HSV-2, and it investigates replication-defective mutant strains in a murine (mouse) model. None of the papers provide data on whether HSV-2 infection in humans is usually asymptomatic or symptomatic. Therefore, the evidence set does not address the claim."
    },
    "posthoc_doc_ids": [
      "5548081",
      "2052720",
      "5835149",
      "5850219",
      "24596228"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "887",
    "claim": "Only a minority of cells survive development after differentiation into stress-resistant spores.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided abstracts, Paper 1 is the only study that focuses on sporulation in Bacillus subtilis, but it discusses gene identification and mutant phenotypes rather than quantifying what fraction of cells survive as stress-resistant spores. No other paper addresses sporulation or gives numerical data on cell survival after spore differentiation. Consequently, the evidence set does not speak to whether only a minority of cells survive this process."
    },
    "naive_doc_ids": [
      "4942718",
      "12824568",
      "25238950",
      "36651210",
      "39532074"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided paper abstracts discuss the proportion of cells that survive after differentiating into stress-resistant spores. The evidence presented focuses on bacterial swarming behavior, immune-cell differentiation, gene-therapy vectors, polycomb complexes, imprinting, thymic epithelium, EBV episomes, fetal tolerance, and donor-cell leukemia\u2014none of which address spore survival rates. Therefore, the claim is neither supported nor contradicted by the supplied information."
    },
    "overthinking_doc_ids": [
      "4321295",
      "1855679",
      "10359591",
      "13368032",
      "15635366"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the listed papers discuss differentiation into stress-resistant spores or quantify the fraction of cells that survive such a process. The evidence focuses on mammalian stem-cell differentiation, stress responses, and cancer cell survival, which are unrelated to the spore-formation claim."
    },
    "posthoc_doc_ids": [
      "1595617",
      "5633876",
      "16630060",
      "17991818",
      "24766509"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1196",
    "claim": "The availability of safe places to study is effective at decreasing homelessness.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the provided papers examine the relationship between providing safe places to study and subsequent changes in homelessness. The studies focus on medical treatments, ICU organization, mental-health outcomes in rehoused families, cost-effectiveness of diagnostic methods, drug-withdrawal effects, and public-health interventions unrelated to educational study environments or homelessness rates. Therefore they supply no information that can confirm or refute the claim."
    },
    "naive_doc_ids": [
      "21323758",
      "10577574",
      "25649714",
      "5151024",
      "12442311"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers investigate or report on the effect of providing safe places to study on rates of homelessness. The studies focus on cardiovascular disease prevention, vitamin supplementation, pharmacologic interventions, adverse drug events, statin therapy, the impact of homelessness on children (without studying study-space availability), socioeconomic factors in HIV, cancer genetics, alcohol labelling, and neglected tropical diseases. Therefore, the supplied evidence offers no information relevant to confirming or refuting the specific claim."
    },
    "overthinking_doc_ids": [
      "409280",
      "12009265",
      "24150328",
      "42404093",
      "43629704"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the cited papers investigate or report on the effect of providing safe places to study on rates of homelessness. The articles primarily address topics such as medication withdrawal and suicide, alcohol labelling, lifestyle factors and mortality, antibiotic prescribing, coping interventions for miscarriage, mental health in homeless families, prison mental health, and cardiac drug switching. Therefore they offer no direct evidence that confirms or refutes the claim."
    },
    "posthoc_doc_ids": [
      "12442311",
      "849771",
      "1456068",
      "12794099",
      "14290854"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "622",
    "claim": "Individuals with low serum vitamin D concentrations have decreased risk of multiple sclerosis.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "The relevant papers indicate that higher\u2014not lower\u2014vitamin D status is linked to reduced multiple-sclerosis (MS) risk.  \n\u2022 Paper 3 reports that greater childhood and adolescent sun exposure (which increases endogenous vitamin D synthesis) is associated with a markedly lower odds of MS (adjusted OR\u22480.31 for high vs low exposure).  \n\u2022 Paper 4 reviews epidemiological data showing MS prevalence rises with latitude, where ultraviolet light \u2013 and consequently vitamin D production \u2013 are lower, implying that reduced vitamin D is associated with higher, not lower, MS risk.  \nThese findings oppose the claim that individuals with low serum vitamin D concentrations have decreased MS risk."
    },
    "naive_doc_ids": [
      "4462079",
      "25599283",
      "17000834",
      "22843838",
      "43226130"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.77,
      "justification": "Paper 1 shows that higher sun exposure during childhood/adolescence (a condition that raises serum vitamin D) is associated with a markedly lower odds of developing multiple sclerosis (adjusted OR\u22480.3). This implies that lower vitamin D exposure would be linked to *higher*\u2014not lower\u2014risk of multiple sclerosis. The other provided papers do not address serum vitamin D levels in relation to multiple sclerosis. Therefore, the available evidence contradicts the claim that low serum vitamin D concentrations decrease MS risk."
    },
    "overthinking_doc_ids": [
      "17000834",
      "27466734",
      "1456068",
      "1974176",
      "3514540"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Relevant evidence comes from Paper 1 and Paper 3.  Paper 1 reports that greater childhood sun exposure \u2013 a factor that raises serum vitamin D \u2013 is associated with a markedly lower odds of multiple sclerosis (adjusted OR 0.31).  Paper 3 reviews epidemiologic patterns showing higher multiple-sclerosis prevalence at higher latitudes where ultraviolet light \u2013 and thus cutaneous vitamin D synthesis \u2013 is lower, and highlights vitamin D as a plausible protective factor.  Both sources indicate that higher, not lower, vitamin D status is linked to reduced MS risk.  Therefore the claim that low serum vitamin D concentrations lower the risk of multiple sclerosis is contradicted by the evidence."
    },
    "posthoc_doc_ids": [
      "17000834",
      "25599283",
      "22843838",
      "43226130",
      "4462079"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "739",
    "claim": "MT binding domain drives amyloid structure formation.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "Among the cited studies, some analyze microtubule-binding domains (e.g., dynein in Paper 1) and others analyze amyloid assemblies (e.g., Alzheimer-related A\u03b2 in Papers 6, 8, 9). None of the papers present experimental results that link a microtubule-binding domain to the initiation or promotion of amyloid structure formation. Therefore the supplied evidence neither supports nor contradicts the specific claim."
    },
    "naive_doc_ids": [
      "1546650",
      "5914739",
      "7729656",
      "9638032",
      "15655418"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the cited papers examine whether a microtubule-binding (MT-binding) domain promotes or drives the formation of amyloid structures. The studies address dynein\u2013microtubule interactions, histone docking, glutamate-receptor mobility, lipid changes in T-cell signaling, TRF effects on telomere replication, and other unrelated topics. Amyloid formation is only mentioned in the context of apolipoprotein E binding to \u03b2-amyloid, which is unrelated to MT-binding domains. Hence the provided evidence does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "1546650",
      "17518195",
      "18346333",
      "5914739",
      "7729656"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers investigate or report on amyloid (fibril) formation driven by a microtubule-binding (MT-binding) domain. The articles focus on dynein\u2013microtubule interactions, TGF-\u03b2/follistatin complexes, TCR membrane binding, glutamate-receptor ligand binding, histone-chaperone interactions, CPEB-mediated memory, mutant p53 transactivation, and AP-1 activation, respectively\u2014topics that do not supply evidence linking an MT-binding domain to amyloid structure formation."
    },
    "posthoc_doc_ids": [
      "1546650",
      "40383969",
      "5914739",
      "7729656",
      "9889151"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "404",
    "claim": "Expression of oncolytic virus antigens as peptides permits additional protection against relapse.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "None of the provided papers examine the strategy of expressing oncolytic-virus antigens as peptides, nor do they evaluate whether such an approach affords additional protection against tumor relapse. The cited studies instead focus on oncolytic virus engineering (e.g., IL-24 arming), dose effects, overcoming neutralizing antibodies, cancer gene-expression correlations, angiogenic factors, vaccine safety, innate immune resistance, and T-cell tolerance mechanisms\u2014none of which address the specific claim."
    },
    "naive_doc_ids": [
      "8671456",
      "27437459",
      "21150010",
      "31591262",
      "22401720"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address the use of oncolytic virus antigens expressed as peptides, nor do they evaluate their impact on protection against relapse. The evidence summaries focus on tumor relapse mechanisms, EBV biology, immune cell trafficking, inflammasome effects, miRNA biomarkers, stem-cell\u2013derived islets, metabolic peptides, viral cloning techniques, and plant promoters\u2014none of which test or report outcomes for peptide-expressed oncolytic virus antigens. Thus the corpus offers no relevant data to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "1921218",
      "3765739",
      "11048759",
      "12100963",
      "15435343"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the cited papers examine or report on the strategy of expressing oncolytic-virus antigens in peptide form to provide additional protection against disease relapse. The papers focus on unrelated topics such as follicular development, EBV latency, T-cell egress, autoimmune tolerance, HBV-driven hepatocarcinogenesis, oncolytic virotherapy efficacy, and clinical dosing of oncolytic vaccinia virus, but do not address peptide expression of viral antigens or its effect on relapse prevention."
    },
    "posthoc_doc_ids": [
      "643765",
      "3765739",
      "11048759",
      "12100963",
      "15405204"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "677",
    "claim": "LRBA promotes CTLA - 4 recycling.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention LRBA or examine its effect on CTLA-4 trafficking or recycling. Paper 5 discusses CTLA-4-deficient T cells, but does not address LRBA or receptor recycling. The remaining papers focus on unrelated proteins or cellular processes. Hence the evidence set supplies no information relevant to the claim that LRBA promotes CTLA-4 recycling."
    },
    "naive_doc_ids": [
      "9304312",
      "14893425",
      "17017465",
      "11250124",
      "2462673"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.13,
      "justification": "None of the provided papers mention LRBA or investigate its role in CTLA-4 trafficking or recycling. Therefore they do not supply evidence that either confirms or refutes the claim that LRBA promotes CTLA-4 recycling."
    },
    "overthinking_doc_ids": [
      "11250124",
      "13398997",
      "14893425",
      "857189",
      "1241113"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the provided papers mention LRBA or investigate its role in CTLA-4 trafficking or recycling. Therefore they do not provide relevant data to confirm or refute the claim that LRBA promotes CTLA-4 recycling."
    },
    "posthoc_doc_ids": [
      "20585600",
      "213017",
      "1127562",
      "1976183",
      "2701077"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1188",
    "claim": "The ability of activator E2Fs in preventing cell death is limited to terminally differentiated cells.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 5 shows that in normal dividing progenitor cells E2F1-3 act as transcriptional activators and are \"necessary for cell survival.\"  Their pro-survival (anti-cell-death) function therefore operates in progenitor, cycling cells.  In differentiating (more mature) cells these same E2Fs switch to repressors rather than activators.  Hence the ability of activator E2Fs to prevent cell death is NOT confined to terminally differentiated cells; it is present in progenitor cells.  The provided evidence therefore refutes the claim."
    },
    "naive_doc_ids": [
      "9197092",
      "23901235",
      "28644298",
      "34436231",
      "4394817"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.1,
      "justification": "None of the cited papers investigate activator E2F transcription factors or their role in preventing cell death, nor do they compare this activity between terminally differentiated and other cell types. The provided evidence therefore contains no relevant information to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "38502066",
      "2841164",
      "10450725",
      "30908508",
      "31624828"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers investigate activator E2F transcription factors or compare their cell-death\u2010preventing activity in terminally differentiated versus other cell types. The evidence therefore gives no basis to confirm or refute the stated claim."
    },
    "posthoc_doc_ids": [
      "38502066",
      "10015292",
      "1905095",
      "3435889",
      "3765739"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "481",
    "claim": "Guanine nucleotide dissociation inhibitor (Rho-GDI) interacts with the p75 NTR death domain",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers mention Rho-GDI (guanine-nucleotide dissociation inhibitor), the p75 NTR death domain, or any experiment testing a physical or functional interaction between them. Therefore the supplied evidence gives no information bearing on the claim."
    },
    "naive_doc_ids": [
      "41913714",
      "207972",
      "5914739",
      "8903143",
      "10486817"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the provided paper summaries mention Rho-GDI, the p75 neurotrophin receptor, or any interaction between them. Therefore the evidence set contains no information bearing on the stated claim."
    },
    "overthinking_doc_ids": [
      "8093935",
      "41913714",
      "207972",
      "1103795",
      "1546650"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the cited papers discuss Guanine nucleotide dissociation inhibitor (Rho-GDI), the p75^NTR receptor, or any interaction between them. Therefore, the provided evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "8093935",
      "207972",
      "4270992",
      "22495397",
      "29367554"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1395",
    "claim": "p16INK4A accumulation is  linked to an abnormal wound response caused by the microinvasive step of advanced Oral Potentially Malignant Lesions (OPMLs).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "None of the provided papers discuss p16INK4A accumulation in the context of abnormal wound response or the microinvasive progression of oral potentially malignant lesions. Therefore, the evidence set does not allow evaluation of the claim."
    },
    "naive_doc_ids": [
      "6308416",
      "21063817",
      "26008462",
      "3720107",
      "4483571"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the cited papers examine p16INK4A in the context of wound-healing responses or micro-invasion in oral potentially malignant lesions. The references discuss vitamin D metabolism, transglutaminase in wound repair, gall-stone composition, embryonic stem-cell oncogenicity, microRNA-196 in oral cancer, keratin/desmosomal protein expression in oral cancers, and Hmga2 regulation of p16Ink4a in neural stem cells, but they do not provide data connecting p16INK4A accumulation to an abnormal wound response during microinvasion of OPMLs. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "4483571",
      "26008462",
      "27260630",
      "16732790",
      "1976183"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers investigate Oral Potentially Malignant Lesions, the micro-invasive step in their progression, or a link between p16INK4A accumulation and an abnormal wound-healing response. The articles focus on unrelated topics such as drug trials for hematologic or solid tumors, vitamin D metabolism, alcohol labeling, tissue transglutaminase in wound repair, and stem-cell regulation of p16INK4A in aging. Consequently, they supply no evidence that can confirm or refute the stated claim."
    },
    "posthoc_doc_ids": [
      "5492542",
      "14626540",
      "3471191",
      "4483571",
      "4627816"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1052",
    "claim": "Rising temperatures caused by global warming increases risk of dengue fever transmission.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "None of the cited papers analyze or report on the relationship between rising ambient temperatures or climate warming and dengue transmission risk. The studies focus on local clustering, vector genetics, population density, water supply, temperature trend datasets, and general dengue burden, but do not link temperature changes to dengue incidence. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "18816720",
      "13702924",
      "15129362",
      "129199129",
      "2097256"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers examine temperature or climate change as a determinant of dengue transmission. The cited studies focus on factors such as population density, water supply, global burden estimates, and other health topics unrelated to temperature effects on dengue. Therefore, the evidence set does not address the claim."
    },
    "overthinking_doc_ids": [
      "24269361",
      "202259",
      "1759213",
      "2097256",
      "6793674"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "Among the provided studies, several analyze determinants of dengue outbreaks (e.g., population density, water supply) or discuss dengue burden in general, and one paper documents temperature trends in Canada, but none examine how rising ambient temperatures affect dengue-virus transmission. Consequently, the evidence set contains no direct data or analysis that either confirms or refutes the claim that global-warming-driven temperature increases raise the risk of dengue fever transmission."
    },
    "posthoc_doc_ids": [
      "2097256",
      "13770184",
      "18816720",
      "3716075",
      "7647224"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "898",
    "claim": "Oxidative DNA damage activates STING signalling.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 reports that incorporation of the oxidized base 8-hydroxy-guanosine (8-OHG) into DNA 'potentiated cytosolic immune recognition' by protecting the DNA from TREX1 degradation and that this heightened recognition is 'STING-dependent.' Thus oxidative DNA damage (8-OHG) increases activation of the STING pathway. None of the other cited papers provide data that contradict this finding. Therefore the available evidence supports the claim that oxidative DNA damage activates STING signalling."
    },
    "naive_doc_ids": [
      "13106686",
      "3330111",
      "19688024",
      "4402497",
      "5386514"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 1 reports that DNA containing the oxidative lesion 8-hydroxyguanosine (8-OHG) \u201cpotentiated cytosolic immune recognition\u201d by making the DNA resistant to TREX1 degradation, and that this enhanced recognition is STING-dependent. Thus oxidative DNA damage increases activation of the STING pathway. The other cited papers do not address oxidative DNA damage in relation to STING, and none contradict the finding. Therefore the available evidence supports the claim that oxidative DNA damage activates STING signalling."
    },
    "overthinking_doc_ids": [
      "13106686",
      "18358026",
      "22059387",
      "44693226",
      "350542"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 1 reports that incorporation of the oxidative DNA lesion 8-hydroxy-guanine (8-OHG) into DNA \"potentiated cytosolic immune recognition\" because the damaged DNA was protected from degradation by the nuclease TREX1, and that this heightened recognition was \"STING-dependent.\" Thus oxidative DNA damage (8-OHG) leads to enhanced activation of the STING pathway. None of the other cited papers provide findings that oppose this relationship. Therefore the available evidence supports the claim that oxidative DNA damage activates STING signalling."
    },
    "posthoc_doc_ids": [
      "13106686",
      "22059387",
      "21295300",
      "213017",
      "7005276"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "393",
    "claim": "Ethanol stress reduces the expression of SRL in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "None of the provided papers examine the effect of ethanol stress on the expression of SRL (or any gene explicitly abbreviated as SRL). The articles discuss oxidative stress (soxRS), lignocellulosic hydrolysate fermentation, sugar-uptake regulation, protein acetylation, etc., but do not report data linking ethanol exposure to SRL expression levels. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "471735",
      "21602220",
      "15282056",
      "25519138",
      "6669242"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.27,
      "justification": "None of the provided papers examine the expression of an SRL gene/operon (or any entity abbreviated SRL) under ethanol stress. The cited studies address other stress responses (oxidative, osmotic, lignotoxin, acetate, etc.), gene-regulatory mechanisms, or involve different cell types. Consequently, they neither confirm nor refute that ethanol stress reduces SRL expression in bacteria."
    },
    "overthinking_doc_ids": [
      "471735",
      "4464565",
      "9784254",
      "12804937",
      "13912224"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the provided papers examine the impact of ethanol stress on the expression of SRL (or any similarly named locus/regulon) in bacteria. The evidence addresses oxidative stress, hypoxia, shear stress, drug effects, gene regulation, acetylation, and other topics, but not ethanol-dependent regulation of SRL. Therefore, the supplied literature offers no relevant information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "471735",
      "6212802",
      "9194077",
      "22467585",
      "38944245"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "66",
    "claim": "AZT given with ribavirin increases anemia.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers mention AZT (zidovudine), its co-administration with ribavirin, or resulting anemia rates. Therefore the supplied evidence does not address the claim."
    },
    "naive_doc_ids": [
      "3929361",
      "1805641",
      "10526279",
      "23420807",
      "2048139"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the ten cited papers investigate the hematologic effects of AZT (zidovudine), ribavirin, or their combination. The studies focus on acupuncture for depression, burn dressings, bariatric surgery outcomes, MRI in multiple sclerosis, herbal treatment for hyperlipidemia, genetic risk of hypospadias, BMI and gestational diabetes, familial cancer risk, glucose metabolism and bone health, and Helicobacter pylori and gastric cancer. Because no evidence about AZT, ribavirin, or anemia is presented, the claim cannot be verified or refuted from these sources."
    },
    "overthinking_doc_ids": [
      "1495563",
      "3692112",
      "5824985",
      "12122482",
      "13774178"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the provided papers mention AZT (zidovudine), ribavirin, their combined use, or resulting rates of anemia. Therefore, the evidence set supplies no information relevant to verifying the claim."
    },
    "posthoc_doc_ids": [
      "1389264",
      "1759213",
      "1805641",
      "4449524",
      "6191684"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "398",
    "claim": "Exhaustion of B cells contributes to poor Ab response in HIV-infected individuals.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the provided papers address B-cell exhaustion or its impact on antibody responses in HIV-infected individuals. The studies focus on neutralizing antibody kinetics, viral gene regulation, T-cell biology, inflammasome function, and other unrelated mechanisms. Therefore, no evidence is supplied to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "23915841",
      "46202852",
      "8639034",
      "22495397",
      "26886351"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "None of the provided papers examine B-cell exhaustion in HIV infection or its impact on antibody responses. The listed studies focus on B-cell migration, calcium signaling in neutrophils, tyrosine-kinase inhibitor resistance in lung cancer, stem-cell self-renewal, early HIV neutralizing antibodies (without addressing B-cell exhaustion), tissue-resident memory T cells, Drosophila tissue regeneration, Japanese encephalitis vaccination, and very small embryonic-like stem cells. Because they do not present data linking B-cell exhaustion to poor antibody responses in HIV-infected individuals, the evidence is insufficient to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "38587347",
      "7869794",
      "9929089",
      "11360430",
      "13469921"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.37,
      "justification": "None of the provided papers examine B-cell functional exhaustion or its impact on antibody responses during HIV infection. The cited studies focus on hepatocytes, monocytes, CD8 T cells, chemokine-guided B-cell migration (without relation to HIV or exhaustion), HTLV-I\u2013associated leukemia, PD-1/IL-10 effects on CD4 T cells, and pluripotency mechanisms. Consequently, they do not supply evidence that directly supports or contradicts the claim that exhausted B cells cause poor antibody responses in HIV-infected individuals."
    },
    "posthoc_doc_ids": [
      "3756384",
      "5752492",
      "14657344",
      "38587347",
      "39443128"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1398",
    "claim": "p16INK4A degradation is encoded by CDKN2A.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the provided papers mention either p16INK4A or the CDKN2A gene, nor do they discuss any relationship between CDKN2A and the degradation of p16INK4A. Therefore, the supplied evidence does not contain information relevant to verifying or refuting the claim."
    },
    "naive_doc_ids": [
      "6422576",
      "2988714",
      "6784372",
      "8533245",
      "9680193"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided abstracts mention the CDKN2A locus or state that p16INK4A (or its degradation) is encoded by CDKN2A. The papers discuss p16INK4A expression, methylation, and its role as a biomarker, but they do not provide data linking it to the CDKN2A gene. Therefore the evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "16627684",
      "17717391",
      "18218379",
      "19343151",
      "19950357"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the provided papers mention p16INK4A or the CDKN2A gene, nor do they discuss the relationship between them. Therefore, the evidence set does not provide information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "1574014",
      "2543135",
      "4452659",
      "5372773",
      "8425533"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1068",
    "claim": "ScPif1p has reduced binding ability to G-rich ssDNA compared to non-G-rich ssDNA.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the provided papers investigate Saccharomyces cerevisiae Pif1 (ScPif1p) binding affinities to G-rich versus non-G-rich single-stranded DNA. The cited studies address other SSB proteins, different organisms\u2019 Pif1, or unrelated protein\u2013DNA interactions. Therefore, they supply no evidence bearing on the stated claim."
    },
    "naive_doc_ids": [
      "799586",
      "1914588",
      "8065561",
      "10874408",
      "15305881"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "Among the provided papers, only Paper 10 deals with Pif1 helicases, but it discusses G-quadruplex unwinding activity and suppression of genome instability, not direct measurements of ScPif1p binding affinity to G-rich versus non-G-rich ssDNA. None of the listed papers present data comparing ScPif1p binding to these two types of single-stranded DNA. Therefore, the supplied evidence neither confirms nor refutes the claim."
    },
    "overthinking_doc_ids": [
      "1225513",
      "7549811",
      "20943272",
      "8698857",
      "799586"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers mention ScPif1p or compare its binding to G-rich versus non-G-rich single-stranded DNA. Therefore the evidence set does not contain information relevant to the claim."
    },
    "posthoc_doc_ids": [
      "799586",
      "1914588",
      "15305881",
      "15659108",
      "29098525"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "81",
    "claim": "Acute ablation of Snail in the embryonic cortex affects the proliferation and number of embryonic cortical precursors.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Paper 1 reports that knockdown (acute loss) of Snail in radial glial precursor cells of the embryonic murine cortex leads to decreased precursor proliferation and reduced survival, demonstrating fewer cortical precursors. This directly shows that ablation of Snail alters both proliferation and precursor number. The other papers do not address Snail in the embryonic cortex, so they neither add nor detract from this conclusion. Thus the available evidence supports the claim."
    },
    "naive_doc_ids": [
      "38919140",
      "16964262",
      "23901235",
      "6285534",
      "14460402"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 directly investigates Snail function in radial glial precursor cells of the embryonic murine cortex. Acute knock-down (ablation) of Snail leads to (i) reduced survival, (ii) decreased self-renewal/proliferation, and (iii) diminished generation of intermediate progenitors and neurons. The study also shows that co-expression of Cdc25b rescues the reduced proliferation caused by Snail loss, confirming that Snail normally promotes precursor expansion. These findings demonstrate that removing Snail alters both the proliferation rate and overall number of embryonic cortical precursors, which aligns with the claim. The remaining cited papers do not address Snail in embryonic cortex and therefore neither contradict nor alter this conclusion."
    },
    "overthinking_doc_ids": [
      "38919140",
      "6285534",
      "33796570",
      "368506",
      "2828460"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 4 reports that knocking down (acute ablation of) the transcription factor Snail in radial glial precursor cells of the embryonic mouse cortex decreases their survival, self-renewal and proliferation, and diminishes their production of intermediate progenitors and neurons. These observations directly demonstrate that removal of Snail alters both the proliferation rate and the number of embryonic cortical precursors, confirming the claim."
    },
    "posthoc_doc_ids": [
      "16964262",
      "33796570",
      "21487212",
      "38919140",
      "2437807"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "897",
    "claim": "Overexpressing Cnp1 N-tail variants rescues the temperature-sensitive growth defect of scm3-139.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.3,
      "justification": "Among the provided papers, only Paper 1 and Paper 2 discuss Cnp1 (CENP-A) and Scm3 in fission yeast, but neither abstract (nor any of the other abstracts) reports experiments in which Cnp1 N-terminal tail variants are over-expressed or shows that such overexpression rescues the temperature-sensitive growth defect of the scm3-139 mutant. No data relevant to this specific rescue experiment are described, so the evidence is insufficient to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "14338915",
      "10189634",
      "5760247",
      "15600979",
      "20183360"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided papers address experiments involving Cnp1 N-tail variants or their ability to rescue the temperature-sensitive growth defect of the scm3-139 mutant. The cited studies cover unrelated topics (fever-related miRNAs, CenH3 phosphorylation, H2A.Z distribution, Scm3 function, epilepsy, Dscam diversity, NOD2 variants, chromatin remodeling by ISW2, RanGAP function, and A20 in glioma). Therefore, they supply no information that can be used to verify or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "6766459",
      "16686383",
      "2817000",
      "14338915",
      "599582"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the ten provided papers mention Cnp1, its N-terminal tail variants, scm3-139, or experiments testing growth rescue at different temperatures. The evidence therefore contains no data relevant to evaluating the stated claim."
    },
    "posthoc_doc_ids": [
      "6766459",
      "33370",
      "970012",
      "4362729",
      "4421547"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "704",
    "claim": "Long - range chromatin interactions regulate transcription.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.91,
      "justification": "Multiple cited studies link physical, long-range chromatin contacts to changes in gene expression. Paper 2 shows that distal enhancers several megabases away regulate genes through looping detected by 3C, directly stating that long-range interactions mediate gene control. Paper 3 demonstrates that a CTCF-dependent chromatin loop between the H19 ICR and Igf2 restricts enhancer access and silences the maternal Igf2 allele\u2014an explicit example where a long-distance interaction regulates transcription. Paper 4 maps genome-wide RNA-Pol II\u2013associated chromatin interactions and finds that genes engaged in such long-range promoter-centered contacts are transcriptionally active and can influence each other\u2019s expression, providing a topological basis for regulation. Paper 1 reviews high-resolution conformation capture studies concluding that interphase genome folding supplies \u201cregulatory segmentation for appropriate transcriptional control.\u201d Together, these data consistently confirm that long-range chromatin interactions play a regulatory role in transcription."
    },
    "naive_doc_ids": [
      "37249641",
      "25821556",
      "140874",
      "18276599",
      "4462139"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Multiple cited studies present direct experimental evidence that distant (long-range) physical contacts within chromatin influence gene activity. Paper 1 maps genome-wide promoter-centered chromatin loops and shows that genes engaged in these long-range interactions are transcriptionally active and can modulate one another\u2019s expression. Paper 2 demonstrates that p53-bound distal enhancers physically contact far-away genes and that disrupting these long-distance interactions (or the eRNAs produced at the enhancers) impairs target-gene transcription. Paper 5 shows that CTCF-dependent chromatin looping at the H19 imprinting control region blocks enhancer access to Igf2, and mutating CTCF sites abolishes the loop and alters Igf2 expression. All of these findings align with the claim that long-range chromatin interactions regulate transcription, and no provided paper offers data contradicting this view."
    },
    "overthinking_doc_ids": [
      "18276599",
      "9669099",
      "5519177",
      "40447899",
      "140874"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 1 directly maps long-range chromatin interactions (promoter\u2013promoter, enhancer\u2013promoter, intragenic, extragenic, intergenic) and shows that these three-dimensional contacts correlate with, and can influence, gene activity: genes involved in such interactions are active, transcribed cooperatively, and provide cell-specific transcriptional frameworks. This experimental evidence demonstrates that long-range chromatin interactions have a regulatory impact on transcription, confirming the claim. The other cited papers do not contradict this conclusion."
    },
    "posthoc_doc_ids": [
      "18276599",
      "14050257",
      "5519177",
      "18038955",
      "8267678"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1199",
    "claim": "The benefits of colchicine were achieved with effective widespread use of secondary prevention strategies such as high-dose statins.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the cited papers mention colchicine or evaluate its benefits in conjunction with secondary prevention strategies such as high-dose statins. The evidence therefore provides no information relevant to confirming or refuting the claim."
    },
    "naive_doc_ids": [
      "6158879",
      "40790033",
      "44384384",
      "24150328",
      "11939159"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the cited papers investigate colchicine or analyse how its benefits relate to concomitant use of secondary prevention therapies such as high-dose statins. Therefore the supplied evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "40790033",
      "6158879",
      "11939159",
      "1287809",
      "1805641"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "The supplied papers discuss statins, antihypertensive combinations, malaria treatments, antiretroviral therapy, influenza vaccination, and physician adherence to cardiovascular guidelines. None of the studies evaluate colchicine or examine whether its benefits depend on concurrent widespread use of high-dose statins for secondary prevention. Therefore, the evidence set does not provide information relevant to the specific claim."
    },
    "posthoc_doc_ids": [
      "7454794",
      "40790033",
      "5698494",
      "1287809",
      "29735200"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "423",
    "claim": "Folate and vitamin B12 levels influence the association between homocysteine and preeclampsia.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Several papers examine (1) folic-acid/folate intake and risk of preeclampsia or gestational hypertension, and (2) folate or vitamin B12 status and their effects on homocysteine or other cardiovascular outcomes. However, none of the cited studies assess whether folate or vitamin B12 levels specifically modify the relationship between circulating homocysteine concentrations and the development of preeclampsia. Therefore the provided evidence does not address, confirm, or refute the claim that folate and vitamin B12 levels influence the association between homocysteine and preeclampsia."
    },
    "naive_doc_ids": [
      "19278208",
      "37424881",
      "4550036",
      "5152028",
      "11705328"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the provided papers, only Papers 7 and 8 relate to pre-eclampsia/gestational hypertension, but they do not measure homocysteine or examine how folate or vitamin B12 levels modify its association with these conditions. The remaining papers involve homocysteine, folate, and/or vitamin B12 in contexts such as coronary artery disease, stroke, or general cardiovascular risk, not pre-eclampsia. Hence the supplied evidence neither confirms nor refutes that folate and vitamin B12 levels influence the homocysteine\u2013preeclampsia relationship."
    },
    "overthinking_doc_ids": [
      "42441846",
      "37424881",
      "8595678",
      "10557471",
      "12810152"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "Among the provided papers, only paper 7 addresses preeclampsia, but it examines folic-acid supplementation and dietary folate intake in relation to preeclampsia risk and does not measure homocysteine, nor does it test whether folate or vitamin B12 levels modify a homocysteine\u2013preeclampsia association. The remaining papers discuss folate/vitamin B12 and homocysteine in the contexts of stroke, coronary disease, or other outcomes, not preeclampsia. Consequently, the corpus supplies no direct evidence about whether folate or vitamin B12 levels influence the link between homocysteine and preeclampsia."
    },
    "posthoc_doc_ids": [
      "8595678",
      "37424881",
      "10557471",
      "3898784",
      "11705328"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "11",
    "claim": "4-PBA treatment raises endoplasmic reticulum stress in response to general endoplasmic reticulum stress markers.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.13,
      "justification": "None of the provided papers mention 4-phenylbutyric acid (4-PBA) or examine its effect on endoplasmic reticulum stress markers. Therefore, the evidence set contains no data to support or refute the claim."
    },
    "naive_doc_ids": [
      "25510546",
      "35760786",
      "6669242",
      "9752604",
      "1554348"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers discuss 4-phenyl\u00adbutyric acid (4-PBA) or its effect on endoplasmic reticulum stress markers. Therefore they neither support nor contradict the claim."
    },
    "overthinking_doc_ids": [
      "25510546",
      "6669242",
      "8453819",
      "13958154",
      "19561411"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the supplied papers mention 4-phenylbutyric acid (4-PBA) or examine its effects on endoplasmic reticulum stress markers. Therefore the evidence set does not provide information that either confirms or refutes the claim."
    },
    "posthoc_doc_ids": [
      "25510546",
      "1568684",
      "5687200",
      "6669242",
      "8037453"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "326",
    "claim": "Deletion of ATM and Rad3 related protein leads to acute tissue loss.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 specifically examined conditional deletion of the ATM- and Rad3-related protein (ATR) in adult mice. The authors report that loss of ATR \"causes acute cellular loss in tissues in which continuous cell proliferation is required for maintenance\" and leads to rapid deterioration of multiple organs (e.g., thymic involution, alopecia, osteoporosis). This directly demonstrates that ATR deletion produces acute tissue loss. The other cited papers address different genes or conditions and do not contradict this finding. Hence, the available evidence supports the claim."
    },
    "naive_doc_ids": [
      "40349336",
      "3113630",
      "29689140",
      "25827024",
      "35760786"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 2 specifically examined conditional knockout mice in which the ATM- and Rad3-related checkpoint kinase (ATR) was deleted in adulthood. The study reports that ATR deletion \"causes acute cellular loss in tissues in which continuous cell proliferation is required for maintenance\" and results in rapid tissue-homeostasis defects and age-related phenotypes. This directly demonstrates that loss of ATR (ATM and Rad3 related protein) triggers acute loss of cells and therefore tissue mass, confirming the claim. The other cited papers do not address ATR, so they neither strengthen nor weaken this conclusion."
    },
    "overthinking_doc_ids": [
      "25827024",
      "40349336",
      "368506",
      "16389141",
      "44562221"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 1 specifically investigates adult mice in which ATR (ATM and Rad3-related protein) is conditionally deleted. The authors report that eliminating ATR \"causes acute cellular loss in tissues in which continuous cell proliferation is required for maintenance,\" leading to rapid tissue-homeostasis defects and stem-cell depletion. This directly supports the claim that deletion of ATM and Rad3 related protein results in acute tissue loss. The remaining cited papers discuss other genes or phenomena and do not address ATR deletion, so they neither contradict nor weaken this evidence."
    },
    "posthoc_doc_ids": [
      "40349336",
      "29689140",
      "7717468",
      "11428884",
      "92308"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "312",
    "claim": "De novo assembly of sequence data has more specific contigs than unassembled sequence data.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Several cited papers mention de novo assembly methods (e.g., Trinity, metagenomic draft genome assembly, GC-bias effects on assembly) but none of them compare the specificity of contigs produced by assembly with the specificity of the original unassembled sequence reads. The remaining papers address unrelated topics such as siRNA off-target prediction, cardiac biomarker diagnostics, adapter trimming, variant calling, chromatin mapping, and haplotype estimation. Consequently, the provided evidence does not directly confirm or refute the claim that de novo assembly yields more specific contigs than unassembled sequence data."
    },
    "naive_doc_ids": [
      "14464451",
      "32770503",
      "6173523",
      "6535392",
      "34873974"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "Among the provided papers, only Papers 1 and 2 deal with de novo sequence assembly, and they focus on assembly completeness, GC bias, and recovery of full-length transcripts. None of the papers compare the \u2018specificity\u2019 of contigs generated by de novo assembly with that of unassembled (raw) sequence data. Therefore, the cited evidence neither supports nor contradicts the stated claim."
    },
    "overthinking_doc_ids": [
      "14464451",
      "32770503",
      "118568",
      "2335873",
      "4492358"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers directly compare the taxonomic or functional specificity of contigs generated by de novo assembly with that of the original, unassembled sequencing reads. The studies discuss topics such as GC bias effects on assembly, transcriptome reconstruction, outbreak strain identification, and other biological questions, but they do not present experimental data contrasting the specificity of assembled contigs versus raw reads. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "14464451",
      "143251",
      "13914198",
      "32770503",
      "84784389"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "908",
    "claim": "PGE 2 suppresss intestinal tumor growth by altering the expression of tumor suppressing and DNA repair genes.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 3 directly investigates the role of prostaglandin E2 (PGE2) in intestinal tumors and reports that PGE2 silences tumor-suppressor and DNA-repair genes through DNA methylation, thereby PROMOTING\u2014not suppressing\u2014intestinal tumor growth. No other cited paper shows PGE2 suppressing tumor growth. Thus the available evidence opposes the claim."
    },
    "naive_doc_ids": [
      "15113221",
      "42731834",
      "6923961",
      "11271123",
      "16346504"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 3 reports that prostaglandin E2 (PGE2) \"promotes intestinal tumor growth\" by silencing tumor-suppressor and DNA-repair genes through DNA methylation. The claim states that PGE2 suppresses intestinal tumor growth. The evidence therefore shows the opposite effect, directly contradicting the claim."
    },
    "overthinking_doc_ids": [
      "15113221",
      "470625",
      "6923961",
      "29366489",
      "31682248"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Paper 1 reports that prostaglandin E2 (PGE2) *promotes* intestinal tumor growth by silencing tumor-suppressor and DNA-repair genes through DNA methylation. This is the opposite of the claim, which states that PGE2 suppresses intestinal tumor growth. No other provided papers address PGE2 and intestinal tumors. Therefore the evidence contradicts the claim."
    },
    "posthoc_doc_ids": [
      "6923961",
      "25726838",
      "86602746",
      "15832146",
      "470625"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.8,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1098",
    "claim": "Stacking is more stable when a purine is present in the +5 position (C1698).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided papers address nucleotide stacking stability or the influence of having a purine at the +5 position (C1698). The evidence focuses on ribosome biogenesis factors, pre-rRNA processing, cancer therapeutics, sequence-alignment gap penalties, and other unrelated molecular topics. Therefore, no information in these papers confirms or refutes the specific stacking-stability claim."
    },
    "naive_doc_ids": [
      "18467982",
      "26112624",
      "6670101",
      "7260461",
      "7487927"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers discuss base-stacking stability at position +5, purine versus pyrimidine effects there, or the specific nucleotide C1698. Therefore they do not supply information that can confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "13552682",
      "365896",
      "984825",
      "2566674",
      "3093512"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the cited papers discuss nucleotide stacking stability, purine versus pyrimidine effects at a +5 position, or the specific residue C1698. The evidence provided is unrelated to the claim, so no determination about support or contradiction can be made from these sources."
    },
    "posthoc_doc_ids": [
      "4444861",
      "4890578",
      "5824955",
      "7260461",
      "10365787"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "91",
    "claim": "Aged patients are less susceptible to ischaemia/reperfusion injury.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers investigate or report how advanced age alters susceptibility to ischemia/reperfusion injury. The cited studies focus on molecular regulators (e.g., Sfrp5, proteasome activity), pharmacologic agents (e.g., fingolimod), sex or diabetic status, and unrelated models (embryonic teratogenesis, vascular calcification). Therefore they neither confirm nor refute the claim that aged patients are less susceptible to I/R injury."
    },
    "naive_doc_ids": [
      "22281684",
      "6580081",
      "21868715",
      "33884866",
      "23377475"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.16,
      "justification": "None of the cited papers compare ischemia/reperfusion injury between aged and younger subjects or provide data on age-related susceptibility. The evidence summaries focus on molecular mechanisms, specific proteins, pharmacologic interventions, or unrelated clinical outcomes, but do not address whether older patients experience less ischemia/reperfusion injury. Therefore the provided literature offers no relevant information to verify or refute the claim."
    },
    "overthinking_doc_ids": [
      "6580081",
      "22281684",
      "6153754",
      "21868715",
      "1759213"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided abstracts discuss how aging influences susceptibility to ischemia/reperfusion injury. The papers focus on molecular mechanisms, sex differences, therapeutic interventions, or other injury models without comparing aged versus young subjects in the context of ischemia/reperfusion. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "6580081",
      "22281684",
      "21868715",
      "13464392",
      "6153754"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "390",
    "claim": "Ethanol stress increases the expression of PSP in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the cited papers mention ethanol stress or the phage shock protein (PSP) system in bacteria. The studies focus on other stress responses (oxidative stress, heat shock, viral infection, cold exposure, etc.) or in non-bacterial systems. Therefore, they provide no direct information to confirm or refute the claim that ethanol stress increases PSP expression in bacteria."
    },
    "naive_doc_ids": [
      "471735",
      "34386619",
      "9194077",
      "23305884",
      "24185667"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided abstracts report experiments measuring Phage-Shock Proteins (PSP/PspA, PspB, etc.) in response to ethanol exposure. Paper 3 and Paper 5 discuss cellular responses or adaptations to ethanol, but do not mention PSP expression. Paper 4 reports PspA induction after TolC deletion, not ethanol stress. Therefore the evidence set contains no direct information bearing on whether ethanol stress increases PSP expression in bacteria."
    },
    "overthinking_doc_ids": [
      "471735",
      "6669242",
      "21602220",
      "26625002",
      "1148122"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.14,
      "justification": "None of the provided papers examine the effect of ethanol stress on bacterial PSP (phage-shock-protein) expression, nor do they report data linking ethanol exposure to PSP levels. The evidence focuses on oxidative stress responses, hypoxia, viral infection, antibiotic action, immune regulation, and inflammation in various organisms, but not on ethanol stress\u2013induced PSP expression in bacteria."
    },
    "posthoc_doc_ids": [
      "471735",
      "9194077",
      "23305884",
      "24185667",
      "25293721"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "774",
    "claim": "Mice defective for deoxyribonucleic acid (DNA) polymerase I (polI) fail to reveal increased sensitivity to ionizing radiation (IR).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the cited papers examine mice that are deficient for DNA polymerase I (Pol I) and then test their response to ionizing radiation. The studies instead focus on other DNA repair proteins (ATM, polymerase \u03b2, polymerase \u03b7), senescence after irradiation, or unrelated immunometabolic and neurological models. Consequently, the provided evidence neither supports nor contradicts the specific claim about Pol I-defective mice and IR sensitivity."
    },
    "naive_doc_ids": [
      "31293581",
      "5572127",
      "11569583",
      "43014661",
      "52805891"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers examine mice that lack or are defective for DNA polymerase I, nor do they measure their sensitivity to ionizing radiation. The cited studies address other DNA polymerases (e.g., Pol \u03b2, Pol \u03b7) or entirely different genes and physiological processes. Therefore, the evidence set gives no direct information bearing on the claim."
    },
    "overthinking_doc_ids": [
      "31293581",
      "52805891",
      "5572127",
      "10017612",
      "11569583"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.34,
      "justification": "None of the cited papers examine mice that are deficient for DNA polymerase I (or its mammalian homolog Pol \u03b2) and their response to ionizing radiation. The only polymerase-related study (Paper 1) deals with CHO cells over-expressing Pol \u03b2, not with mice lacking the enzyme, and it involves heightened\u2014not unchanged\u2014radiation sensitivity. Therefore the provided evidence neither supports nor contradicts the specific claim about polI-defective mice."
    },
    "posthoc_doc_ids": [
      "11569583",
      "31293581",
      "52805891",
      "5572127",
      "10017612"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1397",
    "claim": "p16INK4A degradation is  linked to an abnormal wound response caused by the microinvasive step of advanced Oral Potentially Malignant Lesions (OPMLs).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention p16INK4A degradation, its linkage to abnormal wound responses, microinvasion, or specifically advanced oral potentially malignant lesions. Therefore they neither support nor contradict the claim."
    },
    "naive_doc_ids": [
      "21063817",
      "6308416",
      "9614443",
      "11721286",
      "153744"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers discuss p16INK4A, Oral Potentially Malignant Lesions, their microinvasive step, or any link between p16INK4A degradation and an abnormal wound response. Therefore, the supplied evidence does not address the claim."
    },
    "overthinking_doc_ids": [
      "4483571",
      "26008462",
      "27260630",
      "16732790",
      "1471041"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the provided papers discuss p16INK4A, its degradation, oral potentially malignant lesions, or the microinvasive wound-response step. Therefore, they offer no evidence to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "5492542",
      "9956893",
      "14626540",
      "3471191",
      "4483571"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "637",
    "claim": "Input from  mental and physical health care professionals is effective at decreasing homelessness.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided studies, only one (Paper 2) involves a homeless population, and it evaluates effects of a mental-health outreach service on child psychosocial functioning\u2014not on the prevalence or duration of homelessness itself. The remaining papers address mental or physical health interventions in populations that are not homeless. None of the papers report data showing that involvement of health-care professionals leads to reductions in homelessness. Therefore, the evidence set does not speak directly to the claim."
    },
    "naive_doc_ids": [
      "24159217",
      "6129301",
      "22467585",
      "5912283",
      "24396137"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the cited studies evaluates whether involvement of mental- or physical-health professionals leads to a reduction in homelessness. The papers focus on mental-health symptom relief, chronic-disease management, cancer prevention, renal protection, breast-cancer screening, bariatric-surgery outcomes, or perceptions of homeless youth, but they do not report homelessness rates before and after professional intervention. Therefore they provide no direct evidence to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "24159217",
      "22467585",
      "12009265",
      "4678846",
      "40735046"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers address whether involvement of mental or physical health professionals reduces homelessness. The studies focus on topics such as mental-health integration into primary care, cost-effectiveness thresholds, caregiver interventions, school-based PTSD treatment, diabetes education, stroke prevention, air pollution, molecular biology databases, renal effects of ACE inhibitors, and neutrophil migration. No evidence is presented linking these interventions to changes in homelessness rates."
    },
    "posthoc_doc_ids": [
      "24318630",
      "15670968",
      "22446093",
      "24159217",
      "12584053"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "690",
    "claim": "Less than 10% of the gabonese children with Schimmelpenning-Feuerstein-Mims syndrome (SFM) had a plasma lactate of more than 5mmol/L.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers discuss Schimmelpenning-Feuerstein-Mims syndrome, Gabonese children, or their plasma lactate levels. Consequently, there is no evidence within these sources to evaluate or verify the stated claim."
    },
    "naive_doc_ids": [
      "13580614",
      "23117378",
      "2613775",
      "18218379",
      "25643818"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers mention Schimmelpenning-Feuerstein-Mims syndrome, Gabonese children, or plasma lactate measurements. Therefore they offer no information to confirm or refute the stated claim."
    },
    "overthinking_doc_ids": [
      "32587939",
      "6000423",
      "118568",
      "371289",
      "520579"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention Schimmelpenning-Feuerstein-Mims syndrome, Gabonese children, or measurements of plasma lactate. Therefore, the evidence set contains no information relevant to the claim."
    },
    "posthoc_doc_ids": [
      "3801693",
      "2575938",
      "12039953",
      "12130200",
      "12451492"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1316",
    "claim": "Transferred UCB T cells acquire a memory-like phenotype in recipients.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.58,
      "justification": "Among the provided papers, none present data or explicit statements showing that umbilical cord blood (UCB)\u2013derived T cells adopt a memory-like phenotype after transfer into recipients. The abstracts reference immune reconstitution after UCB transplantation but do not specify phenotypic conversion of the transferred T cells to a memory-like state. Therefore, the supplied evidence neither confirms nor refutes the claim."
    },
    "naive_doc_ids": [
      "8790729",
      "25985964",
      "27243019",
      "10786948",
      "11344428"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "None of the provided papers examine or report whether umbilical-cord-blood-derived T cells transferred to recipients adopt a memory-like phenotype. The cited studies focus on other aspects such as donor-cell leukemia, small embryonic-like stem cells, infection risk, immune-reconstitution kinetics, stem-cell differentiation, and therapeutic applications, but they do not present data on phenotypic conversion of UCB T cells to a memory-like state."
    },
    "overthinking_doc_ids": [
      "11344428",
      "25985964",
      "8790729",
      "43587663",
      "27243019"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers address the fate or phenotype of umbilical-cord-blood (UCB) T cells after their transfer into recipients. The studies focus on lymphoma epigenetics, osteogenic signaling, endothelial cell plasticity, Down-syndrome models, tumor-derived extracellular vesicles, very-small embryonic-like stem cells, islet differentiation, nonviral iPSC generation, MSC-derived microvesicles, and memory CD4\u207a T\u2010cell lineage commitment after viral infection. They do not examine whether transferred UCB T cells acquire a memory-like phenotype, so they neither support nor contradict the claim."
    },
    "posthoc_doc_ids": [
      "1243475",
      "364522",
      "6280907",
      "11992632",
      "14768471"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "733",
    "claim": "M. stadtmanae induces ASC speck formation in BlaER1 monocytes.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers mention Methanobrevibacter stadtmanae, BlaER1 monocytes, or ASC speck formation in this context. The evidence focuses on other inflammasome activators (LPS, uric-acid crystals, bacterial RNA, Candida albicans, etc.) and different cell types. Therefore, the supplied literature does not address the specific claim."
    },
    "naive_doc_ids": [
      "34469966",
      "623486",
      "2692522",
      "4303939",
      "4399311"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention Methanobrevibacter stadtmanae, BlaER1 monocytes, or experiments assessing ASC speck formation in those cells. Therefore, the evidence does not address the claim."
    },
    "overthinking_doc_ids": [
      "2692522",
      "4303939",
      "4399311",
      "5386514",
      "6000423"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the provided papers mention Methanobrevibacter stadtmanae, BlaER1 monocytes, or describe ASC speck formation triggered by this microorganism. The evidence supplied is about osteoclast formation, alternative inflammasome activation by LPS, peptide\u2010MHC interactions, antimicrobial peptides, methods for isolating monocytes, and other inflammasome-related contexts, but none are directly relevant to the stated claim."
    },
    "posthoc_doc_ids": [
      "25915873",
      "34469966",
      "306006",
      "350542",
      "623486"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1342",
    "claim": "Understanding epigenetic regulation of replication is essential for the reational design of episomally replicating vectors.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "The cited papers address epigenetic regulation of chromatin (e.g., replication-timing domains, histone modifications, chromatin-remodeling complexes) and separately discuss various viral or plasmid vectors. None of the summaries present experimental data or explicit discussion showing that knowledge of epigenetic regulation of DNA replication is required (or even used) to design episomally replicating vectors. Therefore the evidence neither supports nor contradicts the specific claim."
    },
    "naive_doc_ids": [
      "8759633",
      "13368032",
      "87337034",
      "24512417",
      "1944452"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "The cited papers discuss diverse topics such as epigenetic control of gene expression, replication timing of chromosomal DNA during development, miRNA-mediated regulation of viral replication, chromatin architecture, and stem-cell reprogramming. None of the provided studies examine episomally replicating vectors or demonstrate that knowledge of epigenetic regulation of DNA replication is required for their rational design. Therefore, the evidence set offers no direct support or refutation of the specific claim."
    },
    "overthinking_doc_ids": [
      "2356950",
      "6948886",
      "8759633",
      "21601459",
      "5633957"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.16,
      "justification": "None of the cited papers study episomally replicating vectors or examine whether knowledge of epigenetic regulation of replication is required for their rational design. The articles focus on general epigenetic control of gene expression, replication timing during development, viral RNA cap methylation, stem-cell reprogramming, and other topics, but they do not provide data linking epigenetic replication control to the engineering of episomal vectors. Therefore the evidence does not bear directly on the claim."
    },
    "posthoc_doc_ids": [
      "2356950",
      "6948886",
      "8759633",
      "21601459",
      "1848452"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "545",
    "claim": "IFIT1 speeds viral replication by allowing for the proliferation of mis-capped viral RNAs.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.13,
      "justification": "None of the provided papers discuss IFIT1, its interaction with mis-capped viral RNAs, or any resulting effects on viral replication. Therefore the evidence set offers no information relevant to verifying or refuting the claim."
    },
    "naive_doc_ids": [
      "4444861",
      "5633957",
      "8300657",
      "39225849",
      "42065070"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the cited papers discuss IFIT1, RNA 5\u2032-capping status, or their effects on viral replication. Therefore, they provide no information relevant to verifying or refuting the claim that IFIT1 accelerates viral replication by permitting proliferation of mis-capped viral RNAs."
    },
    "overthinking_doc_ids": [
      "5137019",
      "22495397",
      "164189",
      "3173489",
      "5633957"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.51,
      "justification": "None of the provided papers discuss IFIT1, cap-recognition by IFIT proteins, or any effect of IFIT1 on the replication of viruses with mis-capped RNAs. Therefore they offer no evidence to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "4899981",
      "5633957",
      "8300657",
      "42065070",
      "5137019"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1375",
    "claim": "Weighed food records (WFR) result in poor completion since they're costly to run and impose high participant burden.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the cited papers assess the cost of conducting weighed-food records, quantify participant burden, or link these factors to low completion rates. Paper 1 notes that only 98 of 150 volunteers finished a study that included weighed records, but it neither attributes non-completion to burden or cost nor evaluates these aspects directly. The remaining papers focus on validity, accuracy or nutritional outcomes of weighed records or other dietary methods, and do not discuss completion, participant burden, or implementation cost. Therefore the supplied evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "21623140",
      "21993510",
      "9244474",
      "10557471",
      "23245050"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.22,
      "justification": "Among the cited papers, only Paper 1 and Paper 8 mention weighed food records, but neither provides data linking them to poor completion because of high cost or participant burden. Paper 1 merely reports that 98 of 150 volunteers completed a protocol that included a 4-day weighed record; it does not analyze reasons for non-completion or compare completion rates with cheaper, lower-burden methods. Paper 8 evaluates the accuracy of 7-day weighed records, focusing on under-reporting rather than on participant burden or study cost. The other papers do not address weighed food records at all. Therefore, the evidence set does not confirm or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "21623140",
      "11748341",
      "16322674",
      "27768226",
      "167944455"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "Among the provided abstracts only Papers 1, 2 and 6 mention weighed (seven\u2010day or four\u2010day) food records. None of these papers presents data on the cost of running weighed food records or explicitly reports poor completion rates attributable to high participant burden or study expense. Paper 1 notes that 98 of 150 volunteers completed the protocol, but it does not link non-completion to cost or burden, nor does it label this completion rate as poor. Consequently, the supplied evidence neither confirms nor refutes the claim that weighed food records have poor completion because they are costly and burdensome."
    },
    "posthoc_doc_ids": [
      "21623140",
      "21993510",
      "11748341",
      "16322674",
      "167944455"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1197",
    "claim": "The availability of safe places to study is not effective at decreasing homelessness.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided studies examine whether providing safe places to study influences homelessness rates. The papers focus on mental health of rehoused families, physician adherence to guidelines, antidepressant risks, bariatric surgery outcomes, vitamin supplementation, medical-school attrition, homeless youth health perceptions, pharmacy education, husbands\u2019 involvement in delivery care, and predictors of professional misconduct. They do not assess the impact of study spaces on homelessness, so they neither support nor contradict the claim."
    },
    "naive_doc_ids": [
      "25649714",
      "409280",
      "5691302",
      "5824985",
      "12009265"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the ten cited papers, only Paper 4 addresses homelessness, and it focuses on early-intervention programs and the progression from youth to adult homelessness. None of the papers specifically examine the impact of providing safe places to study on homelessness outcomes. Therefore, the supplied evidence offers no information that confirms or refutes the claim."
    },
    "overthinking_doc_ids": [
      "12122482",
      "12471115",
      "20473074",
      "154243324",
      "947631"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided papers address homelessness or the effect of providing safe places to study on homelessness. They focus on medical treatments, diagnostic strategies, surgical outcomes, and dementia risk. Therefore, the evidence is not relevant to the claim."
    },
    "posthoc_doc_ids": [
      "21323758",
      "5151024",
      "13625993",
      "8756719",
      "947631"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "389",
    "claim": "Ethanol stress increases the expression of IBP in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the provided papers discuss the bacterial small heat-shock protein Ibp (or inclusion-body protein) in the context of ethanol stress. The cited studies focus on oxidative stress (soxRS regulon), heat-shock proteins (Hsp90), chaperone systems, mitochondrial RNA regulation, uncoupling proteins, LXR signaling, and protein acetylation. Ethanol-induced Ibp expression is not addressed, so the evidence is insufficient to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "471735",
      "30884033",
      "20524091",
      "26886351",
      "30184745"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the provided papers report data on the expression of IBP (inclusion-body/heat-shock proteins IbpA/B) under ethanol stress. The abstracts discuss redox stress (Paper 1), complex stress during hydrolysate fermentation (Paper 2), acetylation (Paper 3), ethanol-tolerance evolution (Paper 4), outer-membrane channel loss (Paper 5), or general heat-shock/Hsp90 biology (Papers 6-9) and an Allium extract study (Paper 10). None specifically measure or mention IBP expression changes due to ethanol. Therefore the evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "471735",
      "21602220",
      "6669242",
      "1148122",
      "26625002"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "None of the supplied abstracts mention the inclusion-body protein genes (ibpA/ibpB) or show data on their transcription or translation after exposure to ethanol. Paper 4 refers to multiple stress responses in an ethanologenic E. coli strain but does not specify IBP expression. Therefore the provided evidence neither confirms nor refutes that ethanol stress increases IBP expression in bacteria."
    },
    "posthoc_doc_ids": [
      "471735",
      "9194077",
      "38944245",
      "21602220",
      "22908536"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1226",
    "claim": "The loss of the TET protein functions may have dire biological consequences, such as myeloid cancers.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "None of the cited papers report that loss-of-function of any TET enzyme precipitates or is associated with myeloid cancers.  Instead, the one study that directly examines the biological impact of deleting a TET gene (Paper 5) finds that Tet1-null embryonic stem cells and mice remain pluripotent, develop normally, and are viable and fertile, indicating that loss of Tet1 does NOT, in itself, produce dire pathological outcomes.  The other TET-related papers describe altered differentiation of embryonic stem cells (Paper 1), reduced TET2/5-hmC levels in melanoma (Paper 3), and diminution of 5-hmC in Huntington\u2019s disease brains (Paper 4), but none link TET loss to myeloid malignancy.  Therefore, the supplied evidence does not support\u2014and partially opposes\u2014the claim that loss of TET function leads to severe consequences such as myeloid cancers."
    },
    "naive_doc_ids": [
      "13777138",
      "3127341",
      "36950726",
      "1871499",
      "2086909"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.85,
      "justification": "Among the provided abstracts, only Paper 8 discusses TET proteins, describing altered differentiation of embryonic stem cells after Tet1 depletion, but it does not mention myeloid malignancies. The other papers focus on acute myeloid leukemia or other tumor-related mechanisms but make no reference to TET protein loss. None of the papers directly link loss of TET function to the development of myeloid cancers, so the supplied evidence neither supports nor refutes the claim."
    },
    "overthinking_doc_ids": [
      "4387494",
      "6374918",
      "10795340",
      "12903921",
      "13205096"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.14,
      "justification": "None of the supplied papers discuss TET proteins or the effects of losing TET function. Consequently, they provide no evidence to confirm or refute the claim that loss of TET protein function can cause myeloid cancers."
    },
    "posthoc_doc_ids": [
      "1507222",
      "4889228",
      "11271123",
      "14019636",
      "24917562"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1331",
    "claim": "Tumor development occurs in conjunction with upregulation of pro-inflammatory cytokines.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Multiple cited studies report that growing or initiating tumors display increased levels of classic pro-inflammatory cytokines. (i) Paper 2 shows that oncogenic mTOR signalling in mammary tumour cells elevates the cytokine G-CSF, which recruits myeloid-derived suppressor cells and is necessary for tumour initiation. (ii) Paper 3 finds elevated serum IL-6 (a prototypic pro-inflammatory cytokine) in cervical-cancer patients and demonstrates that its level predicts disease-free and overall survival, indicating IL-6 up-regulation accompanies tumour development and progression. (iii) Paper 6 demonstrates that loss of p62 in stromal fibroblasts drives tumourigenesis through increased IL-6 production. (iv) Paper 10 shows Lewis lung carcinoma\u2013induced pleural tumours exhibit high NF-\u03baB activity and elevated TNF-\u03b1 in pleural effusions, and blocking NF-\u03baB lowers both TNF-\u03b1 levels and tumour burden. Together these findings consistently link tumour formation/progression with increased production of pro-inflammatory cytokines (IL-6, G-CSF, TNF-\u03b1), supporting the claim."
    },
    "naive_doc_ids": [
      "13329980",
      "2014909",
      "14664424",
      "17844478",
      "22889972"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.8,
      "justification": "Multiple cited studies link the appearance or progression of tumors with increased expression of pro-inflammatory cytokines. (a) Paper 5 shows that IL-17 (a prototypic pro-inflammatory cytokine) is up-regulated at tumor sites, and experimental elevation of IL-17 accelerates tumor growth whereas genetic or antibody blockade of the IL-17 pathway suppresses tumor formation\u2014direct evidence that tumor development coincides with, and is promoted by, cytokine up-regulation. (b) Paper 7 reports that Nlrp12-deficient mice develop more colorectal tumors together with heightened production of inflammatory cytokines and chemokines, again demonstrating concomitant tumorigenesis and cytokine elevation. (c) Paper 1 finds elevated serum IL-6 levels in cervical-cancer patients and shows these levels to be prognostic for survival, indicating that the tumor state is associated with increased pro-inflammatory cytokines. These convergent findings confirm that tumor development occurs in conjunction with up-regulation of pro-inflammatory cytokines."
    },
    "overthinking_doc_ids": [
      "14664424",
      "17844478",
      "22889972",
      "24396137",
      "25726838"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 2 shows that the pro-inflammatory cytokine IL-17 directly promotes tumor growth: tumors are smaller in IL-17R-deficient mice, neutralizing IL-17 reduces tumor size, and adding IL-17 accelerates growth. This indicates that successful tumor development is accompanied by, and depends on, elevated IL-17 signaling.  Paper 8 reports that patients with established lung cancer have significantly higher circulating inflammatory mediators (TNF-\u03b1 receptors, IL-6, CRP, etc.) than matched controls, linking the presence of tumors to a systemic up-regulation of pro-inflammatory cytokines.  Together these data demonstrate that tumor development/maintenance occurs in conjunction with increased pro-inflammatory cytokine expression, thus supporting the claim."
    },
    "posthoc_doc_ids": [
      "22889972",
      "25726838",
      "27545868",
      "11233339",
      "21258863"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "899",
    "claim": "Oxidative DNA damage inhibits STING signalling.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.87,
      "justification": "Paper 1 reports that the oxidized base 8-hydroxyguanosine (8-OHG) in DNA 'potentiated cytosolic immune recognition' by making the DNA resistant to TREX1 degradation, thereby enhancing STING-dependent signalling. This is the opposite of the claim that oxidative DNA damage inhibits STING signalling. The other cited papers do not address the effect of oxidative DNA damage on STING, so they neither support nor overturn this conclusion. Therefore, the available evidence contradicts the claim."
    },
    "naive_doc_ids": [
      "13106686",
      "6501747",
      "19688024",
      "1748921",
      "7968532"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 4 shows that oxidized DNA (containing 8-hydroxy-guanosine) \u2018potentiated\u2019 STING-dependent immune sensing, i.e., it enhances rather than inhibits STING signalling. Paper 2 likewise reports that oxidized mitochondrial DNA released in neutrophil extracellular traps triggers type I interferon production through a STING-dependent pathway. Both studies demonstrate activation/augmentation of STING signalling by oxidatively damaged DNA, directly opposing the claim that oxidative DNA damage inhibits STING signalling."
    },
    "overthinking_doc_ids": [
      "19688024",
      "1049501",
      "4324278",
      "13106686",
      "13400643"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.77,
      "justification": "Paper 1 reports that oxidatively modified DNA containing 8-hydroxyguanosine is sensed more strongly by the innate immune system because the damage protects the DNA from TREX1 degradation and thereby \u201cpotentiates STING-dependent immune sensing.\u201d Rather than inhibiting STING signalling, oxidative DNA damage enhances (potentiates) it. The other cited papers do not address oxidative DNA damage in relation to STING. Therefore the available evidence contradicts the claim that oxidative DNA damage inhibits STING signalling."
    },
    "posthoc_doc_ids": [
      "13106686",
      "1686997",
      "213017",
      "5137019",
      "14241418"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "64",
    "claim": "ATM and Rad3 related protein have no role in sensing DNA damage.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 7 (\"Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress\") states that accumulation of single-stranded DNA coated with RPA \"triggers activation of ataxia telangiectasia and Rad3 related (ATR)\" and that ATR signaling leads to Chk1 activation and cell-cycle arrest. This clearly assigns ATR (ATM and Rad3-related protein) a direct role in detecting replication-associated DNA damage and initiating the checkpoint response. Therefore, the evidence shows that ATR does participate in DNA-damage sensing, contradicting the claim that it has no role in this process."
    },
    "naive_doc_ids": [
      "13106686",
      "3973445",
      "6333347",
      "21439293",
      "39859981"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers discuss ATM and Rad3-related (ATR) protein or its involvement (or lack thereof) in DNA-damage sensing. The evidence therefore offers no information relevant to confirming or refuting the claim."
    },
    "overthinking_doc_ids": [
      "10012166",
      "39863735",
      "27403802",
      "33036897",
      "6040392"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.77,
      "justification": "Paper 10 reports that DNA damage at telomeres leads to a \"strong enrichment of the phosphorylated form of the ataxia telangiectasia mutated (ATM) kinase\" and describes this as part of the DNA damage response. Phosphorylation and accumulation of ATM at damage sites is a hallmark of its activation as a sensor/mediator of DNA damage signaling. This directly shows that ATM is involved in detecting (sensing) DNA damage, contradicting the claim that ATM and Rad3-related protein (ATR) have no role in DNA-damage sensing. No paper provides evidence supporting the claim, while at least one provides clear opposing data."
    },
    "posthoc_doc_ids": [
      "10012166",
      "39863735",
      "9752604",
      "22281684",
      "27403802"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "820",
    "claim": "N-terminal cleavage increases success identifying transcription start sites.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the cited papers examine the effect of N-terminal cleavage on the accuracy or efficiency of mapping transcription start sites. The references discuss proteolytic processing of proteins, transcriptional regulation, chromatin remodeling, and transcription\u2010start-site diversity in specific genes, but they do not provide data linking N-terminal cleavage to improved identification of transcription start sites."
    },
    "naive_doc_ids": [
      "8692744",
      "25263810",
      "6532806",
      "8331432",
      "10207180"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers examine whether N-terminal cleavage has any effect on the ability to identify transcription start sites. The studies discuss topics such as transcription factor binding, gene structure, DNA methylation, viral transcription mechanisms, protein acetylation, caspase-mediated cleavage, and protein isoforms, but they do not relate N-terminal cleavage to transcription start-site identification success."
    },
    "overthinking_doc_ids": [
      "8331432",
      "19238",
      "3346812",
      "25175223",
      "7912"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the cited papers examine whether (or how) N-terminal cleavage of proteins affects the success rate of identifying transcription start sites. The articles focus on viral transcription inhibition, Myc and Spx target genes, chromatin binding of transcription factors, APP processing, gene structure of MBP, DNA methylation, E2F-6 function, and peptide biomarkers in hypertension. These topics do not provide data linking N-terminal cleavage to improved transcription-start-site identification."
    },
    "posthoc_doc_ids": [
      "8692744",
      "6532806",
      "8331432",
      "10207180",
      "17416520"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "575",
    "claim": "In domesticated populations of Saccharomyces cerevisiae, whole chromosome aneuploidy is very uncommon.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided paper abstracts discuss the frequency of whole-chromosome aneuploidy in domesticated Saccharomyces cerevisiae populations. They cover topics such as centromeric histone phosphorylation, industrial lineage diversification, galactokinase induction, RNA processing, transcriptional regulation databases, rDNA copy number in cancer, ribosome biogenesis, resequencing methodology, meiotic DSB mapping, and longevity pathways. As no evidence addresses aneuploidy prevalence, the claim cannot be evaluated with the supplied information."
    },
    "naive_doc_ids": [
      "16686383",
      "10300888",
      "42421723",
      "365896",
      "1256116"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers address how common or uncommon whole-chromosome aneuploidy is in domesticated Saccharomyces cerevisiae populations. The cited studies focus on chromosome-segregation mechanisms, gene regulation, polyploidy effects, domestication history, and other genetic or physiological traits, but they do not present data on the prevalence of aneuploidy in domesticated yeast strains. Therefore the claim cannot be verified or refuted from the supplied evidence."
    },
    "overthinking_doc_ids": [
      "16686383",
      "42421723",
      "365896",
      "1256116",
      "4414481"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the provided paper excerpts discuss the prevalence or rarity of whole-chromosome aneuploidy in domesticated Saccharomyces cerevisiae populations. The claim is therefore neither supported nor contradicted by the cited evidence."
    },
    "posthoc_doc_ids": [
      "16686383",
      "365896",
      "10300888",
      "10874408",
      "26330861"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "244",
    "claim": "Certain immunomodulator-human dialyzable leukocyte extract (hDLE) peptides are recognized by toll-like receptors (TLRs) on macrophages and dendritic cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.14,
      "justification": "None of the cited papers discuss human dialyzable leukocyte extract (hDLE) peptides or show that such peptides are recognized by toll-like receptors on macrophages or dendritic cells. The articles address unrelated topics such as PPAR\u03b3 modulation of TLR2 signaling, Siglec-1 binding to HIV-1, TLR4 decoy peptides, TLR3 effects on HIV transcription, engineered CD40, TLR7 agonists, GLP-1 receptor variants, TLR4 expression on monocytes, and insect Dscam receptors. Therefore, the provided evidence neither supports nor contradicts the stated claim."
    },
    "naive_doc_ids": [
      "56486733",
      "2603304",
      "24042363",
      "25606339",
      "33397197"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers mention immunomodulator-human dialyzable leukocyte extract (hDLE) peptides, nor do they show that such peptides are recognized by toll-like receptors on macrophages or dendritic cells. The studies focus on unrelated receptors, pathways, or different TLR ligands. Therefore, no evidence is supplied that supports or contradicts the claim."
    },
    "overthinking_doc_ids": [
      "1044552",
      "4464565",
      "7875158",
      "9164724",
      "10279084"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the cited papers mention human dialyzable leukocyte extract (hDLE) or demonstrate that hDLE-derived peptides are detected by toll-like receptors on macrophages or dendritic cells. The articles describe general TLR biology, TLR-induced cell differentiation, peptide inhibitors of TLR4 signaling, and other immune pathways, but they do not provide experimental data relating hDLE peptides to TLR recognition. Therefore the supplied evidence is insufficient to verify or refute the claim."
    },
    "posthoc_doc_ids": [
      "21498497",
      "24707550",
      "3616843",
      "24042363",
      "25606339"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "268",
    "claim": "Cold exposure increases BAT recruitment.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Multiple cited studies directly report that exposing mice to cold stimulates the appearance of new brown-like (beige) adipocytes or enhances brown-fat\u2013specific gene programs, i.e. recruits BAT. Paper 1 states that an \u201cinitial cold-induced recruitment of beige adipocytes in WAT\u201d occurs and that prolonged cold further drives differentiation of mural cells into beige adipocytes. Paper 3 documents a cold-driven \u2018browning\u2019 transcriptional program in white fat depots, identifying genes/pathways activated by cold that are characteristic of brown adipose tissue. Paper 8, using AdipoChaser mice, shows that during \u201ccold-induced \u2018browning\u2019\u2026 most \u2018beige\u2019 adipocytes stem from de novo\u2013differentiated adipocytes,\u201d demonstrating new BAT cell recruitment under cold. Together, these experimental findings align with the claim that cold exposure increases BAT recruitment rather than contradicting it."
    },
    "naive_doc_ids": [
      "32955023",
      "970012",
      "29381091",
      "3621011",
      "4854076"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 1 shows that exposing mice to cold induces a \u201cwhite\u2010to\u2010brown\u201d transition in adipose tissue, identifying a cold-induced \u2018brite\u2019 transcriptional program characteristic of newly-recruited brown/beige adipocytes.  Paper 4 further reports that (especially after prolonged cold exposure) new beige/brown adipocytes arise from Pdgfr\u03b2+ precursors, explicitly describing this as cold-induced recruitment.  These experimental findings directly align with the claim that cold exposure increases BAT recruitment, and no cited paper presents opposing evidence."
    },
    "overthinking_doc_ids": [
      "29381091",
      "970012",
      "1568684",
      "32955023",
      "40232172"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 shows that exposing mice to cold up-regulates brown-fat\u2013specific genes in white adipose depots, defining a \u201cbrowning\u201d or brown-adipocyte recruitment response. Paper 4 explicitly states that cold exposure (particularly prolonged exposure) induces the recruitment/differentiation of new beige/brown adipocytes, describing the process as \u201ccold-induced recruitment of beige adipocytes.\u201d These experimental findings demonstrate that cold exposure leads to the appearance or expansion of brown/beige adipocytes, i.e., increased BAT recruitment. None of the cited papers provide data opposing this relationship."
    },
    "posthoc_doc_ids": [
      "29381091",
      "970012",
      "1568684",
      "32955023",
      "40232172"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "173",
    "claim": "Bcp1 is a chaperone for Rpl23.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "The provided papers discuss various chaperones (e.g., CMA components, ASF1, Hcp, APLF, Hop, Yar1) and factors involved in ribosome biogenesis or stress responses, but none of them mention Bcp1 or Rpl23, nor do they present data linking Bcp1 to chaperone activity toward Rpl23. Therefore, the supplied evidence does not address the claim."
    },
    "naive_doc_ids": [
      "1084345",
      "12156187",
      "12428814",
      "13907427",
      "37164306"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention Bcp1, Rpl23, or their functional relationship. The abstracts focus on other chaperones (ASF1, Hcp, APLF, Hop, etc.) and unrelated biological processes. Therefore, the evidence does not address whether Bcp1 is a chaperone for Rpl23."
    },
    "overthinking_doc_ids": [
      "1084345",
      "12156187",
      "12428814",
      "13907427",
      "37164306"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers mention Bcp1 or the ribosomal protein Rpl23, nor do they present data on an interaction or chaperone relationship between the two. The evidence therefore offers no information relevant to verifying or refuting the claim."
    },
    "posthoc_doc_ids": [
      "13907427",
      "20524091",
      "37164306",
      "799586",
      "919007"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1111",
    "claim": "Sudden death can occur in patients with complex ventricular arrhythmias.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Among the supplied abstracts, none study cohorts specifically characterized by complex ventricular arrhythmias or report occurrences of sudden death in such patients. The only paper mentioning ventricular arrhythmias (Paper 6) links them to in-hospital mortality in COPD exacerbations, but it does not describe sudden (unexpected) death, nor does it focus on complex ventricular arrhythmias as a primary condition. Therefore the evidence set neither confirms nor refutes the claim."
    },
    "naive_doc_ids": [
      "24408040",
      "2613775",
      "10984005",
      "13768432",
      "21050357"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.22,
      "justification": "None of the provided papers examine sudden death in the context of complex ventricular arrhythmias. They cover topics such as QT dispersion in diabetes, vegetarian diet and ischemic heart disease, radiation\u2010related cancer risk, homocysteine and stroke, HPV and cervical neoplasia, sudden infant death syndrome, morphologic classification of atherosclerotic lesions, sudden unexpected infant death research priorities, definitions of SIDS, and plasma corin in heart failure. These studies do not present data on sudden death occurring in patients with complex ventricular arrhythmias, so they provide no direct evidence to verify or refute the claim."
    },
    "overthinking_doc_ids": [
      "43483151",
      "44624045",
      "14700857",
      "18256197",
      "829646"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the summarized papers examine patients with complex ventricular arrhythmias or report sudden death specifically in that context. The articles focus on sudden infant death syndrome, ECG predictors in diabetes, drug-related mortality, coronary atherosclerosis, C-reactive protein, PDA screening, ADHD-obesity links, and ACE-inhibitor effects on survival. They do not provide data about sudden death occurring in patients who have complex ventricular arrhythmias; therefore, the evidence set neither confirms nor refutes the claim."
    },
    "posthoc_doc_ids": [
      "2613775",
      "21050357",
      "23117378",
      "43483151",
      "5402581"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "551",
    "claim": "ITAM phosphorylation prevents the transfer of the T cell receptor (TCR) signal from the echo-domain to the cytoplasmic tail of the T cell receptor (TCR).",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Paper 2 shows that phosphorylation of the tyrosine residues within the ITAMs of the TCR\u03b6 chain is REQUIRED for the cytoplasmic tail to disengage from the inner leaflet of the plasma membrane after TCR engagement. This disengagement allows the tail to interact with downstream signaling molecules and is necessary for propagation of the T-cell receptor signal. Thus, ITAM phosphorylation facilitates\u2014rather than prevents\u2014transfer of the activation signal from the extracellular ligand-bound TCR to its cytoplasmic domain. The other cited papers do not provide data supporting the idea that ITAM phosphorylation blocks signaling. Therefore the available evidence contradicts the claim."
    },
    "naive_doc_ids": [
      "38143689",
      "8903143",
      "2714623",
      "3127341",
      "33499189"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Paper 1 shows that phosphorylation of the ITAMs within the TCR\u03b6 cytoplasmic tail triggers its release from the plasma-membrane inner leaflet and that this release is required for subsequent proximal and distal T-cell-activation events. Hence ITAM phosphorylation enables, rather than blocks, the transmission of the signal from the receptor\u2019s ectodomain to its cytoplasmic portions. The remaining papers do not provide data indicating that ITAM phosphorylation impedes signal transfer. Collectively, the evidence refutes the claim."
    },
    "overthinking_doc_ids": [
      "8903143",
      "2714623",
      "2825380",
      "3701541",
      "6163801"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.54,
      "justification": "Paper 4 shows that phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) within the TCR\u03b6 cytoplasmic tail is required for the tail to dissociate from the plasma membrane and for downstream signalling to proceed. Mutations that impair this phosphorylation or the subsequent membrane dissociation attenuate both proximal and distal T-cell responses, indicating that ITAM phosphorylation facilitates\u2015rather than prevents\u2015signal transmission from the extracellular TCR engagement to the cytoplasmic signalling machinery. Paper 8 also indicates that ligand binding initiates a conformational change in the CD3\u03b5 subunit that is essential for signalling, with phosphorylation events occurring subsequently, again inconsistent with phosphorylation blocking signal transfer. No paper presents evidence that ITAM phosphorylation blocks or prevents transmission of the TCR signal, so the claim is contradicted by the available evidence."
    },
    "posthoc_doc_ids": [
      "26117607",
      "21931005",
      "34498093",
      "8903143",
      "14405193"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1235",
    "claim": "The morphology change from large white adipocytes to small brown adipocytes is a sign of decreased energy expenditure potential in white adipose tissue.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.87,
      "justification": "Several papers show that conversion (\"browning\") of large white adipocytes into small brown/beige adipocytes elevates, not lowers, the tissue\u2019s capacity to dissipate energy. Paper 1 reports that WAT browning in cancer cachexia is accompanied by higher UCP1 expression and leads to increased lipid mobilization and energy expenditure. Paper 3 summarizes that brown-fat expansion or activation raises whole-body energy expenditure and produces a negative energy balance. Paper 4 details UCP1-independent SERCA2b-mediated thermogenesis in beige adipocytes, again highlighting enhanced energy dissipation after the white-to-brown transition. These findings show that the morphological change signals a gain, not a loss, of energy-expending potential. Therefore the claim is contradicted by the evidence."
    },
    "naive_doc_ids": [
      "26902591",
      "20532591",
      "14865329",
      "19205437",
      "1568684"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.87,
      "justification": "Paper 1 explicitly reports that the phenotypic switch (\"browning\") of white adipose tissue is accompanied by higher UCP1 expression and leads to increased lipid mobilization and energy expenditure. Paper 2 shows that stimulating brown adipose tissue activity raises whole-body energy expenditure in humans. These data indicate that changing from large white adipocytes to small brown/beige adipocytes is associated with an increase\u2014not a decrease\u2014in energy-expenditure capacity. Therefore, the evidence opposes the claim."
    },
    "overthinking_doc_ids": [
      "26902591",
      "1568684",
      "3621011",
      "20532591",
      "4319174"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Multiple papers show that the conversion (browning) of large white adipocytes into smaller brown/brite adipocytes is accompanied by HIGHER, not lower, energy-expenditure capacity.\n\u2022 Paper 1: Browning of WAT in cancer cachexia elevates UCP1, uncouples respiration, and \"leads to increased lipid mobilization and energy expenditure.\" \n\u2022 Paper 2: Activating human brown adipose tissue increases whole-body energy expenditure after chenodeoxycholic acid treatment.\n\u2022 Paper 4: Brown adipocytes \"dissipate energy,\" and cold-induced browning of white fat is viewed as beneficial for combating metabolic disorders through greater thermogenesis.\n\u2022 Paper 6: Brown fat expansion/activation \"results in increased energy expenditure and a negative energy balance.\" \nThese findings directly oppose the claim that the morphological shift to small brown adipocytes signals decreased energetic potential; the evidence consistently links the shift with enhanced thermogenic and energy-dissipating capacity."
    },
    "posthoc_doc_ids": [
      "26902591",
      "1568684",
      "3621011",
      "29381091",
      "5106691"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.85,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "687",
    "claim": "Lamins are found within the inner layer of the nuclear membrane of all cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.34,
      "justification": "Among the cited papers, only Paper 2 discusses lamins, showing that lamin B1 is a component of the nuclear lamina in mammalian cells and can be degraded by autophagy. None of the papers present data about the presence or absence of lamins in every cell type or across all organisms. Therefore the provided evidence is insufficient to verify (or refute) the universal claim that lamins reside in the inner nuclear membrane of all cells."
    },
    "naive_doc_ids": [
      "25623469",
      "4452659",
      "86231298",
      "2603304",
      "4465608"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers discuss lamins or their localization in the inner nuclear membrane, nor do they address whether lamins are present in all cells. Therefore, the evidence set contains no information relevant to verifying or refuting the claim."
    },
    "overthinking_doc_ids": [
      "4350400",
      "16232581",
      "28230867",
      "86704258",
      "695938"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.1,
      "justification": "None of the supplied papers discuss lamins, their localization at the inner nuclear membrane, or their presence in all cells. Therefore, the evidence set neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "25623469",
      "5914739",
      "29422484",
      "43054703",
      "797114"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "209",
    "claim": "CHOP is a general endoplasmic reticulum stress marker.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Paper 1 shows that induction of ER stress in \u03b2-cells by the fatty acid palmitate is accompanied by a time-dependent increase in Ddit3/CHOP mRNA, and CHOP protein is elevated in islets from diabetic mice and humans\u2014situations in which multiple independent ER-stress markers (BiP, XBP1 splicing) are also up-regulated. Paper 3 demonstrates that genetic or siRNA loss of the lipid-transport protein ARV1 triggers the unfolded-protein response; among the canonical UPR genes selectively induced is CHOP, whose elevation correlates with other ER-stress readouts (HAC1 splicing, UPR-reporter activation) and is required for cell-death downstream of ER disruption. In both independent models, CHOP expression rises in parallel with established ER-stress pathways, supporting its use as a general marker of endoplasmic reticulum stress."
    },
    "naive_doc_ids": [
      "25510546",
      "9752604",
      "35760786",
      "1554348",
      "6669242"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 1 describes palmitate-induced endoplasmic reticulum (ER) stress in \u03b2-cells and reports time-dependent increases in Ddit3/CHOP mRNA as part of the ER-stress gene set. Paper 6 shows that loss of ARV1 activates the unfolded-protein response; this ER-stress activation is accompanied by marked up-regulation of CHOP in both yeast and murine macrophages. In both independent models, CHOP expression rises specifically when ER stress is triggered, indicating that CHOP is a reliable marker of the ER-stress response. No paper presents evidence contradicting this role. Therefore the cited evidence supports the claim that CHOP functions as a general ER-stress marker."
    },
    "overthinking_doc_ids": [
      "25510546",
      "418246",
      "471735",
      "1522647",
      "1539159"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.43,
      "justification": "Paper 1 directly examines endoplasmic reticulum (ER) stress in \u03b2-cells and reports that mRNA levels of Ddit3 (also known as C/EBP-homologous protein, CHOP) rise in parallel with other canonical ER-stress genes (Atf4, Xbp1 splicing, Hspa5/BiP, etc.) when cells are exposed to the ER-stress\u2013inducing fatty acid palmitate. The authors treat CHOP induction as part of a \u201ccomprehensive ER-stress response\u201d and use it, together with other ER-stress markers, to document ER stress in mouse and human islets. This provides experimental evidence that CHOP expression is linked to ER stress and is used as a marker of that stress. The remaining papers do not address CHOP or ER stress, so they neither add support nor contradict the claim. Therefore, the available evidence supports the statement that CHOP functions as a general ER-stress marker."
    },
    "posthoc_doc_ids": [
      "25510546",
      "8453819",
      "19561411",
      "29459383",
      "38477436"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "606",
    "claim": "Increased conversion of PGE 2 to PPARy ligand 15-ket-PGE 2 causes accumulation of PGE.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.76,
      "justification": "Paper 1 shows that the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) converts PGE2 to 15-keto-PGE2. In colorectal cancer this enzyme is down-regulated, i.e., conversion is decreased, and this decrease correlates with higher (accumulated) tissue levels of PGE2. Therefore accumulation of PGE2 is associated with reduced\u2014 not increased\u2014conversion to 15-keto-PGE2. Paper 3 likewise reports reduced amounts of 15-keto-PGE2 (implying lowered conversion) without indicating that conversion increase raises PGE2 levels. No paper provides data supporting the claim that increased conversion causes PGE accumulation. Hence the available evidence opposes the claim."
    },
    "naive_doc_ids": [
      "21181273",
      "5775033",
      "712078",
      "1686997",
      "3930020"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Paper 1 shows that the enzyme (15-PGDH) responsible for converting PGE2 to its metabolite 15-keto-PGE2 is DOWN-regulated in colorectal cancer, and this loss of conversion is associated with higher PGE2 levels. Genetic disruption of 15-PGDH abolishes production of the PGE2 metabolite and therefore leads to PGE2 accumulation. Thus, lowered (not increased) conversion raises PGE levels, contradicting the claim that increased conversion to 15-keto-PGE2 causes PGE accumulation. The other cited papers do not address PGE2 metabolism, so the available evidence opposes the claim."
    },
    "overthinking_doc_ids": [
      "21181273",
      "3113630",
      "5775033",
      "13573143",
      "18691097"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.33,
      "justification": "Paper 1 reports that Cftr-deficient mice have REDUCED amounts of the PPAR\u03b3 ligand 15-keto-PGE\u2082, implying that conversion of PGE\u2082 to 15-keto-PGE\u2082 is diminished rather than increased. No other cited paper shows increased conversion of PGE\u2082 to 15-keto-PGE\u2082 or an associated accumulation of PGE\u2082. Thus the available evidence runs opposite to the claim."
    },
    "posthoc_doc_ids": [
      "712078",
      "3127341",
      "31564409",
      "327319",
      "994800"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "26",
    "claim": "A 100g dose of chloroquine chemoprophylactic regimen results in retinal toxicity after 1 year of weekly intake.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.13,
      "justification": "None of the supplied papers report on retinal (ocular) toxicity associated with long-term chloroquine chemoprophylaxis, nor do they analyse cumulative doses near 100 g or outcomes after one year of weekly use. Therefore the evidence set does not address the specific claim."
    },
    "naive_doc_ids": [
      "38410121",
      "1373287",
      "3613041",
      "22334300",
      "25938221"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the cited papers address cumulative chloroquine dosage, length of prophylaxis, or retinal toxicity. The only chloroquine-related article (Paper 6) discusses self-reported side-effects in travelers but provides no data on retinal toxicity or on a 100 g cumulative intake over one year. Therefore the evidence set neither supports nor contradicts the specific claim."
    },
    "overthinking_doc_ids": [
      "37912677",
      "1373287",
      "4336849",
      "6647414",
      "8182950"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers examine retinal (ocular) toxicity related to cumulative chloroquine doses or report on outcomes after a one-year weekly chloroquine regimen totaling 100 g. The cited studies focus on other side-effects in travelers, alternative antimalarial drugs (tafenoquine, mefloquine), or unrelated biomedical topics. Therefore, the evidence set contains no data that either confirms or refutes the claim about chloroquine-induced retinal toxicity."
    },
    "posthoc_doc_ids": [
      "25789730",
      "38410121",
      "40156901",
      "301866",
      "1373287"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1014",
    "claim": "Rapamycin decreases the concentration of triacylglycerols in fruit flies.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "Among the provided papers, only Paper 1 examines rapamycin in Drosophila, and its abstract reports lifespan extension and stress-resistance phenotypes without mentioning measurements of triacylglycerol (TAG) levels. None of the other papers discuss rapamycin effects on lipid (TAG) concentrations in fruit flies. Therefore the supplied evidence neither confirms nor refutes the claim that rapamycin decreases TAG concentration in fruit flies."
    },
    "naive_doc_ids": [
      "6277638",
      "6718824",
      "7005276",
      "14116046",
      "37207226"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the supplied papers, only Paper 1 involves rapamycin treatment in Drosophila, and the excerpted text reports lifespan extension, stress resistance, and involvement of TORC1, autophagy, and translation. It does not mention measurements or changes in triacylglycerol (TAG) levels. The other papers discuss rapamycin in rodents, general mTOR inhibition, or unrelated topics (myosin, CRISPR, etc.) and do not report data on TAG concentrations in fruit flies. Therefore, the provided evidence neither confirms nor refutes the claim."
    },
    "overthinking_doc_ids": [
      "6277638",
      "116792",
      "735130",
      "1227277",
      "1286352"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "Among the provided papers, only Paper 1 involves rapamycin treatment in Drosophila, but it discusses lifespan, starvation resistance, paraquat resistance, autophagy, and translation, without reporting measurements of triacylglycerol (TAG) levels. None of the other papers address rapamycin\u2019s effects on TAG concentration in fruit flies. Therefore, the supplied evidence does not confirm nor refute the specific claim that rapamycin decreases triacylglycerol concentration in Drosophila."
    },
    "posthoc_doc_ids": [
      "6277638",
      "1227277",
      "2423940",
      "4388082",
      "24632480"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "617",
    "claim": "Increased mobility of retrotransposons is assosciated with mutation and higher tumorigenesis rates.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.76,
      "justification": "Paper 7 directly links elevated activity of endogenous retrotransposons (Alu and L1) to both mutagenesis and cancer. It reports abundant new germ-line insertions and, critically, a high frequency of somatic L1 insertions in human lung-cancer genomes, concluding that \u201ctransposon-mediated mutagenesis is extensive in human genomes and is likely to have a major impact on human \u2026 diseases.\u201d  The presence of many new insertions in tumors demonstrates an association between increased retrotransposon mobility, mutation (new insertions = mutagenic events), and tumorigenesis.  Additional support comes from Paper 6 and Paper 8, where mobilization of engineered transposons or retroviral elements produces insertional mutagenesis that accelerates tumor formation, reinforcing the mechanistic link between transposable-element mobility and cancer development.  No paper presents evidence contrary to this relationship.  Therefore, the supplied literature supports the claim that heightened retrotransposon mobility is associated with increased mutation and higher tumorigenesis rates."
    },
    "naive_doc_ids": [
      "24349992",
      "5649538",
      "7211056",
      "11271123",
      "16732790"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the provided papers discuss retrotransposons, their mobilization, or any link between retrotransposon mobility, mutation load, or tumorigenesis. The studies focus on oncogene mutations (KRAS, EGFR, BRAF), EMT, oxidative stress, tumor-associated macrophages, etc., but do not address retrotransposable elements. Therefore, the evidence set gives no information relevant to the claim."
    },
    "overthinking_doc_ids": [
      "3210545",
      "9505402",
      "85665741",
      "3848469",
      "11271123"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers investigate retrotransposons or their mobility. They focus on point mutations, gene amplifications, autophagy genes, oncogene signaling, and other mechanisms unrelated to retrotransposon activity. Therefore they neither support nor contradict the specific claim about retrotransposon mobility, mutation, and tumorigenesis."
    },
    "posthoc_doc_ids": [
      "3127341",
      "3210545",
      "12887068",
      "25576204",
      "1605392"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1100",
    "claim": "Statins increase blood cholesterol.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Across the cited literature, statins are repeatedly described or used as lipid-lowering / cholesterol-lowering agents\u2014not as drugs that raise blood cholesterol. For example, Paper 1 refers to statins as \u201c3-hydroxy-3-methylglutaryl coenzyme A lipid-lowering drugs,\u201d Paper 4 reviews the century-long evidence that lowering LDL cholesterol (with statins among other measures) prevents coronary disease, and Paper 10 states that statins \u201cdecrease hepatic cholesterol biosynthesis.\u201d None of the papers report an increase in circulating cholesterol due to statin therapy; rather, their background statements and rationales rely on the well-established cholesterol-lowering effect of statins. Hence the supplied evidence contradicts the claim that statins increase blood cholesterol."
    },
    "naive_doc_ids": [
      "4687948",
      "9617381",
      "13933299",
      "7662206",
      "7873737"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.35,
      "justification": "The only papers mentioning statins (Papers 8 and 10) treat them as cholesterol-lowering medications used for primary prevention of atherosclerotic cardiovascular disease. Paper 10 shows that statin therapy lowers the incidence of coronary and cerebrovascular events and all-cause mortality, benefits that rely on reducing rather than increasing serum cholesterol. Paper 8 models cost-effectiveness of starting statins on the basis that they are prescribed to lower cholesterol and cardiovascular risk. No study presents data showing an increase in blood cholesterol after statin use. Hence the available evidence runs contrary to the claim that statins increase blood cholesterol."
    },
    "overthinking_doc_ids": [
      "10692948",
      "14724693",
      "16979690",
      "33409100",
      "1642727"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 7 explicitly describes statins as \u201cpotent inhibitors of cholesterol biosynthesis,\u201d a mechanism that lowers\u2014rather than raises\u2014blood cholesterol levels. Paper 1 also links the availability of statins with the therapeutic goal of lowering LDL cholesterol. No cited paper reports statins causing an increase in blood cholesterol. Therefore the supplied evidence opposes the claim that statins increase blood cholesterol."
    },
    "posthoc_doc_ids": [
      "7662206",
      "169264",
      "7757997",
      "8137081",
      "9171913"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.75,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "507",
    "claim": "Helminths interfere with immune system control of macrophages activated by IL-4 favor Mycobacterium tuberculosis replication.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Paper 1 shows that infection with the intestinal helminth Nippostrongylus brasiliensis creates a Th2/IL-4 milieu that induces alternatively activated macrophages in the lung.  This IL-4R\u03b1-dependent alternative activation correlates with, and is causally linked to, higher Mycobacterium tuberculosis loads: co-infected mice have increased pulmonary bacterial burden, while IL-4R\u03b1-deficient mice or mice receiving IL-4R\u03b1-deficient macrophages control M. tuberculosis better.  Thus helminth-driven IL-4 signaling in macrophages interferes with effective immune control and favors M. tuberculosis replication, matching the claim.  The other cited papers do not address helminth\u2013IL-4 interactions with M. tuberculosis, so they neither contradict nor alter this conclusion."
    },
    "naive_doc_ids": [
      "7433668",
      "11837657",
      "1386103",
      "21626639",
      "15414628"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 1 shows that mice harboring the intestinal helminth Nippostrongylus brasiliensis have higher Mycobacterium tuberculosis (Mtb) burdens in their lungs than non-helminth-infected controls.  The increase is linked to a helminth-driven Th2/IL-4 response that triggers accumulation of alternatively (IL-4) activated macrophages.  When the IL-4 receptor \u03b1 chain is genetically deleted, helminth-infected mice no longer accumulate these macrophages and regain the ability to control Mtb, and adoptive transfer of wild-type (IL-4R\u03b1\u207a) macrophages restores the heightened bacterial load.  Thus helminths, through IL-4\u2013dependent alternative macrophage activation, impair host control and permit greater replication of Mtb, exactly matching the claim.  The remaining cited papers discuss macrophage activation or Mtb biology but do not address helminth/IL-4 interactions and do not conflict with Paper 1\u2019s findings."
    },
    "overthinking_doc_ids": [
      "7433668",
      "1386103",
      "11837657",
      "7230315",
      "5137019"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 shows that infection with the helminth Nippostrongylus brasiliensis creates a Th2/IL-4 environment that drives the accumulation of alternatively activated (IL-4-dependent) macrophages in the lung and that this state \"substantially increases the bacterial burden\" of Mycobacterium tuberculosis. Elimination of IL-4 receptor-\u03b1, or transfer of IL-4R\u03b1-deficient macrophages, reverses this effect, demonstrating that helminth-induced IL-4 signaling in macrophages promotes M. tuberculosis replication. This directly matches the claim that helminths, through IL-4\u2013activated macrophages, interfere with immune control and favor M. tuberculosis growth. Additional mechanistic support is provided by Paper 7, which shows IL-4/IL-13 block autophagic killing of M. tuberculosis in macrophages, explaining how IL-4\u2013polarized macrophages become permissive for bacterial replication. Together these findings confirm the claim."
    },
    "posthoc_doc_ids": [
      "7433668",
      "5137019",
      "1386103",
      "11837657",
      "7230315"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.55,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1401",
    "claim": "qSOFA scores are associated with length of stay in emergency department patients.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "Among the provided papers, those that discuss qSOFA examine its association with sepsis, organ dysfunction, ICU admission, mortality, or ICU length of stay. None of the cited studies specifically evaluate whether qSOFA scores correlate with the length of stay of patients in the emergency department. Therefore, the evidence set does not directly address the stated claim."
    },
    "naive_doc_ids": [
      "3878434",
      "26314743",
      "5185871",
      "14021596",
      "8190282"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Among the supplied abstracts, the few papers that assess qSOFA focus on mortality, sepsis diagnosis, or ICU admission. Only one paper (Paper 5) includes ICU length-of-stay in a composite outcome, and that study involves ICU\u2014not emergency-department\u2014patients. None of the abstracts present data specifically examining whether qSOFA scores correlate with length of stay for patients treated in the emergency department. Therefore the evidence set does not address the stated claim."
    },
    "overthinking_doc_ids": [
      "14021596",
      "27054878",
      "34873974",
      "39059143",
      "5185871"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "Among the provided papers, only Paper 1 analyzes qSOFA, and it examines its ability to predict in-hospital mortality and an ICU length-of-stay outcome in patients already admitted to intensive care units. None of the papers investigate the relationship between qSOFA scores and length of stay specifically in emergency-department patients. Therefore the supplied evidence neither supports nor contradicts the stated claim."
    },
    "posthoc_doc_ids": [
      "5185871",
      "14021596",
      "27054878",
      "34873974",
      "39059143"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "391",
    "claim": "Ethanol stress increases the expression of SRL in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the cited papers examine the effect of ethanol stress on SRL expression in bacteria. The studies address oxidative stress (soxRS regulon), heat-shock genes, ethanol tolerance mechanisms without mention of SRL, viral infection, or unrelated eukaryotic processes. Consequently, the provided evidence does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "471735",
      "19238",
      "23305884",
      "34386619",
      "935538"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "Among the ten cited papers, several discuss ethanol stress or tolerance (e.g., Papers 1 and 8), but none of them report data on a gene or RNA designated \u201cSRL,\u201d nor do they describe changes in its expression under ethanol stress. Therefore the supplied evidence does not address the specific claim."
    },
    "overthinking_doc_ids": [
      "21602220",
      "25488034",
      "26596106",
      "28195565",
      "42489926"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the provided papers investigate how ethanol stress affects expression of an SRL gene (or SRL RNA) in bacteria. The cited studies cover oxidative stress responses (soxRS regulon), hypoxia effects on neprilysin, shear-stress regulation of KLF2, complex stresses in lignocellulosic hydrolysate fermentations, phenotypic heterogeneity in Mycobacterium, flavonoid effects on gene expression, LXR-mediated immunity, stochastic gene expression, NusG/Spt5 mechanisms, and \u03b2-adrenergic effects on immunomodulation. None measure SRL expression under ethanol stress. Hence the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "471735",
      "9194077",
      "38944245",
      "21602220",
      "22908536"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "826",
    "claim": "NAC destabilizes NO to increase the effect of contrast agents on renal functions.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "Paper 2, which directly measured intrarenal mediators after contrast medium, shows that pretreatment with N-acetylcysteine (NAC) *increased* (augmented) intrarenal nitric oxide levels and attenuated vasoconstriction. This indicates that NAC stabilises or enhances NO bio-availability rather than destabilising it. Papers 1 and 3 demonstrate that NAC protects renal function after contrast exposure but do not implicate NO destabilisation; they are consistent with an antioxidant/vasodilatory mechanism. None of the cited studies provide evidence that NAC destabilises (reduces or inactivates) NO to influence contrast-induced renal effects. Hence the available evidence opposes the claimed mechanism."
    },
    "naive_doc_ids": [
      "140098548",
      "26025370",
      "4678846",
      "23377475",
      "1759213"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.79,
      "justification": "The only study that directly examined N-acetyl-cysteine (NAC) in the context of radiographic contrast exposure (Paper 6) shows that NAC does not destabilize or decrease nitric oxide (NO). Instead, NAC \"gradually increased intrarenal NO\" and simultaneously blunted contrast-induced renal vasoconstriction. Thus the experimental findings are opposite to the claim that NAC destabilizes NO to influence renal responses to contrast agents. Other cited papers do not address NAC\u2019s interaction with NO in this context, so the net evidence contradicts the claim."
    },
    "overthinking_doc_ids": [
      "26658659",
      "6923795",
      "11181416",
      "11459139",
      "22995164"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.87,
      "justification": "Paper 1 demonstrates that administration of N-acetylcysteine (NAC) to rats given contrast media actually INCREASED intrarenal nitric oxide levels and attenuated vasoconstriction, thereby protecting renal perfusion. Papers 4 and 9 extend this observation to humans: prophylactic oral NAC significantly reduced the rise in serum creatinine and improved creatinine clearance after exposure to radiographic contrast agents. These findings show that NAC protects (rather than amplifies) renal injury from contrast media and is associated with higher, not destabilized, NO activity. No paper presents data showing NAC destabilizes NO or augments contrast-induced renal impairment. Hence the claim is contradicted by the cited evidence."
    },
    "posthoc_doc_ids": [
      "26025370",
      "2533768",
      "21297708",
      "140098548",
      "7155555"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1032",
    "claim": "Reduction of purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpA in 2D BN-PAGE gels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.11,
      "justification": "None of the provided papers discuss two-dimensional Blue Native PAGE (2D BN-PAGE), the intensity of OmpA spots, or the effect of membrane-protein overexpression on the purity of isolated cytoplasmic membranes. Therefore they do not supply information that can confirm or refute the stated claim."
    },
    "naive_doc_ids": [
      "5914739",
      "24541180",
      "623486",
      "8903143",
      "26117607"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers discuss 2-dimensional Blue Native PAGE analyses of cytoplasmic\u2010membrane preparations from protein over-expressing strains or the appearance of OmpA spots as an indicator of reduced membrane purity. Therefore, the evidence set contains no information that confirms or refutes the specific claim."
    },
    "overthinking_doc_ids": [
      "797114",
      "1889358",
      "5914739",
      "7643848",
      "40094786"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers discuss 2-dimensional Blue Native PAGE of membrane preparations, OmpA spot intensity, or how these relate to the purity of cytoplasmic-membrane fractions from overexpressor strains. Consequently, the evidence set contains no information that either supports or contradicts the stated claim."
    },
    "posthoc_doc_ids": [
      "5914739",
      "8903143",
      "26117607",
      "350542",
      "13411519"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1282",
    "claim": "Therapeutic use of the drug Dapsone to treat pyoderma gangrenous is based on anecdotal evidence.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Among the supplied papers, only Paper 6 addresses treatment of pyoderma gangrenosum and mentions dapsone. The study is a retrospective review of just seven patients and simply reports that oral dapsone (along with several other drugs) was \u2018effective\u2019 in some cases. It is not a randomized or controlled trial; it provides only observational, case-series experience\u2014i.e., anecdotal evidence. No higher-level experimental data are presented for dapsone in this setting. Hence the statement that therapeutic use of dapsone for pyoderma gangrenosum is based on anecdotal evidence is consistent with the available literature."
    },
    "naive_doc_ids": [
      "4678846",
      "10582939",
      "39281140",
      "3944632",
      "5912283"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Among the provided papers, only Paper 1 addresses treatment of pyoderma gangrenosum with dapsone. The study is a retrospective review of just seven patients and reports dapsone as one of several \u2018effective therapies.\u2019 This constitutes a very small, uncontrolled case series\u2014an anecdotal level of evidence rather than rigorously controlled clinical data. No randomized or otherwise higher-quality trials of dapsone for pyoderma gangrenosum are presented in the evidence set. Therefore the available evidence supports the claim that therapeutic use of dapsone for this condition rests on anecdotal observations."
    },
    "overthinking_doc_ids": [
      "23649163",
      "26150367",
      "2052720",
      "12869200",
      "15663829"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "The only relevant article (Paper 1) reports on a retrospective case series of seven patients with peristomal pyoderma gangrenosum in which oral dapsone was one of several treatments tried. There is no controlled trial or systematic comparative study; the evidence for dapsone\u2019s benefit comes solely from this small, observational, experience-based report. None of the other provided papers address dapsone or pyoderma gangrenosum. Thus, the therapeutic use of dapsone in this condition, according to the supplied literature, rests on anecdotal (case-series) evidence, supporting the claim."
    },
    "posthoc_doc_ids": [
      "23649163",
      "493346",
      "2052720",
      "2841164",
      "3623127"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1302",
    "claim": "Tirasemtiv has no effect on cardiac muscle.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.36,
      "justification": "Among the cited papers, only Paper 7 deals with tirasemtiv (CK-2017357). It shows that the compound binds selectively to the fast-skeletal-muscle troponin complex and increases force production in skeletal, but not cardiac, preparations. Because cardiac muscle expresses a different (cardiac) troponin isoform, the demonstrated isoform-selective binding implies that tirasemtiv does not act on cardiac muscle. None of the other listed papers examine tirasemtiv or report any cardiac actions of the drug. Therefore, the available evidence supports the claim that tirasemtiv has no effect on cardiac muscle, albeit indirectly rather than through direct cardiac experiments."
    },
    "naive_doc_ids": [
      "25970224",
      "106301",
      "1905095",
      "6270720",
      "9622258"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention tirasemtiv or investigate its effects on cardiac muscle. The evidence therefore provides no information to verify or refute the claim."
    },
    "overthinking_doc_ids": [
      "9846940",
      "106301",
      "317204",
      "1905095",
      "2060137"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers mention tirasemtiv or investigate its effects on cardiac muscle. Therefore the evidence set does not allow verification of the claim."
    },
    "posthoc_doc_ids": [
      "31200375",
      "40156901",
      "106301",
      "1507222",
      "4164929"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "74",
    "claim": "Active H. pylori urease has a polymeric structure consisting of five distinct subunits.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.27,
      "justification": "Among the cited papers, none describes the quaternary (subunit) composition of active Helicobacter pylori urease. Papers 2 and 3 only mention individual urease subunits (UreA or UreB) as antigen sources for vaccines, and the other papers focus on unrelated proteins (HpUreI channel, VacA toxin, plant urease, epidemiological or cell-signalling studies). They neither state that H. pylori urease is built from five distinct subunits nor provide data contradicting that number. Therefore the supplied evidence is insufficient to verify or refute the claim."
    },
    "naive_doc_ids": [
      "4387784",
      "13965483",
      "2837758",
      "25657127",
      "2052720"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "None of the provided papers describe the quaternary (polymeric) structure of Helicobacter pylori urease or specify the number of distinct subunits composing the active enzyme. The cited articles focus on the urea channel (HpUreI), vaccine development using urease epitopes, plant urease structure, epidemiology of H. pylori infection, and unrelated protein structures. Therefore they supply no direct evidence for or against the claim that active H. pylori urease consists of five distinct subunits."
    },
    "overthinking_doc_ids": [
      "4387784",
      "13965483",
      "2837758",
      "25657127",
      "2052720"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the cited papers present experimental data or structural descriptions of active Helicobacter pylori urease that specify the number of distinct subunits in the mature enzyme. The articles focus on a urea channel (HpUreI), epitope-based vaccines, accessory genes in Klebsiella aerogenes, and unrelated biological topics. Consequently, they neither confirm nor refute the statement that active H. pylori urease is a polymer composed of five different subunits."
    },
    "posthoc_doc_ids": [
      "4387784",
      "2837758",
      "13965483",
      "2052720",
      "2099400"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "269",
    "claim": "Cold exposure reduces BAT recruitment.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.92,
      "justification": "Multiple papers report that cold exposure stimulates, not reduces, the appearance or activation of brown/beige adipocytes (i.e., BAT recruitment). Paper 1 shows cold-induced \u2018browning\u2019 of white fat; Paper 2 explicitly states there is an initial cold-induced recruitment of beige adipocytes (followed by mural-cell contribution after prolonged cold); Paper 4 reviews that prolonged cold exposure induces browning of white adipose tissue and brown fat expansion. These findings collectively oppose the claim that cold exposure reduces BAT recruitment."
    },
    "naive_doc_ids": [
      "29381091",
      "32955023",
      "4854076",
      "14865329",
      "3621011"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Several cited papers show that cold exposure induces or increases brown/beige adipocyte formation and BAT activity. Paper 1 reports that cold exposure up-regulates brown fat\u2013enriched genes in white adipose tissue, defining a cold-induced \u2018browning\u2019 (i.e., recruitment of brown-like adipocytes). Paper 4 explicitly states that there is \u201cinitial cold-induced recruitment of beige adipocytes in WAT.\u201d These findings demonstrate that cold exposure stimulates, rather than reduces, BAT/beige adipocyte recruitment. No provided paper presents evidence that cold exposure diminishes BAT recruitment."
    },
    "overthinking_doc_ids": [
      "29381091",
      "970012",
      "1568684",
      "32955023",
      "40232172"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.87,
      "justification": "Several cited studies show that cold exposure stimulates, rather than reduces, the appearance or activity of brown/beige adipocytes. \n\u2022 Paper 1 reports that cold exposure triggers the \u201cinitial cold-induced recruitment of beige adipocytes in WAT,\u201d with additional differentiation after prolonged cold exposure. This indicates recruitment is increased, not reduced.\n\u2022 Paper 3 demonstrates that cold exposure induces a \u201cwhite-to-brown transition (browning)\u201d in white adipose depots, again showing enhanced recruitment/activation of BAT-like cells.\n\u2022 Paper 2 shows that persistent cold exposure activates UCP1-dependent lipolysis in BAT, implying increased BAT activity and, by extension, functional recruitment.\nNo paper presents data showing a decrease in BAT recruitment with cold. Therefore, the claim that cold exposure reduces BAT recruitment is contradicted by the available evidence."
    },
    "posthoc_doc_ids": [
      "32955023",
      "970012",
      "29381091",
      "13000926",
      "22467585"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "894",
    "claim": "Osteoparthritis (OA) is characterized by degeneration of articular cartilage, joint edge, and subchondral bone hyperplasia.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the cited papers, several (e.g., Papers 1 and 2) demonstrate that articular cartilage in osteoarthritis undergoes degenerative, catabolic and inflammatory changes, which is only one component of the claim. None of the provided studies gives direct evidence that osteoarthritis is characterized by (i) degeneration of the joint edge or (ii) hyperplasia of subchondral bone. Paper 3 describes subchondral bone necrosis\u2014not hyperplasia\u2014after monoiodoacetate injection, and the remaining papers are unrelated to osteoarthritis bone changes. Because key parts of the stated triad (joint-edge degeneration and subchondral bone hyperplasia) are not addressed, the evidence set does not verify the full claim."
    },
    "naive_doc_ids": [
      "1044552",
      "33912748",
      "37562370",
      "15365719",
      "24632480"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "Among the cited studies, only Paper 6 deals with an osteoarthritis model, and it reports patellar cartilage and subchondral bone necrosis as well as synovial hyperplasia. None of the papers present data describing the typical pathological triad of articular-cartilage degeneration, joint-edge changes, and subchondral bone hyperplasia that the claim asserts. Therefore the supplied evidence neither confirms nor refutes the claim."
    },
    "overthinking_doc_ids": [
      "15365719",
      "8037453",
      "12130067",
      "23305547",
      "24632480"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "The provided papers focus on inflammation, molecular pathways, and experimental models related to osteoarthritis or other skeletal conditions but do not directly state that OA is characterized by simultaneous degeneration of articular cartilage, joint edge changes, and subchondral bone hyperplasia. No paper explicitly links all three pathological features together as defining characteristics of OA, so the evidence is insufficient to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "37562370",
      "58050905",
      "15365719",
      "97884",
      "1044552"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "876",
    "claim": "Obesity raises life quality.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.76,
      "justification": "Several of the cited papers link excess body weight to poorer\u2014not better\u2014quality-of-life or health outcomes. Paper 2 reports that binge-eating disorder, a condition strongly associated with obesity, \u2018was associated with significant impairment in aspects of HRQoL relating to both physical and mental health.\u2019  Paper 6 shows higher BMI is correlated with lower concentrations of brain metabolites that reflect neuronal viability, suggesting worse brain integrity.  Paper 7 finds that each 5 kg/m\u00b2 increase in BMI is associated with about 30 % higher overall mortality and a reduction in median survival of 2\u201310 years, indicating diminished life quality and longevity.  None of the provided studies present evidence that obesity improves (raises) life quality; the available data instead show negative or detrimental effects. Therefore the claim is contradicted by the evidence supplied."
    },
    "naive_doc_ids": [
      "463533",
      "40666943",
      "17693849",
      "42913391",
      "1538080"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "Among the provided papers none directly examine how obesity itself affects (raises or lowers) overall or health-related quality of life. The studies focus on other topics (binge-eating disorder, chronic diseases in general, ADHD, weight-loss interventions, etc.) or report outcomes unrelated to quality of life. Consequently, they neither confirm nor refute the specific claim that obesity raises life quality."
    },
    "overthinking_doc_ids": [
      "40666943",
      "463533",
      "42913391",
      "1831916",
      "12672066"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.47,
      "justification": "None of the cited papers investigate the relationship between obesity and quality of life. The studies focus on glaucoma, antihypertensive medications, chronic diseases in general, health literacy, cancer drugs, pulmonary hypertension, heart failure, global DALY trends, C. elegans metabolomics, and Down syndrome. Therefore, they provide no direct evidence for or against the claim that obesity raises life quality."
    },
    "posthoc_doc_ids": [
      "31208367",
      "26199970",
      "463533",
      "17693849",
      "32421068"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "494",
    "claim": "HSCT-T dosage may not be diagnostic if the onset of symptoms occurs less than 3 hours before AMI.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 (systematic review/meta-analysis of the Elecsys high-sensitivity cardiac troponin-T assay) explicitly states that a single baseline HS-cTnT measurement \u2018may not be appropriate for patients who present less than three hours after symptom onset.\u2019 This directly supports the claim that HSCT-T dosage (i.e., a single HS-cTnT measurement) may not be diagnostic when symptoms have begun <3 h before an acute myocardial infarction. The other cited papers do not address timing of HS-cTnT measurement relative to symptom onset, so they neither strengthen nor weaken this conclusion. Hence the available evidence supports the claim."
    },
    "naive_doc_ids": [
      "34873974",
      "32159283",
      "44384384",
      "1905095",
      "29526125"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 evaluates the diagnostic accuracy of a single baseline measurement of high-sensitivity cardiac troponin T (HSCT-T) for detecting acute myocardial infarction (AMI). The authors explicitly state in the conclusions that although very low cut-off values can rule out AMI in many patients, \u201cthis method should be part of a comprehensive triage strategy and may not be appropriate for patients who present less than three hours after symptom onset.\u201d  This directly supports the claim that HSCT-T dosage may not be diagnostic when symptoms began <3 h before AMI. The remaining papers do not address timing of symptom onset in relation to HSCT-T measurement, so they provide no contradictory information. Therefore, the net evidence supports the claim."
    },
    "overthinking_doc_ids": [
      "34873974",
      "5558754",
      "29526125",
      "17897801",
      "44384384"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 1 specifically evaluates the diagnostic accuracy of a single baseline high-sensitivity cardiac troponin T (hs-cTnT) measurement and concludes that, although very sensitive at low cut-off values, \u201cthis method \u2026 may not be appropriate for patients who present less than three hours after symptom onset.\u201d  That statement directly mirrors the claim that an hs-cTnT dosage may fail to be diagnostic when symptoms began <3 h before an acute myocardial infarction.  The other cited papers do not address the timing of hs-cTnT measurement relative to symptom onset, so they neither add nor detract from this conclusion.  Thus the available evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "34873974",
      "29526125",
      "34054472",
      "1905095",
      "3984231"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "6",
    "claim": "10% of sudden infant death syndrome (SIDS) deaths happen in newborns aged less than 6 months.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers report the proportion of SIDS deaths that occur in infants younger than 6 months. They discuss risk factors, definitions, and research priorities, but do not give quantitative age\u2010specific incidence figures. Therefore the evidence is insufficient to verify or refute the 10 % figure."
    },
    "naive_doc_ids": [
      "2613775",
      "23117378",
      "21050357",
      "7711685",
      "14021596"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.22,
      "justification": "Among the listed papers, only Paper 1 addresses sudden infant death syndrome, and it focuses on bed-sharing as a risk factor. It does not report what proportion of SIDS deaths occur in infants younger than 6 months (or any similar statistic). The remaining papers are on unrelated medical topics. Consequently, the corpus provides no information that can confirm or refute the specific 10 % figure cited in the claim."
    },
    "overthinking_doc_ids": [
      "20240998",
      "32766786",
      "991139",
      "1428840",
      "1991105"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.47,
      "justification": "None of the cited papers give quantitative data on what proportion of SIDS deaths occur in infants younger than 6 months. They discuss risk factors, definitions, and age-related trends, but no paper reports that only 10 % (or any specific percentage) of SIDS cases fall in the <6-month age group. Therefore the evidence provided is insufficient to verify or refute the claim."
    },
    "posthoc_doc_ids": [
      "35521287",
      "17877537",
      "20240998",
      "30786800",
      "1263446"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "830",
    "claim": "NF2 (Merlin) causes phosphorylation and subsequent cytoplasmic sequestration of YAP in Drosophila by activating LATS1/2 kinases.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers discuss NF2/Merlin, its effects on YAP (or the Drosophila orthologue Yorkie), or activation of LATS1/2 kinases in Drosophila. The abstracts instead cover topics such as myosin light-chain phosphorylation, embryonic mitotic cycles, TEAD regulation by p38, HP1 phosphorylation, T-cell receptor signalling, Hippo interactomes in mammalian cells, YAP in hepatic stellate cells, an LKB1\u2013MARK axis, estrogen-receptor phosphorylation, and PI3K in cardiomyopathy. Therefore the evidence set does not bear on the specific claim, providing neither supporting nor contradicting data."
    },
    "naive_doc_ids": [
      "735130",
      "25670099",
      "52873726",
      "8417211",
      "8903143"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers address the role of NF2 (Merlin) in regulating YAP through activation of LATS1/2 kinases in Drosophila. The papers focus on unrelated topics such as myosin light-chain phosphorylation, embryonic nuclear cycles, HP1 phosphorylation, T-cell receptor signaling, NMDA/AMPA receptor regulation, PI3-kinases, and an LKB1\u2013MARK axis affecting Hippo\u2013YAP, but do not mention Merlin or its effect on YAP via LATS1/2. Therefore, the evidence set does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "735130",
      "25670099",
      "8417211",
      "8903143",
      "14405193"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.12,
      "justification": "None of the provided papers discuss NF2/Merlin, its effect on LATS1/2 activity, or the resulting phosphorylation-dependent cytoplasmic sequestration of YAP (or its Drosophila ortholog Yorkie). The papers focus on unrelated topics such as myosin light chain phosphorylation during oogenesis, early embryonic mitoses, p38-mediated TEAD regulation, calcium oscillations, MUC1\u2013NF-\u03baB signalling, LKB1\u2013MARK influence on Hippo signalling, Hippo protein-interaction networks, TOR-controlled transcription factors, ubiquitin regulation of Notch ligands, and T-cell receptor signalling. Therefore they provide no direct or indirect evidence to confirm or refute the stated claim."
    },
    "posthoc_doc_ids": [
      "735130",
      "25670099",
      "52873726",
      "14719322",
      "23078022"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "848",
    "claim": "Nigerian physicians constitue the largest component of sub-Saharan Africa-trained physicians in the United States.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "The cited papers discuss overall numbers and trends of sub-Saharan Africa\u2013trained physicians in the United States, but the provided excerpts do not specify which country supplies the largest number. No quantitative breakdown showing that Nigerian physicians form the largest component is included, so the evidence neither confirms nor refutes the claim."
    },
    "naive_doc_ids": [
      "14500725",
      "3662510",
      "641459",
      "9547722",
      "18268012"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Among the supplied abstracts, only Paper 2 addresses the composition of sub-Saharan Africa\u2013trained physicians practicing in the United States. The excerpt indicates that migration from Nigeria rose by more than 1,100 physicians between 2002 and 2011, but it does not state the absolute numbers from each source country or explicitly say that Nigerians now form the largest group. The remaining papers do not discuss the nationality distribution of sub-Saharan African physicians in the United States. Consequently, the provided evidence neither confirms nor refutes the claim that Nigerian physicians constitute the largest component of this cohort."
    },
    "overthinking_doc_ids": [
      "3662510",
      "14500725",
      "8593263",
      "25811797",
      "30844602"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "The only relevant excerpt (Paper 1) notes that Nigerian physician migration to the United States has increased substantially (+1,113 in the last decade) but does not specify how many Nigerian-trained physicians are currently practicing in the United States relative to other sub-Saharan African countries. Without data showing that Nigeria supplies the largest absolute number of sub-Saharan Africa-trained physicians, the evidence neither confirms nor refutes the claim."
    },
    "posthoc_doc_ids": [
      "14500725",
      "3662510",
      "8593263",
      "25811797",
      "25953438"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1099",
    "claim": "Statins decrease blood cholesterol.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.14,
      "justification": "None of the cited papers investigate statin therapy or report its effects on blood cholesterol concentrations. They address topics such as zinc supplementation, antipsychotics, dietary fat restriction, tai chi, blood-pressure drugs, physical activity, cellular lipid transport, nuclear receptors, chemotherapy response, and RNAi therapy. Therefore the evidence provided offers no information relevant to verifying whether statins lower blood cholesterol."
    },
    "naive_doc_ids": [
      "4515975",
      "5402581",
      "10692948",
      "24396137",
      "202259"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Among the provided abstracts only Paper 8 deals with statin therapy, and it reports effects on mortality and major cardiovascular events. None of the supplied abstracts present data on changes in serum cholesterol or other lipid parameters after statin treatment. Therefore the evidence given does not address whether statins decrease blood cholesterol."
    },
    "overthinking_doc_ids": [
      "10692948",
      "19182166",
      "19878070",
      "3944632",
      "4678846"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.32,
      "justification": "Paper 1 reviews the history of cholesterol research and, in discussing statins, states that \"effective means to achieve [lowering LDL] are currently available.\" Because the topic of the review (as indicated in the title \u201c... to Statins\u201d) is the use of statins, the paper directly links statins with the ability to lower circulating LDL cholesterol. Paper 10 further treats statins as a therapy within U.S. cholesterol-treatment guidelines, whose purpose is to reduce cholesterol levels to prevent cardiovascular events. Together these papers regard statins as interventions whose accepted role is to lower blood (LDL) cholesterol, thereby supporting the claim. No cited paper presents evidence that statins fail to lower cholesterol, so the net evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "7662206",
      "1958440",
      "9617381",
      "4910408",
      "7116734"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "907",
    "claim": "PGE 2 promotes intestinal tumor growth by altering the expression of tumor suppressing and DNA repair genes.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 3 reports that prostaglandin E2 (PGE2) \u2018silences certain tumor-suppressor and DNA-repair genes through DNA methylation to promote tumor growth\u2019 and specifically identifies this effect in intestinal tumors (title: \u201cProstaglandin E2 promotes intestinal tumor growth via DNA methylation\u201d). Silencing of these genes is an alteration in their expression. Thus the experimental findings directly match the claim that PGE2 promotes intestinal tumor growth by altering (silencing) tumor-suppressor and DNA-repair gene expression."
    },
    "naive_doc_ids": [
      "15113221",
      "22049489",
      "6923961",
      "57783564",
      "11968641"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.87,
      "justification": "Paper 6 reports that prostaglandin E2 (PGE2) promotes intestinal tumor growth by silencing tumor-suppressor and DNA-repair genes through DNA methylation. This directly matches the claim that PGE2 promotes intestinal tumor growth by altering (i.e., down-regulating) the expression of tumor-suppressing and DNA-repair genes. The other papers do not contradict this statement. Therefore, the available evidence supports the claim."
    },
    "overthinking_doc_ids": [
      "7165938",
      "23830488",
      "1507222",
      "6790197",
      "11271123"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.87,
      "justification": "Paper 2 reports that prostaglandin E2 (PGE2) \"silences certain tumor-suppressor and DNA-repair genes through DNA methylation to promote tumor growth.\" This directly matches the claim that PGE2 promotes intestinal tumor growth by altering (silencing) the expression of tumor-suppressing and DNA-repair genes. The other cited papers do not address PGE2, so they neither add support nor contradiction. Therefore, the available evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "15113221",
      "6923961",
      "470625",
      "7028976",
      "9486930"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.8,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "775",
    "claim": "Mice defective for deoxyribonucleic acid (DNA) polymerase I (polI) reveal increased sensitivity to ionizing radiation (IR).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the cited papers examine mice that are defective for DNA polymerase I or their response to ionizing radiation. The studies focus on other polymerases (\u03b7, \u03b2, \u03bc, \u03bb) or unrelated genes and pathways. Therefore, the provided evidence gives no information relevant to the specific claim about Pol I-deficient mice and IR sensitivity."
    },
    "naive_doc_ids": [
      "43014661",
      "21878751",
      "31293581",
      "11569583",
      "5572127"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers mention DNA polymerase I\u2013defective mice or evaluate their response to ionizing radiation. The evidence concerns other DNA polymerases (e.g., Pol \u03b7, Pol \u03b2), different genes (PRIMPOL, PARP-1, ATM, etc.), or unrelated biological processes. Hence, the claim is neither supported nor contradicted by the supplied literature."
    },
    "overthinking_doc_ids": [
      "17368516",
      "23286603",
      "43014661",
      "123859",
      "188911"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the provided papers examine mice that lack or are defective for DNA polymerase I (Polymerase \u03b9) and their response to ionizing radiation. The studies focus on other DNA-repair proteins (ATM, Pol \u03b2, Pol \u03b7) or on unrelated biological processes. Hence the evidence set does not address the claim."
    },
    "posthoc_doc_ids": [
      "31293581",
      "5572127",
      "11569583",
      "43014661",
      "712078"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1190",
    "claim": "The amount of publicly available DNA data doubles every 10 months.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.27,
      "justification": "While several cited papers describe public DNA/functional-genomics databases (e.g., EMBL, GEO) and tools that process such data, none of them report quantitative statistics on how rapidly the amount of publicly available DNA sequence data is growing, nor do they state that the data volume doubles every 10 months. Therefore the provided evidence neither supports nor contradicts the specific growth-rate claim."
    },
    "naive_doc_ids": [
      "30655442",
      "15617300",
      "20375264",
      "33370",
      "1544804"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers discuss the growth rate of publicly available DNA (sequence) databases or state that such data double every 10 months. The abstracts focus on cancer genome instability, socioeconomic health behaviors, circadian photoreceptors, physical activity and mortality, histone chaperones, a read-trimming tool, rice genome evolution, hierarchical phylogenetic models, species delimitation, and an update on the GEO repository without any quantitative claim about doubling time. Therefore the evidence neither supports nor contradicts the stated claim."
    },
    "overthinking_doc_ids": [
      "7211056",
      "456304",
      "5035851",
      "6647414",
      "8411251"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the supplied papers report data on the growth rate of publicly available DNA sequence repositories. The abstracts focus on topics such as health surveys, bioinformatics algorithms, visualization tools, siRNA specificity, and genomics studies, but they do not quantify how quickly public DNA data sets are expanding. Therefore they neither confirm nor refute the claim that DNA data doubles every 10 months."
    },
    "posthoc_doc_ids": [
      "1781626",
      "175735",
      "2883827",
      "3444507",
      "6535392"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1402",
    "claim": "r-protein chaperones are found in complexes with their r-protein binding partners.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 1 reports that the ribosomal protein S3 is imported into the nucleus \u201cassociated with the chaperone Yar1,\u201d i.e., S3 and its dedicated chaperone form a complex. Paper 4 shows an RNA-independent association between the nucleolar chaperone B23/NPM and ribosomal protein S9, describing how B23 stores and protects S9 in nucleoli. Both papers therefore document r-protein chaperones physically complexed with their specific ribosomal-protein binding partners, directly supporting the claim."
    },
    "naive_doc_ids": [
      "15893330",
      "8327914",
      "22896970",
      "26495128",
      "43602749"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Paper 3 shows that ribosomal protein S3 is imported into the nucleus \"associated with the chaperone Yar1,\" demonstrating a stable complex between an r-protein chaperone (Yar1) and its ribosomal-protein client (S3). Paper 10 independently reports that Yar1 \"physically interacts with RpS3\" and that overexpression of RPS3 suppresses Yar1-loss phenotypes, further confirming the existence of an Yar1\u2013Rps3 complex. These data directly support the claim that r-protein chaperones are found in complexes with their r-protein binding partners. None of the other cited papers provide contradictory evidence."
    },
    "overthinking_doc_ids": [
      "22896970",
      "12428814",
      "15893330",
      "23195302",
      "30835854"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Paper 1 reports that the chaperone B23/NPM forms an RNA-independent complex with its ribosomal-protein binding partner RPS9 and stabilizes it in the nucleolus. This is direct evidence that a ribosomal-protein (r-protein) chaperone is physically found in a complex with the r-protein it binds. The other cited papers do not address r-protein chaperones, and none refute this observation. Therefore the available evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "26495128",
      "35231675",
      "30184745",
      "7729656",
      "22896970"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "969",
    "claim": "PrimPol degrades short DNA replication intermediates on the leading strand during DNA replication.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "Among the provided papers, those that mention PrimPol (Papers 3 and 5) describe its roles in repriming and lesion bypass during DNA replication, but they present no data indicating that PrimPol degrades replication intermediates, on the leading strand or otherwise. The remaining papers do not address PrimPol at all. Therefore, the supplied evidence neither supports nor contradicts the stated claim."
    },
    "naive_doc_ids": [
      "2758012",
      "41314611",
      "28904104",
      "7151961",
      "15077696"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.58,
      "justification": "Among the cited papers, the ones that concern PrimPol (papers 4, 7, 8, 9) describe it as a primase-polymerase that reprimines DNA synthesis or performs translesion synthesis to help replication fork progression. None of these studies report PrimPol acting as a nuclease or degrading replication intermediates on the leading strand (or anywhere else). The remaining papers do not discuss PrimPol at all. Because no evidence in the provided literature addresses\u2014let alone supports or refutes\u2014the specific claim that PrimPol degrades short leading-strand intermediates, there is insufficient information to evaluate the claim."
    },
    "overthinking_doc_ids": [
      "2758012",
      "13106686",
      "41314611",
      "28904104",
      "888896"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Among the provided papers, the only ones that discuss PrimPol (Paper 4 and Paper 5) describe its roles in translesion synthesis, repriming, and facilitating fork progression after DNA damage or nucleotide depletion. They do not report any nuclease or degradative activity, nor do they examine the fate of short leading-strand intermediates. The remaining papers do not involve PrimPol at all. Therefore, the supplied evidence neither supports nor refutes the claim that PrimPol degrades short DNA replication intermediates on the leading strand."
    },
    "posthoc_doc_ids": [
      "2758012",
      "41314611",
      "7151961",
      "15077696",
      "28904104"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "392",
    "claim": "Ethanol stress lowers the expression of PSP in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.16,
      "justification": "None of the provided papers discuss ethanol stress or its effect on PSP (phage shock protein) expression in bacteria, so they neither support nor contradict the claim."
    },
    "naive_doc_ids": [
      "471735",
      "34386619",
      "9194077",
      "23305884",
      "24185667"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "Among the provided papers, none describe experiments that measure phage-shock protein (PSP) expression in response to ethanol stress. Some papers discuss ethanol stress (Papers 2 and 5) and others mention PSP/PspA in different contexts (Paper 4), but no study links ethanol exposure to changes\u2014whether increases or decreases\u2014in PSP levels. Therefore the claim cannot be verified or refuted with the supplied evidence."
    },
    "overthinking_doc_ids": [
      "471735",
      "21602220",
      "6669242",
      "26625002",
      "1148122"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "None of the cited papers mention ethanol stress together with bacterial PSP (phage shock protein or any similarly named protein) expression levels. Therefore they provide no direct information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "471735",
      "9194077",
      "23305884",
      "24185667",
      "25293721"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "4",
    "claim": "1-1% of colorectal cancer patients are diagnosed with regional or distant metastases.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.88,
      "justification": "Paper 2 reports that 19 % of colorectal cancer patients had synchronous distant metastases (Stage IV) in 1996\u20131999, rising to 23 % in 2008\u20132011. These values are far higher than the claimed 1 % (or 1-1 %) for regional or distant metastases. Therefore the evidence refutes the claim."
    },
    "naive_doc_ids": [
      "5641851",
      "10958594",
      "2058909",
      "22942787",
      "23136735"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 2 reports that 19\u201323 % of all colorectal cancer patients in the Netherlands between 1996 and 2011 already had synchronous distant metastases (Stage IV) at diagnosis. This proportion is far higher than the claimed 1 %. Therefore, the evidence contradicts the statement that only 1 % of colorectal cancer patients present with regional or distant metastases."
    },
    "overthinking_doc_ids": [
      "5641851",
      "10958594",
      "39903312",
      "520579",
      "7165938"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Paper 1 reports that among 160 278 colorectal cancer cases in the Netherlands, 19 % of patients were Stage IV (had synchronous distant metastases) in 1996-1999, rising to 23 % in 2008-2011. This proportion of distant-metastatic disease at diagnosis is roughly twenty-times higher than the 1 % figure claimed. Because regional (Stage III) cases are additional to these, the combined proportion of regional or distant metastases is even higher. No paper provides data supporting a prevalence as low as 1 %; instead the available evidence shows that metastases at presentation are common (> 15-20 %). Therefore the claim that only ~1 % of colorectal cancer patients are diagnosed with regional or distant metastases is contradicted by the evidence."
    },
    "posthoc_doc_ids": [
      "10958594",
      "24980622",
      "3329824",
      "8037453",
      "15476777"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "474",
    "claim": "Glycan adaptation is rarely observed in the B-cell repertoire.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the cited papers investigate how often glycan adaptation occurs within the B-cell receptor repertoire. The studies focus on T-cell tolerance (papers 1, 3, 4, 8), viral escape and antibody epitopes (paper 2), pre-B-cell receptor function (paper 5), insect immune receptors (paper 6), myeloid-cell regulation (paper 7), autoantibody generation in celiac disease (paper 9) and retrotransposon variation (paper 10). They provide no quantitative or qualitative data about the frequency of glycan adaptation events in B cells, so they neither support nor contradict the claim."
    },
    "naive_doc_ids": [
      "8354687",
      "7177329",
      "21392223",
      "27910499",
      "34254203"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided studies investigate how frequently glycan adaptations occur in immunoglobulin genes within the B-cell repertoire. The cited papers focus on T-cell selection and diversity, pre-B-cell receptor function (without discussing glycan sequence changes), HIV envelope glycosylation, transcription-factor\u2013mediated chromatin changes, pluripotent stem cells, T-cell receptor excision circles, macrophage cytokine regulation, simian lentiviruses, and cancer-cell signaling. Consequently, they offer no direct evidence that either supports or contradicts the claim that glycan adaptation is rarely observed in the B-cell repertoire."
    },
    "overthinking_doc_ids": [
      "8354687",
      "27910499",
      "34254203",
      "2601135",
      "4896726"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the summarized papers address glycan adaptation within B-cell repertoires. The articles focus on transcription factors, T-cell and NK-cell selection, stem-cell differentiation, vaccine responses, and related topics, but provide no experimental data or discussion about glycans or their adaptation in B cells. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "4896726",
      "8354687",
      "21392223",
      "27910499",
      "34254203"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "698",
    "claim": "Lmna knock-in models are appropriate for testing therapeutic approaches against Hutchinson-Gilford progeria syndrome (HGPS).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the provided papers, none describes an LMNA knock-in animal model of Hutchinson-Gilford progeria syndrome or evaluates therapeutic interventions in such a model. The cited studies either use different genetic models (e.g., Zmpste24-deficient mice), review human HGPS phenotypes, or focus on unrelated diseases and gene-editing methods. Therefore, the evidence set contains no direct information to confirm or refute the suitability of LMNA knock-in models for therapy testing in HGPS."
    },
    "naive_doc_ids": [
      "31324978",
      "15692098",
      "22544171",
      "19308127",
      "31884697"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Among the cited papers the only in-vivo therapeutic study for progeria is in Zmpste24-deficient mice (Paper 8). None of the papers describe or evaluate Lmna knock-in animal models, nor do they compare their suitability for testing therapies. Therefore the evidence set gives no information that confirms or refutes the appropriateness of Lmna knock-in models for Hutchinson-Gilford progeria syndrome therapeutic studies."
    },
    "overthinking_doc_ids": [
      "13774178",
      "1495563",
      "3613041",
      "7751726",
      "25938251"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.34,
      "justification": "None of the cited papers describe or evaluate Lmna knock-in animal models (e.g., mice carrying the HGPS LMNA mutation) or assess their suitability for therapeutic testing. The progeria-related study (Paper 3) uses Zmpste24-deficient mice, not an Lmna knock-in model. Therefore the evidence set neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "15692098",
      "22544171",
      "31324978",
      "2565138",
      "7239105"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1183",
    "claim": "The TRaF1/C5 rs10818488 allele polymorphism regulates the neighboring C5 gene.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Among the supplied abstracts, only Paper 7 mentions the TRAF1/C5 locus and the SNP rs10818488, and it does so in the context of genetic association with rheumatoid arthritis. The abstract offers no data about how this polymorphism affects expression or regulation of the adjacent C5 gene. The remaining papers discuss unrelated topics (dosage compensation in chickens, keratin regulation, semaphorin expression after CNS injury, COMPASS-mediated histone methylation, sexually dimorphic gene expression, LXR signaling in macrophages, long non-coding RNAs, MBP transcription, IL28B polymorphisms in HCV). None contain experiments or conclusions on rs10818488 modulating C5 expression. Therefore, the provided evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "12232678",
      "12580014",
      "33535447",
      "42009630",
      "28928964"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.22,
      "justification": "None of the provided papers discuss the TRaF1/C5 locus, the rs10818488 polymorphism, or present data showing that this variant regulates expression of the neighboring C5 gene. The papers focus on general eQTL mapping methods, other genes (MBP, IL-6, GLP-1R, survivin, bcl-2, etc.), signaling pathways, or chromatin regulation, but do not provide any experimental results about TRaF1/C5 rs10818488. Therefore they offer no information relevant to confirming or refuting the specific claim."
    },
    "overthinking_doc_ids": [
      "4378885",
      "15286783",
      "28928964",
      "19238",
      "164985"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the provided papers mention the TRaF1/C5 locus, the rs10818488 polymorphism, or experimental data on how this variant affects regulation of the neighboring C5 gene. Therefore, the evidence set does not contain information that can confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "5519177",
      "12232678",
      "12580014",
      "14050257",
      "17919731"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "654",
    "claim": "Intra-cerebroventricular infusion of amyloid-\u03b2 oligomers increases expression of fibronectin type-III domain-containing protein 5 mRNA in mice hippocampi.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.37,
      "justification": "Paper 1 directly examined fibronectin type-III domain-containing protein 5 (FNDC5) in Alzheimer\u2019s-related conditions. It reports that \u201cFNDC5/irisin levels are reduced in AD hippocampi \u2026 and in experimental AD models.\u201d Experimental AD models commonly include intra-cerebroventricular administration of amyloid-\u03b2 oligomers; thus the observed effect is a decrease, not an increase, in hippocampal FNDC5 expression after A\u03b2 exposure. No other cited paper provides data supporting an up-regulation of FNDC5 after A\u03b2 oligomer infusion. Hence the available evidence opposes the claim."
    },
    "naive_doc_ids": [
      "57574395",
      "20943272",
      "56486733",
      "20937018",
      "24142891"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.41,
      "justification": "Among the provided papers, only Paper 6 discusses fibronectin type-III domain-containing protein 5 (FNDC5) expression, reporting that its levels are reduced in Alzheimer\u2019s disease hippocampi and experimental AD models. None of the abstracts mention experiments in which mice received intra-cerebroventricular infusions of amyloid-\u03b2 oligomers, nor do they describe resulting increases in FNDC5 mRNA in the hippocampus. Therefore, the supplied evidence neither confirms nor refutes the specific claim."
    },
    "overthinking_doc_ids": [
      "24989194",
      "7221410",
      "20937018",
      "36180468",
      "45336190"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers discuss the effects of intra-cerebroventricular infusion of amyloid-\u03b2 oligomers on fibronectin type-III domain-containing protein 5 (FNDC5) mRNA expression in mouse hippocampus. The cited studies address unrelated topics such as WT1\u2013mRNA interactions, adenoviral proteins, myelin basic protein transcripts, ADAM13\u2013fibronectin binding, ER dislocation, caveolin-1 in cardiac fibrosis, maternal diet effects, dendritic-cell-based vaccines, metabolomic effects of Schisandra, and Wnt5a in planar cell polarity. Therefore the evidence set does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "39929509",
      "207972",
      "3788528",
      "20943272",
      "38477436"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1218",
    "claim": "The first MBT repeat of the four malignant brain tumor (4MBT) domain of Drosophila's Sfmbt and of the orthologous mammalian L3MBTL2 is required for the interaction with the spacer region of Drosophila's Pleiohomeotic (Pho) or its human ortholog YY1.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the summarized papers discuss the 4MBT domain of Drosophila Sfmbt, its individual MBT repeats, or their interaction with Pleiohomeotic (Pho) or the mammalian ortholog L3MBTL2 with YY1. Therefore, the supplied evidence provides no information to verify or refute the stated claim."
    },
    "naive_doc_ids": [
      "4270992",
      "140874",
      "169264",
      "207972",
      "20935673"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided papers discuss Sfmbt, L3MBTL2, MBT repeats, Pleiohomeotic (Pho), YY1, or their interactions. Therefore, they offer no evidence for or against the claim."
    },
    "overthinking_doc_ids": [
      "10698739",
      "12462961",
      "12669325",
      "13242763",
      "28107602"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the provided papers address the interaction between Drosophila Sfmbt or mammalian L3MBTL2 and the spacer region of Pho/YY1, nor do they examine the requirement of the first MBT repeat for that interaction. The abstracts discuss unrelated topics such as mitochondrial proteases, GATA factors, chromatin architecture, trophectoderm differentiation, drug scheduling, structural studies of MBTD1 (but not its interaction with Pho/YY1), LIM homeobox genes, glutamate receptors, dynein\u2013microtubule interactions, and MHC\u2013CD4 contacts. Hence the evidence set contains no information relevant to verifying or refuting the claim."
    },
    "posthoc_doc_ids": [
      "10698739",
      "12462961",
      "12669325",
      "13242763",
      "28107602"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "418",
    "claim": "Fibroblast Growth Factor is a ligand which signals through receptor tyrosine kinases.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 10 repeatedly refers to FGFR1 as \u201cFGFR1TK,\u201d explicitly identifying the fibroblast-growth-factor receptor-1 as a receptor tyrosine kinase and shows that blocking its kinase activity with the selective inhibitor PD173074 suppresses downstream (angiogenic) signalling. Because FGFR1 is the cognate receptor for Fibroblast Growth Factor, the data demonstrate that the biological effects initiated by the FGF ligand are conveyed through a receptor tyrosine-kinase mechanism. Thus the evidence aligns with the claim that Fibroblast Growth Factor signals through receptor tyrosine kinases."
    },
    "naive_doc_ids": [
      "16494316",
      "21931005",
      "9486930",
      "24974080",
      "17648235"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Paper 3 describes PD173074 as a \u201cselective FGFR1 tyrosine kinase (TK) inhibitor\u201d and shows that blocking this FGFR1 TK suppresses angiogenic responses. Since FGFR1 is the receptor for Fibroblast Growth Factor (FGF) and it is explicitly identified as a receptor tyrosine kinase, the data indicate that FGF transmits its signal through an RTK. The other papers do not contradict this point. Therefore, the evidence supports the claim that Fibroblast Growth Factor is a ligand that signals via receptor tyrosine kinases."
    },
    "overthinking_doc_ids": [
      "40710501",
      "21931005",
      "23420807",
      "34066665",
      "1065627"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Paper 4 studies PD173074, described as a \u201cselective FGFR1 tyrosine-kinase (TK) inhibitor.\u201d FGFR1 is the Fibroblast Growth Factor Receptor-1. Because an inhibitor directed at the receptor\u2019s tyrosine-kinase activity blocks downstream signalling and angiogenic responses, the paper implicitly establishes that the receptor for Fibroblast Growth Factor possesses intrinsic tyrosine-kinase activity and that FGF signalling is mediated through this RTK. No paper presents data contradicting this relationship. Hence the evidence supports the claim that Fibroblast Growth Factor signals through receptor tyrosine kinases."
    },
    "posthoc_doc_ids": [
      "34066665",
      "16494316",
      "21931005",
      "23420807",
      "40710501"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "175",
    "claim": "Beta-band coherence is enhanced for visible stimuli over invisible stimuli.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 reports that consciously perceived (unmasked, i.e., visible) words show \u201cincreases in long-distance phase synchrony in the beta range,\u201d whereas non-conscious (masked, invisible) words show no coherent long-distance beta activity. This is a direct demonstration that beta-band coherence is stronger for visible than for invisible stimuli. Paper 9 reviews converging studies and likewise states that conscious access is accompanied by \u201clong-distance cortico-cortical synchronization at beta and gamma frequencies,\u201d again implying enhanced beta synchrony for consciously perceived (visible) information compared with non-conscious (invisible) processing. No paper presents opposing evidence. Hence the available literature supports the claim that beta-band coherence is enhanced for visible stimuli over invisible stimuli."
    },
    "naive_doc_ids": [
      "1710116",
      "25653703",
      "79336156",
      "6955746",
      "24523573"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 2 reports that consciously perceived (unmasked, thus visible) words show \"increases in long-distance phase synchrony in the beta range,\" whereas non-conscious (masked, invisible) words show no coherent long-distance beta activity. This directly indicates greater beta-band coherence for visible than for invisible stimuli.  Paper 5, a review that summarizes converging evidence, likewise notes that conscious access is accompanied by \u201clong-distance cortico-cortical synchronization at beta and gamma frequencies,\u201d compared with non-conscious processing. Both sources therefore align with the claim that beta-band coherence is enhanced for visible relative to invisible stimuli."
    },
    "overthinking_doc_ids": [
      "79336156",
      "1710116",
      "5137019",
      "6985854",
      "14535322"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 7 reports that when words are consciously perceived (unmasked, i.e., visible), intracranial recordings show \u2018increases in long-distance phase synchrony in the beta range\u2019, whereas the same words presented invisibly (masked) evoke no coherent long-distance beta activity. This directly indicates stronger beta-band coherence for visible than for invisible stimuli. Paper 6 reviews converging studies and also lists \u2018long-distance cortico-cortical synchronization at beta and gamma frequencies\u2019 as a neural signature of conscious (visible) processing compared with non-conscious (invisible) processing. Together these findings align with the claim that beta-band coherence is enhanced for visible stimuli over invisible stimuli."
    },
    "posthoc_doc_ids": [
      "10128893",
      "79336156",
      "602760",
      "3943235",
      "5137019"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "36",
    "claim": "A deficiency of vitamin B12 increases blood levels of homocysteine.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Among the provided papers, none examine subjects who are specifically vitamin B12\u2013deficient and none report that vitamin B12 deficiency leads to higher plasma/serum homocysteine levels. Paper 1 shows homocysteine changes with folate while vitamin B12 remains unchanged; Paper 9 shows that adding B12 (with folate and B6) lowers homocysteine in kidney-disease patients but does not establish that B12 deficiency raises it. The remaining papers do not address vitamin B12 or homocysteine. Therefore the supplied evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "18557974",
      "24049225",
      "4353857",
      "9555784",
      "13312471"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.35,
      "justification": "None of the cited papers examine the relationship between vitamin B12 deficiency and blood (plasma/serum) homocysteine concentrations. The articles focus on vitamin D, magnesium, folic acid, calcium, acupuncture, and other vitamins, but do not present data on how a lack of vitamin B12 affects homocysteine levels. Therefore the claim is neither confirmed nor refuted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "9555784",
      "13312471",
      "30720103",
      "1495563",
      "3222187"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Among the supplied abstracts, none reports experimental or observational data showing that individuals with vitamin B12 deficiency have higher circulating homocysteine than those with adequate vitamin B12. Several papers discuss homocysteine in relation to folate status, MTHFR genotype, or combined B-vitamin supplementation, but they do not isolate vitamin B12 deficiency as the determinant. Therefore the evidence provided does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "9555784",
      "13312471",
      "16252863",
      "42441846",
      "275294"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "45",
    "claim": "A mutation in HNF4A leads to an increased risk of diabetes by the age of 14 years.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Among the provided papers, only Paper 4 deals with HNF4A mutations, but it focuses on birth-weight, neonatal hypoglycaemia, and effects on fetal/neonatal insulin secretion. None of the excerpts report data on the later development of diabetes or its incidence by age 14. Therefore, the evidence set does not confirm or refute the specific claim about increased diabetes risk by age 14 in individuals with HNF4A mutations."
    },
    "naive_doc_ids": [
      "4353857",
      "4647303",
      "43311750",
      "56893404",
      "2605032"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the provided papers, only Paper 2 concerns HNF4A mutations, but the abstract discusses birthweight, neonatal hypoglycaemia and insulin secretion; it does not report on the incidence or risk of developing diabetes by age 14. None of the other papers mention HNF4A or childhood-onset diabetes linked to this gene. Therefore, the supplied evidence neither confirms nor refutes the specific claim about increased diabetes risk by age 14."
    },
    "overthinking_doc_ids": [
      "3127341",
      "56893404",
      "120626",
      "195352",
      "439670"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Among the supplied papers, only Paper 7 discusses individuals carrying heterozygous mutations in HNF4A, and its abstract focuses on birth-weight, neonatal hypoglycaemia and in-utero insulin secretion. None of the provided summaries mention follow-up through childhood or report diabetes incidence (or increased risk) specifically by age 14. Therefore, the cited evidence does not confirm or refute the stated claim."
    },
    "posthoc_doc_ids": [
      "43417006",
      "27166444",
      "4353857",
      "31347396",
      "76463821"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1161",
    "claim": "The DEXI promoter region is bound by multiple transcription factors in a murine haematopoietic progenitor cell line.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.89,
      "justification": "None of the provided papers discuss the DEXI promoter or transcription-factor binding to this promoter in murine haematopoietic progenitor cells. The evidence summaries concern other genes, cell types, pathways or organisms, so they neither confirm nor refute the claim."
    },
    "naive_doc_ids": [
      "7155555",
      "3052213",
      "18489989",
      "8331432",
      "9724974"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers mention the DEXI gene, its promoter, or transcription-factor binding to this promoter in murine haematopoietic progenitor cells. Therefore they neither support nor contradict the claim."
    },
    "overthinking_doc_ids": [
      "3052213",
      "8331432",
      "9724974",
      "5116145",
      "20179918"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the provided papers discuss the DEXI promoter or transcription-factor binding to the DEXI promoter in murine hematopoietic progenitor cells. Therefore they neither confirm nor refute the claim."
    },
    "posthoc_doc_ids": [
      "18489989",
      "54561384",
      "3052213",
      "7155555",
      "9724974"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1204",
    "claim": "The combination of H3K4me3 and H3K79me2 is found in quiescent hair follicle stem cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "Among the provided paper summaries, only Paper 2 addresses histone modifications in hair-follicle stem cells, and its abstract discusses H3K27me3 rather than the specific combination of H3K4me3 and H3K79me2. None of the other papers mention hair-follicle stem cells together with H3K4me3 and H3K79me2. Therefore, the supplied evidence does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "6455142",
      "31141365",
      "40349336",
      "33370",
      "106301"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.64,
      "justification": "Among the supplied abstracts, only Paper 2 investigates chromatin marks in hair-follicle stem cells, and it focuses on H3K27me3 (PcG-mediated repression). None of the listed papers report the presence, absence, or co-occurrence of the active marks H3K4me3 and H3K79me2 in quiescent hair follicle stem cells. Therefore the provided evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "15907458",
      "31141365",
      "16630060",
      "92499",
      "104130"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Among the provided abstracts, only Paper 2 examines histone-modification profiles in quiescent and activated hair-follicle stem cells, but it discusses H3K27me3 and does not report the presence or co-occurrence of H3K4me3 and H3K79me2. None of the other papers address histone marks in hair-follicle stem cells. Therefore the supplied evidence neither confirms nor refutes the claim about H3K4me3 + H3K79me2 in quiescent hair-follicle stem cells."
    },
    "posthoc_doc_ids": [
      "25597580",
      "31141365",
      "15907458",
      "2853291",
      "3140772"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "502",
    "claim": "Healthcare delivery efficiency in crowded delivery centers is impaired by improving structural, logistical, and interpersonal elements.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "The cited studies address patient experience in primary care, reliability of patient surveys, palliative care quality, husbands\u2019 involvement in childbirth decisions, point-of-care drug assays, ICU organizational formats, sepsis scoring tools, costs of COPD care units, and fluid balance in ICU patients. None of them investigate healthcare delivery efficiency in crowded delivery centers or the effect of enhancing structural, logistical, and interpersonal factors on that efficiency. Therefore they provide no direct evidence to confirm or refute the stated claim."
    },
    "naive_doc_ids": [
      "19945096",
      "21377587",
      "77971703",
      "10854174",
      "18153456"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the provided studies examine how improvements to structural, logistical, or interpersonal elements affect healthcare-delivery efficiency in crowded delivery centres. The papers focus on topics such as neglected tropical diseases, pharmacist interventions, HIV treatment modelling, deliberate self-harm, maternal nutrition, and husbands' involvement in childbirth, but they do not present data addressing whether such improvements impair (or improve) efficiency in crowded delivery settings."
    },
    "overthinking_doc_ids": [
      "1215116",
      "39300105",
      "13899137",
      "38799797",
      "1102268"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the cited studies examine how improving structural, logistical, or interpersonal elements affects healthcare-delivery efficiency specifically in crowded delivery centers. The papers deal with topics such as cloning efficiency, dietary interventions in pregnancy, nutrition programmes, mental-health integration, tumor stroma, ACE-inhibitor renal effects, ICU organization, platelet indices in cancer, alcohol labelling, and HIV treatment modeling. Consequently, they offer no direct evidence for or against the stated claim."
    },
    "posthoc_doc_ids": [
      "22490293",
      "11360768",
      "11748341",
      "24318630",
      "2565138"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "758",
    "claim": "Marmosets have a brain region homologous to Broca's area.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 2 reports that the ventrolateral prefrontal cortex of common marmosets is activated during spontaneous vocal production. The authors explicitly identify this ventrolateral prefrontal sector as \"the region that comprises Broca's area in humans\" and emphasize that it is part of the same cortical network that supports vocal communication in Old-World primates. This constitutes direct evidence that marmosets possess a cortical territory considered homologous to human Broca\u2019s area. No paper in the provided set presents data contradicting this interpretation, so the claim is supported."
    },
    "naive_doc_ids": [
      "3095620",
      "1391126",
      "27815697",
      "14195528",
      "35329820"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 7 reports that the ventrolateral prefrontal cortex of the common marmoset is activated during vocal production and explicitly identifies this region as the part of cortex that \"comprises Broca's area in humans.\" The authors conclude that the neocortical network for vocal communication in marmosets is similar to that of Old-World primates, implying a homologous Broca-like region. Paper 6 likewise records single-unit activity in marmoset ventrolateral frontal cortex during natural vocal behavior, providing additional functional evidence that this frontal area participates in vocal-motor control. Together these findings indicate that marmosets possess a brain region in ventrolateral prefrontal cortex that is considered homologous to human Broca's area, supporting the claim."
    },
    "overthinking_doc_ids": [
      "3095620",
      "11884867",
      "13322804",
      "21003930",
      "21323758"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 4 reports that the ventrolateral prefrontal cortex of common marmosets is activated during vocal production. This cortical sector is described as \"the region that comprises Broca's area in humans\" and is the same part of frontal cortex previously identified as the Broca's-area homologue in Old-World monkeys (areas 44/45). The finding that this specific ventrolateral prefrontal region is functionally engaged in marmoset vocal behaviour demonstrates the presence of a Broca-like, homologous brain area in this species. No cited paper provides contradictory evidence, and several (e.g., Paper 8) further document vocal-motor activity in the same frontal region. Therefore, the supplied evidence supports the claim that marmosets possess a brain region homologous to Broca's area."
    },
    "posthoc_doc_ids": [
      "3095620",
      "30351165",
      "23869951",
      "1391126",
      "6036535"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "o3",
    "claim_id": "176",
    "claim": "BiP is a general endoplasmic reticulum stress marker.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 1 shows that when \u03b2-cells are exposed to a pro-apoptotic fatty acid (palmitate) they mount \u2018a comprehensive ER stress response\u2019 in which HSPA5/BiP mRNA and protein are up-regulated together with other canonical ER-stress genes (ATF4, CHOP, XBP1 splicing). The same study reports increased BiP protein in islets from diabetic db/db mice and from humans with type 2 diabetes, conditions in which ER stress is present. Because BiP expression consistently rises in multiple ER-stress settings and is analyzed alongside other accepted ER-stress markers, the paper supports the statement that BiP functions as a general marker of endoplasmic reticulum stress."
    },
    "naive_doc_ids": [
      "25510546",
      "8453819",
      "19561411",
      "29459383",
      "38477436"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Paper 1 directly links ER stress with increased expression of BiP/HSPA5 in three independent settings: (i) palmitate-induced ER stress in MIN6 \u03b2-cells, (ii) islets from diabetic db/db mice, and (iii) pancreatic islets from humans with type 2 diabetes. In each case, BiP levels rose in parallel with multiple unfolded-protein-response genes, and over-expression of BiP attenuated ER-stress-induced apoptosis, establishing it as a read-out of the stress response. None of the other cited papers provide data that contradict this relationship. Thus the available evidence supports the claim that BiP serves as a general marker of endoplasmic reticulum stress."
    },
    "overthinking_doc_ids": [
      "25510546",
      "8453819",
      "19561411",
      "29459383",
      "38477436"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Paper 1 examines several models in which endoplasmic reticulum (ER) stress is triggered (palmitate-treated MIN6 \u03b2-cells, islets from diabetic db/db mice, and pancreatic islets from humans with type 2 diabetes). In every case, ER stress is accompanied by a strong up-regulation of the ER chaperone BiP/HSPA5 and the authors explicitly list BiP among the \u2018marker genes of ER stress\u2019. The study therefore shows that BiP expression reliably rises when ER stress occurs in disparate cell types and species, consistent with its use as a general ER-stress marker. None of the other cited papers present data that conflict with this interpretation. Hence, the available evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "25510546",
      "8453819",
      "19561411",
      "29459383",
      "38477436"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "628",
    "claim": "Infection of human T-cell lymphotropic virus type 1 is most frequent in individuals of African origin.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "None of the provided excerpts give quantitative or comparative data showing that HTLV-1 infection is more common in people of African origin than in other populations. Paper 10 merely notes that HTLV-1 is endemic in several geographically and ethnically diverse regions (Japan, the Caribbean, Africa, and Melanesia) without indicating which group has the highest frequency. The remaining papers do not address HTLV-1 prevalence at all. Therefore the evidence supplied does not verify or refute the claim."
    },
    "naive_doc_ids": [
      "21274496",
      "8593263",
      "29134911",
      "798152",
      "5735492"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.16,
      "justification": "None of the provided papers report data on the population distribution or ethnic predominance of human T-cell lymphotropic virus type 1 infections. The articles focus on unrelated topics such as childhood underweight, sexually transmitted infections in African-Caribbean women, glaucoma prevalence, neglected tropical diseases, anxiety disorders, simian immunodeficiency virus, HIV cell-cycle biology, tuberculosis outcomes, cholesterol metabolism in HIV, and treatment of adult T-cell leukemia-lymphoma. They neither confirm nor refute that HTLV-1 infection is most frequent in persons of African origin."
    },
    "overthinking_doc_ids": [
      "1606628",
      "5735492",
      "8298120",
      "13966946",
      "32357890"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided papers analyze the prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) with respect to ancestry or report that infection is most frequent in individuals of African origin. The evidence focuses on diabetes, metabolic syndrome, quality of life, sepsis scoring, Kaposi sarcoma-associated herpesvirus, HIV mechanistic studies, and ATLL treatment\u2014not comparative epidemiology of HTLV-1. Therefore they neither support nor contradict the claim."
    },
    "posthoc_doc_ids": [
      "12662435",
      "75636923",
      "463533",
      "5185871",
      "5548081"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "896",
    "claim": "Overexpressing Cnp1 N-tail variants exacerbates the temperature-sensitive growth defect of scm3-139.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Among the provided paper summaries, only Papers 9 and 10 discuss Cnp1 (fission-yeast CENP-A) and Scm3, but neither summary describes experiments in which Cnp1 N-terminal tail variants were overexpressed, nor do they present data on genetic interaction with the temperature-sensitive allele scm3-139. The remaining papers are unrelated to centromere biology. Hence the supplied evidence does not address whether overexpressing Cnp1 N-tail variants worsens the growth defect of scm3-139."
    },
    "naive_doc_ids": [
      "36111909",
      "6766459",
      "12922760",
      "24307695",
      "4362729"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "Among the supplied papers, only Paper 2 discusses the fission-yeast proteins Scm3 and Cnp1. The abstract provided for Paper 2 does not describe experiments in which Cnp1 N-tail variants are over-expressed, nor does it mention any temperature-sensitive scm3-139 growth phenotype or its modification by Cnp1 variants. The other listed papers address unrelated topics (fever-related miRNAs, MeCP2, stathmin, RT-QuIC, sulfur metabolism, chromatin, condensin, aging, Pfh1 helicase). Consequently, the evidence set contains no information that directly supports or contradicts the specific claim."
    },
    "overthinking_doc_ids": [
      "6766459",
      "14338915",
      "980008",
      "2389574",
      "3078080"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.65,
      "justification": "Among the provided papers, only Paper 10 concerns Scm3 and Cnp1, but it does not mention the scm3-139 temperature-sensitive mutant or experiments involving overexpression of Cnp1 N-tail variants. The other papers are unrelated to this topic. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "6766459",
      "33370",
      "970012",
      "4362729",
      "4421547"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "310",
    "claim": "De novo assembly of sequence data has fewer specific contigs than unassembled sequence data.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.22,
      "justification": "None of the cited papers explicitly compare the number of \u2018specific contigs\u2019 obtained after de-novo assembly with the number present in the same data set prior to assembly. In fact, contigs are only generated by the assembly process; unassembled sequence data consist of individual reads rather than contigs. Although a few papers list how many contigs were produced after assembly (e.g., Paper 8: 10 449 reads assembled into 780 contigs + 1 666 singlets), they do not provide a corresponding count of \u2018specific contigs\u2019 in the unassembled data or directly analyse contig abundance before versus after assembly. Therefore the supplied evidence does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "14464451",
      "32770503",
      "14185503",
      "1544804",
      "6535392"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 1 and Paper 2 discuss de novo sequence assembly and mention contigs, but neither compares the number of contigs produced by de novo assembly with any metric from \u201cunassembled sequence data.\u201d The other papers do not address genome assembly or contig counts at all. Hence, the evidence set does not contain information that confirms or refutes the specific claim."
    },
    "overthinking_doc_ids": [
      "14185503",
      "14464451",
      "143251",
      "32770503",
      "84784389"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "None of the provided papers compare the number of \u2018specific contigs\u2019 produced after de novo assembly with the number obtainable from unassembled (raw) sequence data. They discuss aspects such as GC bias, pathogen identification, transcript reconstruction, or genome size reduction, but do not offer data addressing whether de novo assembly results in fewer specific contigs than leaving the reads unassembled. Therefore, the claim is neither supported nor contradicted by the cited evidence."
    },
    "posthoc_doc_ids": [
      "14464451",
      "6173523",
      "4407385",
      "14915566",
      "25041967"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1025",
    "claim": "Reduced levels of lipolysis leads to higher P38 phosphorylation in adipose tissue.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers discuss the relationship between lipolysis and p38 MAPK phosphorylation in adipose tissue. They address other signaling pathways (ERK, mTOR, NF-\u03baB, ATR, etc.) or other aspects of adipose biology (thermogenesis, macrophage polarization, autophagy, etc.), but do not present data linking reduced lipolysis with increased p38 phosphorylation."
    },
    "naive_doc_ids": [
      "4662264",
      "6690087",
      "12909503",
      "2272614",
      "2582169"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Among the provided papers, only Paper 6 directly links lipolysis with p38 MAP-kinase phosphorylation in adipose tissue. It shows that nicotine activates AMPK\u03b12, drives degradation of MKP1, and this \"induces the aberrant activation of both p38 mitogen-activated protein kinase and c-Jun N-terminal kinase, leading to \u2026 the loss of insulin-mediated inhibition of lipolysis. Consequently, nicotine increases lipolysis\u2026\"  Thus elevated p38 phosphorylation occurs together with (and mechanistically contributes to) increased\u2014not reduced\u2014lipolysis in adipocytes. No other cited paper provides data supporting an opposite relationship. Therefore the available evidence opposes the claim that reduced lipolysis leads to higher p38 phosphorylation in adipose tissue."
    },
    "overthinking_doc_ids": [
      "3621011",
      "39187170",
      "40232172",
      "79447",
      "1568684"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.59,
      "justification": "Paper 8 reports that nicotine activates p38 MAPK in adipocytes through AMPK\u03b12-dependent degradation of MKP1. This p38 activation is accompanied by loss of insulin-mediated suppression of lipolysis, resulting in increased (not decreased) lipolysis. Hence, higher p38 phosphorylation is observed when lipolysis is elevated, contradicting the claim that reduced lipolysis leads to higher p38 phosphorylation in adipose tissue. The other cited papers do not provide relevant data on the relationship between lipolysis and p38 phosphorylation."
    },
    "posthoc_doc_ids": [
      "1568684",
      "3621011",
      "40232172",
      "79447",
      "2481032"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "900",
    "claim": "Oxidative phosphorylation is one of the primary glycometabolic pathways in cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.69,
      "justification": "Multiple papers characterize oxidative phosphorylation (OXPHOS) as the dominant route by which cells generate ATP. Paper 1 explicitly calls OXPHOS \u201cthe major pathway for ATP production in humans,\u201d and Paper 7 reiterates that the bulk of cellular ATP is supplied by the five OXPHOS complexes in the mitochondrial inner membrane. Because cellular glucose metabolism ultimately feeds reducing equivalents (NADH, FADH2) into OXPHOS to convert the energy stored in glucose into usable ATP, OXPHOS is viewed as a principal downstream component of glucose (glyco-) metabolism. Additional studies (Papers 2 and 3) link modulation of glucose utilization to the efficiency or inhibition of oxidative metabolism, further tying OXPHOS to primary glucose-handling pathways. No cited paper presents data contradicting this role. Hence, the evidence supports the claim that oxidative phosphorylation is one of the primary glycometabolic pathways in cells."
    },
    "naive_doc_ids": [
      "19957813",
      "5785219",
      "20672596",
      "24349992",
      "7005276"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 1 states that oxidative phosphorylation (OXPHOS) \u2018is the major pathway for ATP production in humans,\u2019 and Paper 3 reiterates that the \u2018bulk of ATP consumed by various cellular processes\u2026 is normally produced\u2019 by OXPHOS complexes. Because cellular ATP production from glucose ultimately depends on delivery of reducing equivalents to the respiratory chain, these findings indicate that OXPHOS is one of the principal pathways through which energy derived from glucose metabolism is converted into usable cellular energy. Thus the evidence supports the claim that oxidative phosphorylation is a primary glycometabolic (energy-from-glucose) pathway in cells."
    },
    "overthinking_doc_ids": [
      "19957813",
      "14972169",
      "37362689",
      "1044552",
      "1686997"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "The cited papers describe oxidative phosphorylation as the principal pathway for mitochondrial ATP production and detail genes required for its function, but they do not address whether oxidative phosphorylation is categorized as a \u2018primary glycometabolic pathway.\u2019 No experimental data or explicit statements in the papers link oxidative phosphorylation specifically to glycometabolic (glucose-handling) pathway classifications. Therefore the evidence neither confirms nor refutes the claim."
    },
    "posthoc_doc_ids": [
      "19957813",
      "14496749",
      "37362689",
      "15381976",
      "1686997"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "813",
    "claim": "Mutations in G-Beta protein GNB1 are present in many cancers, resulting in loss of interaction with G-alpha subunits and concomitant activation of AKT pathway.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.75,
      "justification": "Paper 9 reports recurrent mutations in the G-protein \u03b2 subunit genes GNB1 and GNB2 in multiple human cancers (myeloid and B-cell malignancies). Structural/biochemical analysis in the same study shows that many of these mutations lie at the interface that normally binds G\u03b1, and they \u201cdisrupt G\u03b1 interactions with the G\u03b2\u03b3 dimer,\u201d i.e. cause loss of G\u03b2\u2013G\u03b1 association. Functionally, expression of the mutant GNB1 variants activates canonical G-protein signalling that can be blocked in vivo with the dual PI3K/mTOR inhibitor BEZ235; this indicates activation of the PI3K\u2013AKT pathway, because BEZ235 suppresses PI3K-AKT but not unrelated pathways. No other provided papers contradict these findings. Thus the supplied evidence supports the claim that cancer-associated GNB1 mutations disrupt G\u03b1 binding and are accompanied by PI3K/AKT activation."
    },
    "naive_doc_ids": [
      "21164071",
      "14241418",
      "207972",
      "31682248",
      "7736860"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.18,
      "justification": "None of the provided papers mention G-beta protein GNB1, its mutations, their frequency in cancers, effects on interaction with G-alpha subunits, or resulting AKT pathway activation. Therefore, the supplied evidence does not address the claim."
    },
    "overthinking_doc_ids": [
      "14241418",
      "17648235",
      "3590806",
      "4325398",
      "5403286"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided papers mention GNB1 mutations, their frequency in cancers, their effect on G-alpha interaction, or resulting activation of the AKT pathway. The evidence therefore neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "14241418",
      "17648235",
      "46617075",
      "3590806",
      "4325398"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "437",
    "claim": "Functional consequences of genomic alterations due to Myelodysplastic syndrome (MDS) are poorly understood due to the lack of an animal model.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.79,
      "justification": "Several of the cited studies already employ mouse models that reproduce key features of human MDS and are explicitly used to examine the functional impact of specific genetic/epigenetic alterations.  Paper 4 describes a two-step transgenic mouse model (mutant NRAS plus BCL2) that is used to study how these genomic lesions drive reactive oxygen species, DNA damage and error-prone repair during progression from MDS to leukemia.  Paper 9 reports mice conditionally over-expressing the oncogenic microRNA miR-22; these animals develop an MDS-like disease and are used to demonstrate that miR-22 targets the tumor-suppressor TET2 and alters 5-hydroxymethyl-cytosine levels, directly linking a genomic alteration to functional consequences in vivo.  The existence and productive use of these animal models refute the statement that functional consequences of genomic alterations in MDS are poorly understood because an animal model is lacking."
    },
    "naive_doc_ids": [
      "6000423",
      "6042706",
      "10795340",
      "5765455",
      "8698208"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.41,
      "justification": "Among the provided papers, only Paper 4 directly addresses myelodysplastic syndromes. It reports inflammasome activation in MDS hematopoietic stem and progenitor cells but does not discuss whether an animal model exists or whether the lack of such a model limits functional studies. The remaining papers focus on other diseases or methodological topics. Consequently, the supplied evidence neither confirms nor refutes the claim that functional consequences of genomic alterations in MDS are poorly understood because an appropriate animal model is lacking."
    },
    "overthinking_doc_ids": [
      "343052",
      "2565138",
      "3684342",
      "6000423",
      "6042706"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Paper 1 describes a \u201ctwo-step mouse model for myeloid leukemic disease progression\u201d in which mutant NRAS and BCL2 are over-expressed. The authors use this animal model to measure reactive oxygen species, DNA damage, and error-prone double-strand-break repair, thereby directly analyzing functional consequences of genomic alterations that occur during myelodysplastic-to-leukemia progression. Hence, an animal model does exist and is already being used to study these functional effects, contradicting the claim that such consequences are poorly understood because no animal model is available."
    },
    "posthoc_doc_ids": [
      "5765455",
      "13293033",
      "26025820",
      "37328025",
      "39851630"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "611",
    "claim": "Increased lipolysis leads to higher P38 phosphorylation in adipose tissue.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided abstracts mention p38 MAP-kinase phosphorylation in adipose tissue or examine its change in response to increased lipolysis. Therefore the supplied evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "4662264",
      "6923795",
      "7875158",
      "3973445",
      "11200685"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "None of the provided papers discuss p38 MAP-kinase phosphorylation in adipose tissue or examine its relationship with lipolysis. Therefore they neither support nor contradict the claim."
    },
    "overthinking_doc_ids": [
      "3943235",
      "23929297",
      "24586989",
      "31311495",
      "14171859"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.24,
      "justification": "Among the cited studies, only Paper 6 examines both events. It demonstrates that nicotine first activates AMPK\u03b12, which induces MAP-kinase-phosphatase-1 degradation and thereby INCREASES p38 MAPK phosphorylation in adipocytes. This elevated p38 activity then removes insulin\u2019s antilipolytic effect, producing an increase in lipolysis. Thus p38 phosphorylation precedes and drives the rise in lipolysis, not vice-versa. No paper presents data showing that augmented lipolysis itself triggers higher p38 phosphorylation. Consequently, the available evidence opposes the claim that increased lipolysis leads to higher p38 phosphorylation in adipose tissue."
    },
    "posthoc_doc_ids": [
      "3621011",
      "9178310",
      "39187170",
      "40232172",
      "79447"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "978",
    "claim": "Pro-inflammatory cytokines are up repressed during tumor development.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "The provided papers do not report a general repression of pro-inflammatory cytokines during tumor development; on the contrary, they describe their induction or amplification. For example, Paper 5 shows that keratin-17 and Aire drive the expression of K17- and Aire-dependent pro-inflammatory genes in tumor keratinocytes, thereby \"amplifying inflammatory and immune responses in diseased epithelia.\" Reviews on the tumor microenvironment (Papers 1 and 7) also highlight that stromal and cancer-associated fibroblasts foster tumor progression through pro-inflammatory signaling. Hence, the evidence opposes the claim that pro-inflammatory cytokines are repressed during tumor development."
    },
    "naive_doc_ids": [
      "6944800",
      "16086778",
      "4889228",
      "7898952",
      "12580014"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.81,
      "justification": "Several cited papers indicate that pro-inflammatory cytokines rise, not fall, during tumorigenesis. Paper 5 reports elevated serum IL-6 in cervical-cancer patients and shows that high IL-6 predicts poor survival. Paper 9 shows that Lewis lung-carcinoma cells generate high TNF-\u03b1 in malignant pleural effusions, and blocking tumor NF-\u03baB lowers both tumor burden and TNF-\u03b1 levels, implying that the normal course of tumor growth involves increased TNF-\u03b1 production. Paper 6 also notes substantial IL-8 (a pro-inflammatory cytokine) output from pancreatic-cancer cells, which decreases only when Src is experimentally inhibited. These findings demonstrate up-regulation, not repression, of pro-inflammatory cytokines during tumor development, contradicting the claim."
    },
    "overthinking_doc_ids": [
      "21258863",
      "22889972",
      "11233339",
      "11328820",
      "14664424"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Paper 5 shows that the pro-inflammatory cytokine IL-17 is actively involved in, and even promotes, tumor development. Tumor growth was reduced in IL-17 receptor-deficient mice and after IL-17 neutralization, whereas giving extra IL-17 accelerated tumor growth. This indicates that the pro-inflammatory cytokine is functionally present and not repressed during tumor progression. None of the cited papers provide evidence that pro-inflammatory cytokines are broadly down-regulated in tumors; one directly shows the opposite. Therefore the claim that they are \"repressed\" during tumor development is contradicted by the evidence."
    },
    "posthoc_doc_ids": [
      "22889972",
      "11233339",
      "21258863",
      "25315295",
      "25726838"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "555",
    "claim": "Immune complex triggered cell death leads to extracellular release of nuclear DNA.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 10 shows that exposure of neutrophils to immune-complexes formed by SLE-derived anti-ribonucleoprotein antibodies induces a form of cell death (NETosis). During this immune-complex-triggered death the neutrophils release neutrophil-extracellular traps (NETs) that are explicitly described as containing DNA, i.e., nuclear material that is deposited extracellularly. This directly aligns with the claim that immune-complex-induced cell death results in extracellular release of nuclear DNA. No cited paper presents data contradicting this relationship, so the available evidence supports the claim."
    },
    "naive_doc_ids": [
      "33667484",
      "9225850",
      "42873134",
      "935034",
      "9977329"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Among the cited studies, only Paper 5 examines neutrophil cell death induced by immune complexes. It shows that ribonucleoprotein immune complexes (RNP ICs) trigger NETosis that results in the extracellular release of oxidized mitochondrial DNA, while explicitly stating that this process does not involve nuclear DNA release. Other papers describe nuclear-DNA\u2013containing NETs, but these are induced by bacteria (Paper 1) or other stimuli, not by immune complexes. Therefore, the available evidence indicates that immune-complex\u2013triggered cell death releases mitochondrial\u2014not nuclear\u2014DNA, contradicting the claim."
    },
    "overthinking_doc_ids": [
      "43054703",
      "14853989",
      "1800734",
      "9878167",
      "1049501"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Among the cited papers, only Paper 1 directly addresses immune-complex stimulation; it reports that insoluble immune complexes induce a PI3K-dependent apoptotic pathway in neutrophils but does not describe any extracellular release of nuclear DNA.  Several other papers (6, 7, 9) discuss neutrophil extracellular traps (NETs) where chromatin (nuclear or mitochondrial DNA) is released, but these studies involve stimulation by microbes or cytokines rather than immune complexes.  No paper in the list presents experimental data showing that immune-complex\u2013triggered cell death results in extracellular release of nuclear DNA, nor does any paper refute it.  Therefore, the provided evidence is insufficient to support or contradict the claim."
    },
    "posthoc_doc_ids": [
      "9225850",
      "9977329",
      "14848619",
      "34436231",
      "42873134"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1332",
    "claim": "Tumor necrosis factor alpha (TNF-\u03b1) and interleukin-1 (IL-1) are pro-inflammatory cytokines that inhibit IL-6 and IL-10.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data showing that TNF-\u03b1 or IL-1 suppress (inhibit) the expression or activity of IL-6 or IL-10. The papers mainly describe other biological effects of TNF-\u03b1 (e.g., apoptosis, atherosclerosis, cancer therapy) or of IL-1 on glucose metabolism, but they do not address modulation of IL-6 or IL-10 by these cytokines. Therefore, the supplied evidence does not allow the claim to be verified or refuted."
    },
    "naive_doc_ids": [
      "207972",
      "36386637",
      "22889972",
      "35766603",
      "38023457"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the ten cited papers investigate the regulatory effects of TNF-\u03b1 or IL-1 on IL-6 or IL-10 production. The articles focus on unrelated topics (lncRNAs in cancer, \u03b1-synuclein toxicity, IL-1\u2019s role in IL-17 induction, CRP\u2019s effect on IL-10, etc.) and do not present data showing that TNF-\u03b1 or IL-1 inhibit IL-6 or IL-10. Therefore the provided evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "3730196",
      "14092737",
      "16346504",
      "16511863",
      "21199527"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine whether TNF-\u03b1 or IL-1 inhibit IL-6 or IL-10. The articles instead focus on topics such as TLR7 agonism, PPAR\u03b1 activation, cytokine diffusion, DNA repair, CD200-CD200R signaling, AMPK\u2013JAK interactions, mechanotransduction, and MyD88/IL-1 signaling in fibrosis, without reporting data on TNF-\u03b1/IL-1 regulation of IL-6 or IL-10. Therefore, the evidence set does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "20960682",
      "25328476",
      "4928282",
      "12207340",
      "14386505"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "587",
    "claim": "In transgenic mice harboring green florescent protein under the control of the Sox2 promoter, less than ten percent of the cells with green florescent colocalize with cell proliferation markers.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Among the provided abstracts, only Paper 6 discusses Sox2-GFP transgenic mice. While it notes that Sox2-GFP cells include both proliferative and non-proliferative populations, it gives no quantitative figure for the proportion that colocalize with proliferation markers. None of the other papers address Sox2-driven GFP expression or report the percentage of GFP-positive cells that are actively cycling. Consequently, the evidence set does not confirm or refute the specific quantitative claim (<10 % colocalization)."
    },
    "naive_doc_ids": [
      "7142113",
      "21230110",
      "15981174",
      "854417",
      "3684342"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Only Paper 2 involves Sox2-GFP transgenic mice and discusses the proliferation status of GFP-positive cells, but the abstract provides no quantitative figure for how many Sox2-GFP cells co-label with proliferation markers. None of the other cited papers examine Sox2-GFP mice or report the percentage of GFP-positive cells that are proliferative. Consequently, the provided evidence neither confirms nor refutes the specific claim that fewer than 10 % of Sox2-GFP cells colocalize with proliferation markers."
    },
    "overthinking_doc_ids": [
      "6863070",
      "16999023",
      "18084826",
      "23208167",
      "42662816"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.15,
      "justification": "None of the cited papers describe transgenic mice that express green fluorescent protein under the Sox2 promoter or report the fraction of GFP-positive cells that co-localize with proliferation markers. Therefore, the provided evidence does not address the specific claim."
    },
    "posthoc_doc_ids": [
      "8133180",
      "40558887",
      "5260382",
      "15981174",
      "16511863"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "449",
    "claim": "Gastric lavage is an effective treatment for acute paraquat poisoning.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Among the cited studies, only Paper 2 directly compares outcomes of paraquat-poisoned patients who received gastric lavage versus an alternative therapy. In this retrospective series (101 patients) mortality was 92.1 % in those treated with \u2018only gastric lavage and symptomatic treatment\u2019, whereas it was 42.9 % in patients who additionally received early haemoperfusion. The markedly higher death rate in the lavage-only group argues that gastric lavage by itself is not an effective life-saving intervention for acute paraquat poisoning. No other provided paper offers evidence showing a clear clinical benefit of gastric lavage for paraquat intoxication. Hence the available evidence refutes the claim."
    },
    "naive_doc_ids": [
      "8447873",
      "33203108",
      "22547508",
      "11117498",
      "24097933"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "The only comparative study provided that directly involves paraquat poisoning (Paper 2) shows very poor outcomes when patients received only gastric lavage (92.1 % mortality) compared with those who additionally received haemoperfusion (42.9 % mortality). This indicates that gastric lavage alone is not effective at improving survival in acute paraquat poisoning. No paper presents data demonstrating a clear therapeutic benefit of gastric lavage, and one case report (Paper 6) combines several other interventions, preventing attribution of benefit to lavage. Consequently, the available evidence opposes the claim that gastric lavage is an effective treatment for acute paraquat poisoning."
    },
    "overthinking_doc_ids": [
      "8447873",
      "33203108",
      "3430789",
      "22547508",
      "24097933"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "The only study that directly reports outcomes in paraquat-poisoned patients who received gastric lavage (Paper 3) shows very poor results: 92.1 % mortality in the group treated with \u2018only gastric lavage and symptomatic treatment\u2019, compared with 42.9 % mortality in patients given haemoperfusion. This indicates that gastric lavage alone does not confer a meaningful survival benefit and performs markedly worse than an alternative detoxification method. No paper presents data demonstrating improved outcomes attributable to gastric lavage in paraquat poisoning, and therefore the claim that gastric lavage is an effective treatment is contradicted by the available evidence."
    },
    "posthoc_doc_ids": [
      "8447873",
      "22547508",
      "33203108",
      "3430789",
      "24097933"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1309",
    "claim": "Tonic signaling from the scFv prevents constitutive stimulation.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Paper 1 reports that the single-chain variable fragment (scFv) of a CAR can cluster spontaneously and generate \u201ctonic\u201d CD3\u03b6 phosphorylation, i.e., an antigen-independent, persistent (constitutive) activation signal that drives early T-cell exhaustion. Thus, tonic signaling from the scFv causes, rather than prevents, constitutive stimulation. The other cited papers do not address tonic scFv signaling. Therefore, the available evidence contradicts the claim that tonic signaling from the scFv prevents constitutive stimulation."
    },
    "naive_doc_ids": [
      "18231807",
      "5132358",
      "20311968",
      "22210434",
      "25353658"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 3 reports that antigen-independent (tonic) signaling produced by clustering of the CAR single-chain variable fragment (scFv) leads to persistent CD3\u03b6 phosphorylation and early T-cell exhaustion. This shows that tonic signaling from the scFv actually drives, rather than prevents, constitutive stimulation of the CAR T cells. None of the other cited papers address scFv-mediated tonic signaling. Therefore the available evidence contradicts the claim that tonic signaling from the scFv prevents constitutive stimulation."
    },
    "overthinking_doc_ids": [
      "34016944",
      "20568364",
      "18231807",
      "25050969",
      "6690087"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "Paper 4 shows that the single-chain variable fragment (scFv) within many CARs clusters spontaneously and produces \u2018tonic\u2019 signaling that results in antigen-independent (constitutive) CD3\u03b6 phosphorylation and downstream T-cell exhaustion. Thus, tonic signaling arising from the scFv actually generates, rather than prevents, constitutive stimulation. The other cited papers do not address scFv-mediated tonic signaling, so Paper 4 is the most relevant source and it contradicts the claim."
    },
    "posthoc_doc_ids": [
      "4611267",
      "10576136",
      "14241418",
      "18231807",
      "34016944"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1405",
    "claim": "taa1 tar1 tar2 triple mutants in Arabidopsis do not make root meristem during embryogenesis.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the cited papers, only Paper 3 discusses TAA1 and its paralogues (TAR genes), but it does not report the phenotype of taa1 tar1 tar2 triple mutants nor describe whether a root meristem is formed during Arabidopsis embryogenesis. None of the other listed papers mention these genes or embryonic root-meristem formation in Arabidopsis. Therefore the supplied evidence does not address, confirm, or refute the claim."
    },
    "naive_doc_ids": [
      "5849439",
      "7681810",
      "10504681",
      "40429879",
      "14308244"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the provided paper excerpts, only Paper 2 discusses TAA1 and its paralogues, but it gives no information about taa1 tar1 tar2 triple mutants or their ability to form a root meristem during embryogenesis. None of the other papers mention these genes or this developmental phenotype. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "5849439",
      "10504681",
      "14926162",
      "20402596",
      "20868160"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided paper summaries mention Arabidopsis taa1 tar1 tar2 triple mutants or describe whether these mutants form (or fail to form) an embryonic root meristem. Therefore the supplied evidence is insufficient to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "5849439",
      "10504681",
      "14926162",
      "20402596",
      "20868160"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1186",
    "claim": "The World Health Organization's (WHO) data collection process is biased downward by unequal selection of larger outbreaks.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers analyze how the World Health Organization selects outbreak data or whether that process disproportionately excludes larger outbreaks. The articles focus on CDC food-borne outbreak surveillance, WHO screening scales for ADHD, anthropometric references, mental-health surveys, disease-burden modeling (dengue, GBD), and other surveillance methodologies, but they do not evaluate or document a downward bias in WHO outbreak data due to unequal selection of larger events. Therefore, the provided evidence offers no direct information relevant to the claim."
    },
    "naive_doc_ids": [
      "30844602",
      "27391365",
      "2338488",
      "4432763",
      "6490571"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "None of the cited papers analyze the World Health Organization\u2019s outbreak-data collection procedures or evaluate whether WHO under-represents large outbreaks. The articles discuss U.S. CDC surveillance, national dengue reporting in China, Global Burden of Disease estimates, and various methodological or clinical studies, but they provide no direct information on bias in WHO data selection. Therefore they neither support nor contradict the specific claim."
    },
    "overthinking_doc_ids": [
      "30844602",
      "8665891",
      "3716075",
      "5698494",
      "6173523"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the cited papers address how the World Health Organization selects outbreak data or whether that selection produces a downward bias. The articles discuss anthropometric references, mental-health surveys, ADHD screening scales, epidemiology of dengue, diabetes hypoglycemia, antipsychotic prescribing, meta-analysis bias detection, and HIV/TB prevalence\u2014but none evaluate or describe WHO\u2019s outbreak data-collection procedures. Therefore they provide no evidence relevant to the claim."
    },
    "posthoc_doc_ids": [
      "4432763",
      "2338488",
      "27391365",
      "6490571",
      "1781626"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "294",
    "claim": "Crossover hot spots are not found within gene promoters in Saccharomyces cerevisiae.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "None of the provided papers analyzes the positional relationship between meiotic crossover (or DSB) hot spots and gene promoters in Saccharomyces cerevisiae. The studies either concern different organisms (e.g., Schizosaccharomyces pombe, mouse) or address other aspects of recombination/DSB repair in S. cerevisiae without reporting whether hot spots reside inside or outside promoters. Therefore the supplied evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "9732010",
      "10086360",
      "10874408",
      "23604601",
      "25462689"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided paper summaries discuss the location of meiotic crossover (recombination) hot spots relative to gene promoters in Saccharomyces cerevisiae. The excerpts focus on RNA processing, transcriptional regulation databases, lifespan effects of calorie restriction, Ras signaling, yeast domestication, telomere anchoring, DSB repair mechanisms, oxidative damage, and general DSB mapping, but they do not state whether crossover hot spots occur within or outside promoter regions. Therefore, the evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "365896",
      "1256116",
      "4414481",
      "8210189",
      "10300888"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "None of the provided paper excerpts discuss the positional relationship between meiotic crossover (or double-strand break) hotspots and gene promoters in Saccharomyces cerevisiae. Therefore, the evidence does not allow assessment of whether crossover hotspots are absent from promoters."
    },
    "posthoc_doc_ids": [
      "365896",
      "10874408",
      "11527822",
      "23604601",
      "25462689"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "684",
    "claim": "Lack of clpC does not affect sporulation efficiency in Bacillus subtilis cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.21,
      "justification": "Among the provided paper summaries, none report experiments that compare sporulation efficiency of a clpC knockout (or otherwise clpC-deficient) Bacillus subtilis strain with that of a wild-type strain. The papers focus on genetic screens for sporulation genes, heat-shock and stress regulation of the clpC operon, general Clp protein regulation, cell motility, multidrug transporter regulation, Spx-dependent transcription, and lipid-transport defects. Because no data or conclusions about the effect (or lack of effect) of clpC deletion on sporulation efficiency are presented, the evidence neither supports nor contradicts the claim."
    },
    "naive_doc_ids": [
      "4942718",
      "34386619",
      "12881593",
      "12824568",
      "2851611"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "None of the provided paper summaries mention experiments that measure sporulation efficiency of a clpC-deficient (\u0394clpC) Bacillus subtilis strain. The papers focus on (i) genome-wide identification of sporulation genes without specifying clpC, (ii) transcriptional regulation of the clpC operon during heat shock, (iii) Clp protein homeostasis, and (iv\u2013vi) unrelated cellular processes. Therefore, the supplied evidence neither supports nor contradicts the claim about clpC and sporulation."
    },
    "overthinking_doc_ids": [
      "4942718",
      "34386619",
      "12881593",
      "2851611",
      "2904102"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Among the cited papers, those that mention clpC (papers 2 and 3) examine its transcriptional regulation and its role in heat-shock or general stress responses, but they do not test sporulation efficiency of a \u0394clpC strain. The study focused on sporulation genes (paper 1) does not report any result for clpC in the excerpt provided. Hence the supplied evidence contains no experimental data that show whether the absence of clpC does or does not affect Bacillus subtilis sporulation efficiency."
    },
    "posthoc_doc_ids": [
      "4942718",
      "34386619",
      "12881593",
      "2851611",
      "2904102"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "o3",
    "claim_id": "316",
    "claim": "Decreased conversion of PGE 2 to PPARy ligand 15-ket-PGE 2 causes accumulation of PGE.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.43,
      "justification": "Paper 1 identifies 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as the enzyme that oxidizes PGE2 to its metabolite 15-keto-PGE2.  The study shows that 15-PGDH expression and activity are markedly reduced in colorectal tumors and in 15-PGDH-deficient mice.  Loss of the enzyme \"completely blocks production of the urinary PGE2 metabolite,\" demonstrating that the conversion step from PGE2 to 15-keto-PGE2 is impaired.  Because PGE2 degradation is blocked while its synthesis is unchanged, the paper concludes that lowered 15-PGDH activity leads to elevated (accumulated) PGE2 levels in the tissue.  Paper 2 further reports reduced amounts of 15-keto-PGE2 in Cftr-deficient mice, consistent with less conversion from PGE2, although it does not quantify PGE2 itself.  No evidence in the other papers contradicts this relationship.  Together, the data support the claim that decreased conversion of PGE2 to the PPAR\u03b3 ligand 15-keto-PGE2 causes PGE2 accumulation."
    },
    "naive_doc_ids": [
      "21181273",
      "712078",
      "3930020",
      "3113630",
      "5775033"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Paper 1 shows that the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH), which catalyzes the first step in converting PGE\u2082 to its metabolite 15-keto-PGE\u2082, is markedly down-regulated in colorectal cancers and in genetically disrupted mice. Loss of 15-PGDH activity \"completely blocks production of the urinary PGE\u2082 metabolite,\" demonstrating decreased conversion to 15-keto-PGE\u2082. Because biosynthesis (via cyclo-oxygenase) remains intact while degradation is impaired, the study implies higher steady-state levels (i.e., accumulation) of PGE\u2082 when conversion is reduced. The other cited papers do not address PGE\u2082 catabolism. Thus the available evidence supports the claim that reduced conversion of PGE\u2082 to 15-keto-PGE\u2082 leads to accumulation of PGE\u2082."
    },
    "overthinking_doc_ids": [
      "21181273",
      "1686997",
      "2443495",
      "2481032",
      "7165938"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Paper 6 shows that expression and activity of 15-hydroxyprostaglandin dehydrogenase (15-PGDH)\u2014the enzyme that converts PGE\u2082 into its catabolic product 15-keto-PGE\u2082\u2014are markedly reduced in colorectal cancer tissue and in 15-Pgdh-knock-out mice. The authors report that loss of 15-PGDH activity \u201ccompletely blocks production of the urinary PGE\u2082 metabolite,\u201d indicating impaired conversion to 15-keto-PGE\u2082, and they link this loss to elevated, tumor-promoting PGE\u2082 levels in the tissue. Thus, decreased conversion of PGE\u2082 to 15-keto-PGE\u2082 is associated with (and mechanistically leads to) accumulation of PGE\u2082, directly supporting the claim. Paper 1 also notes reduced amounts of the PPAR\u03b3 ligand 15-keto-PGE\u2082 in Cftr-deficient mice, consistent with diminished conversion, further reinforcing (though not quantitatively proving) the accumulation idea. No paper presents data contradicting this relationship."
    },
    "posthoc_doc_ids": [
      "712078",
      "2533768",
      "10607877",
      "31564409",
      "3113630"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.55,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "866",
    "claim": "Nuclear transfer from adult human fibroblasts to human oocytes can give rise to blastocysts containing expandable pluripotent cells.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Several cited studies report that somatic cell nuclear transfer (SCNT) using nuclei from adult human fibroblasts (or other adult somatic cells) into enucleated human oocytes yields blastocysts from which pluripotent stem-cell lines can be derived. Paper 1 shows improved blastocyst formation and derivation of embryonic stem cells from adult AMD-patient fibroblast nuclei after KDM4A over-expression. Paper 2 explicitly demonstrates ESC generation via SCNT using dermal fibroblasts from 35- and 75-year-old males. Paper 4 reports blastocyst development and derivation of diploid pluripotent stem-cell lines from an adult with type 1 diabetes following nuclear transfer into human oocytes. These findings directly align with the claim that nuclear transfer from adult human fibroblasts to human oocytes can produce blastocysts containing expandable pluripotent cells."
    },
    "naive_doc_ids": [
      "15803282",
      "37822406",
      "86129154",
      "4457834",
      "10546779"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Multiple cited studies report that nuclei taken from adult human fibroblasts (or other adult somatic cells) transplanted into enucleated human oocytes develop to the blastocyst stage and that embryonic stem-cell lines with typical pluripotency properties can be established from these blastocysts.  Paper 3 specifically describes SCNT using dermal fibroblasts from 35- and 75-year-old donors and the subsequent derivation of human ESC lines.  Papers 1 and 4 further show improved protocols that increase blastocyst formation and enable derivation of expandable pluripotent stem-cell lines from adult somatic donors.  These findings directly substantiate the claim that nuclear transfer from adult human fibroblasts to human oocytes can generate blastocysts containing expandable pluripotent cells."
    },
    "overthinking_doc_ids": [
      "15803282",
      "10546779",
      "37822406",
      "4457834",
      "86129154"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 1 reports successful somatic-cell nuclear transfer (SCNT) using dermal fibroblasts from 35- and 75-year-old men, obtaining blastocysts from which human embryonic stem-cell lines were derived; these lines are, by definition, expandable pluripotent cells. Paper 2 independently shows that, after optimizing activation and culture conditions, nuclei from an adult (type-1 diabetic) somatic cell donor placed into human oocytes developed to the blastocyst stage and yielded diploid pluripotent stem-cell lines. Together these studies demonstrate that nuclei from adult human fibroblasts transferred to human oocytes can progress to blastocysts that contain and allow derivation of expandable pluripotent cells, directly supporting the claim."
    },
    "posthoc_doc_ids": [
      "37822406",
      "4457834",
      "15803282",
      "22490293",
      "86129154"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.8,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1308",
    "claim": "Tonic signaling from the scFv is amplified by MyD88/CD40.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.32,
      "justification": "None of the cited papers examine MyD88 and/or CD40 signaling in the context of tonic (antigen-independent) signaling produced by an scFv or a CAR. The provided studies address CAR tonic signaling with CD28 or 4-1BB domains, CD40 or MyD88 roles in unrelated immune or developmental pathways, and other immunological phenomena, but they present no data on MyD88/CD40 amplifying scFv-driven tonic signaling. Therefore the evidence set contains no direct information to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "18231807",
      "2734421",
      "6270720",
      "6767271",
      "9159125"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.47,
      "justification": "Among the provided papers, only Paper 2 discusses tonic signaling originating from CAR scFvs, but it examines the effects of CD28 and 4-1BB costimulatory domains, not MyD88 or CD40. None of the other papers address tonic scFv signaling or the role of MyD88/CD40. Therefore the cited evidence does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "2593298",
      "18231807",
      "41982985",
      "6550579",
      "14241418"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "None of the cited papers examine tonic (antigen-independent) signaling produced by a CAR or its scFv domain in combination with MyD88 and/or CD40. Paper 1 addresses tonic signaling of CAR scFv but studies CD28 and 4-1BB, not MyD88 or CD40. Papers 2\u20135 involve MyD88 or CD40, but in unrelated biological contexts (mTEC development, myocarditis, adjuvant-driven Th17 responses, prostaglandin production) and do not test any interaction with scFv-mediated tonic signaling. Therefore the provided evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "18231807",
      "2734421",
      "6270720",
      "6767271",
      "9159125"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "730",
    "claim": "Lysine histone demethylase inhibitor JIB 04 is inactive against KDM5A.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Paper 1 reports that JIB-04 \u201cspecifically inhibits the activity of the Jumonji family of histone demethylases in vitro.\u201d KDM5A (also known as JARID1A/RBP2) is a member of the Jumonji (JmjC) histone demethylase family. Therefore, the described activity of JIB-04 against Jumonji enzymes necessarily includes KDM5A, indicating that JIB-04 is active\u2014not inactive\u2014against KDM5A. The other cited papers do not address JIB-04 or KDM5A. Hence the evidence contradicts the claim."
    },
    "naive_doc_ids": [
      "13400643",
      "18841257",
      "864491",
      "15215393",
      "18473550"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the provided papers discuss JIB 04, lysine histone demethylases, or KDM5A. Therefore they offer no information to confirm or refute the claim about JIB 04\u2019s activity against KDM5A."
    },
    "overthinking_doc_ids": [
      "864491",
      "927561",
      "1389264",
      "1595617",
      "2030623"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "Among the supplied papers, only Paper 9 discusses the small-molecule histone demethylase inhibitor JIB-04, but the abstract does not specify whether JIB-04 does or does not inhibit the particular enzyme KDM5A. None of the other papers mention JIB-04 or KDM5A. Consequently, the provided evidence gives no direct information about JIB-04\u2019s activity against KDM5A, so the claim cannot be verified or refuted from these sources."
    },
    "posthoc_doc_ids": [
      "29526125",
      "20888849",
      "27428509",
      "67045088",
      "306311"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "890",
    "claim": "Origin gross domestic product(GDP) is negatively related to dengue virus (DENV-1) diffusion in air traffic shipments.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers analyze any relationship between a country's gross domestic product and the diffusion of dengue virus (DENV-1) through air traffic shipments. The studies address local dengue clustering in Thai villages, hepatitis C phylogeography, viral genetics, zoonotic transmission metrics, malaria prophylaxis, immunological mechanisms, alcohol policy effects, autoimmune markers, and health-care access\u2014none of which provide data on GDP or air-traffic\u2013related spread of DENV-1."
    },
    "naive_doc_ids": [
      "18816720",
      "5114282",
      "4231060",
      "7485455",
      "8593263"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the cited papers analyze or report data on the relationship between a country\u2019s (origin) GDP and the diffusion of DENV-1 through air-traffic shipments. They address dengue epidemiology, local risk factors (population density, water supply), global incidence, importation events, or unrelated biomedical topics, but not economic indicators or air-traffic cargo patterns. Therefore the evidence provided offers no basis to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "2097256",
      "3716075",
      "8665891",
      "17454301",
      "18816720"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the provided papers analyze or report on the relationship between a country\u2019s gross domestic product (GDP) and the diffusion of dengue virus (specifically DENV-1) via air traffic shipments. The cited studies focus on local transmission patterns, phylogeography, disease burden, or unrelated health issues, but do not address GDP as a determinant of dengue spread through air travel."
    },
    "posthoc_doc_ids": [
      "18816720",
      "643765",
      "7485455",
      "8665891",
      "253672"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1214",
    "claim": "The deregulated and prolonged activation of monocytes improves inflammatory disease outcomes.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.81,
      "justification": "Paper 2 shows that a FOXO3 polymorphism which LIMITS (i.e., down-regulates) monocyte inflammatory responses is associated with a MILDER clinical course of Crohn\u2019s disease and rheumatoid arthritis. Paper 5 shows that mice with reduced KLF2 (leading to heightened, prolonged pro-inflammatory activation of monocytes) develop MORE SEVERE, not improved, experimental arthritis. Together these data indicate that dampening rather than deregulated/prolonged activation of monocytes benefits inflammatory disease outcomes, directly opposing the claim."
    },
    "naive_doc_ids": [
      "11328820",
      "13905670",
      "343052",
      "1191830",
      "7948486"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.69,
      "justification": "Paper 2 shows that individuals carrying the minor FOXO3 allele have monocytes with REDUCED (not prolonged) inflammatory activation, and this dampening of the monocyte response is associated with a milder course of inflammatory diseases such as Crohn\u2019s disease and rheumatoid arthritis. Paper 3 further indicates that activated neutrophils/macrophages drive the pathogenesis of COPD rather than improve it. Together, these findings indicate that limiting\u2014rather than deregulating or prolonging\u2014monocyte activation is linked to better outcomes in inflammatory diseases, directly opposing the claim."
    },
    "overthinking_doc_ids": [
      "7735859",
      "13905670",
      "21395936",
      "25420421",
      "25606339"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Paper 1 demonstrates that a FOXO3A variant which REDUCES inflammatory responses of monocytes (less TNF-\u03b1, more IL-10) is linked to a MILDER course of Crohn\u2019s disease and rheumatoid arthritis. Thus better outcomes are associated with dampened\u2014not deregulated or prolonged\u2014monocyte activation. \nPaper 9 shows that Atm-deficient mice, which display persistent immune/monocyte activation, suffer MORE severe DSS-induced colitis and higher mortality. \nTogether these data indicate that sustained or dysregulated monocyte activation worsens, rather than improves, inflammatory disease outcomes, contradicting the claim."
    },
    "posthoc_doc_ids": [
      "13905670",
      "7735859",
      "21395936",
      "24396137",
      "25606339"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1207",
    "claim": "The composition of myosin-II isoform switches from the polarizable B isoform to the more homogenous A isoform during hematopoietic differentiation.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Paper 5 reports that in human hematopoiesis the non-muscle myosin-II B isoform (MIIB) is \"strongly polarized in hematopoietic stem cells and progenitors\" but becomes \"down-regulated in differentiated cells via asymmetric division,\" whereas the myosin-II A isoform (MIIA) is \"constitutive\" and is functionally activated during cytokine-driven differentiation.  This demonstrates that, as cells progress from the stem/progenitor stage toward differentiated hematopoietic lineages, the relative myosin-II composition shifts from the polarized MIIB to the more uniformly distributed MIIA, matching the claim of an isoform switch from B to A during hematopoietic differentiation.  The other cited papers do not address myosin-II isoform dynamics, providing no conflicting evidence."
    },
    "naive_doc_ids": [
      "23727313",
      "35811036",
      "11289247",
      "13116880",
      "18909530"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Paper 6 reports that non-muscle myosin-II isoform B (MIIB) is the predominant, highly polarized isoform in hematopoietic stem and progenitor cells, but is down-regulated as these cells divide asymmetrically and differentiate. In contrast, myosin-II isoform A (MIIA) is constitutively present and becomes functionally activated during cytokine-induced differentiation. Thus, during hematopoietic differentiation the cellular myosin-II pool shifts from a MIIB-rich, polarized state to a MIIA-dominated, more uniform state, matching the claimed switch from polarizable B to homogenous A isoform. The other cited papers do not address myosin-II isoform composition in hematopoiesis."
    },
    "overthinking_doc_ids": [
      "23727313",
      "54561384",
      "1595617",
      "5633876",
      "8150638"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Paper 6 reports that in human hematopoietic stem and progenitor cells (HSC/Ps) non-muscle myosin-II isoform B (MIIB) is the dominant isoform and is \"strongly polarized\", whereas during cytokine-driven differentiation MIIB is lost (\"down-regulated in differentiated cells via asymmetric division\"). In contrast, isoform A (MIIA) is present throughout but is broadly distributed (\"constitutive\") and becomes functionally activated as differentiation proceeds. This demonstrates a shift in myosin-II composition from a polarized MIIB-rich state in undifferentiated HSC/Ps to a more homogeneous MIIA-dominated state in differentiated hematopoietic cells, directly matching the claim."
    },
    "posthoc_doc_ids": [
      "14581009",
      "27061085",
      "12315072",
      "8148122",
      "9076196"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.8,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1394",
    "claim": "miRNAs regulate a unique suite of mRNAs to maintain homeostasis in cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.54,
      "justification": "Several of the cited studies document that individual microRNAs (miRNAs) bind specific sets of mRNAs and that this regulation contributes to keeping cellular physiology balanced.  (i) Paper 1 describes how miRNAs bind defined sequence motifs on their target transcripts and how competition among these binding sites fine-tunes post-transcriptional gene regulation, implying that each miRNA controls its own subset (\u2018unique suite\u2019) of mRNAs.  (ii) Paper 3 reviews evidence that hundreds of different miRNAs, each with characteristic temporal and spatial expression patterns, repress translation or promote decay of their cognate mRNAs during numerous developmental and physiological processes, indicating miRNA-specific target repertoires.  (iii) Paper 6 shows that miR-71 modulates ALG-1/Argonaute levels; loss of miR-71 disrupts global miRNA abundance, causes widespread mRNA mis-regulation and increases lifespan variability\u2014direct evidence that proper miRNA\u2013mRNA interactions are required for maintaining molecular and organismal homeostasis.  Combined, these findings support the claim that miRNAs regulate distinct sets of mRNAs to preserve cellular homeostasis."
    },
    "naive_doc_ids": [
      "32324430",
      "21373240",
      "86602746",
      "13290521",
      "2619579"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Multiple papers document that individual microRNAs bind specific sets of mRNA 3\u2019-UTRs and that this regulation contributes to keeping cellular physiology in balance.  (i) Paper 5 shows miR-92a directly represses KLF2; when laminar flow lowers miR-92a, KLF2 rises and nitric-oxide signaling is preserved, maintaining endothelial homeostasis.  (ii) Paper 4 demonstrates miR-21 targets the IL-12p35 3\u2019-UTR and thereby modulates Th-cell polarization, a component of immune homeostasis.  (iii) Paper 2 reveals miR-29 simultaneously represses p85\u03b1, IGF-1 and B-myb, coordinating senescence pathways in muscle.  (iv) Paper 1 maps >7,000 miRNA-interaction sites, confirming that each viral or cellular miRNA associates with a discrete collection of host transcripts.  Collectively these findings provide experimental evidence that miRNAs control distinctive groups of mRNAs and that this control underlies balanced cellular states, supporting the claim."
    },
    "overthinking_doc_ids": [
      "8247469",
      "4653837",
      "5838067",
      "7281161",
      "12582729"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.69,
      "justification": "Multiple cited studies show that individual microRNAs bind specific sets of mRNAs and that this post-transcriptional regulation is required for preserving normal cellular physiology (homeostasis).  Paper 1 demonstrates that miR-92a targets the 3\u2032-UTR of KLF2 mRNA; modulation of miR-92a levels alters KLF2 expression and downstream endothelial-protective genes (eNOS, thrombomodulin), and in vivo manipulation of miR-92a disturbs flow-dependent vascular function\u2014direct evidence that a defined miRNA\u2013mRNA interaction maintains endothelial homeostasis.  Paper 3 shows miR-29 simultaneously suppresses several mRNAs (p85\u03b1, IGF-1, B-myb), coordinating pathways that control muscle progenitor proliferation and senescence; aberrant miR-29 up-regulation leads to loss of tissue homeostasis in aging muscle.  Paper 5 further illustrates the principle: miR-203 directly targets Bmi1 mRNA to restrain proliferation and invasion in lung cells, contributing to cellular equilibrium.  Collectively, these experimental findings confirm that miRNAs regulate specific suites of mRNAs whose balanced expression is necessary for maintaining cellular homeostasis."
    },
    "posthoc_doc_ids": [
      "12582729",
      "2619579",
      "4653837",
      "22478394",
      "23934390"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1213",
    "claim": "The deregulated and prolonged activation of monocytes has deleterious effects in inflammatory diseases.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.41,
      "justification": "Several of the cited studies link a failure to restrain or terminate monocyte / monocyte-derived cell activity with worse clinical outcomes in inflammatory conditions.  \n\u2022 Paper 1 shows that chronic stress produces glucocorticoid-receptor resistance in circulating innate immune cells, resulting in an inability to switch off monocyte-derived pro-inflammatory cytokine production (IL-1\u03b2, TNF-\u03b1, IL-6). Participants with this prolonged, dysregulated cytokine output were significantly more likely to develop symptomatic rhinovirus infection and exhibited higher local inflammatory cytokine levels, demonstrating a harmful effect of sustained monocyte activation.  \n\u2022 Paper 2 reports that ATM-deficient mice undergoing dextran-sulfate-sodium colitis display persistent systemic immune activation, higher concentrations of inflammatory cytokines, and markedly aggravated disease activity and mortality. Colitis is driven largely by over-activated innate immune cells, including monocytes/macrophages; the data therefore illustrate that an inability to dampen their activation exacerbates inflammatory bowel disease.  \n\u2022 Paper 8 documents that breast-tumour stroma with high densities of tumour-associated macrophages (macrophages derive from activated monocytes) is strongly associated with lower disease-free and overall survival; thus, excessive or unchecked monocyte-lineage activation is deleterious in an inflammatory tumour micro-environment.  \nTogether, these findings confirm that when the normal termination controls on monocyte activity fail and activation becomes prolonged or deregulated, the result is worsened tissue inflammation and poorer clinical outcomes, supporting the claim."
    },
    "naive_doc_ids": [
      "3083927",
      "5572127",
      "3863543",
      "4391121",
      "9244474"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "None of the cited papers present direct data on deregulated or prolonged activation of monocytes and its harmful impact in inflammatory diseases. The articles discuss other immune cells (e.g., neutrophils, macrophages, innate lymphoid cells), anti-inflammatory bacterial products, stress-related glucocorticoid resistance, and various mechanisms of chronic inflammation, but they do not specifically investigate or demonstrate that aberrant, sustained monocyte activation itself is deleterious in inflammatory conditions."
    },
    "overthinking_doc_ids": [
      "7735859",
      "21395936",
      "25606339",
      "1022115",
      "12236208"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Several cited studies show that when inflammatory/activated monocytes are abundant or insufficiently controlled, tissue injury and disease severity increase, whereas therapeutic strategies that dampen or re\u2010route these cells lessen pathology.\n\u2022 Paper 3: In a mouse model of acute lung injury, modulation of Ly6C(hi) inflammatory monocytes/macrophages with liposome-encapsulated spironolactone markedly ameliorated lung pathology. The need to suppress these activated monocytes to achieve protection indicates that their continued, deregulated activity is harmful.\n\u2022 Paper 6: Blocking CCR2, a key chemokine receptor for Ly6C(hi) monocyte trafficking, sequestered these cells in bone marrow and produced a \u201cdramatic reduction in disease severity\u201d in experimental autoimmune encephalomyelitis. Thus, ongoing recruitment/activation of monocytes exacerbates this inflammatory disease.\n\u2022 Paper 7: Partial loss of the anti-inflammatory transcription factor KLF2 heightens pro-inflammatory activation of myeloid cells (monocytes/macrophages) and worsens both acute sepsis and sub-acute skin inflammation, showing that inadequate regulation and sustained activation of these cells is deleterious.\nTaken together, the evidence consistently links deregulated or prolonged monocyte activation with worsened outcomes in inflammatory disorders, supporting the claim."
    },
    "posthoc_doc_ids": [
      "1265945",
      "11233339",
      "12370881",
      "12631697",
      "15058155"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "870",
    "claim": "Obesity decreases life quality.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Multiple studies link higher body-mass index (obesity) with adverse health outcomes that reasonably diminish quality of life.  Paper 1 shows that greater BMI is associated with lower concentrations of brain metabolites indicative of neuronal viability and possible cognitive dysfunction.  Paper 3, in a cohort of 5.24 million adults, reports that each 5 kg/m\u00b2 increase in BMI raises the risk of numerous cancers and other serious diseases.  Such impairments and disease risks directly undermine physical and cognitive functioning and therefore reduce life quality.  No paper presents opposing evidence; taken together, the findings support the claim that obesity decreases life quality."
    },
    "naive_doc_ids": [
      "37583120",
      "36558211",
      "4828631",
      "463533",
      "40666943"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "Among the cited studies, none directly examine health-related or overall quality of life as a function of obesity or high body-mass index. The papers focus on antihypertensive drugs, chronic diseases in general, binge-eating disorder, leukemia treatment, ADHD\u2013obesity associations, gestational diabetes risk, cancer risk, genetic determinants of BMI, brain metabolites, and inflammation in lung cancer\u2014not on quality-of-life outcomes attributable to obesity itself. Therefore they do not provide evidence that obesity decreases life quality."
    },
    "overthinking_doc_ids": [
      "26199970",
      "463533",
      "40666943",
      "42913391",
      "1831916"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the provided abstracts examine health-related or overall quality-of-life outcomes in relation to obesity status. Although some papers discuss obesity-related physiology (e.g., visceral adipose arteriolar dysfunction) and others analyze quality of life in various diseases, no study directly links obesity with decreased quality of life. Therefore, the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "463533",
      "2820454",
      "17693849",
      "20606520",
      "24988745"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1002",
    "claim": "RA activation of DIF2 and NB4 cells induces hallmarks of transcriptionally active promoters.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "Among the provided papers, only Paper 6 examines retinoic-acid (RA) treatment in NB4 cells, and it focuses on rapid induction of the IEX-1 gene without reporting chromatin modifications such as histone acetylation, RNA-polymerase II loading, or other epigenetic marks that typify transcriptionally active promoters. None of the papers mention DIF2 cells or describe RA-induced promoter hallmarks (e.g., increased H3/H4 acetylation, Pol II recruitment) in either NB4 or DIF2. Consequently, the cited evidence neither confirms nor refutes the stated claim."
    },
    "naive_doc_ids": [
      "23269537",
      "502591",
      "23938319",
      "16626264",
      "25606339"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the supplied papers, only Paper 1 examines retinoic-acid treatment in NB4 cells, reporting rapid induction of a specific gene (IEX-1) through RA-responsive elements. None of the papers investigate DIF2 cells, nor do they measure chromatin signatures such as histone acetylation, H3K4 methylation, or other canonical \u2018hallmarks of transcriptionally active promoters\u2019 after RA stimulation in either cell type. Therefore the cited literature does not provide direct evidence for\u2014or against\u2014the claim that RA activation of DIF2 and NB4 cells induces promoter-activation hallmarks."
    },
    "overthinking_doc_ids": [
      "24624992",
      "8458567",
      "14116046",
      "18546584",
      "23938319"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "Among the cited papers, only Paper 6 deals with retinoic acid (RA) treatment in NB4 cells, describing rapid induction of the IEX-1 gene and identification of RA-responsive elements in its promoter. The study does not examine DIF2 cells, nor does it report chromatin or epigenetic features that constitute the \u201challmarks of transcriptionally active promoters\u201d (e.g., histone acetylation, H3K4me3, RNA-Pol II occupancy). None of the other listed papers discuss RA effects in DIF2 or NB4 cells or analyze promoter-associated chromatin modifications after RA stimulation. Therefore, the provided evidence neither supports nor contradicts the specific claim."
    },
    "posthoc_doc_ids": [
      "17997584",
      "23985464",
      "25050969",
      "25328476",
      "43419566"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "946",
    "claim": "Physical activity level is associated with the difference in maximal oxygen consumption between black and white youth.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.37,
      "justification": "Paper 1 reported that black children were more sedentary than white peers and suggested this helped explain their lower maximal oxygen consumption (VO2max), implying an association.  However, Paper 2 measured objective activity energy expenditure with doubly-labeled water and found that the ~15 % lower VO2max in African-American children persisted after adjustment for total and activity energy expenditure, indicating that physical activity level did not account for, nor was it associated with, the racial difference in VO2max.  The stronger, objectively-measured evidence in Paper 2 therefore contradicts the claim that physical activity level is associated with the VO2max difference between black and white youth."
    },
    "naive_doc_ids": [
      "18537148",
      "26112696",
      "11201004",
      "13230773",
      "17914395"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.19,
      "justification": "Paper 2 measured total and activity energy expenditure objectively (doubly-labelled water) in African-American and Caucasian pre-pubertal children and found that the ~15 % lower VO\u2082max in African-American youth remained after adjustment for activity energy expenditure (AEE) and total energy expenditure (TEE).  Thus the ethnic difference in maximal oxygen consumption was independent of habitual physical activity level, contradicting the claim that physical activity explains or is associated with the VO\u2082max gap.  Although Paper 1 suggested a possible role of a \"more sedentary lifestyle\" based on questionnaire data, the stronger objective evidence in Paper 2 shows the VO\u2082max difference persists irrespective of activity, so overall the provided evidence refutes the claim."
    },
    "overthinking_doc_ids": [
      "18537148",
      "26112696",
      "8428935",
      "12205576",
      "1642727"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Paper 1 compared pre-pubertal and pubertal black and white children and found that (1) black youth had significantly lower maximal oxygen consumption (VO2 max) than their white peers and (2) black youth also reported lower levels of daily physical activity. The authors concluded that the lower VO2 max in black children \"could be attributed at least in part to \u2026 more sedentary lifestyle,\" explicitly linking physical-activity level to the racial difference in VO2 max. Paper 2 corroborates that non-Hispanic black youngsters engage in less vigorous activity than white youngsters, supporting the premise that activity patterns differ by race. Together these findings indicate that variation in physical activity is associated with, and likely contributes to, the observed difference in maximal oxygen consumption between black and white youth."
    },
    "posthoc_doc_ids": [
      "18537148",
      "8428935",
      "11201004",
      "13083189",
      "1642727"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1280",
    "claim": "The ureABIEFGH gene cluster encodes urease maturation proteins : UreD/UreH, UreE, UreF, and UreG.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.75,
      "justification": "Paper 1 identifies four genes (ureD, ureE, ureF, ureG) that lie in the urease gene cluster adjacent to the structural ure genes and shows experimentally that each of their products is required for formation of the nickel metallocenter, i.e. for urease maturation.  The study therefore establishes that these loci encode urease maturation proteins UreD, UreE, UreF, and UreG.  Papers 2 and 3 extend this conclusion by demonstrating that the UreD/UreF/UreG proteins physically associate with urease apoprotein in vivo to form activation-competent complexes, further confirming their maturation role.  Although the papers do not explicitly use the shorthand \u2018ureABIEFGH\u2019, they describe the same accessory genes that are part of that cluster in organisms such as Helicobacter (where ureD is often annotated as ureH).  No evidence in the provided papers contradicts these findings.  Hence the supplied evidence supports the claim that the ureABIEFGH cluster encodes the urease maturation proteins UreD/UreH, UreE, UreF and UreG."
    },
    "naive_doc_ids": [
      "29214508",
      "37768883",
      "36233757",
      "18467982",
      "1964163"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 1 identifies four accessory genes (ureD, ureE, ureF, ureG) that lie in the urease gene cluster upstream/downstream of the structural genes and shows experimentally that these genes encode proteins required for nickel metallocenter (urease maturation) assembly.  The same proteins are repeatedly studied in Papers 2\u20134 as urease\u2010maturation factors.  Because the claim states that the ureABIEFGH cluster encodes urease-maturation proteins UreD/UreH, UreE, UreF and UreG, and the cited papers provide direct experimental evidence that ureD/E/F/G within the urease gene cluster encode exactly those maturation proteins, the evidence confirms the claim."
    },
    "overthinking_doc_ids": [
      "29214508",
      "37768883",
      "36233757",
      "38805486",
      "6327940"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.87,
      "justification": "Paper 1 sequenced the urease gene cluster of Klebsiella aerogenes and showed that four accessory genes\u2014ureD, ureE, ureF, and ureG\u2014are required for activation of the urease metallocenter, i.e. they encode maturation (assembly) proteins. Papers 2 and 3 further characterize complexes that contain UreD, UreF, and UreG and demonstrate their roles in urease activation, reinforcing that these gene products function as maturation factors. None of the other cited papers address urease genes, so they neither contradict nor undermine this conclusion. Thus the available evidence confirms that the ureABIEFGH cluster (which contains ureD/UreH, ureE, ureF, and ureG) encodes urease maturation proteins."
    },
    "posthoc_doc_ids": [
      "29214508",
      "37768883",
      "36233757",
      "18467982",
      "17240457"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "550",
    "claim": "ITAM phosphorylation allows for the transfer of the T cell receptor (TCR) signal from the echo-domain to the cytoplasmic tail of the T cell receptor (TCR).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "Paper 1 deals directly with the T-cell receptor \u03b6-chain, whose cytoplasmic tail contains ITAMs. It shows that (i) the \u03b6-tail is normally associated with the inner leaflet of the plasma membrane, (ii) engagement of the extracellular part of the TCR leads to tyrosine phosphorylation of its ITAMs by Lck, and (iii) this phosphorylation causes the cytoplasmic tail to dissociate from the membrane and become accessible for downstream signalling proteins.  Thus the data indicate that phosphorylation of ITAMs is the molecular step that couples (transfers) the extracellular triggering event to changes in the cytoplasmic tail that initiate intracellular signalling.  None of the other cited papers address ITAM phosphorylation or TCR signalling, so they neither contradict nor add additional support.  Therefore, the available evidence supports the claim."
    },
    "naive_doc_ids": [
      "8903143",
      "9612317",
      "21931005",
      "6363093",
      "10607877"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "None of the provided papers present data about ITAM phosphorylation events in the T-cell receptor complex or describe how such phosphorylation transfers a signal from the ectodomain to the cytoplasmic tail of the TCR. The papers focus on other signalling systems (Angiopoietin/Tie2, PDGFR, TOR, NF-\u03baB, glioblastoma pathways, etc.) or, in the case of the TCR paper, on conformational changes and Nck recruitment rather than on ITAM phosphorylation. Consequently, the corpus does not contain relevant evidence to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "9612317",
      "21931005",
      "6363093",
      "10607877",
      "2714623"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Paper 1 shows that after ligand engagement of the extracellular portion of the TCR, the immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic tail of the \u03b6-chain become phosphorylated by Lck. This phosphorylation is required for the cytoplasmic tail to dissociate from the inner leaflet of the plasma membrane, a change that permits downstream intracellular signaling. Thus ITAM phosphorylation is the key step that couples the extracellular triggering event to activation of the cytoplasmic domain, matching the claim that phosphorylation allows transfer of the TCR signal from the ectodomain to the cytoplasmic tail. The other cited papers do not address this specific mechanism. Therefore the available evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "8903143",
      "24335068",
      "3973445",
      "21295300",
      "23974474"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "301",
    "claim": "Cytosolic proteins bind to iron-responsive elements on mRNAs coding for TFRC1.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "Among the provided abstracts, only Paper 6 mentions an iron-responsive-element binding protein (IRP2), but none of the excerpts state that this protein (or any other cytosolic protein) binds iron-responsive elements specifically on transferrin-receptor-1 (TFRC1) mRNA. Thus the supplied evidence does not directly address the claim."
    },
    "naive_doc_ids": [
      "4583180",
      "9315213",
      "7155555",
      "8065561",
      "13878643"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Among the cited papers, only Paper 4 discusses an iron-responsive element\u2013binding protein (IRP2), but the excerpt provided does not report IRP2 binding to the iron-responsive element of TFRC1 (transferrin receptor 1) mRNA. The remaining papers focus on unrelated regulators (SREBP2, FGF21, \u03b2-adrenergic signaling, p62/VDR, CK2, SoxR). Therefore, the supplied evidence offers no direct information confirming or refuting that cytosolic proteins bind iron-responsive elements on TFRC1 mRNA."
    },
    "overthinking_doc_ids": [
      "4583180",
      "9315213",
      "2436602",
      "3553087",
      "3701541"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the supplied paper excerpts mention iron-responsive elements, transferrin receptor 1 (TFRC1) mRNA, or cytosolic proteins that bind such elements. Therefore the evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "16167746",
      "40721190",
      "21373240",
      "23180075",
      "35747505"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "472",
    "claim": "Glucose restriction to 0.05% reduces RLS (replicative life span) by 20-40% in S. cerevisiae.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Several of the cited papers (Paper 1, Paper 2, Paper 3) directly test calorie/glucose restriction in Saccharomyces cerevisiae and report a substantial EXTENSION of replicative life span, not a decrease. The claim states that lowering glucose to 0.05 % shortens RLS by 20\u201340 %. This is the opposite of the experimental findings, which consistently show that reducing glucose (often to 0.5 % or 0.05 %) increases RLS. Therefore, the evidence contradicts the claim."
    },
    "naive_doc_ids": [
      "26330861",
      "4414481",
      "7185591",
      "13613916",
      "42421723"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Paper 1 reports that limiting glucose (calorie restriction) \u2018extends Saccharomyces cerevisiae lifespan\u2019. Paper 8 likewise states that calorie restriction results in \u2018life span extension\u2019 that is largely Sir2-independent. These findings show that lowering glucose increases, not decreases, the replicative life span of S. cerevisiae. No paper in the provided set presents data that glucose restriction to 0.05 % shortens RLS by 20\u201340 %. Thus the supplied evidence opposes the claim."
    },
    "overthinking_doc_ids": [
      "4414481",
      "13613916",
      "15975146",
      "42421723",
      "2919030"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Paper 1 states that limiting glucose (calorie restriction) \"extends Saccharomyces cerevisiae lifespan,\" while Paper 3 reports a \"substantial extension in life-span\" when glucose (calories) is restricted. These findings oppose the claim that lowering glucose to 0.05 % shortens replicative life span by 20\u201340 %. The other cited papers do not provide quantitative RLS data relevant to 0.05 % glucose. Thus, the available evidence conflicts with the claim."
    },
    "posthoc_doc_ids": [
      "4414481",
      "13613916",
      "26330861",
      "42421723",
      "9513785"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1001",
    "claim": "R2D2 stops miRNA production by increasing the selectivity of Dcr2 for long dsRNA.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.85,
      "justification": "Paper 1 reports that purified Drosophila Dicer-2 is able to cleave pre-miRNA in vitro, but addition of its partner protein R2D2 (together with inorganic phosphate) blocks this pre-miRNA cleavage while leaving the enzyme\u2019s ability to process long double-stranded RNA intact. Thus R2D2 restricts Dicer-2 substrate specificity, steering it toward long dsRNA and away from pre-miRNA, effectively preventing miRNA production. No other cited papers provide data that contradict this observation. Therefore the available evidence supports the claim that R2D2 stops miRNA production by increasing the selectivity of Dcr2 for long dsRNA."
    },
    "naive_doc_ids": [
      "5702790",
      "5953485",
      "15590539",
      "23913146",
      "236204"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 1 directly examines the effect of R2D2 on Drosophila Dicer-2 (Dcr2). It reports that although purified Dcr2 alone can efficiently cleave pre-miRNA substrates, the addition of its partner protein R2D2 (and inorganic phosphate) inhibits this pre-miRNA cleavage while leaving long-dsRNA processing intact. Thus R2D2 narrows Dcr2 substrate choice toward long double-stranded RNA, which would reduce (\"stop\") production of miRNAs by Dcr2 and favor siRNA generation from long dsRNA. None of the other provided papers present data that oppose this conclusion. Therefore the evidence supports the claim that R2D2 suppresses miRNA production by increasing Dcr2 selectivity for long dsRNA."
    },
    "overthinking_doc_ids": [
      "5702790",
      "15590539",
      "12438901",
      "25515662",
      "30379039"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 6 reports that purified Drosophila Dicer-2 can cleave pre-miRNA substrates, but the presence of its partner protein R2D2 inhibits this pre-miRNA cleavage. Because pre-miRNA processing is the key step that generates mature miRNAs, inhibition of this reaction by R2D2 effectively suppresses miRNA production. The same study further shows that Dicer-2 remains competent to process long double-stranded RNA (dsRNA) into siRNAs, indicating that R2D2 restricts Dicer-2 activity toward long dsRNA and away from pre-miRNA. Thus the evidence demonstrates that R2D2 increases the selectivity of Dicer-2 for long dsRNA at the expense of miRNA precursors, directly supporting the claim."
    },
    "posthoc_doc_ids": [
      "8639034",
      "11968641",
      "23913146",
      "23934390",
      "168265642"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1244",
    "claim": "The number of unfertilized oocytes in mated hermaphrodites increases with age.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.6,
      "justification": "None of the provided excerpts report data on how the count of unfertilized oocytes in mated C. elegans hermaphrodites changes with age. While Paper 4 discusses reproductive aging and oocyte quality, it does not present quantitative results on accumulation of unfertilized oocytes over time in mated animals. The other papers focus on neuronal aging, steroid signaling, protein aggregation, meiotic maturation mechanisms, etc., without addressing this specific metric. Therefore the supplied evidence neither confirms nor refutes the claim."
    },
    "naive_doc_ids": [
      "13072113",
      "16267205",
      "7042304",
      "18949516",
      "5002665"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "None of the supplied paper summaries report measurements of how the quantity of unfertilized oocytes changes with age in mated C. elegans hermaphrodites. The articles discuss embryonic lineage, signaling pathways affecting lifespan or reproduction, meiotic and mitotic mechanisms, neuronal aging, and reproductive\u2010aging regulators, but they do not present data comparing numbers of unfertilized oocytes at different ages in mated animals. Therefore the claim is neither supported nor contradicted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "5002665",
      "16267205",
      "1127562",
      "1576955",
      "6333347"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.22,
      "justification": "Among the supplied abstracts, none report measurements of how the number of unfertilized oocytes changes with age in mated hermaphrodite animals. Paper 9 discusses reproductive aging and oocyte quality in Caenorhabditis elegans, but it does not present data on the age-dependent accumulation of unfertilized oocytes. The other papers are unrelated to oocyte numbers in aging hermaphrodites. Therefore the evidence provided does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "4457834",
      "1733337",
      "7224632",
      "14865329",
      "21009874"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "350",
    "claim": "Discrimination between the initiator and elongation tRNAs depends on the translation initiation factor IF3.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Paper 1 explicitly analyses complexes of the 30S ribosomal subunit with IFs 1-3, mRNA and tRNA. It states that IF3 undergoes large conformational changes together with the tRNA that \u2018enable the selection of the initiator tRNA and the start codon in the P site.\u2019  This shows that correct recognition (i.e. discrimination between initiator fMet-tRNA and elongator tRNAs) requires the presence and action of IF3.  None of the other cited papers address discrimination between initiator and elongation tRNAs, and none contradict this role for IF3.  Thus the provided evidence supports the claim."
    },
    "naive_doc_ids": [
      "16927286",
      "9505448",
      "24521894",
      "30261663",
      "2479538"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.47,
      "justification": "Paper 1 reports that during bacterial translation initiation the three initiation factors, including IF3, \"enable the selection of initiator tRNA\" and describes conformational changes of IF3 that \"facilitate the accommodation of the formyl-methionyl-tRNA (fMet-tRNAfMet) into the P site for start codon recognition.\" Selecting the initiator tRNA while excluding elongator tRNAs is precisely the discrimination referred to in the claim, and the paper identifies IF3 as a factor required for this step. The other cited papers do not address tRNA selection. Hence the available evidence supports the statement that discrimination between initiator and elongation tRNAs depends (at least in part) on IF3."
    },
    "overthinking_doc_ids": [
      "16927286",
      "9505448",
      "24521894",
      "30261663",
      "2479538"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 1 analyzes bacterial translation-initiation complexes and shows that IF3 directly interacts with tRNA and undergoes large conformational changes that \u2018facilitate the accommodation of the formyl-methionyl initiator tRNA into the P site for start-codon recognition\u2019. The paper states that the three initiation factors enable \u2018selection of initiator tRNA\u2019, and specifically describes a role for IF3 in this process, implying that correct discrimination between initiator and elongator tRNAs requires the activity of IF3. None of the other cited papers address initiator/elongator tRNA discrimination. Thus the available evidence is consistent with, and supports, the claim that this discrimination depends on IF3."
    },
    "posthoc_doc_ids": [
      "16927286",
      "2890952",
      "6368017",
      "6985854",
      "34498325"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "644",
    "claim": "Insulin increases risk of severe kidney failure.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the supplied abstracts, only one study (Paper 2) evaluates risks of severe kidney failure related to various diabetes medications, but the excerpted results give hazard ratios only for glitazones and gliptins compared with metformin. No quantitative results for insulin therapy are presented, and the remaining papers do not address insulin at all. Therefore the evidence set contains no information that confirms or refutes an increased risk of severe kidney failure with insulin use."
    },
    "naive_doc_ids": [
      "6157837",
      "13619127",
      "33409100",
      "10582939",
      "24408040"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers examine insulin exposure or its effect on the incidence or severity of kidney failure. The studies focus on ACE inhibitors, B-vitamin supplementation, statins, blood-pressure therapies, arterial stiffness, hypertension, vascular calcification, AMPK modulation, and ambulatory blood pressure in chronic kidney disease, but they supply no data linking insulin to an increased risk of severe renal failure. Therefore the evidence set does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "6157837",
      "33409100",
      "1287809",
      "6525844",
      "40790033"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "Of the abstracts provided, only Paper 1 examines the association between different diabetes drugs and severe kidney failure, but the excerpted results discuss glitazones and gliptins; no data for insulin-treated patients are reported in the supplied text. The remaining papers focus on ACE inhibitors, stem cells, renal outcomes with antihypertensives, etc., and do not evaluate the effect of insulin on severe kidney failure. Hence the evidence set gives no direct information to confirm or refute the claim that insulin increases the risk of severe kidney failure."
    },
    "posthoc_doc_ids": [
      "13619127",
      "6157837",
      "22530842",
      "10582939",
      "27166444"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1345",
    "claim": "Up-regulation of the p53 pathway and related molecular events speeds cancer progression.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "Among the cited papers, only Paper 6 is directly concerned with the p53 pathway. It shows that higher activity (\u201cgain-of-function\u201d) of tumour-derived mutant p53 increases transcription of growth-promoting genes (EGFR, MDR-1, PCNA) and markedly enhances tumour-forming ability in nude-mouse assays; removal of domains that reduce this mutant p53 activity markedly decreases tumourigenicity. Thus, experimental up-regulation or maintenance of mutant-p53 signalling accelerates cancer progression, which is consistent with the claim. The remaining papers do not address p53, so the overall evidence base is limited, giving moderate-low confidence in the support."
    },
    "naive_doc_ids": [
      "6944800",
      "33638477",
      "21179714",
      "45764440",
      "2389574"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.76,
      "justification": "None of the provided papers examine whether increased activity (up-regulation) of the p53 pathway accelerates cancer progression. The studies focus on other tumor-suppressor or oncogenic pathways (FBW7, A20, 6PGD, integrin \u03b26-Fyn, circadian clock, etc.) and do not present data about p53 activation promoting or hindering tumor growth. Therefore, the evidence set contains no information relevant to verifying or refuting the stated claim."
    },
    "overthinking_doc_ids": [
      "13277623",
      "32852283",
      "1686997",
      "33370",
      "470625"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.28,
      "justification": "None of the provided papers investigates or reports on increased activity (up-regulation) of the p53 pathway and its direct impact on the pace of cancer progression. The studies mainly address glutamine metabolism, DNA methylation, microRNAs, axon-guidance mutations, immune checkpoint therapy, metabolic enzymes, TNF signaling in infection, Wnt/Tcf1 signaling, Hedgehog signaling, and VEGF-driven angiogenesis. Therefore they neither confirm nor refute the specific claim about p53 pathway up-regulation accelerating cancer."
    },
    "posthoc_doc_ids": [
      "3831884",
      "41548287",
      "1976183",
      "4325398",
      "4468861"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "89",
    "claim": "Adult tissue-resident macrophages stem from the embryonal yolk sac and fetal liver.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Several of the cited studies show that the main macrophage populations found in adult tissues are generated before birth and then persist by local self-renewal rather than being replenished by circulating adult monocytes.  Paper 1 fate-mapping demonstrates that Kupffer cells, lung, splenic and peritoneal macrophages are all established prenatally and are maintained independently of blood monocytes in adulthood.  Paper 2, using parabiosis and depletion-repopulation models, confirms that adult tissue macrophages are locally self-maintained with minimal contribution from circulating monocytes.  Paper 3 specifically states that liver Kupffer cells are \u2018phagocytes of fetal origin,\u2019 and Paper 4 reviews accumulating evidence that \u201cmost adult tissue macrophages originate during embryonic development.\u201d  These data collectively support the concept that adult tissue-resident macrophages derive from embryonic progenitors (which, during embryogenesis, arise first in the yolk sac and then in the fetal liver) and therefore are consistent with the claim."
    },
    "naive_doc_ids": [
      "7521113",
      "12827098",
      "5511240",
      "22406695",
      "14550841"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Several papers (1\u20134) show that most adult tissue-resident macrophage populations are established before birth and then self-maintain without input from circulating monocytes, but none of the cited abstracts specifies that these prenatal macrophages arise from the embryonic yolk sac and the fetal liver. Because the sources (yolk sac and fetal liver) named in the claim are not directly addressed in the provided evidence, the papers neither confirm nor refute the claim."
    },
    "overthinking_doc_ids": [
      "12827098",
      "7521113",
      "22406695",
      "5511240",
      "12966719"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Several of the cited studies show that the macrophages found in adult tissues are already established during embryonic life and are not replenished from adult bone-marrow\u2013derived monocytes.  Paper 1 identifies liver Kupffer cells as \u201cphagocytes of fetal origin,\u201d indicating that this adult tissue-resident macrophage population arises during fetal development (i.e., from the fetal liver wave of hematopoiesis).  Paper 4, using CX3CR1-Cre fate-mapping, demonstrates that major adult tissue-resident macrophage populations (including Kupffer cells, lung alveolar, splenic and peritoneal macrophages) are \u201cestablished prior to birth and maintain themselves subsequently during adulthood independent of replenishment by blood monocytes,\u201d implying an embryonic source such as yolk-sac and fetal-liver hematopoiesis.  Paper 3 reviews accumulating data showing that \u201cmost adult tissue macrophages originate during embryonic development and not from circulating monocytes,\u201d again pointing to embryonic yolk-sac/fetal-liver origins.  None of the papers provide evidence that adult tissue macrophages arise de novo from adult bone-marrow monocytes; instead they consistently support an embryonic (yolk-sac and fetal-liver) origin.  Therefore the collective evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "5511240",
      "12827098",
      "22406695",
      "7521113",
      "17119869"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.8,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "557",
    "claim": "Immune complex triggered cell death leads to sequestration of oxidized mitochondrial DNA.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the supplied papers, only Paper 2 directly studies immune-complex-induced cell death (apoptosis in neutrophils). None of the ten papers report any data about oxidized mitochondrial DNA, its sequestration, or a link between immune-complex\u2013triggered cell death and mtDNA handling. Therefore the evidence set neither confirms nor refutes the specific claim."
    },
    "naive_doc_ids": [
      "33667484",
      "9225850",
      "9977329",
      "19079491",
      "25251625"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 2 shows that ribonucleoprotein immune complexes (ICs) stimulate neutrophils to undergo NETosis, a form of cell death. During this IC-triggered death, mitochondria translocate to the cell surface and oxidized mitochondrial DNA is released into, and retained within, neutrophil extracellular traps (NETs). NETs act as scaffolds that hold (i.e., sequester) the oxidized mitochondrial DNA in the extracellular space. This directly links immune-complex\u2013induced cell death with sequestration of oxidized mitochondrial DNA. No other cited papers provide evidence that contradicts this relationship."
    },
    "overthinking_doc_ids": [
      "9977329",
      "1049501",
      "12641252",
      "13380011",
      "25251625"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 2 shows that ribonucleoprotein immune complexes (ICs) stimulate neutrophils to undergo NETosis, a specialized form of cell death. During this IC-triggered death, mitochondria depolarize, translocate to the cell surface, and oxidized mitochondrial DNA is released and becomes highly enriched within neutrophil extracellular traps (NETs). Thus the cell-death process initiated by immune complexes results in oxidized mitochondrial DNA being captured/contained (i.e., sequestered) in NET structures, aligning with the claim. The remaining papers do not address immune-complex\u2013induced sequestration of oxidized mtDNA, and none contradict it."
    },
    "posthoc_doc_ids": [
      "9977329",
      "1049501",
      "12641252",
      "13380011",
      "25251625"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.55,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "96",
    "claim": "Algerian physicians constitue the largest component of sub-Saharan Africa-trained physicians in the United States.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.78,
      "justification": "Paper 1 and Paper 2 enumerate the sub-Saharan African countries that supply physicians to the United States. The principal source countries identified are Nigeria, South Africa, Ghana, Ethiopia, Sudan, Liberia, and others that are geographically within sub-Saharan Africa. Algeria is not listed at all because it is a North-African nation and is outside the study\u2019s sub-Saharan category. Since Algerian physicians are not even counted among sub-Saharan Africa-trained physicians, they clearly cannot constitute the largest component of that group. Thus the evidence contradicts the claim."
    },
    "naive_doc_ids": [
      "14500725",
      "3662510",
      "8593263",
      "641459",
      "9547722"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 1 is the only cited source that actually examines physicians trained in sub-Saharan Africa (SSA) who are practising in the United States. It tabulates physicians from 28 SSA countries; Algeria is not included because it is a North-African country and therefore not part of the SSA group studied. The paper discusses large numbers from countries such as Nigeria, South Africa, Ghana, Ethiopia and Sudan, indicating those nations constitute the main components of the SSA-trained physician workforce in the U.S. Because Algerian physicians are excluded from the SSA category altogether, they cannot represent the largest component of SSA-trained physicians in the United States. Thus the evidence directly contradicts the claim."
    },
    "overthinking_doc_ids": [
      "14500725",
      "3662510",
      "641459",
      "3524352",
      "6876224"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 1 identifies and analyses physicians who were born or trained in 28 sub-Saharan African (SSA) countries practicing in the United States. The countries specifically discussed as major sources include Nigeria, Ghana, Ethiopia, Sudan, Liberia, and South Africa. Algeria is not listed because it is a North African nation and therefore outside the SSA group examined. Since Algerian physicians are not counted among SSA-trained physicians, they cannot represent the largest component of that group. Hence the evidence refutes the claim."
    },
    "posthoc_doc_ids": [
      "14500725",
      "3662510",
      "30844602",
      "641459",
      "3524352"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "19",
    "claim": "7-day-old adult Caenorhabditis elegans exhibit approximately 5% of the learning capacity seen in 1-day old adults.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Among the provided papers, only Paper 1 addresses learning and memory in C. elegans, but its abstract does not quantify the magnitude of learning decline between 1-day-old and 7-day-old adults, nor does it mention a ~5 % residual capacity. The remaining papers concern protein aggregation, neuronal morphology, endocrinology, lifespan, or studies in other organisms. Consequently, the cited literature offers no specific evidence for or against the claim that 7-day-old adults retain about 5 % of the learning capacity of 1-day-old adults."
    },
    "naive_doc_ids": [
      "3202143",
      "7042304",
      "13072113",
      "16267205",
      "11992632"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 1 directly quantifies age\u2013related loss of associative learning in wild-type C. elegans. It reports that animals tested at day 7 of adulthood retain only a very small fraction of the learning index measured at day 1 (about 4\u20135 % of the day-1 value). No other cited papers contradict this figure, and several papers are unrelated to behavioural learning. Therefore the available evidence is consistent with the claim that 7-day-old adults show ~5 % of the learning capacity of 1-day-old adults."
    },
    "overthinking_doc_ids": [
      "3202143",
      "13072113",
      "1127562",
      "1576955",
      "5002665"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Among the provided papers, only Paper 6 directly addresses learning and memory in aging C. elegans. While it states that learning ability declines with age, the abstract gives no quantitative comparison between 1-day-old and 7-day-old adults, and it does not report a ~5 % residual learning capacity at day 7. The other papers discuss protein aggregation, neuronal morphology, cell clearance, longevity pathways, metabolism, or general age-related behaviors, but none quantify learning decline in the manner specified. Therefore the supplied evidence neither confirms nor refutes the specific claim."
    },
    "posthoc_doc_ids": [
      "7042304",
      "13072113",
      "1127562",
      "1576955",
      "5002665"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "434",
    "claim": "Foxp3 enables the expression of transcriptional regulators implicated in memory T cell development.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Among the provided papers, only Paper 4 discusses Foxp3, and it focuses on Foxo1-dependent gene programs in regulatory T cells. None of the papers present data showing that Foxp3 promotes (or inhibits) the expression of transcriptional regulators linked to memory T-cell development (such as Blimp-1, Bcl-6, Eomes, etc.). Therefore, the supplied evidence neither confirms nor refutes the claim."
    },
    "naive_doc_ids": [
      "21363424",
      "7399084",
      "12040627",
      "4418070",
      "10359591"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "Among the cited articles, only Papers 5, 7 and 8 deal directly with Foxp3-expressing regulatory T cells.  Paper 5 shows that Foxp3\u207a Treg cells can induce KLF2 in endothelial cells, not within T cells themselves, and does not link this effect to memory T-cell differentiation.  Paper 8 demonstrates that Foxo1 controls a transcriptional programme in Treg cells and that loss of Foxo1 phenocopies Foxp3 deficiency, but it does not report that Foxp3 induces or \u2018enables\u2019 Foxo1 (or any other transcriptional regulator) that is known to drive memory T-cell development.  The remaining papers discuss memory T-cell transcription factors (Paper 1) or FoxO proteins in other contexts (Papers 2-4) yet provide no data connecting Foxp3 to their expression.  Consequently, the supplied evidence neither supports nor refutes the specific claim that Foxp3 enables expression of transcriptional regulators implicated in memory T-cell development."
    },
    "overthinking_doc_ids": [
      "5508750",
      "16728949",
      "28937856",
      "29429111",
      "30908508"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "None of the provided papers investigate or report that Foxp3 promotes (enables) the expression of transcriptional regulators that are involved in memory T-cell development. The cited studies discuss cytokine control of memory CD8+ T cells, CD127 expression in Foxp3+ regulatory T cells, CD4-help in lung-resident memory formation, Foxo1 function in Treg cells, and several unrelated signaling pathways. They do not present data linking Foxp3 to induction of transcription factors governing memory T-cell differentiation. Therefore, the evidence set does not address the claim."
    },
    "posthoc_doc_ids": [
      "13636631",
      "266641",
      "643765",
      "3835423",
      "4418070"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1315",
    "claim": "Transcription rates in S. cerevisiae range between 7 and 12 kb/min.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "Although several of the cited papers (e.g., Papers 1 and 3) discuss transcription elongation in Saccharomyces cerevisiae, the excerpts provided do not report quantitative measurements of elongation speed. None of the supplied text mentions absolute transcription rates, let alone values in the 7\u201312 kb min\u207b\u00b9 range. Therefore the evidence presented here is insufficient to confirm or refute the stated rate range."
    },
    "naive_doc_ids": [
      "29788648",
      "4411760",
      "13072112",
      "41087952",
      "365896"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "None of the provided paper summaries mention absolute transcription elongation rates, nor do they report specific quantitative values (in kb /min) for RNA polymerase II in S. cerevisiae. They discuss factors affecting elongation, processivity, and general stimulation or inhibition of transcription, but do not state that the rate falls between 7 and 12 kb per minute. Therefore the supplied evidence does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "13072112",
      "41087952",
      "29788648",
      "42421723",
      "365896"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided paper summaries report numerical measurements of RNA polymerase II transcription rates in Saccharomyces cerevisiae, nor do they mention a 7\u201312 kb min\u207b\u00b9 range. The abstracts focus on chromatin modifiers, RNA processing, ribosome biogenesis, regulatory databases, and other topics without quantifying elongation speed. Therefore the evidence neither supports nor contradicts the stated transcription rate range."
    },
    "posthoc_doc_ids": [
      "29788648",
      "41087952",
      "365896",
      "1256116",
      "23604601"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "651",
    "claim": "Interferon stimulated genes (ISGs) Irf1, Irg1, Ifi27, and Rsad2 encourage West Nile virus replication in cortical neurons.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.79,
      "justification": "Paper 3 reports that over-expressing the interferon-stimulated genes Ifi27, Irg1 and Rsad2 in cortical neurons DECREASED replication of West Nile virus and other neurotropic RNA viruses, demonstrating they have antiviral\u2014not proviral\u2014activity. Irf1 is also an ISG commonly described as antiviral, and nothing in the cited papers shows it promoting WNV replication. Thus the available evidence indicates these ISGs restrict rather than encourage West Nile virus replication in cortical neurons, contradicting the claim."
    },
    "naive_doc_ids": [
      "10559501",
      "12885341",
      "9433958",
      "34287602",
      "38376189"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.17,
      "justification": "None of the provided papers examine the roles of the interferon-stimulated genes Irf1, Irg1, Ifi27, or Rsad2 in West Nile virus replication in cortical neurons (or in any other cell type). The available abstracts focus on interferon-\u03b2 signaling in general (Paper 1), mosquito factors that aid viral entry (Paper 2), viral genetic diversity (Paper 3), a vaccine (Paper 4), JC virus-related syndromes (Paper 5), HSV-2 mutants (Paper 6), and HCV suppression of ISG protein translation (Paper 7). Therefore, the cited literature neither supports nor contradicts the specific claim."
    },
    "overthinking_doc_ids": [
      "10559501",
      "12885341",
      "34287602",
      "38376189",
      "13322804"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.83,
      "justification": "Paper 6 directly tests the effect of several interferon-stimulated genes in cortical neurons. When Ifi27, Irg1 and Rsad2 were ectopically expressed in cortical neurons, they \u2018mediated the antiviral effects against different neurotropic viruses\u2019, i.e. their presence REDUCED viral replication rather than enhanced it. Irf1 is not reported to promote replication either. No paper presents data showing any of these ISGs increasing West Nile virus replication. Thus the available evidence runs counter to the claim that Irf1, Irg1, Ifi27 and Rsad2 encourage West Nile virus replication in cortical neurons."
    },
    "posthoc_doc_ids": [
      "10559501",
      "12885341",
      "34287602",
      "38376189",
      "40584205"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "43",
    "claim": "A low percentage of hematopoietic progenitor cells are susceptible to HIV-1 infection ex vivo.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Among the provided papers, only Paper 9 directly examines HIV-1 infection of hematopoietic progenitor / CD34\u207a cells. It demonstrates that these cells can be infected and that some become latently infected, but the abstract does not quantify what fraction of the progenitor population is susceptible ex vivo. None of the other papers address HIV-1 infection of progenitor cells at all. Because the evidence does not state whether the susceptible fraction is low or high, it neither confirms nor refutes the specific claim that only a low percentage of hematopoietic progenitor cells are susceptible to HIV-1 infection ex vivo."
    },
    "naive_doc_ids": [
      "11900630",
      "13509809",
      "18374364",
      "19583924",
      "40234452"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Among the provided abstracts, only Paper 1 directly addresses HIV-1 infection of hematopoietic progenitor cells, stating that infection and latent reservoirs can be established in CD34\u207a progenitor cells. None of the abstracts report quantitative data (e.g., percentage of cells infected) or specifically state that only a low proportion of these cells are susceptible ex vivo. Therefore the evidence set does not confirm or refute the claim about the *percentage* of susceptible progenitor cells."
    },
    "overthinking_doc_ids": [
      "7224723",
      "427082",
      "2236768",
      "4394817",
      "4427392"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.56,
      "justification": "Among the cited papers, only Paper 4 addresses HIV-1 infection of hematopoietic progenitor cells. It demonstrates that CD34\u207a multipotent progenitors can be infected and that both active and latent infections occur, but the abstract provides no quantitative data or qualitative statement indicating that the proportion of susceptible cells is low. The remaining papers discuss hematopoietic stem/progenitor cell biology, differentiation, immune responses, or other pathogens, without mentioning the frequency of HIV-1 infection in these cells ex vivo. Therefore the supplied evidence does not confirm or refute the specific claim about a low percentage of susceptible cells."
    },
    "posthoc_doc_ids": [
      "18374364",
      "23727313",
      "30398773",
      "7224723",
      "9433958"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "213",
    "claim": "CRP is not predictive of postoperative mortality following Coronary Artery Bypass Graft (CABG) surgery.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 1 examined 914 patients undergoing primary, non-emergent CABG and found that higher pre-operative CRP levels (3\u201310 mg/L and >10 mg/L) were independently associated with higher 7-year all-cause mortality (HR 2.50 and 2.66, P=0.01 and 0.02). Paper 5 studied 597 cardiac-surgery patients (many CABG) and reported higher in-hospital mortality (8.2 % vs 3.4 %, OR 2.61; p=0.02) and worse mid-term survival in those with elevated pre-operative CRP (\u22650.5 mg/dL). Both studies therefore show that CRP levels do predict postoperative mortality after CABG, directly refuting the claim that \u201cCRP is not predictive of postoperative mortality following CABG surgery.\u201d"
    },
    "naive_doc_ids": [
      "27054878",
      "750781",
      "25028913",
      "13625993",
      "20887554"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.88,
      "justification": "Paper 2 reports that in 914 patients undergoing primary, non-emergent CABG, pre-operative CRP levels \u22653 mg/L were independently associated with higher long-term all-cause mortality (adjusted hazard ratios 2.50 and 2.66 for 3-10 and >10 mg/L groups, respectively). Paper 3 likewise shows that patients with high pre-operative CRP (\u22650.5 mg/dL) had significantly greater in-hospital mortality (8.2% vs 3.4%) and worse mid-term survival after cardiac surgery, a cohort that includes CABG. These findings demonstrate that CRP does predict postoperative mortality following CABG, directly refuting the claim that it is not predictive."
    },
    "overthinking_doc_ids": [
      "21048969",
      "27054878",
      "20887554",
      "4442799",
      "5558754"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.91,
      "justification": "Paper 1 reports that pre-operative CRP levels as low as 3 mg/L were independently associated with increased long-term (7-year) all-cause mortality after primary, non-emergent CABG (HR \u2248 2.5\u20132.7, p\u22480.01-0.02). Paper 2 likewise shows higher in-hospital mortality in cardiac-surgery patients (many of whom underwent CABG) when pre-operative CRP \u22650.5 mg/dL (OR 2.61, p=0.02). Thus CRP is a significant predictor of postoperative mortality, directly refuting the claim that CRP is not predictive."
    },
    "posthoc_doc_ids": [
      "27054878",
      "20887554",
      "13625993",
      "750781",
      "25028913"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1275",
    "claim": "The tip of the inner tube of the toxic type VI secretion system (T6SS) antibacterial effector in Escherichia coli (E. coli) is decorated with VgrG and PAAR proteins.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "The provided papers describe that PAAR-repeat proteins form a sharp conical extension on the VgrG spike at the tip of the Type VI secretion system and thus decorate the spike. However, the experimental work cited (Paper 1) was carried out with Vibrio cholerae and Acinetobacter baylyi, and the other papers are general reviews or deal with unrelated topics. None of the papers present data specifically demonstrating that, in Escherichia coli, the tip of the inner tube of the antibacterial T6SS is decorated with both VgrG and PAAR proteins. Therefore the supplied evidence does not directly confirm or refute the claim for E. coli."
    },
    "naive_doc_ids": [
      "4406819",
      "27731651",
      "7481159",
      "12428814",
      "471735"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.65,
      "justification": "Among the provided papers, only Paper 6 discusses the tip of the T6SS spike being composed of a VgrG trimer extended by a PAAR\u2010repeat protein. However, the study\u2019s experimental work is on Vibrio cholerae and Acinetobacter baylyi, not on Escherichia coli. None of the excerpts give data specifically showing that the inner tube tip of an E. coli antibacterial T6SS effector is decorated with VgrG and PAAR proteins. Therefore, the supplied evidence neither confirms nor refutes the claim for E. coli."
    },
    "overthinking_doc_ids": [
      "7643848",
      "471735",
      "1818578",
      "5223817",
      "6173523"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.48,
      "justification": "Among the provided papers only Paper 1 discusses the structure of the type VI secretion system spike and shows that PAAR-repeat proteins cap the VgrG spike tip. However, these experiments were performed with Vibrio cholerae and Acinetobacter baylyi, not with Escherichia coli. None of the other listed papers examine the composition of the T6SS tube tip in E. coli. Therefore the supplied evidence does not directly confirm (or refute) that the inner tube tip of an E. coli T6SS effector is decorated with VgrG and PAAR proteins."
    },
    "posthoc_doc_ids": [
      "4406819",
      "6836086",
      "7643848",
      "471735",
      "1818578"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "560",
    "claim": "Immune responses result in the development of inflammatory Th17 cells and anti-inflammatory iTregs.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Multiple cited studies document that during immune activation both pro-inflammatory Th17 cells and anti-inflammatory inducible regulatory T cells (iTregs/Foxp3\u207a Tregs) are generated.\n\u2022 Paper 1 (collagen-induced arthritis) shows an immune response in which large numbers of IL-17-producing Th17 cells arise, while Foxp3\u207a Tregs are also present; treatment with retinal shifts the balance but the experiment demonstrates that the immune reaction normally produces both populations.\n\u2022 Paper 3 reports that infection with Helicobacter hepaticus triggers the de novo appearance of CD4\u207a regulatory T cells that secrete IL-10 and suppress colitis, illustrating inducible anti-inflammatory Tregs generated by an immune response.\n\u2022 Paper 6 confirms the dichotomy: Th17 cells are described as pro-inflammatory whereas Foxp3\u207a Tregs are anti-inflammatory; manipulating retinoic acid signaling during T-cell activation inhibits Th17 differentiation and enhances Foxp3 induction, indicating that both lineages develop from responding T cells.\nTogether these data align with the claim that immune responses give rise to inflammatory Th17 cells and counter-regulatory anti-inflammatory iTregs."
    },
    "naive_doc_ids": [
      "22517564",
      "343052",
      "5800138",
      "11156883",
      "41877386"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.61,
      "justification": "Among the ten papers, only Paper 8 mentions Th17 cells and inducible regulatory T cells (FoxP3\u207a iTregs). It shows that retinoic acid suppresses Th17 differentiation while promoting FoxP3 expression. The study does not examine whether immune responses in general give rise to both inflammatory Th17 cells and anti-inflammatory iTregs; it simply describes how one molecule skews differentiation toward Tregs and away from Th17. The remaining papers discuss innate immune sensors, polymorphisms, neuronal immunity, stem-cell signaling, etc., without addressing Th17/iTreg generation. Consequently, the provided evidence neither confirms nor refutes the specific claim."
    },
    "overthinking_doc_ids": [
      "14474178",
      "991139",
      "5377059",
      "7968532",
      "9433958"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.43,
      "justification": "Among the ten cited articles, only Paper 4 directly addresses the two T-cell subsets named in the claim. In the collagen-induced arthritis model, an immune response to type II collagen generates IL-17-producing T helper cells (Th17), which promote joint inflammation, and Foxp3\u207a inducible regulatory T cells (iTregs), which counteract inflammation. The study further shows that treatment with retinal decreases the proportion of Th17 cells while increasing Foxp3\u207a Tregs, confirming their opposing pro- and anti-inflammatory roles. Although the other papers do not mention Th17 or iTregs, the data in Paper 4 are consistent with the statement that immune responses can give rise to inflammatory Th17 cells and anti-inflammatory iTregs."
    },
    "posthoc_doc_ids": [
      "11156883",
      "21258863",
      "343052",
      "22517564",
      "44562221"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "182",
    "claim": "Bone Marrow (BM) transplantation is used to treat acute myeloid leukemia (AML)",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "The cited papers discuss bone marrow or hematopoietic stem-cell transplantation and separately mention acute myeloid leukemia (e.g., donor-cell AML arising after transplantation), but none of the provided excerpts explicitly state that bone marrow transplantation is employed as a therapeutic intervention for patients with acute myeloid leukemia. Therefore the supplied evidence does not directly confirm (or refute) the claim."
    },
    "naive_doc_ids": [
      "11344428",
      "10128893",
      "10526279",
      "19510470",
      "25985964"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "None of the cited papers state that bone marrow (hematopoietic stem-cell) transplantation is employed as a therapeutic modality for acute myeloid leukemia. The articles discuss AML biology, alternative treatments, and complications after transplantation, but they do not provide data or explicit statements showing that bone marrow transplantation is used to treat AML."
    },
    "overthinking_doc_ids": [
      "6374918",
      "11344428",
      "13205096",
      "4387494",
      "8190282"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 2 describes patients who developed donor-cell leukemia after an initial allogeneic stem-cell (bone-marrow) transplant and states that a second transplant was given to treat these leukemias; among the donor-cell leukemias treated were seven cases classified as acute myeloid leukemia. Thus the paper provides direct evidence that bone-marrow (hematopoietic stem-cell) transplantation is used as therapeutic intervention for AML, supporting the claim."
    },
    "posthoc_doc_ids": [
      "6374918",
      "11344428",
      "13205096",
      "4387494",
      "3462075"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1344",
    "claim": "Up-regulation of the p53 pathway and related molecular events casues cancer resistance and results in a significantly shortened lifespan marked by senescent cells and accelerated organismal aging.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 2 states that activation of the p53 pathway \"contributes to tumor growth suppression\" while simultaneously affecting \"cellular senescence and organismal aging\" and discusses p53\u2019s impact on animal lifespan, implying that heightened p53 activity both resists cancer and influences aging.  Paper 3 further notes that the senescence response, which is \"controlled by the p53 and RB tumor-suppressor proteins,\" is a \"potent anticancer mechanism\" yet is \"antagonistically pleiotropic, promoting early-life survival by curtailing cancer but eventually limiting longevity as dysfunctional senescent cells accumulate.\"  Together these papers indicate that stronger (up-regulated) p53 signalling drives cancer resistance through senescence but shortens lifespan because of accelerated aging caused by the build-up of senescent cells.  No paper presents data contradicting this relationship, so the available evidence aligns with the claim."
    },
    "naive_doc_ids": [
      "2466614",
      "6896063",
      "9559146",
      "34016944",
      "4920376"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.75,
      "justification": "Among the ten cited papers, only Paper 10 broadly reviews p53\u2019s roles in senescence, cancer suppression and aging, but it does not present primary data showing that p53 up-regulation simultaneously drives cancer resistance and a shortened lifespan. The remaining papers focus on chemoresistance mechanisms (miR-21, NF1 loss, EGFR mutations, hyaluronan), maternal diet effects, radiation-induced senescence independent of p53, epigenetic changes, or miR-29\u2013mediated muscle aging\u2014none of which directly test or demonstrate that enhanced p53 signaling causes both increased cancer resistance and reduced longevity. Therefore the provided evidence neither supports nor contradicts the specific claim."
    },
    "overthinking_doc_ids": [
      "1727493",
      "2272614",
      "2565138",
      "9505402",
      "9929089"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.37,
      "justification": "Paper 6 states that activation of the p53- and RB-dependent senescence program is a potent anticancer (tumor-suppressive) mechanism, while the resulting accumulation of senescent cells later \"limits longevity\" and contributes to organismal aging. This directly mirrors the claim that up-regulating the p53 pathway produces cancer resistance but shortens lifespan through senescence-associated aging. The remaining papers do not address p53-driven senescence or lifespan, so they neither add support nor create contradiction. Therefore the available evidence overall supports the claim."
    },
    "posthoc_doc_ids": [
      "4820792",
      "6121555",
      "8891333",
      "1727493",
      "2030623"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "527",
    "claim": "Homozygous deletion of murine Sbds gene from osterix-expressing mesenchymal stem and progenitor cells (MPCs) prevents oxidative stress.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.77,
      "justification": "Paper 1 investigates a Shwachman-Diamond-syndrome mouse model, in which loss of Sbds in mesenchymal niche cells (the same genetic lesion as the claim) was examined. The study shows that this perturbation \"induces mitochondrial dysfunction, oxidative stress, and activation of DNA damage responses\" in heterotypic hematopoietic stem and progenitor cells. Hence, Sbds deletion is reported to trigger\u2014rather than prevent\u2014oxidative stress. None of the other cited papers addresses Sbds deletion or provide data relevant to oxidative-stress outcomes in osterix-expressing mesenchymal progenitors. Therefore, the supplied evidence contradicts the claim."
    },
    "naive_doc_ids": [
      "3863543",
      "43385013",
      "4427392",
      "7506409",
      "14972169"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.76,
      "justification": "Paper 7 examines a mouse model of Shwachman-Diamond syndrome, a disorder caused by loss of the Sbds gene. In this model, Sbds deficiency specifically in mesenchymal niche cells (the same cell type that expresses the osterix transcription factor) \u201cinduces mitochondrial dysfunction, oxidative stress, and activation of DNA-damage responses\u201d in hematopoietic stem and progenitor cells. Thus, rather than preventing oxidative stress, homozygous deletion of Sbds in osterix-positive mesenchymal cells causes or exacerbates oxidative stress. None of the other cited papers provide evidence that Sbds loss prevents oxidative stress. Therefore, the supplied literature contradicts the claim."
    },
    "overthinking_doc_ids": [
      "1748921",
      "471735",
      "2686003",
      "4680262",
      "5687200"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.77,
      "justification": "Paper 1 studies a mouse model of Shwachman-Diamond syndrome, a disorder caused by loss of the Sbds gene. It reports that disruption of mesenchymal cells in this Sbds-deficient model \u201cinduces mitochondrial dysfunction [and] oxidative stress.\u201d Thus, rather than preventing oxidative stress, homozygous Sbds deletion in mesenchymal (including osterix-expressing) cells leads to, or at least is associated with, increased oxidative stress. The other cited papers do not address Sbds deletion, so they provide no information to support the opposite view. Therefore the provided evidence contradicts the claim."
    },
    "posthoc_doc_ids": [
      "3863543",
      "7506409",
      "40349336",
      "43385013",
      "3531388"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1085",
    "claim": "Side effects associated with antidepressants lower risk of myocardial infarction.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.25,
      "justification": "None of the cited papers investigate antidepressants or their side-effects in relation to myocardial infarction risk. The studies focus on antiplatelet therapies, biomarkers, imaging, influenza vaccination, and SSRI withdrawal symptoms without examining MI outcomes. Thus, the evidence provided does not address the claim."
    },
    "naive_doc_ids": [
      "17897801",
      "6158879",
      "29526125",
      "44827480",
      "44384384"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.23,
      "justification": "The only paper that examines antidepressant use and cardiovascular outcomes (Paper 1) reports hazard ratios for multiple adverse events in older adults prescribed antidepressants. For myocardial infarction the study does not report any reduction in risk; instead, it emphasizes that the drugs were associated with increased risks for several other outcomes and that no class of antidepressants showed the lowest risk for the outcomes studied. No other provided paper evaluates antidepressant side-effects in relation to myocardial infarction. Consequently, the available evidence does not show a lowered risk of myocardial infarction attributable to antidepressant side-effects and therefore contradicts the claim."
    },
    "overthinking_doc_ids": [
      "5691302",
      "12130200",
      "18256197",
      "34054472",
      "829646"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.2,
      "justification": "Among the provided papers, only Paper 3 examines antidepressant use and cardiovascular outcomes, but the abstract does not report any reduction in myocardial infarction risk; the other papers do not involve antidepressants at all. Consequently, the evidence set neither demonstrates nor refutes a lowered myocardial-infarction risk attributable to antidepressant side effects."
    },
    "posthoc_doc_ids": [
      "32159283",
      "34054472",
      "5691302",
      "12130200",
      "17897801"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "365",
    "claim": "ER-localized phosphatase Sac1 processes PI4P through coordination with OSBP and the endosome-localized protein sorting nexin 2.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "Among the provided papers, only Paper 1 discusses regulation of PI4P at ER\u2013endosome contact sites involving VAP, OSBP, and the endosomal protein sorting nexin 2 (SNX2). None of the papers mention the ER-localized PI4P phosphatase Sac1, nor do they present data showing Sac1 acting in concert with OSBP and SNX2 to process PI4P. Therefore the supplied evidence does not confirm or refute the specific claim that Sac1 processes PI4P through coordination with OSBP and SNX2."
    },
    "naive_doc_ids": [
      "600437",
      "1554348",
      "5254463",
      "6492658",
      "8133180"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Among the supplied papers, only Paper 1 discusses PI4P regulation involving OSBP and the endosome-localized sorting nexin 2, but it does not mention the ER-localized phosphatase Sac1 or show that Sac1 is responsible for PI4P processing in this context. The remaining papers are unrelated to PI4P metabolism at ER\u2013endosome contacts. Consequently, the provided evidence neither confirms nor refutes the specific role of Sac1 in coordination with OSBP and SNX2."
    },
    "overthinking_doc_ids": [
      "600437",
      "927561",
      "9304312",
      "9680193",
      "12800122"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 1 discusses PI4P regulation at ER\u2013endosome contact sites involving VAP, OSBP, and SNX2, but it does not indicate that the ER-localized phosphatase Sac1 is the enzyme that processes PI4P in this context. None of the other papers mention Sac1, OSBP, or SNX2 together with PI4P. Therefore the supplied evidence neither confirms nor refutes the claim that Sac1 processes PI4P through coordination with OSBP and SNX2."
    },
    "posthoc_doc_ids": [
      "600437",
      "418246",
      "1917068",
      "4373445",
      "4889228"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1075",
    "claim": "Sequence conservation in gene regulatory regions between species is a poor predictor of conserved functionality.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.65,
      "justification": "Among the cited papers only Paper 2 directly compares regulatory sequence conservation with regulatory activity across species.  In liver from 20 mammals the majority of enhancers that are biochemically active (H3K27ac-positive) in one species are not detectably active or even alignable in others, leading the authors to conclude that \u201crapid evolution of enhancers is a universal feature of mammalian genomes.\u201d  Thus functional conservation of enhancers is frequently uncoupled from primary-sequence conservation, indicating that sequence conservation is a poor predictor of conserved regulatory function.  \n\nPaper 4 shows that a specific class of CTCF anchor sites is both conserved and functional, but this represents a limited subset of regulatory elements and does not negate the overall observation from Paper 2 that most enhancer activity is not predictable from sequence conservation.  The remaining papers deal with synteny, single-species regulatory mechanisms, or computational motif prediction and do not test the relationship between cross-species sequence conservation and functional conservation.\n\nTherefore, the available evidence supports the claim that sequence conservation in gene regulatory regions is, in general, a poor predictor of conserved functionality."
    },
    "naive_doc_ids": [
      "3823862",
      "14658685",
      "20935673",
      "5373138",
      "12271486"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Paper 1 systematically mapped active liver promoters and enhancers in 20 mammals and found that while almost all promoters are sequence-conserved, the great majority of active enhancers show rapid sequence turnover from species to species. Despite poor primary-sequence conservation, these rapidly evolving regions still exhibit canonical enhancer chromatin marks and are associated with regulation of liver-expressed genes, demonstrating preserved regulatory function. Therefore, sequence conservation proves to be an unreliable indicator of enhancer functionality. None of the other cited papers provide data that contradict this conclusion; most are unrelated to cross-species regulatory\u2010sequence comparisons. Hence the available evidence supports the claim that sequence conservation in gene regulatory regions is a poor predictor of conserved functionality."
    },
    "overthinking_doc_ids": [
      "14658685",
      "38805486",
      "3823862",
      "4465608",
      "8502193"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.35,
      "justification": "Paper 4 profiled active liver promoters and enhancers (defined by H3K27ac/H3K4me3) in 20 mammalian species. It shows that while most promoters are sequence-conserved, the great majority of functionally active enhancers are not: enhancer sequences have evolved rapidly and many active enhancers are species-specific or recently evolved from non-regulatory ancestral DNA. Thus functional enhancer activity is often retained or newly acquired in the absence of cross-species sequence conservation, demonstrating that simple sequence conservation is a weak predictor of whether a regulatory element is functionally active in another species. The other provided papers do not address cross-species regulatory sequence/function relationships. Therefore the available evidence supports the claim that sequence conservation in gene regulatory regions is a poor predictor of conserved functionality."
    },
    "posthoc_doc_ids": [
      "4434951",
      "8148304",
      "12271486",
      "14658685",
      "20935673"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1215",
    "claim": "The effect of Lipopolysaccharides on kidney barrier function is dependent on inflammation levels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "The cited studies show that lipopolysaccharide (LPS) can (i) disrupt kidney barrier integrity through uPAR\u2013integrin signaling (paper 3) and (ii) induce inflammatory gene expression in the kidney (paper 4). However, none of the papers present data comparing different levels of inflammation or demonstrating that the magnitude of LPS-induced barrier disruption varies according to inflammatory status. Therefore, the evidence supplied does not address whether the kidney barrier response to LPS is \u2018dependent on inflammation levels.\u2019"
    },
    "naive_doc_ids": [
      "21369472",
      "4447785",
      "16355392",
      "27545868",
      "8318922"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the cited papers, the only study that links lipopolysaccharide (LPS) to kidney barrier function is Paper 7, which shows that LPS induces proteinuria via urokinase receptor\u2013dependent activation of podocyte \u03b1v\u03b23 integrin. Although LPS is an inflammatory stimulus, the paper does not examine whether different levels of inflammation modulate this barrier effect. The other LPS-related paper (Paper 2) investigates LPS-induced prostaglandin E2 production in macrophages, but it has no data on kidney barrier function. Consequently, none of the provided evidence directly addresses whether the impact of LPS on kidney permeability varies with the degree of inflammation, leaving the claim unsubstantiated by the supplied literature."
    },
    "overthinking_doc_ids": [
      "18450716",
      "9159125",
      "888896",
      "1550937",
      "5821617"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Among the supplied abstracts only Paper 1 examines lipopolysaccharide (LPS) effects on kidney barrier function, showing that LPS induces proteinuria through a urokinase-receptor/\u03b1v\u03b23-integrin pathway in podocytes. The paper does not measure, vary, or relate these effects to the overall level of inflammation; it focuses on uPAR expression within podocytes as the critical requirement. The remaining papers discuss LPS-induced prostaglandin production in macrophages or other inflammatory pathways in non-renal contexts, but they do not connect inflammation intensity to renal barrier alterations. Therefore the provided evidence neither supports nor contradicts the specific claim that LPS effects on kidney barrier function depend on inflammation levels."
    },
    "posthoc_doc_ids": [
      "16355392",
      "19828689",
      "1550937",
      "9159125",
      "12130690"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "411",
    "claim": "Febrile seizures reduce the threshold for development of epilepsy.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.26,
      "justification": "Among the listed papers, only Paper 2 deals with febrile (fever-induced) seizures. It reports that a single episode of hyperthermia-induced seizures in immature rats produces long-lasting changes in synaptic transmission within hippocampal circuits, arguing that such seizures are not entirely \u2018benign\u2019. However, the study does not measure the subsequent probability of developing epilepsy, nor does it quantify any change in seizure-threshold or show the later emergence of spontaneous epileptic activity. The remaining papers address other forms of epileptogenesis, genetic risk factors, models using kainate, therapeutic diets, etc., and do not examine prior febrile seizures. Consequently, the provided evidence does not directly confirm or refute the specific claim that febrile seizures lower the threshold for later epilepsy."
    },
    "naive_doc_ids": [
      "116792",
      "14924526",
      "29723642",
      "35520219",
      "37592824"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.42,
      "justification": "Among the provided citations, only Paper 7 deals directly with febrile seizures.  In that rat-model study, a single episode of hyperthermia-induced (febrile) seizures in the immature brain produced persistent alterations in hippocampal synaptic function that lasted into adulthood.  The authors note that these long-lasting changes in neuronal excitability \u2018do not support the prevalent view of the benign nature of early-life febrile convulsions,\u2019 implying that the seizures leave the limbic circuitry in a state more prone to subsequent epileptiform activity.  Such persistent increases in excitability are consistent with a lowered threshold for later development of epilepsy.  No other papers provide contradictory data regarding febrile seizures and epileptogenesis.  Therefore, the evidence in Paper 7 supports the claim that febrile seizures reduce the threshold for developing epilepsy."
    },
    "overthinking_doc_ids": [
      "44672703",
      "15648443",
      "23136735",
      "5691302",
      "10128893"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.35,
      "justification": "The only relevant paper (Paper 1) examines a rat model of complex febrile seizures and shows that a single episode of febrile seizure in the immature brain produces long-lasting alterations in hippocampal neuronal excitability that persist into adulthood. The authors state that these persistent changes \"do not support the prevalent view of the \u2018benign\u2019 nature of early-life febrile convulsions,\" implying that febrile seizures create conditions that can facilitate later epileptogenesis\u2014i.e., they lower the threshold for developing epilepsy. None of the other cited papers address febrile seizures and epilepsy risk. Therefore, the available evidence tends to support (though indirectly and with limited strength) the claim that febrile seizures reduce the threshold for development of epilepsy."
    },
    "posthoc_doc_ids": [
      "14924526",
      "1410197",
      "23670644",
      "116792",
      "3878434"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "410",
    "claim": "Febrile seizures increase the threshold for development of epilepsy.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Among the 10 cited papers, only Paper 4 deals with febrile seizures. It reports that hyper-thermia\u2013induced (febrile) seizures in immature rats produce long-lasting changes in hippocampal synaptic transmission, specifically a presynaptic increase in inhibitory signaling. The study does not test or report whether these changes make later epileptogenesis more or less likely, nor does it examine a seizure or epilepsy threshold. None of the other papers address febrile seizures or their influence on the development of epilepsy. Consequently, the corpus supplies no direct evidence confirming or refuting the claim that febrile seizures increase the threshold for developing epilepsy."
    },
    "naive_doc_ids": [
      "116792",
      "1410197",
      "6334188",
      "14924526",
      "8133180"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Among the supplied papers, only Paper 6 deals with febrile seizures. In a rat model, hyperthermia-induced (febrile) seizures produced long-lasting modifications of hippocampal circuitry; the authors explicitly state that these findings \"do not support the prevalent view of the \u2018benign\u2019 nature of early-life febrile convulsions.\"  Rather than showing a protective effect or a higher threshold for later epilepsy, the results imply that febrile seizures may have maladaptive, possibly pro-epileptogenic consequences. No paper provides evidence that febrile seizures raise the threshold for developing epilepsy. Hence the available evidence opposes the claim."
    },
    "overthinking_doc_ids": [
      "5691302",
      "829646",
      "2097256",
      "4828631",
      "13619127"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.58,
      "justification": "The only paper that addresses febrile seizures (Paper 1) shows that hyperthermia-induced seizures in immature rats produce long-lasting changes in hippocampal circuitry. The authors state that these changes \u201cdo not support the prevalent view of the \u2018benign\u2019 nature of early-life febrile convulsions,\u201d implying that febrile seizures promote, rather than hinder, later epileptogenesis. This opposes the claim that febrile seizures raise (i.e., make more difficult) the threshold for developing epilepsy. The remaining papers do not examine febrile seizures, so they provide no relevant support. Therefore, the available evidence contradicts the claim."
    },
    "posthoc_doc_ids": [
      "14924526",
      "116792",
      "1410197",
      "30534237",
      "35520219"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "63",
    "claim": "ATM and Rad3 related protein are critical for sensing DNA damage.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Multiple papers describe ATM and ATR (Ataxia-telangiectasia and Rad3 related) as the apical kinases that detect and initiate signalling from DNA lesions. Paper 2 explicitly states that ATM and ATR \"act as master regulators of the checkpoint response to DSBs\" and that these pathways \"can sense DNA damage and transduce this information\". Paper 1 shows that replication-stress-generated single-stranded DNA activates ATR, leading to downstream checkpoint signalling, illustrating its damage-sensing role, while ATM is discussed as part of the same checkpoint network. Paper 3 reviews biochemical evidence that ATM is a \u201ccrucial nexus for the cellular response to DNA double-strand breaks,\u201d implying an early sensing function. None of the cited studies contradict this view. Together, the evidence supports the claim that ATM and Rad3 related protein (ATR) are critical sensors of DNA damage."
    },
    "naive_doc_ids": [
      "12909503",
      "30122260",
      "30353437",
      "5572127",
      "13023410"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Paper 6 directly examined the roles of ATR (ataxia-telangiectasia and Rad3-related) and ATM in the initial checkpoint response to DNA replication stress, a form of DNA damage. The study showed that blocking ATR activity prevents the normal checkpoint (RPA phosphorylation, Chk1 activation and cell-cycle arrest), demonstrating that ATR is essential in sensing this damage. In contrast, chemical inhibition of ATM had no effect on these sensing/checkpoint events, indicating that ATM is not required in this context. Therefore, the evidence supports ATR\u2019s critical role but shows ATM is dispensable for sensing at least one class of DNA damage, contradicting the claim that both ATM and Rad3-related proteins are critical for DNA-damage sensing in general."
    },
    "overthinking_doc_ids": [
      "2617858",
      "2831620",
      "6333347",
      "10012166",
      "14155726"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Among the ten abstracts, only Paper 10 discusses ATM and shows that it is activated by DNA damage and participates in downstream signaling. None of the provided papers mention ATR (Ataxia-telangiectasia and Rad3-related protein) or present data on its role in sensing DNA damage. Because evidence is given for ATM but not for the Rad3-related protein component of the claim, the supplied literature does not establish that both ATM and Rad3-related protein are critical DNA-damage sensors."
    },
    "posthoc_doc_ids": [
      "10012166",
      "39863735",
      "9752604",
      "22281684",
      "27403802"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "315",
    "claim": "Decrease of p62 in prostate tumor stroma results in defective autophagy.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.61,
      "justification": "Among the supplied articles, only Paper 8 discusses p62 levels in the tumor stroma. It reports that p62 is reduced in stromal fibroblasts and that this loss boosts prostate-epithelial tumorigenesis through an mTORC1/c-Myc/IL-6 pathway. None of the quoted text indicates that p62 reduction causes defective (decreased) autophagy; autophagy is neither measured nor described as impaired in the stromal cells. The other papers address autophagy or stromal biology in general but do not connect decreased p62 in prostate stroma to autophagy status. Therefore the evidence set does not confirm or refute the specific claim."
    },
    "naive_doc_ids": [
      "27647593",
      "8702697",
      "10024681",
      "24349992",
      "26952804"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Among the provided abstracts, only Paper 4 deals with reduced p62 in the tumor stroma, but it discusses metabolic and inflammatory consequences (mTORC1/c-Myc activation and IL-6 production) rather than changes in autophagy. None of the excerpts report experimental data showing that loss or reduction of p62 in prostate tumor stroma impairs or otherwise alters autophagic flux. Therefore the supplied evidence neither confirms nor refutes the specific claim that a decrease of p62 causes defective autophagy."
    },
    "overthinking_doc_ids": [
      "27647593",
      "8702697",
      "24349992",
      "26735905",
      "9648896"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided paper summaries mention p62 (SQSTM1) expression in prostate tumor stroma or examine its impact on autophagy. While several papers discuss autophagy in cancer-associated fibroblasts or other contexts, they do not provide data linking a decrease of p62 to defective autophagy in prostate cancer stroma. Therefore the claim cannot be assessed with this evidence."
    },
    "posthoc_doc_ids": [
      "24349992",
      "27647593",
      "7228140",
      "38243984",
      "8702697"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1206",
    "claim": "The composition of myosin-II isoform switches from the A isoform to the B isoform during hematopoietic differentiation.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Paper 3 directly examines non-muscle myosin-II (MII) isoforms during human hematopoiesis. It reports that the MIIB isoform is the predominant form in hematopoietic stem and progenitor cells and is down-regulated as these cells differentiate, whereas the MIIA isoform remains present and becomes functionally activated during cytokine-induced differentiation. Thus, differentiation is associated with a relative loss of MIIB and persistence/activation of MIIA, i.e., a shift from B toward A rather than from A toward B. No other provided papers give data on myosin-II isoform composition in hematopoietic differentiation. Therefore, the available evidence opposes the claim that the composition switches from the A isoform to the B isoform during hematopoietic differentiation."
    },
    "naive_doc_ids": [
      "11840194",
      "11951999",
      "18909530",
      "23727313",
      "27061085"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "None of the summarized papers discuss myosin-II isoform A or B, nor do they report any switch in these isoforms during hematopoietic differentiation. The evidence provided focuses on RNA-seq isoform changes in muscle cells, chromatin remodeling, microRNA regulation, stem-cell differentiation into smooth-muscle cells, and various aspects of hematopoiesis, but none specifically address myosin-II isoform composition in hematopoietic cells. Therefore, the supplied literature offers no information relevant to confirming or refuting the stated claim."
    },
    "overthinking_doc_ids": [
      "27061085",
      "12315072",
      "23727313",
      "11840194",
      "23253955"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Paper 6 is the only source that discusses non-muscle myosin-II isoforms during hematopoiesis. It reports that isoform B (MIIB) is highly expressed in hematopoietic stem and progenitor cells and becomes down-regulated as cells differentiate, whereas isoform A (MIIA) is constitutively present and becomes functionally activated during differentiation. Hence the observed change is from high MIIB to lower MIIB with continued/activated MIIA\u2014not a switch from isoform A to isoform B during differentiation. No other cited papers address myosin-II isoform composition in hematopoiesis. Therefore the claim is contradicted by the available evidence."
    },
    "posthoc_doc_ids": [
      "14581009",
      "27061085",
      "12315072",
      "8148122",
      "9076196"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "407",
    "claim": "FACT and other histone chaperone(s) compensate for Histone 2A (H2A)-histone 2B (H2B) dimer eviction during the histone exchange process.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 6 shows that the histone chaperone FACT contains two acidic H2A-H2B-binding motifs and that an Spt16\u2013Pob3 heterodimer can simultaneously bind the two H2A-H2B dimers that are released from a nucleosome, illustrating FACT\u2019s role in capturing/handling dimers that become displaced.  Papers 3 and 4 analyse the SWR1 histone-exchange machinery and demonstrate that several of its subunits (e.g. Swc2, the Swr1 N-terminus) act as H2A.Z-H2B chaperone modules that bind the incoming variant dimer and are required for efficient ATP-dependent replacement of nucleosomal H2A.  Together, these studies provide experimental evidence that, during the H2A\u2194H2A.Z exchange reaction, multiple histone chaperones\u2014including FACT for the evicted canonical H2A-H2B and SWR1-associated chaperone modules for the incoming H2A.Z-H2B\u2014manage the displaced dimers, thereby compensating for their eviction and ensuring efficient histone exchange."
    },
    "naive_doc_ids": [
      "9881829",
      "12156187",
      "24311787",
      "27274441",
      "502591"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Paper 4 demonstrates that the histone chaperone FACT binds directly to two H2A\u2013H2B dimers \u2013 the very dimers that are displaced during nucleosome reorganization \u2013 and that this binding underlies FACT-mediated nucleosome disruption and reassembly. The authors also note structural similarity between FACT\u2019s H2A\u2013H2B-binding mode and that of other chaperones (e.g., ANP32E, Swr1 subunits), indicating that multiple histone chaperones share the ability to sequester or escort H2A\u2013H2B dimers when they are evicted in histone-exchange reactions. No paper among the provided set contradicts this idea. Hence the evidence supports the claim that FACT and additional histone chaperones compensate for H2A\u2013H2B dimer eviction during histone exchange."
    },
    "overthinking_doc_ids": [
      "12156187",
      "13907427",
      "8411251",
      "9889151",
      "9451052"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Among the cited papers, FACT (Paper 6) is shown to bind H2A\u2013H2B dimers, and other studies describe H2A/H2AZ exchange by the SWR1 complex. However, none of the provided articles present experimental data demonstrating that FACT (or any other histone chaperone) specifically compensates for, or replaces, H2A\u2013H2B dimers that have been evicted during the histone-exchange reaction. Therefore the supplied literature does not directly confirm or refute the stated claim."
    },
    "posthoc_doc_ids": [
      "9881829",
      "11822354",
      "24311787",
      "27274441",
      "406733"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1330",
    "claim": "Tumor development occurs in conjunction with suppression of pro-inflammatory cytokines.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.29,
      "justification": "The cited papers discuss tumor-associated immunosuppression, dendritic-cell activation, cyclo-oxygenase\u2013driven immune evasion, myeloid-derived suppressor cells, and other micro-environmental factors, but none of the provided abstracts present data showing that levels of classical pro-inflammatory cytokines (e.g., IL-1\u03b2, IL-6, TNF-\u03b1, IL-12, IFN-\u03b3) are specifically suppressed during tumor development. Consequently, the evidence given neither directly supports nor contradicts the claim that tumor development occurs together with suppression of pro-inflammatory cytokines."
    },
    "naive_doc_ids": [
      "6944800",
      "13231899",
      "7975937",
      "9955779",
      "19130782"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.77,
      "justification": "Several cited papers show that pro-inflammatory cytokines are elevated \u2013 not suppressed \u2013 during tumor development.  Paper 2 reports that Lewis lung carcinoma cells display high NF-\u03baB activity and secrete TNF-\u03b1; blocking NF-\u03baB lowers TNF-\u03b1 levels and simultaneously reduces tumor burden, indicating that the presence (rather than suppression) of the pro-inflammatory cytokine supports tumor growth.  Paper 3 states that macrophages create an inflammatory milieu that is \"mutagenic and promotes growth\" and that macrophage-derived inflammatory factors stimulate angiogenesis, invasion and metastasis.  These findings demonstrate tumor progression occurring with increased inflammatory cytokine activity, directly opposing the claim that tumor development occurs together with suppression of pro-inflammatory cytokines."
    },
    "overthinking_doc_ids": [
      "13329980",
      "14615911",
      "24282306",
      "1782201",
      "4583180"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the cited papers examine whether pro-inflammatory cytokines are suppressed during the process of tumor development. Some articles discuss inflammatory cytokines in non-tumor diseases (atherosclerosis), the impact of cytokine release after drug treatment, or entirely different molecular mechanisms of cancer, but they do not provide data linking tumor formation with reduced (suppressed) pro-inflammatory cytokine levels. Hence the supplied evidence neither supports nor contradicts the claim."
    },
    "posthoc_doc_ids": [
      "22889972",
      "7898952",
      "8133180",
      "9559146",
      "11233339"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "514",
    "claim": "High dietary calcium intakes are unnecessary for prevention of secondary hyperparathyroidism in subjects with 25(OH)D levels above 75 nmol/liter.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "Paper 1 directly relates calcium intake, serum 25(OH)D and parathyroid hormone.  In 944 adults, once 25(OH)D exceeded 18 ng/mL (\u224845 nmol/L) serum PTH was already low and was not further lowered by increasing calcium intake above 800 mg/d.  Thus, even at vitamin-D concentrations well below 75 nmol/L, high calcium intake did not add any benefit for suppressing secondary hyperparathyroidism; by extension, at \u226575 nmol/L the need for extra calcium would be even less.  \n\nPaper 2 strengthens this inference: calcium absorption was 65 % higher at a mean 25(OH)D of 86 nmol/L than at 50 nmol/L, implying that efficient absorption at \u226575 nmol/L reduces the dietary calcium requirement needed to maintain calcium balance and keep PTH in check.  \n\nNo cited paper presents data showing that high calcium intakes remain necessary when 25(OH)D is \u226575 nmol/L.  Therefore the available evidence supports the claim that high dietary calcium is unnecessary for preventing secondary hyperparathyroidism in individuals whose 25(OH)D exceeds 75 nmol/L."
    },
    "naive_doc_ids": [
      "16256507",
      "3034412",
      "19278208",
      "36960449",
      "21553394"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.33,
      "justification": "The only paper that simultaneously evaluates calcium intake, vitamin-D status and secondary hyperparathyroidism (Paper 1) shows that once vitamin-D status is adequate, increasing calcium intake above about 800 mg/d does not further suppress PTH concentrations. Although their highest vitamin-D category (>18 ng/ml \u2248 45 nmol/l) is below the 75 nmol/l threshold in the claim, the finding implies that at even higher 25(OH)D concentrations calcium requirements for preventing secondary hyperparathyroidism would not increase. No paper provides data that higher calcium is required when 25(OH)D is \u226575 nmol/l, and no contradictory evidence is presented. Therefore the available evidence leans toward, albeit indirectly, supporting the claim."
    },
    "overthinking_doc_ids": [
      "16256507",
      "21199527",
      "3034412",
      "3758260",
      "9301606"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.54,
      "justification": "Paper 3 examined 944 healthy adults grouped by serum 25-hydroxyvitamin D [25(OH)D] concentration and by calcium intake.  When vitamin-D status was adequate (serum 25(OH)D > 18 ng/mL \u2248 45 nmol/L), raising calcium intake above 800 mg/day did not further lower serum intact parathyroid hormone (PTH); PTH was already low.  Only when vitamin-D status was poor (<10 ng/mL) did higher calcium intake reduce PTH.  The authors concluded that, \u201cAs long as vitamin D status is ensured, calcium intake levels of more than 800 mg/d may be unnecessary for maintaining calcium metabolism.\u201d  Although their sufficiency cut-off (\u224845 nmol/L) is below the \u226575 nmol/L level specified in the claim, the data show that once vitamin-D levels are well within or above sufficiency, additional dietary calcium is not required to prevent secondary hyperparathyroidism.  No paper provided evidence contradicting this relationship.  Hence the available evidence supports the claim, albeit indirectly."
    },
    "posthoc_doc_ids": [
      "10557471",
      "12102963",
      "16256507",
      "19278208",
      "25135304"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "361",
    "claim": "During the primary early antibody response activated B cells migrate toward the inner-and outer follicular areas where oxysterol accumulation is generated by stromal cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "The cited papers show that: (i) activated B cells are guided to inner- and outer-follicular niches by the receptor EBI2 (Paper 1) and (ii) the EBI2 ligand is the oxysterol 7\u03b1,25-dihydroxycholesterol, whose gradient regulates B-cell migration (Papers 6 and 8). However, the excerpts provided do not state that these oxysterols accumulate specifically in the inner/outer follicular areas during the primary antibody response, nor that the source of the oxysterols is stromal cells. Therefore the evidence neither confirms nor refutes the full claim."
    },
    "naive_doc_ids": [
      "38587347",
      "30369606",
      "11721286",
      "15128866",
      "24879055"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 2 states that the orphan receptor EBI2 (GPR183) \"guides activated B cells to inter and outer follicular niche(s)\" during the early, T-dependent antibody response, directly supporting the migration aspect of the claim.  Paper 1 identifies the endogenous EBI2 ligand as the oxysterol 7\u03b1,25-dihydroxycholesterol and explains that an in-vivo gradient of this oxysterol is formed and \"regulate[s] migration, activation, and functions of B cells,\" indicating that B cells move toward sites of oxysterol accumulation.  Paper 2 further notes that events in these follicular niches occur \"in association with distinct stromal cells,\" linking stromal cells to the specialized microenvironments involved.  Together, the papers provide evidence that (i) activated B cells migrate to inner/outer follicular areas early in the response and (ii) this migration is directed by a stromal-cell\u2013associated gradient of the oxysterol ligand for EBI2, thus supporting the claim."
    },
    "overthinking_doc_ids": [
      "15058155",
      "38587347",
      "3835423",
      "7370282",
      "13283919"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "The only relevant excerpt (Paper 1) reports that the receptor EBI2 directs activated B cells to inter- and outer-follicular areas during early antibody responses, but it does not state that these areas contain oxysterol accumulations produced by stromal cells. None of the other supplied papers address B-cell positioning in follicles or oxysterol production. Therefore the provided evidence neither confirms nor refutes the full claim."
    },
    "posthoc_doc_ids": [
      "38587347",
      "7736860",
      "15435343",
      "25328476",
      "30369606"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "90",
    "claim": "Adult tissue-resident macrophages stem from the embryonal yolk sac and fetal liver.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.85,
      "justification": "Several cited studies show that the macrophages found in adult tissues originate before birth and are not replenished from adult bone-marrow\u2013derived monocytes.  \n\u2022 Paper 2 (fate-mapping) demonstrates that major adult tissue-resident macrophage populations (Kupffer cells, alveolar, splenic and peritoneal macrophages) are \"established prior to birth\" and are self-maintained thereafter, indicating an embryonic source rather than adult hematopoietic stem cells.  \n\u2022 Paper 10 genetically separates yolk-sac\u2013derived macrophages from HSC-derived cells, showing that adult Kupffer cells, microglia and Langerhans cells come from a Myb-independent yolk-sac lineage that persists lifelong.  \n\u2022 Paper 1 describes adult Kupffer cells as \"phagocytes of fetal origin\" and treats them as a pre-existing fetal population later replaced by monocyte-derived cells only after experimental ablation, underscoring their fetal (fetal-liver/yolk-sac) origin under homeostasis.  \nNo paper presents data contradicting these findings.  Collectively, the evidence supports the claim that adult tissue-resident macrophages stem from embryonal yolk sac and fetal liver precursors."
    },
    "naive_doc_ids": [
      "5511240",
      "7521113",
      "12827098",
      "12966719",
      "14550841"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "The cited papers agree that many adult tissue-resident macrophages arise before birth and are largely independent of circulating monocytes, but the supplied excerpts do not explicitly trace their developmental origin to the embryonic yolk sac and the fetal liver. Because the specific embryonic sources named in the claim are not documented in the provided evidence, the material neither confirms nor refutes the statement."
    },
    "overthinking_doc_ids": [
      "5511240",
      "22406695",
      "12827098",
      "7521113",
      "3155731"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Several papers directly show that the macrophages found in adult tissues arise during embryogenesis\u2014first in the yolk sac and then in the fetal liver\u2014rather than being replenished from adult circulating monocytes.\n\u2022 Paper 6 demonstrates that yolk-sac\u2013derived macrophages seed multiple tissues (e.g., Kupffer cells, Langerhans cells, microglia) and persist into adulthood independent of hematopoietic stem cells, establishing a yolk-sac origin for many adult tissue-resident macrophages.\n\u2022 Paper 1 calls Kupffer cells \u201cphagocytes of fetal origin,\u201d confirming that liver macrophages present in the adult trace back to fetal (liver) hematopoiesis.\n\u2022 Paper 4\u2019s fate-mapping shows most major tissue macrophage populations are established before birth and then self-maintain, implying their prenatal (yolk sac/fetal liver) derivation.\n\u2022 Paper 3 reviews accumulating data that \u201cmost adult tissue macrophages originate during embryonic development,\u201d reinforcing the overall conclusion.\nNo cited study provides data contradicting this developmental pathway. Collectively, the evidence supports the claim that adult tissue-resident macrophages stem from the embryonal yolk sac and fetal liver."
    },
    "posthoc_doc_ids": [
      "5511240",
      "12827098",
      "22406695",
      "7521113",
      "17119869"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "o3",
    "claim_id": "1037",
    "claim": "Replacement of OCT4 and SOX2 genes with GATA3 has the ability to reprogram human cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.91,
      "justification": "None of the ten cited papers discuss using GATA3 in place of OCT4 and SOX2 to reprogram human cells. The evidence focuses on standard Yamanaka factors, their stoichiometry, epigenetic regulation, microRNA influence, or nuclear transfer. Therefore the corpus supplies no experimental data that either supports or contradicts the specific claim about GATA3-mediated reprogramming."
    },
    "naive_doc_ids": [
      "2853685",
      "86129154",
      "16541762",
      "21601459",
      "36637129"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.31,
      "justification": "Among the provided abstracts, only Paper 3 addresses replacement of OCT4 and SOX2 during human-cell reprogramming, stating that certain \u2018lineage specifiers\u2019 can substitute for these genes. However, the excerpt does not identify which specifiers were used, and none of the other papers mention GATA3 in the context of factor replacement. Because the evidence set contains no explicit data showing that GATA3 specifically replaces OCT4 and SOX2 to reprogram human cells, the claim cannot be verified or refuted from the supplied information."
    },
    "overthinking_doc_ids": [
      "4380451",
      "6054657",
      "16287725",
      "1630949",
      "2853685"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.46,
      "justification": "Among the cited papers, only Paper 4 discusses replacing OCT4 and SOX2 with other \u2018lineage specifier\u2019 transcription factors during human cell reprogramming, but the excerpt does not name which specifiers were used. None of the provided text explicitly states that GATA3, in particular, substituted for both OCT4 and SOX2 and successfully reprogrammed human cells. Therefore the supplied evidence neither confirms nor refutes the specific claim about GATA3."
    },
    "posthoc_doc_ids": [
      "42662816",
      "21387297",
      "4380451",
      "16287725",
      "6054657"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "755",
    "claim": "Many cytokines that are produced by cancer cells also contribute to carcinogenesis.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.8,
      "justification": "Several of the cited studies show that cancer cells synthesize cytokines (or cytokine-like secreted factors) and that these same molecules actively drive tumor-promoting processes such as proliferation, angiogenesis, immune evasion or metastasis.\n\u2022 Paper 3: Breast\u2010cancer cells highly express VEGF, TGF-\u03b21, thymidine phosphorylase, etc.; high VEGF levels are associated with poorer prognosis, indicating that tumor-derived VEGF and other cytokines foster disease progression.\n\u2022 Paper 5: Breast-cancer cells with activated mTOR signaling up-regulate G-CSF, which recruits myeloid-derived suppressor cells and promotes tumor initiation; blocking G-CSF or MDSCs impairs tumor growth.\n\u2022 Paper 7: Skin-tumor models show that autocrine VEGF produced by neoplastic epidermal cells is required for their own proliferation; deleting VEGF or its receptor FLT1 in tumor cells markedly delays tumorigenesis.\n\u2022 Paper 4: Gastric-cancer exosomes carry HMGB1 (a pro-inflammatory cytokine-like mediator) that activates neutrophils, which in turn enhance gastric-cancer cell migration; silencing HMGB1 abolishes this effect.\n\u2022 Paper 2 and Paper 9 further document tumor-derived IL-6, VEGF and other pro-inflammatory cytokines correlating with poor outcome or stimulating tumor-stroma interactions that increase invasiveness.\nTogether these findings demonstrate that many cytokines secreted by cancer cells themselves actively contribute to carcinogenesis, supporting the claim."
    },
    "naive_doc_ids": [
      "22049489",
      "14664424",
      "22401720",
      "52925737",
      "2014909"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Paper 6 shows that epidermal tumor cells over-produce the cytokine/ growth factor VEGF and that this tumor-cell\u2013derived VEGF acts autocrinely to drive their own proliferation and is required for skin-tumor formation. When VEGF or its receptor Flt1 is deleted in the cancer cells, tumorigenesis is markedly delayed, demonstrating that the cytokine produced by the cancer cells itself promotes carcinogenesis.  \nPaper 3 reports that gastric-cancer-cell\u2013derived exosomes contain the pro-inflammatory mediator HMGB1; this tumor-cell\u2013derived cytokine-like protein activates neutrophils via TLR4/NF-\u03baB signalling, and the activated neutrophils in turn enhance gastric-cancer-cell migration. High HMGB1 expression in tumors correlates with poor patient prognosis, indicating that the cancer-cell-secreted factor contributes to tumor progression.  \nTogether, these studies provide direct experimental evidence that cytokines produced by cancer cells (e.g., VEGF, HMGB1) actively promote carcinogenesis, supporting the claim."
    },
    "overthinking_doc_ids": [
      "3930020",
      "22049489",
      "52925737",
      "7869794",
      "14664424"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.79,
      "justification": "Several of the cited papers report that cytokines secreted by the cancer cells themselves actively drive tumor-promoting processes.  (1) Paper 7 shows that epidermal tumor cells make VEGF and require this autocrine VEGF signal, together with EGFR, to sustain their own proliferation and tumor formation, demonstrating a direct carcinogenic role of a tumor-cell\u2013derived cytokine.  (2) Paper 8 demonstrates that activation of oncogenic mTOR signaling in mammary carcinoma cells up-regulates their production of G-CSF; the secreted G-CSF recruits myeloid-derived suppressor cells that, in turn, enhance tumor initiation\u2014again establishing a carcinogenic function for a cytokine produced by the cancer cells.  (3) Paper 4 reports that higher expression of PD-ECGF (thymidine phosphorylase) in non-small-cell lung cancer cells correlates with increased angiogenesis and a more aggressive clinical course, indicating that this tumor-cell-derived cytokine contributes to malignant progression.  Together these studies provide direct experimental and clinical evidence that cytokines produced by cancer cells themselves promote tumor growth, angiogenesis, and initiation, thereby supporting the claim that many such cytokines contribute to carcinogenesis."
    },
    "posthoc_doc_ids": [
      "3930020",
      "2030623",
      "3376731",
      "12358173",
      "21719289"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "814",
    "claim": "Mutations in G-Beta protein GNB2 are present in many cancers, resulting in loss of interaction with G-alpha subunits and concomitant activation of AKT pathway.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.75,
      "justification": "Paper 9 reports recurrent somatic mutations in the G-beta proteins GNB1 and GNB2 across several human malignancies (myeloid and B-cell neoplasms and others). Functional analysis showed that these mutations disrupt the normal G\u03b1\u2013G\u03b2\u03b3 interface, \u2018disrupt[ing] G\u03b1 interactions with the G\u03b2\u03b3 dimer.\u2019 Expression of patient-derived GNB2 (and GNB1) mutants in hematopoietic cells produced factor-independent growth and malignancy, and the resulting signaling was suppressed by the dual PI3K-mTOR inhibitor BEZ235, demonstrating activation of the PI3K/AKT pathway. No other provided papers contradict or refute these findings. Thus the supplied evidence aligns with the claim that cancer-associated GNB2 mutations impair G\u03b1 binding and drive AKT-pathway activation."
    },
    "naive_doc_ids": [
      "207972",
      "15113221",
      "4583180",
      "26019505",
      "3590806"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Paper 9 reports recurrent somatic mutations in the G-protein \u03b2 subunits GNB1 and GNB2 across several human tumour types. The study shows that these mutations cluster at the interface that normally binds G\u03b1 subunits and experimentally demonstrate that the mutant G\u03b2 proteins lose normal G\u03b1 interaction. Expression of patient-derived GNB2 (and GNB1) mutants in cells leads to constitutive downstream signalling that is sensitive to the dual PI3K-mTOR inhibitor BEZ235, indicating activation of the PI3K/AKT pathway. No other provided papers contradict or refute this observation. Thus, the evidence directly supports the claim that cancer-associated GNB2 mutations disrupt G\u03b1 binding and drive AKT-pathway activation."
    },
    "overthinking_doc_ids": [
      "21551568",
      "1976183",
      "3210545",
      "3590806",
      "3831884"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "Paper 6 reports recurrent, cancer-associated mutations in the G-beta proteins GNB1 and GNB2. The study shows that these mutations map to the interface that normally binds G-alpha subunits and that they \"disrupt G\u03b1 interactions with the G\u03b2\u03b3 dimer,\" demonstrating loss of G-alpha binding. Expression of the mutant GNB proteins produced oncogenic signaling that could be suppressed in vivo with the dual PI3K-mTOR inhibitor BEZ235, indicating activation of the PI3K/AKT pathway. No other cited papers contradict or override these data. Thus the available evidence supports the claim that GNB2 mutations occur in multiple cancers, impair G-alpha interaction, and drive AKT-pathway activation."
    },
    "posthoc_doc_ids": [
      "14241418",
      "46617075",
      "3590806",
      "4325398",
      "4414547"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "362",
    "claim": "During the primary early antibody response activated B cells migrate toward the inner-and outer paracortical areas where oxysterol accumulation is generated by stromal cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "The cited papers note that the receptor EBI2 guides activated B cells to inter- and outer-follicular (extrafollicular) regions during the early antibody response, and that EBI2 is activated by oxysterols. However, the excerpts do not state that these migration targets correspond to the inner and outer paracortical areas, nor do they show that oxysterol accumulation in those regions is generated by stromal cells. Because the specific elements of the claim (paracortical location and stromal-cell\u2013derived oxysterols) are not documented in the provided evidence, the papers neither confirm nor refute the claim."
    },
    "naive_doc_ids": [
      "38587347",
      "15488881",
      "11721286",
      "13469921",
      "30208015"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.58,
      "justification": "The excerpts describe that the oxysterol 7\u03b1,25-dihydroxycholesterol creates a gradient that guides EBI2-expressing activated B-cell migration to extrafollicular or inter/outer-follicular niches during early antibody responses, but the quoted text does not state (1) that these niches correspond to the inner and outer paracortical areas, nor (2) that the oxysterol is produced specifically by stromal cells at those sites. Because the supplied passages lack those specific details, they neither confirm nor refute the claim."
    },
    "overthinking_doc_ids": [
      "15058155",
      "2506153",
      "15488881",
      "36399109",
      "519974"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "Among the provided papers, only Paper 1 discusses the positioning of activated B cells early in an antibody response, noting that the receptor EBI2 directs them to inter- and outer-follicular niches. The excerpt does not mention migration into inner- or outer-paracortical areas, nor does it state that these regions contain oxysterol gradients produced by stromal cells. None of the other papers address B-cell migration, paracortical localization, or stromal-cell\u2013derived oxysterols. Consequently, the supplied evidence neither confirms nor refutes the specific claim."
    },
    "posthoc_doc_ids": [
      "38587347",
      "11721286",
      "10704438",
      "13469921",
      "42065070"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "1026",
    "claim": "Reduced phosphorylation of PP2A increases HDAC4 dephosphorylation by enhancing PP2A-HDAC4 interaction.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.42,
      "justification": "The cited studies show that loss of ATM-mediated phosphorylation of PP2A increases PP2A catalytic activity and produces HDAC4 dephosphorylation and nuclear accumulation. However, the abstracts do not report that PP2A phosphorylation status modulates a physical PP2A-HDAC4 interaction, nor that such an interaction is responsible for the increased dephosphorylation. Because the specific mechanism claimed (enhanced PP2A-HDAC4 binding) is not addressed, the provided papers do not supply enough information to confirm or refute the full claim."
    },
    "naive_doc_ids": [
      "22185730",
      "3113630",
      "3973445",
      "6157371",
      "7137057"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.35,
      "justification": "Among the provided abstracts, only Paper 2 links PP2A phosphorylation status to HDAC4 dephosphorylation: ATM-mediated phosphorylation inhibits PP2A, and loss of this phosphorylation (ATM deficiency) increases PP2A activity and results in HDAC4 dephosphorylation.  However, none of the abstracts state that the change in HDAC4 dephosphorylation is due to an enhanced physical interaction between PP2A and HDAC4.  Because the critical mechanistic detail (increased PP2A-HDAC4 interaction) is not documented in the supplied evidence, the claim cannot be verified from these papers."
    },
    "overthinking_doc_ids": [
      "22185730",
      "3113630",
      "3973445",
      "17768946",
      "21307488"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.34,
      "justification": "The cited ATM-deficiency paper shows that less phosphorylation of PP2A (because ATM no longer phosphorylates it) increases PP2A activity and results in HDAC4 dephosphorylation. However, the excerpt does not indicate that this effect is due to an enhanced physical interaction between PP2A and HDAC4; it only attributes the change to higher catalytic activity of PP2A. None of the other papers discuss PP2A-HDAC4 binding. Thus the specific mechanism claimed\u2014greater PP2A-HDAC4 interaction\u2014lacks direct evidence in the provided texts."
    },
    "posthoc_doc_ids": [
      "22185730",
      "3113630",
      "3973445",
      "6157371",
      "8417211"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "975",
    "claim": "Primary pro-inflammatory cytokines induce secondary pro- and anti-inflammatory mediators.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.45,
      "justification": "Among the cited studies the only direct examples of a primary pro-inflammatory cytokine acting on cells are those in which IL-1\u03b2 stimulates additional pro-inflammatory mediators (e.g., IL-1\u03b2\u2192COX-2/PGE2 in breast-cancer cells; IL-1\u03b2\u2192NO, PGE2, MMPs in chondrocytes).  None of the provided papers demonstrates that a primary pro-inflammatory cytokine triggers production of an anti-inflammatory mediator such as IL-10, TGF-\u03b2, IL-1Ra, HO-1, etc.  Therefore the supplied evidence does not address \u2013 and thus cannot confirm or refute \u2013 the full claim that primary pro-inflammatory cytokines induce both secondary pro- and anti-inflammatory mediators."
    },
    "naive_doc_ids": [
      "164985",
      "5137019",
      "14474178",
      "16905344",
      "21439640"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.61,
      "justification": "Paper 4 describes how the primary pro-inflammatory cytokines IL-1\u03b2 and TNF-\u03b1 (often combined with IFN-\u03b3) activate NF-\u03baB and STAT-1 in pancreatic \u03b2-cells, resulting in the subsequent production of nitric oxide and various chemokines. These downstream products constitute secondary inflammatory mediators; some (certain chemokines) are pro-inflammatory, whereas others (e.g., NO can also have regulatory/anti-inflammatory effects depending on context). Paper 9 discusses the compensatory anti-inflammatory response syndrome, noting that the initial pro-inflammatory reaction is followed by induction of counter-regulatory anti-inflammatory mechanisms. Together these papers provide evidence that primary pro-inflammatory cytokines stimulate the generation of both additional pro- and anti-inflammatory mediators, which is consistent with the claim."
    },
    "overthinking_doc_ids": [
      "26731863",
      "5137019",
      "21164071",
      "42873134",
      "55040297"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "None of the cited papers examine whether a primary pro-inflammatory cytokine (for example TNF-\u03b1 or IL-1) directly stimulates production of downstream (secondary) pro- or anti-inflammatory mediators. The articles focus on statin effects on cytokine levels after cardiopulmonary bypass, T-cell\u2013derived factors on bone cells, AMPK effects on JAK-STAT signalling, IAP antagonists generating type-I interferon responses, AGE-RAGE signalling in chondrocytes, NSAIDs in cancer models, Th17-related cytokines in disease, STIM1 signalling in cancer, IL-17F expression in IBD, and HDL-induced macrophage activation. None provide experimental data showing primary cytokines inducing secondary mediators, so the supplied evidence is not relevant to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "2391552",
      "43619625",
      "3973445",
      "3981033",
      "9956893"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "o3",
    "claim_id": "357",
    "claim": "During non-homologous end joining, the ligation step is not as tolerant of disrepairs and other distortions when joining 3' of strand breaks as compared to 5' strand breaks.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Paper 3 shows that when an abasic (damaged) nucleotide is situated close to the break, Ku\u2019s dRP/AP-lyase acts efficiently on 5\u2032-overhangs to prepare them for ligation, but is strongly suppressed on comparable 3\u2032 termini because cleavage there would generate an \u03b1,\u03b2-unsaturated aldehyde that blocks DNA ligase IV.  The need to avoid creating this ligation-blocking structure indicates that the ligation step is less able to accommodate distortions on the 3\u2032 side than on the 5\u2032 side.\n\nPaper 8 further indicates polarity-dependent requirements for end processing: double-strand breaks bearing 3\u2032 overhangs with gaps require Pol 4-mediated filling before ligation, whereas 5\u2032 overhangs of the same sequence can be ligated without this extra processing.  This difference demonstrates that the ligase readily joins distorted 5\u2032 ends but needs additional correction for comparable 3\u2032 ends, again implying lower tolerance at 3\u2032 strand breaks.\n\nTogether these findings support the claim that, during non-homologous end joining, the ligation step is less tolerant of mispairs, damage, or structural distortions at 3\u2032 termini than at 5\u2032 termini."
    },
    "naive_doc_ids": [
      "18111172",
      "17768946",
      "20821402",
      "27635177",
      "6535392"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.49,
      "justification": "Paper 2 examines how abasic (dRP/AP) lesions at opposite strand polarities affect the last step of NHEJ. It shows that when the lesion is located close to a 5\u2032 end, Ku\u2019s dRP/AP-lyase efficiently removes the damage and the processed end can subsequently be ligated. In contrast, if the same type of damage lies near a 3\u2032 strand terminus, Ku is largely inactive because excision would generate an \u03b1,\u03b2-unsaturated aldehyde that blocks the NHEJ ligase; hence the ligation step is far less able to accommodate distortions at 3\u2032 termini than at 5\u2032 termini.  \nPaper 10 reaches a similar conclusion from a different angle: double-strand breaks carrying 3\u2032 overhangs with gaps require Pol4-dependent processing before ligation, whereas breaks with equivalent 5\u2032 overhangs are joined directly without this extra processing. This indicates that the ligase can tolerate structural irregularities on the 5\u2032 side more readily than on the 3\u2032 side.  \nTogether, these findings support the claim that, in NHEJ, the ligation step is less tolerant of damage or distortions at 3\u2032 ends than at 5\u2032 ends."
    },
    "overthinking_doc_ids": [
      "18111172",
      "20821402",
      "21561474",
      "26059876",
      "27635177"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Paper 6 directly compares how damaged nucleotides near the two different termini are handled during non-homologous end joining (NHEJ).  It shows that when an abasic (damaged) nucleotide is located close to a 5\u2032 strand end, Ku\u2019s 5\u2032-dRP/AP lyase efficiently excises the lesion and the XRCC4-ligase IV complex can readily complete ligation.  In contrast, Ku is \u201cless active near 3\u2032 strand termini, where excision would leave a ligation-blocking \u03b1,\u03b2-unsaturated aldehyde,\u201d indicating that the ligation machinery is far less able to accommodate or bypass distortions at 3\u2032 ends.  Thus the ligation step of NHEJ is more tolerant of damage/distortion on the 5\u2032 side of a break than on the 3\u2032 side, which is exactly what the claim asserts.  The other cited papers discuss general NHEJ factors or unrelated topics and do not contradict this conclusion."
    },
    "posthoc_doc_ids": [
      "27635177",
      "20420780",
      "1941721",
      "12552297",
      "12892137"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "660",
    "claim": "Ivermectin is used to treat onchocerciasis.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers mention ivermectin or onchocerciasis, nor do they present data about treatments for onchocerciasis. The studies focus on tuberculosis regimens, mindfulness and sleep, pancreatic cancer therapy, diabetes treatment, and neuroglutamatergic mechanisms."
    },
    "naive_doc_ids": [
      "21479231",
      "17973630",
      "24634621",
      "341324",
      "3654468"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided excerpts, none mention ivermectin or describe its use for onchocerciasis. Paper 10 references onchocerciasis within the context of neglected tropical diseases and control efforts but does not specify treatment with ivermectin. Therefore, the supplied evidence does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "1986482",
      "15541119",
      "24916604",
      "44827480",
      "2048139"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers mention ivermectin or onchocerciasis. The papers focus on topics such as HIV treatment guidelines, tumor response criteria, bisphosphonates in cancer care, antiplatelet therapy in ACS, interferon therapy for hepatitis C, metformin mechanisms, antibiotic-induced oxidative damage, telomeric DNA synthesis, and LDL effects on macrophage cholesterol efflux. Therefore, they provide no relevant evidence to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "1986482",
      "15541119",
      "24916604",
      "44827480",
      "2048139"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1168",
    "claim": "The HSV-2 infection is typically asymptomatic.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 1 concerns HSV-2, and it reports outcomes in a murine intranasal infection model (including lethal encephalitis at high doses) without addressing the typical clinical presentation or frequency of asymptomatic infection in humans. The other papers are about unrelated viruses or conditions. Therefore, the evidence does not support or refute the claim that HSV-2 infection is typically asymptomatic."
    },
    "naive_doc_ids": [
      "40584205",
      "9591368",
      "12885341",
      "20996244",
      "22495397"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers address HSV-2 or the symptomatic/asymptomatic presentation of herpes simplex virus type 2 infection. Mentions of asymptomatic conditions in the evidence pertain to bacteriuria, cerebral aneurysms, and spinal cord lesions, which are unrelated to HSV-2. Therefore, the claim cannot be evaluated using these sources."
    },
    "overthinking_doc_ids": [
      "301866",
      "3272084",
      "8398627",
      "13732033",
      "23801039"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers address herpes simplex virus type 2 (HSV-2) or its symptomatology. The studies focus on asymptomatic bacteriuria, Salmonella infection and autophagy, HCV in pregnancy, HIV PrEP and APOBEC3G, celiac disease BMI, KSHV prevalence, malaria immunology, and antiplatelet therapy switching. Therefore, they do not provide evidence to confirm or refute whether HSV-2 infection is typically asymptomatic."
    },
    "posthoc_doc_ids": [
      "18574146",
      "22159299",
      "92308",
      "437924",
      "544971"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1191",
    "claim": "The amount of publicly available DNA data doubles every 10 years.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers report quantitative growth rates or doubling times for publicly available DNA sequence data. While some papers describe sequence databases (e.g., EMBL, GEO) or sequencing tools, they do not present longitudinal metrics indicating that DNA data doubles every 10 years."
    },
    "naive_doc_ids": [
      "30655442",
      "4432763",
      "2492146",
      "4231060",
      "7324039"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers present data or analyses about the growth rate of publicly available DNA data. Paper 7 mentions NCBI GEO as a repository for functional genomics data but does not quantify data volumes or their doubling time. The other papers address unrelated topics (health behaviors, cancer treatment timing, DNA replication biology, mortality in schizophrenia, fracture incidence, protein interactions, SNP distributions, anthropometric references, and cancer genome doubling). Therefore, there is no relevant evidence to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "456304",
      "7852582",
      "19974105",
      "25293616",
      "7209559"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers report on the growth rate or volume of publicly available DNA data or databases (e.g., GenBank, ENA, SRA). The articles focus on dietary assessment, breast cancer screening, enzyme structure, nucleosome inference, Alzheimer pathology, genomic imprinting, genomics software/tools, genome doubling in cancer, data processing frameworks, and essential genomic regions in M. tuberculosis. They do not contain quantitative assessments of DNA data accumulation over time or doubling rates."
    },
    "posthoc_doc_ids": [
      "2295434",
      "11880289",
      "25657127",
      "175735",
      "739734"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "186",
    "claim": "British female students are bullied more than British male students.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "Among the provided papers, only Paper 1 addresses bullying, focusing on height-related risk in a UK adolescent cohort. The excerpt does not report differences in bullying by gender. The remaining papers concern medical curricula, infection outcomes, health care utilization, anxiety prevalence, retroviral disease, Creutzfeldt-Jakob disease, breast density, bariatric surgery, and perinatal mortality, none of which provide data on bullying among British students by sex. Therefore, there is no relevant evidence here to confirm or refute the claim that British female students are bullied more than British male students."
    },
    "naive_doc_ids": [
      "16855829",
      "38664102",
      "2488880",
      "45920278",
      "32357890"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers present data on bullying among British students or gender differences in bullying. The studies focus on topics such as self-harm in prisons, analgesic withdrawal, cervical cancer screening, tuberculosis mortality, HTLV-related disease, patient experiences in primary care/out-of-hours care, infection outcomes by gender in hospitalized patients, and physical activity/TV viewing among US children. Therefore, they do not provide evidence to confirm or refute the claim about bullying among British female vs male students."
    },
    "overthinking_doc_ids": [
      "13900610",
      "12442311",
      "12779444",
      "22194407",
      "24512064"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "Among the provided papers, only Paper 6 concerns school bullying, and it focuses on whether short pupils are at greater risk. The abstract does not report sex-based differences in bullying prevalence. The other papers are unrelated to bullying. Therefore, there is no direct evidence here comparing bullying rates between British female and male students."
    },
    "posthoc_doc_ids": [
      "5687200",
      "7729656",
      "8780599",
      "24351680",
      "41380943"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1033",
    "claim": "Reduction of purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpF in 2D BN-PAGE gels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers discuss 2D BN-PAGE analysis of E. coli membrane preparations, OmpF detection as an indicator of cytoplasmic membrane purity, or effects of overexpression on membrane fraction purity. The abstracts cover topics such as OM biogenesis, TolC-related metabolism, inner membrane protein topology, immunological signaling, SOD mutants, EBV host responses, beta cell proteins, kinetochore function, calcium nanobiosensing, and kinesin motors, but do not provide data linking stronger OmpF spots in 2D BN-PAGE to reduced purity of cytoplasmic membranes from overexpressors."
    },
    "naive_doc_ids": [
      "6836086",
      "26625002",
      "7643848",
      "5914739",
      "46346525"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers discuss 2D BN-PAGE analyses of cytoplasmic membrane preparations, overexpression conditions, or the use of OmpF spot intensity as an indicator of outer membrane contamination. The references focus on unrelated topics (outer membrane biogenesis broadly, TolC-related metabolism, kinetochore biology, mitochondrial aging, TCR membrane interactions, kinesin transport, and beta cell proteins) and do not provide experimental data supporting or refuting the specific claim."
    },
    "overthinking_doc_ids": [
      "6836086",
      "26625002",
      "38528892",
      "797114",
      "5914739"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers address bacterial membrane preparations, OmpF (an outer membrane porin), or 2D BN-PAGE analyses indicating contamination/purity. The studies focus on T-cell receptor membrane interactions, shrimp Dscam, antimicrobial peptide mechanisms, Gq protein localization, neutrophil PCNA, and cancer/autoantibodies\u2014topics unrelated to cytoplasmic membrane purity in overexpressors or OmpF spot intensities on BN-PAGE."
    },
    "posthoc_doc_ids": [
      "5914739",
      "8903143",
      "26117607",
      "350542",
      "13411519"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "517",
    "claim": "High levels of copeptin decrease risk of diabetes.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers mention copeptin or vasopressin or evaluate their association with diabetes risk. The studies focus on fruit consumption, thiazolidinediones, TMAO, preconception care, flavonols, HOMA, beta-cell function, and immunology, which are not directly relevant to copeptin levels and diabetes risk."
    },
    "naive_doc_ids": [
      "1974176",
      "31229233",
      "6793674",
      "76463821",
      "12102963"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers assess copeptin (a surrogate marker for vasopressin) or its relationship to diabetes risk. The studies focus on fruit intake, endothelial dysfunction markers (E-selectin, ICAM-1, VCAM-1), BNP/NT-proBNP, cardiovascular risk prediction, sugar-sweetened beverage taxation, links between type 2 diabetes and cancers, mast cells in mice, thiazolidinediones and bladder cancer, steroid hormones, and vitamin D genetics. Therefore, they provide no relevant evidence to evaluate whether high copeptin levels decrease diabetes risk."
    },
    "overthinking_doc_ids": [
      "1974176",
      "6176498",
      "15663829",
      "27466734",
      "10071552"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers examine copeptin (a surrogate marker for vasopressin) in relation to diabetes risk. The studies address vitamin D and diabetes, natriuretic peptides (BNP/NT-pro-BNP) and diabetes, corin and myocardial infarction, DOAC levels, influenza vaccination and cardiovascular events, fruit consumption and diabetes, cardiovascular risk prediction (QRISK3), endothelial dysfunction biomarkers and diabetes, hypoglycemia and dementia, and diabetes treatments with complications. No data on copeptin levels or their association with diabetes risk are presented."
    },
    "posthoc_doc_ids": [
      "25599283",
      "15663829",
      "34054472",
      "4910408",
      "11939159"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "36",
    "claim": "A deficiency of vitamin B12 increases blood levels of homocysteine.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, those that address homocysteine focus primarily on folate status or interventions (Papers 1, 5, 10) or on MTHFR genotype\u2013folate interactions (Paper 8). Paper 7 is an editorial-style discussion referencing B vitamins but does not provide specific results in the excerpt. None of the excerpts present direct experimental or observational data showing that vitamin B12 deficiency increases homocysteine levels. Other papers are methodological (Paper 4) or unrelated (Papers 2, 3, 6, 9). Therefore, based on the provided evidence, the claim is not directly supported or refuted."
    },
    "naive_doc_ids": [
      "18557974",
      "9555784",
      "13312471",
      "13801259",
      "21636085"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "Among the provided papers, several address homocysteine and folate (papers 6, 7) or homocysteine as a cardiovascular risk factor (papers 3, 8, 9), but none present data showing that vitamin B12 deficiency increases homocysteine levels. Paper 9 adjusts for B12 deficiency but does not report its effect on homocysteine; paper 7 notes unchanged B12 during a folate-driven homocysteine reduction. The remaining papers focus on vitamin D, magnesium, or iron-related topics. Therefore, the supplied evidence does not directly confirm or refute the claim about B12 deficiency elevating homocysteine."
    },
    "overthinking_doc_ids": [
      "9555784",
      "13312471",
      "16252863",
      "21553394",
      "23267371"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 5 measures homocysteine alongside serum vitamin B12, and it reports that homocysteine decreased with increased dietary folate while serum B12 remained unchanged. This does not test or show the effect of vitamin B12 deficiency on homocysteine levels. The other papers do not address vitamin B12 status or homocysteine. Therefore, the set does not provide relevant evidence to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "2481032",
      "9555784",
      "13312471",
      "18691097",
      "18557974"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1183",
    "claim": "The TRaF1/C5 rs10818488 allele polymorphism regulates the neighboring C5 gene.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.79,
      "justification": "Among the provided papers, only Paper 1 addresses the TRAF1/C5 locus, reporting genetic association with rheumatoid arthritis and a correction to allele ratio notation. It does not present functional evidence that rs10818488 regulates C5 expression (e.g., eQTL, allele-specific expression, reporter assays, or perturbation studies). The remaining papers concern RA classification, neutrophil extracellular traps, and general mechanisms of chromatin interactions and DNA methylation, without specific data on rs10818488 or regulation of the neighboring C5 gene. Therefore, the supplied evidence does not confirm or refute the claimed regulatory effect."
    },
    "naive_doc_ids": [
      "1967017",
      "1191830",
      "11328820",
      "20186513",
      "30041340"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on the TRAF1/C5 locus SNP rs10818488 or its effect on C5 expression. While some papers discuss eQTL methodology or general gene expression regulation, there is no specific evidence linking rs10818488 to regulation of the neighboring C5 gene."
    },
    "overthinking_doc_ids": [
      "15286783",
      "4378885",
      "28928964",
      "6948886",
      "8496132"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers examine the TRAF1/C5 locus, the rs10818488 polymorphism, or report eQTL effects specifically linking rs10818488 to regulation of the neighboring C5 gene. The cited works cover general eQTL methods or unrelated genes/traits (e.g., PTEN, MBP, IL-6, insulin, TLR4, PDYN) and do not provide direct evidence for this claim."
    },
    "posthoc_doc_ids": [
      "4378885",
      "15286783",
      "28928964",
      "19238",
      "164985"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "762",
    "claim": "Measuring routine outcomes is more beneficial to clinical practice than assessing treatment adherence.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate or compare the clinical benefit of measuring routine outcomes versus assessing treatment adherence. The studies focus on intervention efficacy, diagnostic monitoring (e.g., blood pressure), and clinical outcomes in various conditions, but do not address the relative utility of routine outcome measurement compared with adherence assessment in clinical practice."
    },
    "naive_doc_ids": [
      "26199970",
      "15997009",
      "24159217",
      "44048701",
      "5402581"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers compare measuring routine outcomes with assessing treatment adherence or evaluate their relative benefits to clinical practice. The studies address intervention effects, associations with clinical outcomes, organizational differences, prognostic biomarkers, industry interactions, and roles of clinicians, but do not investigate or contrast routine outcomes measurement versus adherence assessment."
    },
    "overthinking_doc_ids": [
      "5402581",
      "4515975",
      "20473074",
      "34139429",
      "40817021"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "The provided papers include examples of measuring clinical outcomes in routine practice (e.g., bariatric surgery outcomes in Paper 1) and interventions/strategies related to treatment adherence (e.g., ART adherence reminders in Paper 6 and adherence clubs in Paper 8). However, none of the papers directly compare the benefits of routine outcome measurement versus assessing treatment adherence, nor do they present evidence establishing that one is more beneficial to clinical practice than the other. Therefore, the claim cannot be verified or refuted with the given evidence."
    },
    "posthoc_doc_ids": [
      "5824985",
      "24873253",
      "19308127",
      "341324",
      "6137330"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "628",
    "claim": "Infection of human T-cell lymphotropic virus type 1 is most frequent in individuals of African origin.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Only Paper 9 mentions HTLV-I/II, stating HTLV-I is endemic in Japan, the Caribbean, Africa, and Melanesia, and found among immigrants from these regions. It does not provide comparative prevalence data showing infection is most frequent in individuals of African origin. The other papers address unrelated conditions (glaucoma, HIV/TB, MDR-TB adverse events, bacterial meningitis sequelae, anxiety disorders, malaria, and health workforce migration). Therefore, the provided evidence does not confirm or refute the specific claim about highest frequency in individuals of African origin."
    },
    "naive_doc_ids": [
      "8298120",
      "4883040",
      "11254040",
      "27866735",
      "32357890"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "Only Paper 1 is relevant to HTLV-1 and it states that HTLV-1 infection is endemic in Japan, the Caribbean, Africa, and Melanesia, and found among immigrants from these regions in Europe. It does not provide comparative prevalence indicating that infection is most frequent in individuals of African origin. The other papers do not address HTLV-1. Therefore, the provided evidence does not verify the claim."
    },
    "overthinking_doc_ids": [
      "24512064",
      "5735492",
      "8298120",
      "21274496",
      "40666943"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers present data on human T-cell lymphotropic virus type 1 (HTLV-1) infection or its prevalence by ethnic origin. The studies focus on other infections (HIV, KSHV, SIV, malaria, HBV, HSV, HPV), non-infectious conditions (glaucoma, COPD), or nutrition. Therefore, they do not provide evidence to confirm or refute the claim about HTLV-1 being most frequent in individuals of African origin."
    },
    "posthoc_doc_ids": [
      "5548081",
      "8593263",
      "22705234",
      "29134911",
      "798152"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "377",
    "claim": "Emodin forms hydrogen bonds with residues involved in PGAM1 substrate binding.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine emodin or its binding to PGAM1. Paper 1 discusses PGAM1 regulation (Y26 and H11 phosphorylation) and substrate/cofactor binding but provides no data on emodin or hydrogen bonding with substrate-binding residues. The remaining papers are unrelated to PGAM1-emodin interactions."
    },
    "naive_doc_ids": [
      "18810195",
      "8331432",
      "21557055",
      "23698769",
      "30208015"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on emodin binding to PGAM1 or hydrogen-bond interactions with PGAM1 substrate-binding residues. Paper 3 discusses PGAM1 activation via Tyr26 and His11 phosphorylation and provides structural insights into PGAM1, but does not mention emodin. Paper 1 involves Aloe emodin effects on gene expression in glioblastoma, not PGAM1 binding. The remaining papers are unrelated to PGAM1-emodin interactions."
    },
    "overthinking_doc_ids": [
      "14180565",
      "17518195",
      "18810195",
      "21932297",
      "26658659"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "Among the provided papers, only Paper 3 discusses PGAM1, focusing on its regulation by Tyr26 and His11 phosphorylation and effects on substrate binding and activation. None of the papers mention emodin or detail small-molecule binding interactions with PGAM1, including hydrogen bonding to substrate-binding residues. Therefore, the evidence set does not contain information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "1225513",
      "12225214",
      "18810195",
      "1574014",
      "4740447"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "730",
    "claim": "Lysine histone demethylase inhibitor JIB 04 is inactive against KDM5A.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "Among the provided papers, only Paper 3 discusses JIB-04, describing it as an inhibitor of Jumonji family histone demethylases, but it does not specify activity against KDM5A (JARID1A/RBP2). Paper 2 identifies KDM5A as an H3K4 demethylase but provides no inhibitor data. The other papers focus on different enzymes (e.g., KDM6B/JMJD3, LSD1) or unrelated targets. Therefore, there is no direct evidence here confirming or refuting JIB-04\u2019s activity against KDM5A."
    },
    "naive_doc_ids": [
      "18841257",
      "8548635",
      "13400643",
      "15215393",
      "4387494"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers mention JIB 04, lysine histone demethylases, or KDM5A. The studies focus on CDK4/6 inhibition (PD 0332991), mechanosensitive ion channels, PI3K inhibition (PI103), vasodilation mechanisms, cell colony dynamics, combined PI3K/mTOR inhibition in brain metastases, CDK1 inhibition in trophoblast differentiation, and fatty acid oxidation in myeloid-derived suppressor cells. Therefore, they provide no relevant data to assess JIB 04 activity against KDM5A."
    },
    "overthinking_doc_ids": [
      "864491",
      "1275505",
      "1285713",
      "10697096",
      "15721252"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers discuss JIB 04 (a lysine histone demethylase inhibitor) or KDM5A, nor do they present data on JIB 04\u2019s activity against KDM5A. The topics range from asthma treatments, RA classification, miRNA stress responses, malaria vaccines, histone variant H2A.Z, beta-adrenoceptor antagonists, G-quadruplex ligands, kinase inhibitor selectivity, and mechanosensitive ion channels. Therefore, the evidence set contains no relevant information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "602760",
      "1191830",
      "2251426",
      "2264455",
      "2817000"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "199",
    "claim": "CCL19 is predominantly present within dLNs.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers assess or report on CCL19 levels or localization. Although several studies involve draining lymph nodes (e.g., Papers 6, 7, and 10 discuss lymph node T cell responses and dendritic cell migration), they do not measure or describe CCL19. The remaining papers are unrelated to chemokines or lymph node chemokine profiles. Therefore, the evidence set does not support or contradict the claim about CCL19 being predominantly present within draining lymph nodes."
    },
    "naive_doc_ids": [
      "654735",
      "2389574",
      "14938990",
      "28910120",
      "313403"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers address CCL19 or its distribution. While several studies involve lymph nodes (e.g., antigen presentation, T cell responses, macrophage roles), they do not measure or discuss CCL19 levels or its predominance in draining lymph nodes (dLNs). Therefore, the claim is not evaluated by the supplied evidence."
    },
    "overthinking_doc_ids": [
      "2389574",
      "1071991",
      "2374637",
      "11020556",
      "35256900"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address CCL19 or its distribution in draining lymph nodes (dLNs). The closest relevant topic is lymph node immunobiology (Paper 6 on CD169+ macrophages and iNKT cells), but it does not mention CCL19. Therefore, the evidence set contains no information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "3698758",
      "15832146",
      "22130056",
      "22712546",
      "43385013"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.03,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "649",
    "claim": "Integrating classroom-based collaborative learning with Web-based collaborative learning leads to subpar class performance",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers present empirical data on classroom-based collaborative learning, Web-based collaborative learning, or their integration and effects on class performance. Most papers are medical (vitamin D in pregnancy, TB regimens, dialysis outcomes, drug safety, BPA, antidepressants, perioperative colloids) and one is a commentary on computer-assisted learning without comparative performance outcomes for integrated collaborative modalities. Therefore, the evidence does not address the specific educational claim."
    },
    "naive_doc_ids": [
      "2425364",
      "15997009",
      "10072941",
      "202259",
      "1759213"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "All provided papers concern biomedical topics (e.g., zinc supplementation, blood pressure in dialysis, drug safety, genetics and stroke, TB treatment, inflammation and CHD, NSAID GI risk, bacterial meningitis sequelae, gestational diabetes risk, and an internet-based grief intervention). None address educational settings, classroom- or Web-based collaborative learning, or class performance outcomes. Therefore, the evidence does not inform the claim about integrating classroom and Web-based collaborative learning."
    },
    "overthinking_doc_ids": [
      "4515975",
      "202259",
      "1759213",
      "8595678",
      "15997009"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers present empirical results on integrating classroom-based collaborative learning with Web-based collaborative learning or its effect on class performance. Paper 7 discusses computer-assisted learning in medical education but is largely opinion/commentary and does not provide data showing that such integration leads to subpar performance. The remaining papers address unrelated topics (medical treatments, neuroimaging, fitness, immune signaling, dietary assessment, reproductive outcomes, and kidney injury)."
    },
    "posthoc_doc_ids": [
      "18025240",
      "3202143",
      "1412089",
      "2424794",
      "5798227"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.03,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1190",
    "claim": "The amount of publicly available DNA data doubles every 10 months.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers quantify the growth rate or doubling time of publicly available DNA data. They describe databases (EMBL, GEO), tools (alignment, trimming, variant calling), and specific biological studies, but offer no data or statements about DNA data doubling every 10 months."
    },
    "naive_doc_ids": [
      "30655442",
      "7324039",
      "4231060",
      "14915566",
      "15048300"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers report on the growth rate or doubling time of publicly available DNA data. They cover topics such as health inequalities, nucleosome inference, bioinformatics tools (Cytoscape, IGV, SAMtools), siRNA specificity, repository description (GEO), and specific biological findings, but do not present data or analyses about how quickly public DNA data accumulates. Therefore, the claim cannot be verified or refuted from these sources."
    },
    "overthinking_doc_ids": [
      "1781626",
      "175735",
      "2883827",
      "3444507",
      "6535392"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers address the growth rate of publicly available DNA data or trends in DNA databases. The papers cover topics such as surgical meshes, tubulin isotypes, HIV treatment financing and adherence, stroke biomarkers, immune recovery post-transplant, sepsis definitions, cancer genome doubling, screening timelines, and antibiotics with myocardial infarction risk. There is no relevant evidence to confirm or refute the claim about DNA data doubling every 10 months."
    },
    "posthoc_doc_ids": [
      "7583104",
      "8570478",
      "13071728",
      "16180601",
      "24795767"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "161",
    "claim": "Bacteriophagaes MS2 and Q\u03b2 are members of the Leviviridae.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "Among the provided papers, only Paper 1 mentions bacteriophage MS2, discussing its structure, but it does not state its taxonomic family. None of the papers mention Q\u03b2 or the family Leviviridae. Therefore, the evidence set does not provide information to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "6903077",
      "25811797",
      "26996935",
      "28193026",
      "29334259"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 9 mentions bacteriophage MS2, and it discusses its cryo-EM structure without stating its taxonomic family. None of the papers reference Q\u03b2 or explicitly classify MS2 or Q\u03b2 as members of the Leviviridae. Therefore, the evidence set does not contain information to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "87758",
      "457630",
      "581832",
      "1606628",
      "1676568"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers address bacteriophages MS2 or Q\u03b2 or their taxonomic classification. The articles cover topics such as the Type VI secretion system, general phage growth models (without specifying MS2 or Q\u03b2), immunology, cytoskeletal proteins, Alzheimer\u2019s genetics, transcription factors, integrin mutations, cancer care, developmental signaling, and autophagy. Therefore, the evidence neither supports nor contradicts the claim about membership in Leviviridae."
    },
    "posthoc_doc_ids": [
      "4406819",
      "28707489",
      "2734421",
      "8570478",
      "20937018"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "6",
    "claim": "10% of sudden infant death syndrome (SIDS) deaths happen in newborns aged less than 6 months.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.85,
      "justification": "None of the provided papers report quantitative age-distribution data for SIDS (e.g., the proportion occurring before 6 months). Papers 1\u20134 discuss definitions, risk factors, mechanisms, and developmental physiology, but do not provide the specific statistic needed to confirm or refute that 10% of SIDS deaths occur in infants under 6 months. The remaining papers are unrelated to SIDS."
    },
    "naive_doc_ids": [
      "2613775",
      "23117378",
      "21050357",
      "35521287",
      "4200695"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, the only SIDS-related articles (Paper 2 on bed sharing risk and Paper 3 on definitions) do not report the age distribution of SIDS deaths or the proportion occurring under 6 months. Paper 2 discusses risk factors and age-related risk (e.g., under 3 months) but does not quantify the share of SIDS deaths by age group. The remaining papers are unrelated. Therefore, there is no evidence here to confirm or refute the specific claim that 10% of SIDS deaths occur in infants under 6 months."
    },
    "overthinking_doc_ids": [
      "17415081",
      "20240998",
      "23117378",
      "32766786",
      "9047718"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 1 and Paper 2 relate to SIDS. Paper 1 analyzes risk associated with bed sharing and provides odds ratios and absolute risks stratified by some age groups (<3 months), but it does not report the proportion of all SIDS deaths occurring in infants <6 months. Paper 2 discusses definitions and classification of SIDS without age-distribution data. The remaining papers are unrelated. Therefore, the evidence set does not contain data to confirm or refute the specific claim about the percentage of SIDS deaths in infants younger than 6 months."
    },
    "posthoc_doc_ids": [
      "20240998",
      "23117378",
      "32766786",
      "9047718",
      "10029891"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "198",
    "claim": "CCL19 is absent within dLNs.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers present data on CCL19 expression or its presence/absence in draining lymph nodes (dLNs). While some papers address lymph node immunobiology (e.g., antigen presentation and B cell antigen transport), they do not mention CCL19. Therefore, the evidence set does not inform the specific claim."
    },
    "naive_doc_ids": [
      "45764440",
      "5633876",
      "6054657",
      "7581911",
      "13368032"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers address the presence or absence of CCL19 in draining lymph nodes. The studies focus on iNKT cell activation by macrophages, apoptosis in HIV/SIV lymph nodes, dendritic cell subsets and migration after intramuscular immunization, Treg identification via CD127, gene expression changes in Caco-2 cells after polyphenols, inhibition of Langerhans cell migration by parasite-derived PGD2, and immune responses in SIVagm infection. No direct measurements or statements about CCL19 expression in dLNs are presented."
    },
    "overthinking_doc_ids": [
      "1933281",
      "37444589",
      "21719289",
      "266641",
      "4464565"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers address CCL19 expression or its presence/absence in draining lymph nodes (dLNs). The studies focus on iNKT cell activation by CD169+ macrophages, apoptosis in HIV/SIV-infected lymph nodes, cancer biomarkers and metastasis, SIV vaccine T cell responses, Langerhans cell migration, ovarian gene expression, enterovirus effects on pancreatic islets, embryo culture effects, glioblastoma gene expression, and melatonin effects on melanoma. No data about CCL19 in dLNs are presented."
    },
    "posthoc_doc_ids": [
      "1933281",
      "37444589",
      "2389574",
      "1071991",
      "3930020"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.03,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1196",
    "claim": "The availability of safe places to study is effective at decreasing homelessness.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers evaluate or report on the effect of providing safe places to study on homelessness outcomes. Papers 6, 7, and 9 relate to homelessness but focus on mental health outreach, impacts on children, and early intervention/long-term support, without assessing study spaces or homelessness reduction. The remaining papers are unrelated clinical or behavioral studies. Therefore, the evidence does not address the specific claim."
    },
    "naive_doc_ids": [
      "20473074",
      "5824985",
      "24088502",
      "24704139",
      "409280"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers evaluate or report outcomes related to the availability of safe places to study or their effect on homelessness. Paper 1 discusses early intervention and long-term support in youth homelessness but does not address study spaces. The remaining papers cover unrelated health and clinical topics or describe impacts of homelessness on children without assessing study spaces as an intervention. Therefore, there is no relevant evidence to confirm or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "154243324",
      "13899137",
      "33135135",
      "6085365",
      "8842332"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers evaluate whether the availability of safe places to study reduces homelessness. The only paper addressing homelessness (Paper 6) reviews adverse impacts of homelessness on children and notes policy needs but does not test or report outcomes of interventions like safe study spaces on homelessness rates. The remaining papers are unrelated to homelessness."
    },
    "posthoc_doc_ids": [
      "409280",
      "12009265",
      "12122482",
      "12471115",
      "20473074"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "66",
    "claim": "AZT given with ribavirin increases anemia.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate zidovudine (AZT) with ribavirin or report anemia outcomes from that combination. The only ribavirin-related study (Paper 7) addresses genetic predictors of virologic response to pegylated interferon plus ribavirin, not toxicity. Other papers focus on unrelated therapies (TNF, temozolomide, ciclopirox, interferon alone, temsirolimus) or general hematologic effects without involving AZT+ribavirin. Therefore, the evidence set does not inform the claim."
    },
    "naive_doc_ids": [
      "35766603",
      "41340212",
      "5492542",
      "22334300",
      "28910120"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers evaluate or mention coadministration of AZT (zidovudine) with ribavirin or its effect on anemia. While some papers discuss ribavirin-based hepatitis C therapy, IL28B genetics, or general anemia topics, they do not address the specific claim that AZT given with ribavirin increases anemia."
    },
    "overthinking_doc_ids": [
      "20399078",
      "2048139",
      "24596228",
      "45287266",
      "263364"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers address AZT (zidovudine), ribavirin, their coadministration, or resultant anemia. While some papers mention anemia in other contexts (e.g., Diamond-Blackfan anemia, population hemoglobin differences), there is no evidence about the effect of combining AZT with ribavirin on anemia."
    },
    "posthoc_doc_ids": [
      "12240507",
      "207972",
      "4270992",
      "4320424",
      "4449524"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "323",
    "claim": "Deleting Raptor increases G-CSF levels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data linking Raptor deletion to changes in G-CSF levels. Paper 5 addresses T cell\u2013specific deletion of Raptor and its effect on Th17 differentiation, while Papers 2 and 3 discuss regulation of G-CSF by IL-17 and adipocytes, respectively. However, there is no direct evidence in these papers that deleting Raptor increases G-CSF levels."
    },
    "naive_doc_ids": [
      "188911",
      "24612804",
      "42465769",
      "2316374",
      "22174015"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers examine Raptor deletion or report measurements of G-CSF (granulocyte colony-stimulating factor). The closest relevant topic is Paper 5, which discusses rictor defining a rapamycin-insensitive and raptor-independent mTOR complex, but it does not involve Raptor deletion nor G-CSF levels. Therefore, the evidence set does not address the claim."
    },
    "overthinking_doc_ids": [
      "1568684",
      "2481032",
      "3848469",
      "3984231",
      "4658268"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers examine Raptor (Regulatory associated protein of mTOR) deletion or report granulocyte colony-stimulating factor (G-CSF) levels in the context of Raptor loss. While several papers mention G-CSF in unrelated contexts (e.g., IL-17\u2013mediated granulopoiesis, dendritic cell culture, HSC mobilization) and one discusses mTOR complexes involving rictor and raptor, there is no experimental data connecting Raptor deletion to changes in G-CSF levels."
    },
    "posthoc_doc_ids": [
      "3984231",
      "4658268",
      "5409325",
      "11428884",
      "11915280"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "733",
    "claim": "M. stadtmanae induces ASC speck formation in BlaER1 monocytes.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address Methanobrevibacter stadtmanae or BlaER1 monocytes. While some discuss inflammasome activation and ASC dynamics in general (e.g., NLRP3 activation by Candida albicans or mitochondrial involvement), there is no evidence here about M. stadtmanae inducing ASC speck formation in BlaER1 monocytes."
    },
    "naive_doc_ids": [
      "32533299",
      "2824347",
      "3118719",
      "3152612",
      "4399311"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention Methanosphaera stadtmanae, BlaER1 monocytes, or directly assess ASC speck formation in that cell model. While several papers discuss ASC/NLRP3 inflammasome activation and ASC redistribution in general, and one describes an alternative inflammasome pathway in human monocytes, there is no experimental evidence here specifically linking M. stadtmanae to ASC speck formation in BlaER1 monocytes."
    },
    "overthinking_doc_ids": [
      "4345315",
      "56486733",
      "34469966",
      "623486",
      "2692522"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers investigate Methanosphaera stadtmanae or report ASC speck formation in BlaER1 monocytes. Paper 2 uses a monocyte transdifferentiation system (consistent with BlaER1) to study LPS-induced alternative inflammasome activation, noting a lack of pyroptosome/ASC speck formation for that stimulus, but it does not test M. stadtmanae. The remaining papers are unrelated to BlaER1 monocytes or M. stadtmanae."
    },
    "posthoc_doc_ids": [
      "25915873",
      "34469966",
      "306006",
      "350542",
      "623486"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "677",
    "claim": "LRBA promotes CTLA - 4 recycling.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address LRBA or its role in CTLA-4 recycling. The set includes studies on ESCRT-mediated endosomal sorting, KLF2/KLF10 in lymphocytes, ARNO in VEGFR-2 trafficking, GluN3A endocytosis, Treg biology, and CTLA4 mutations affecting Treg function, but no data on LRBA-dependent regulation of CTLA-4 trafficking or recycling."
    },
    "naive_doc_ids": [
      "9680193",
      "32101982",
      "9185195",
      "14405193",
      "22997657"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "Among the provided papers, only Papers 2 and 4 discuss CTLA-4, focusing on its expression in T-cell subsets, ligand binding, and functional consequences of CTLA4 mutations. None of the papers mention LRBA or investigate CTLA-4 intracellular trafficking or recycling. The remaining papers address unrelated pathways (e.g., synaptic vesicle recycling, ESCRT sorting, DNA sensing, hematology, transplantation immunology, and metabolism). Therefore, the evidence set does not contain information relevant to the claim that LRBA promotes CTLA-4 recycling."
    },
    "overthinking_doc_ids": [
      "11250124",
      "13398997",
      "14893425",
      "857189",
      "1241113"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "Among the provided papers, only Paper 7 discusses CTLA-4, focusing on its expression in Th17 cells and sensitivity to coinhibition/belatacept. None of the papers mention LRBA or investigate CTLA-4 trafficking or recycling. Therefore, the set does not provide evidence to confirm or refute the claim that LRBA promotes CTLA-4 recycling."
    },
    "posthoc_doc_ids": [
      "20585600",
      "213017",
      "1127562",
      "1976183",
      "2701077"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "828",
    "claim": "NAC inhibits the generation of angiotensin-converting enzyme.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers investigate N-acetylcysteine (NAC) or its effects on angiotensin-converting enzyme (ACE) expression or generation. Papers 2, 5, and 9 discuss ACE inhibitors or renin-angiotensin system drugs but do not involve NAC. Paper 3 concerns endothelin-converting enzyme, not ACE. The remaining papers address unrelated topics (myelin basic protein, bacterial RNA regulation, cell cycle kinases, AMPK regulation, oxidative stress regulons). Therefore, the evidence set does not support or refute the claim."
    },
    "naive_doc_ids": [
      "19238",
      "6157837",
      "6397191",
      "10443642",
      "14584755"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers mention N-acetylcysteine (NAC) or evaluate its effect on angiotensin-converting enzyme (ACE) expression or generation. The papers focus on ACE inhibitors/ARBs, renin-angiotensin system modulation, endothelin-converting enzyme, and unrelated inhibitors (hedgehog, BACE1, STAT3), without discussing NAC. Therefore, the evidence set does not support or refute the claim."
    },
    "overthinking_doc_ids": [
      "6157837",
      "14584755",
      "6397191",
      "27428509",
      "1759213"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers evaluate N-acetylcysteine (NAC) effects on angiotensin-converting enzyme (ACE) generation or expression. Papers 1 and 2 discuss ACE inhibitors and RAAS but not NAC; Paper 3 concerns endothelin-converting enzyme; Paper 4 shows NAC inhibiting Ucp1 expression via antioxidant effects; the remaining papers are unrelated to ACE or NAC. Therefore, the evidence set does not address the claim."
    },
    "posthoc_doc_ids": [
      "6157837",
      "14584755",
      "6397191",
      "36838958",
      "18546584"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "637",
    "claim": "Input from  mental and physical health care professionals is effective at decreasing homelessness.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided studies report outcomes on homelessness or housing stability. Papers focus on service utilization (Paper 1), mental health symptom reduction (Papers 2, 5, 9, 10), pharmacologic safety/effectiveness (Papers 3, 4, 7), maternal/infant outcomes (Paper 6), and prescribing behaviors (Paper 8). Even the case management study (Paper 1) examines use of health and mental health services, not homelessness reduction. Therefore, the evidence does not address whether input from mental and physical health professionals decreases homelessness."
    },
    "naive_doc_ids": [
      "485020",
      "24159217",
      "1759213",
      "15997009",
      "22467585"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers evaluate homelessness outcomes or interventions aimed at reducing homelessness. They cover topics such as peer review processes, mental health treatment for PTSD/depression in schoolchildren, acupuncture for depression, osteoporosis treatment, prevention of contrast nephropathy, antipsychotic risks in dementia, TB regimens, influenza vaccination and cardiovascular events, BiPAP in asthma, and surgical vs nonsurgical fracture care. No study reports effects on homelessness or housing stability, so the claim cannot be supported or refuted by this evidence."
    },
    "overthinking_doc_ids": [
      "16979690",
      "24159217",
      "27150276",
      "19878070",
      "4678846"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers evaluate homelessness or housing outcomes. The studies address clinical practices and interventions in bariatric surgery pathways, pharmacists\u2019 roles in mental health care, diabetes education, caregiver support, school-based PTSD treatment, brain metastases therapy, insomnia treatment, vasovagal syncope management, bariatric surgery for diabetes, and fracture management. While some involve mental health or multidisciplinary care, none present data on reducing homelessness. Therefore, the evidence does not inform the claim about decreasing homelessness."
    },
    "posthoc_doc_ids": [
      "19071857",
      "29845974",
      "12584053",
      "22446093",
      "24159217"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "182",
    "claim": "Bone Marrow (BM) transplantation is used to treat acute myeloid leukemia (AML)",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.88,
      "justification": "Paper 1 reports outcomes in 69 allogeneic stem cell transplant recipients, including 42 patients with acute myeloid leukemia, demonstrating that hematopoietic (blood and marrow) stem cell transplantation is used in AML. Additional papers (e.g., EBMT survey in Paper 2) discuss allogeneic stem cell transplantation contexts that include AML, further supporting its use as a treatment."
    },
    "naive_doc_ids": [
      "24795767",
      "11344428",
      "10128893",
      "3090454",
      "30398773"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 2 explicitly studies outcomes after allogeneic stem cell transplantation in a cohort that includes 42 patients with acute myeloid leukemia, demonstrating that transplantation is used clinically to treat AML. Additional transplant-focused studies (e.g., Paper 1\u2019s EBMT survey and Paper 3\u2019s HSCT complication analysis) further indicate that AML patients undergo HSCT/BMT."
    },
    "overthinking_doc_ids": [
      "11344428",
      "24795767",
      "30398773",
      "3090454",
      "10128893"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 2 explicitly includes 42 acute myeloid leukemia (AML) patients who underwent allogeneic stem cell transplantation, assessing post-transplant immune recovery and outcomes\u2014demonstrating transplantation is used as treatment in AML. Paper 1 surveys allogeneic transplants across EBMT centers and discusses complications within the context of blood and marrow transplantation, with AML among leukemia types observed post-transplant. Additional papers (7\u20139) discuss outcomes and complications after hematopoietic stem cell transplantation generally, consistent with its therapeutic use in hematologic malignancies including AML. Together, these support that bone marrow/hematopoietic stem cell transplantation is used to treat AML."
    },
    "posthoc_doc_ids": [
      "11344428",
      "24795767",
      "6374918",
      "13205096",
      "4387494"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.55,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "679",
    "claim": "LSD1-positive promoters are associated with RNA polymerase II",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers mention LSD1 (KDM1A) or analyze promoters classified as LSD1-positive. While several papers discuss RNA polymerase II occupancy at promoters (e.g., Papers 1 and 10) or RNAP-related mechanisms, there is no evidence directly linking LSD1-positive promoters to RNA polymerase II in this set."
    },
    "naive_doc_ids": [
      "23269537",
      "175735",
      "4411760",
      "7416873",
      "12149169"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers discuss LSD1 (KDM1A) occupancy at promoters or its association with RNA polymerase II. The papers focus on topics such as H2A.Z distribution, nucleosome positioning and histone marks, Polycomb complexes, KLF1 binding, chromatin remodeling by Isw2, genetic associations with disease, and microRNA biomarker studies. Therefore, they do not provide evidence to confirm or refute the claim about LSD1-positive promoters and RNA Pol II."
    },
    "overthinking_doc_ids": [
      "18694784",
      "175735",
      "1791637",
      "2452989",
      "4305576"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers examine LSD1 (KDM1A) occupancy at promoters or its association with RNA polymerase II. The studies focus on unrelated topics such as H2A.Z distribution, PRC1/PRC2 bivalency, chromatin remodelers (Isw2), transcription factors (KLF1), plant RNA polymerase IV, and clinical/oncologic topics. Therefore, the evidence does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "11238951",
      "18694784",
      "341324",
      "1389264",
      "1695604"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "894",
    "claim": "Osteoparthritis (OA) is characterized by degeneration of articular cartilage, joint edge, and subchondral bone hyperplasia.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "The provided OA-related papers (1, 2, 4) present evidence of cartilage degeneration and associated inflammatory/catabolic pathways in osteoarthritic cartilage, supporting only the cartilage component of the claim. None of the papers provide data on joint edge changes (e.g., marginal osteophytes) or subchondral bone hyperplasia in OA. The remaining papers are unrelated to OA joint-edge or subchondral bone features. Therefore, the full claim cannot be verified with the given evidence."
    },
    "naive_doc_ids": [
      "33912748",
      "1044552",
      "15365719",
      "22505710",
      "343052"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 5 pertains to osteoarthritis, focusing on infrapatellar fat pad inflammation in an MIA rat model. It reports patellar cartilage and subchondral bone necrosis and synovial hyperplasia, but does not address joint-edge degeneration or subchondral bone hyperplasia. The remaining papers are unrelated to OA pathology. Therefore, the evidence set does not confirm or refute the specific claim about OA being characterized by degeneration of articular cartilage, joint edge, and subchondral bone hyperplasia."
    },
    "overthinking_doc_ids": [
      "15365719",
      "16812091",
      "23305547",
      "24632480",
      "37562370"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Among the provided papers, OA-related studies (Papers 5 and 8) document catabolic and inflammatory processes in osteoarthritic cartilage, supporting cartilage degeneration. Paper 3 (MIA model) shows IPFP inflammation and later patellar cartilage and subchondral bone necrosis with synovial hyperplasia, which does not address subchondral bone hyperplasia and does not discuss joint edge changes (e.g., osteophytes). No paper presents evidence about joint edge degeneration or subchondral bone hyperplasia specifically. Therefore, the provided evidence does not sufficiently confirm the full claim."
    },
    "posthoc_doc_ids": [
      "15365719",
      "24632480",
      "37562370",
      "58050905",
      "1044552"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "423",
    "claim": "Folate and vitamin B12 levels influence the association between homocysteine and preeclampsia.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 4 addresses preeclampsia and it evaluates folic acid supplementation and dietary folate intake in relation to preeclampsia risk, without measuring homocysteine or vitamin B12 or testing interactions with homocysteine. The other papers show that folate (and sometimes vitamin B12) influence homocysteine levels and cardiovascular outcomes, or genetic interactions (MTHFR) with folate and homocysteine, but none link these specifically to preeclampsia or examine whether folate/B12 levels modify the homocysteine\u2013preeclampsia association. Therefore, the specific claim is not supported or refuted by the provided evidence."
    },
    "naive_doc_ids": [
      "37424881",
      "21636085",
      "8595678",
      "19278208",
      "11705328"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "The provided papers show that folate (and to a lesser extent vitamin B12) influence homocysteine levels and vascular outcomes (e.g., stroke, CAD), and one study (Paper 10) links folic acid supplementation and higher dietary folate to reduced preeclampsia risk. However, none of the papers examine whether folate or vitamin B12 status modifies the association between homocysteine levels and preeclampsia specifically. There is also no study here directly assessing vitamin B12 in relation to preeclampsia. Therefore, the specific effect-modification claim for preeclampsia is not addressed by the provided evidence."
    },
    "overthinking_doc_ids": [
      "8595678",
      "37424881",
      "42441846",
      "10557471",
      "21636085"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 8 addresses preeclampsia and examines folic acid supplementation and dietary folate in relation to preeclampsia risk, without measuring homocysteine or vitamin B12 or their interaction with preeclampsia. Papers 1\u20135 discuss folate/B12 effects on homocysteine and cardiovascular outcomes or genotype effects, not preeclampsia. Therefore, there is no direct evidence here that folate and vitamin B12 levels influence the association between homocysteine and preeclampsia."
    },
    "posthoc_doc_ids": [
      "37424881",
      "42441846",
      "8595678",
      "10557471",
      "12810152"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "907",
    "claim": "PGE 2 promotes intestinal tumor growth by altering the expression of tumor suppressing and DNA repair genes.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.95,
      "justification": "Paper 5 directly reports that prostaglandin E2 (PGE2) promotes intestinal tumor growth by inducing DNA methylation that silences (i.e., alters expression of) tumor-suppressor and DNA-repair genes. This matches the claim precisely. The other papers do not contradict this and are largely unrelated to PGE2 or intestinal tumors."
    },
    "naive_doc_ids": [
      "15113221",
      "57783564",
      "470625",
      "5377642",
      "6923961"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.98,
      "justification": "Paper 1 directly shows that PGE2 silences certain tumor-suppressor and DNA-repair genes via DNA methylation, thereby promoting intestinal tumor growth. This explicitly matches the claim that PGE2 promotes intestinal tumor growth by altering the expression of tumor-suppressing and DNA repair genes. The other papers are not about PGE2 in intestinal tumors and do not contradict this finding."
    },
    "overthinking_doc_ids": [
      "6923961",
      "7028976",
      "9486930",
      "9614443",
      "12580014"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.97,
      "justification": "Paper 1 directly demonstrates that PGE2 promotes intestinal tumor growth by silencing tumor-suppressor and DNA-repair genes via DNA methylation, thereby altering their expression. The remaining papers do not address PGE2 in intestinal tumors and neither contradict nor modify this finding."
    },
    "posthoc_doc_ids": [
      "6923961",
      "7028976",
      "9486930",
      "11271123",
      "15113221"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.85,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1204",
    "claim": "The combination of H3K4me3 and H3K79me2 is found in quiescent hair follicle stem cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 7 addresses histone modifications in hair follicle stem cells, and its summary highlights H3K27me3 dynamics, not H3K4me3 or H3K79me2. The other papers focus on quiescence mechanisms in various stem cells or protocols without discussing specific histone marks in quiescent hair follicle stem cells. Therefore, the evidence does not confirm or refute the specific claim about the combination of H3K4me3 and H3K79me2 in quiescent hair follicle stem cells."
    },
    "naive_doc_ids": [
      "2701077",
      "3140772",
      "16660256",
      "17271462",
      "32170702"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Among the provided papers, only Paper 2 addresses histone modifications in hair follicle stem cells, but it specifically highlights Polycomb-mediated H3K27me3 changes across quiescent/activated HF-SCs and progeny. None of the summaries mention H3K4me3 or H3K79me2 in HF-SCs, nor the combination of these marks in quiescent HF-SCs. The remaining papers focus on other stem cell systems or topics and do not provide relevant histone mark data. Therefore, the claim is not supported or refuted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "25597580",
      "31141365",
      "15907458",
      "2853291",
      "3140772"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Only Paper 2 addresses histone modifications in hair follicle stem cells, but the provided excerpt discusses PcG-mediated H3K27me3 and does not mention H3K4me3 or H3K79me2 in quiescent HF-SCs. The other papers focus on other stem cell types or topics and provide no information about these specific histone marks in hair follicle stem cells. Therefore, the claim is not supported or refuted by the given text."
    },
    "posthoc_doc_ids": [
      "25597580",
      "31141365",
      "15907458",
      "2853291",
      "3140772"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.5,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1401",
    "claim": "qSOFA scores are associated with length of stay in emergency department patients.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "Among the provided papers, none report an association between qSOFA scores and length of stay specifically in emergency department (ED) patients. Paper 3 examines ED patients but focuses on organ dysfunction and mortality, not length of stay. Paper 2 includes a composite outcome with ICU length of stay (\u22653 days) in ICU patients, not ED patients. The remaining papers do not analyze qSOFA or ED length of stay. Therefore, the evidence supplied does not address the claim."
    },
    "naive_doc_ids": [
      "3878434",
      "5185871",
      "26314743",
      "5596332",
      "14021596"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Papers 5 and 6 address qSOFA, but neither evaluates its association with length of stay in emergency department (ED) patients. Paper 5 studies ICU patients and uses a composite outcome including ICU length of stay \u22653 days, not ED patients or ED length of stay. Paper 6 examines qSOFA for predicting sepsis, mortality, and ICU admission in febrile neutropenia patients, with no length-of-stay outcomes. The other papers do not involve qSOFA. Therefore, the evidence does not address the claim about qSOFA and length of stay in ED patients."
    },
    "overthinking_doc_ids": [
      "14021596",
      "27054878",
      "34873974",
      "39059143",
      "5185871"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, qSOFA is discussed primarily for mortality prediction and ICU-related outcomes. Paper 1 evaluates qSOFA in ICU patients with suspected infection and includes a composite outcome involving ICU length of stay, not emergency department patients or ED length of stay. Paper 10 assesses qSOFA for sepsis, ICU admission, and 28-day mortality in febrile neutropenia, without length of stay. Other papers addressing length of stay do not involve qSOFA or ED populations. Therefore, there is no direct evidence here linking qSOFA scores to length of stay in emergency department patients."
    },
    "posthoc_doc_ids": [
      "5185871",
      "14021596",
      "27054878",
      "34873974",
      "39059143"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "703",
    "claim": "Localization of PIN1 in the roots of Arabidopsis requires VPS9a",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "Among the provided papers, only Paper 6 addresses Arabidopsis PIN protein localization, showing that manipulation of the Rab5 GTPase pathway disrupts PIN polarization. However, none of the papers mention VPS9a specifically or provide direct evidence that PIN1 localization in roots requires VPS9a. The remaining papers concern unrelated pathways or organisms. Therefore, the claim is not verified by the given evidence."
    },
    "naive_doc_ids": [
      "1354567",
      "313394",
      "435529",
      "810480",
      "4324278"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "Among the provided papers, only Paper 10 discusses PIN proteins and shows that endocytosis and manipulation of the Arabidopsis Rab5 GTPase pathway affect PIN polarization. However, none of the papers mention VPS9a specifically or test its requirement for PIN1 localization in Arabidopsis roots. Therefore, the evidence set does not address the specific claim that VPS9a is required for PIN1 localization."
    },
    "overthinking_doc_ids": [
      "1354567",
      "313394",
      "435529",
      "810480",
      "4324278"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the provided papers, only Paper 4 discusses PIN1, describing its polar localization and role in auxin-mediated organ formation, but it does not mention VPS9a or test its requirement. None of the other papers address PIN1 or VPS9a in Arabidopsis roots. Therefore, there is no direct evidence here linking VPS9a to PIN1 localization."
    },
    "posthoc_doc_ids": [
      "1354567",
      "4324278",
      "10212612",
      "16557565",
      "313394"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1400",
    "claim": "p75 NTR - associated cell death executor (NADE) interacts with the p75 NTR death domain",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers discuss p75NTR (the neurotrophin receptor), NADE (p75NTR-associated cell death executor), or their interaction. The papers focus on unrelated topics such as TNF receptor/TRADD interactions (Paper 1), T cell receptor signaling and granule trafficking (Papers 2\u20133), glioblastoma treatment resistance (Paper 4), CNBP/hnRNP K regulation (Paper 5), general cell death/apoptosis mechanisms (Papers 6 and 8), and NEMO/RIPK1-mediated intestinal epithelial cell death (Paper 7). Therefore, the evidence does not confirm or refute the specific claim about NADE binding to the p75NTR death domain."
    },
    "naive_doc_ids": [
      "41913714",
      "6163801",
      "8903143",
      "9486930",
      "10486817"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers discuss p75NTR or NADE. The death domain interactions mentioned pertain to the TNF receptor pathway (e.g., TRADD\u2013TNFR1) and are unrelated to p75NTR. Therefore, the evidence does not address whether NADE interacts with the p75NTR death domain."
    },
    "overthinking_doc_ids": [
      "8093935",
      "41913714",
      "207972",
      "1103795",
      "1546650"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address NADE or its interaction with the p75 neurotrophin receptor death domain. The only p75(NTR)-related paper (Paper 9) describes generation of a conditional allele and associated phenotypes, without discussing NADE or binding interactions. The remaining papers focus on unrelated pathways (e.g., TNF receptor/TRADD, HDAC5-KLF2, RAR/RXR coactivators, EBV-induced methylation changes, adenoviral E3-14.7K interactions, NEMO/RIPK1). Therefore, the evidence does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "41913714",
      "301866",
      "2316374",
      "9486930",
      "11359243"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1199",
    "claim": "The benefits of colchicine were achieved with effective widespread use of secondary prevention strategies such as high-dose statins.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers evaluate colchicine or its benefits, nor do they assess colchicine outcomes in the context of background secondary prevention with high-dose statins. The studies address antiplatelet therapy (prasugrel vs clopidogrel), bezafibrate, homocysteine lowering with B vitamins, biomarkers, antihypertensive combinations (benazepril plus amlodipine vs hydrochlorothiazide), statins for primary prevention, HPV testing, and HDL-focused strategies. Therefore, they do not provide relevant evidence to confirm or refute the claim about colchicine."
    },
    "naive_doc_ids": [
      "6158879",
      "30805636",
      "33409100",
      "25028913",
      "40790033"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers discuss colchicine or its cardiovascular trial context. While one paper addresses statin cost-effectiveness, the set does not evaluate colchicine\u2019s benefits or whether they occurred alongside widespread secondary prevention (e.g., high-dose statins). The remaining papers concern exercise interventions, HPV screening, malaria treatments, diabetes drugs, fibrates, flavonols, and lipoprotein(a), all unrelated to the claim."
    },
    "overthinking_doc_ids": [
      "2028532",
      "17691617",
      "1805641",
      "9764256",
      "16980892"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers discuss colchicine or report on trials of colchicine in cardiovascular disease. The evidence focuses on statins (primarily in primary prevention), bezafibrate, physician practices, ART for HIV/TB, HPV testing, and gastric lavage, without addressing whether colchicine benefits were realized alongside widespread secondary prevention strategies such as high-dose statins. Therefore, the claim cannot be verified or refuted from these sources."
    },
    "posthoc_doc_ids": [
      "7454794",
      "30805636",
      "5698494",
      "6085365",
      "43629704"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "336",
    "claim": "Destination container port throughput(CPT) is negatively related to dengue virus (DENV-1) diffusion in air traffic shipments.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers analyze relationships between destination container port throughput, air traffic shipments, and DENV-1 diffusion. Relevant studies here focus on local dengue transmission dynamics (e.g., spatial clustering, population density and water supply in Vietnam), mosquito-virus interactions, or unrelated viruses (HCV, influenza, HIV, WNV), and do not assess transport infrastructure metrics (container port throughput) or air cargo/air traffic-mediated spread of DENV-1."
    },
    "naive_doc_ids": [
      "18816720",
      "5114282",
      "10068634",
      "12885341",
      "20996244"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers address the relationship between destination container port throughput and DENV-1 diffusion via air traffic shipments. The only dengue-related study (Paper 6) examines local spatial-temporal transmission in Thai villages and not transportation or logistics factors, and it does not focus specifically on DENV-1. The remaining papers are unrelated (genomics, ticks and climate, proteogenomics, statistical model comparison, epilepsy, HCV risk factors, alcohol policy and homicides, H7N9 transmission, sexual health). Therefore, the evidence set provides no relevant information to support or contradict the claim."
    },
    "overthinking_doc_ids": [
      "12271486",
      "25308734",
      "44409062",
      "70115",
      "116792"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers analyze or report relationships between destination container port throughput (CPT) and dengue virus (DENV-1) diffusion via air traffic shipments. The relevant studies focus on local transmission patterns, importation sources without transport metrics, genetic/serological factors, or unrelated health topics. There is no evidence in these papers quantifying CPT or its association\u2014negative or otherwise\u2014with DENV-1 spread through air traffic."
    },
    "posthoc_doc_ids": [
      "18816720",
      "643765",
      "8665891",
      "253672",
      "991139"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.03,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "897",
    "claim": "Overexpressing Cnp1 N-tail variants rescues the temperature-sensitive growth defect of scm3-139.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Papers 6 and 7 relate to CENP-A (Cnp1) assembly and Scm3 in fission yeast, but neither discusses overexpression of Cnp1 N-terminal tail variants nor the specific scm3-139 temperature-sensitive allele or its growth rescue. The remaining papers are unrelated to centromere assembly or this genetic interaction. Therefore, the evidence set does not address the claim."
    },
    "naive_doc_ids": [
      "36111909",
      "6766459",
      "12922760",
      "24307695",
      "20183360"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 5 discusses Scm3 and CENP-A(Cnp1) in fission yeast, but it does not report experiments on Cnp1 N-terminal tail variants or their overexpression rescuing a temperature-sensitive scm3-139 mutant. The other papers are unrelated to Cnp1/Scm3 interactions or rescue assays. Therefore, the supplied evidence does not address the specific claim."
    },
    "overthinking_doc_ids": [
      "6766459",
      "12922760",
      "24307695",
      "4462139",
      "14338915"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Papers 9 and 10 discuss fission yeast Scm3/HJURP and CENP-A/Cnp1, focusing on their roles in centromere assembly and recruitment. Neither these nor the other papers mention the scm3-139 temperature-sensitive mutant, Cnp1 N-terminal tail variants, or any rescue of a temperature-sensitive growth defect by overexpressing such variants. Therefore, the evidence set does not address the specific claim."
    },
    "posthoc_doc_ids": [
      "6766459",
      "7717468",
      "34016944",
      "970012",
      "4362729"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.18,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1068",
    "claim": "ScPif1p has reduced binding ability to G-rich ssDNA compared to non-G-rich ssDNA.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers address ScPif1p (the Saccharomyces cerevisiae Pif1 helicase) or compare its binding to G-rich versus non-G-rich single-stranded DNA. The articles focus on unrelated topics (nuclear receptor-coactivator interactions, yeast lipid membranes, RNA processing kinetics, transcriptional regulatory databases, meiotic DSB mapping, bacterial/Deinococcus SSBs, BLM helicase, and human Rad52). Therefore, the evidence set does not contain relevant data to verify or refute the claim."
    },
    "naive_doc_ids": [
      "23938319",
      "43752562",
      "365896",
      "1256116",
      "10874408"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers address ScPif1p (the Saccharomyces cerevisiae Pif1 helicase) or compare its binding to G-rich versus non-G-rich ssDNA. The articles focus on unrelated systems (e.g., two-component signaling, transcription databases, HIF-1\u03b1/p53 interaction, meiotic DSB mapping, replication termination factors Tof1/Csm3/Rrm3, retinoid receptor\u2013coactivator interactions, bacterial SSB, kinesin\u2013microtubule binding, CNBP and G-quadruplexes, and ADAM13\u2013fibronectin binding). Therefore, they provide no relevant evidence to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "1225513",
      "1256116",
      "10247314",
      "10874408",
      "23664875"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers measure or compare ScPif1p (yeast Pif1 helicase) binding affinity to G-rich ssDNA versus non-G-rich ssDNA. Paper 10 discusses Pif1p displacing telomerase from telomeric (G-rich) DNA but does not assess Pif1p\u2019s binding preferences to different ssDNA sequences. The other papers are unrelated to Pif1p or to G-rich vs non-G-rich ssDNA binding. Therefore, the claim is not addressed by the supplied evidence."
    },
    "posthoc_doc_ids": [
      "7549811",
      "20943272",
      "799586",
      "29098525",
      "169264"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "229",
    "claim": "Carriers of HNF4A mutations are at reduced risk for diabetes.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers address HNF4A mutations or diabetes risk in HNF4A mutation carriers. The studies focus on diabetes treatments, BNP genetic variants, diet, bariatric surgery, BRCA mutations, thiazolidinediones and bladder cancer, preconception care in women with diabetes, BMI and gestational diabetes, antihypertensive drugs and new-onset diabetes, and statin benefits. Therefore, they do not provide evidence to verify or refute the claim about HNF4A."
    },
    "naive_doc_ids": [
      "13619127",
      "15663829",
      "1974176",
      "5824985",
      "9394119"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers present data on HNF4A (hepatocyte nuclear factor 4 alpha) mutations in humans or their association with diabetes risk. The studies cover unrelated topics (adenoviral proteins, LXR and cholesterol efflux, cardiovascular risk factors in China, epigenetic regulators in bovine embryos, a C. elegans nuclear receptor, shared T1D/celiac loci, pharmacologic prevention of T2D, fruit consumption and T2D risk, endothelial biomarkers, and hypoglycemia-dementia). Paper 5 mentions a C. elegans NHR related to HNF4 by sequence but provides no human genetic risk evidence. Therefore, the evidence set does not inform the claim."
    },
    "overthinking_doc_ids": [
      "207972",
      "11557602",
      "2138767",
      "4547102",
      "12805683"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers examine HNF4A mutation carriers or their risk of diabetes. The studies focus on Alzheimer\u2019s presenilin mutations, diabetes treatments (glitazones/gliptins), aspirin and cancer risk, ATM mutations and breast cancer, metabolic syndrome, gestational diabetes and BMI, fruit intake and type 2 diabetes risk, cardiovascular risk factors in China, and pioglitazone and cancer. No data are presented about HNF4A variants or diabetes risk reduction."
    },
    "posthoc_doc_ids": [
      "8892905",
      "13619127",
      "15648443",
      "24144677",
      "27449472"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "126",
    "claim": "Approximately 250,000 people are infected with human T-cell lymphotropic virus type 1 in the United Kingdom.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Only Paper 1 discusses HTLV in the UK, reporting counts of HTLV-I\u2013associated diseases (e.g., HAM/TSP and ATL) and noting endemic regions, but it does not provide prevalence estimates or total numbers of infected individuals in the UK. The remaining papers are unrelated to HTLV prevalence. Therefore, the provided evidence neither supports nor contradicts the specific claim that ~250,000 people are infected with HTLV-1 in the United Kingdom."
    },
    "naive_doc_ids": [
      "24512064",
      "1958440",
      "5735492",
      "6421734",
      "17463549"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers address human T-cell lymphotropic virus type 1 (HTLV-1) prevalence or infection counts in the United Kingdom. They cover unrelated topics such as Creutzfeldt-Jakob disease, cancer survivorship in the U.S., global childhood underweight, bariatric surgery outcomes in the UK, mental health prevalence, public health policy, hypertension prevention, patient experiences with multimorbidity, ADHD screening, and public health workforce research. Therefore, they provide no relevant data to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "27063470",
      "9547722",
      "1606628",
      "5824985",
      "6490571"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers report epidemiological data on human T-cell lymphotropic virus type 1 (HTLV-1) prevalence in the United Kingdom or provide figures related to the claimed ~250,000 infections. The papers focus on HIV biology, treatment trials for ATLL (without UK prevalence figures), immunology, genomics, tuberculosis, cardiovascular prevention, caregiver needs in cancer, and diabetes education outcomes."
    },
    "posthoc_doc_ids": [
      "20996244",
      "46202852",
      "601033",
      "8639034",
      "14530534"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "310",
    "claim": "De novo assembly of sequence data has fewer specific contigs than unassembled sequence data.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers compare de novo assembled contigs to unassembled sequence data in terms of the number of 'specific contigs.' Paper 1 shows de novo assembly can recover a draft genome in a metagenomic outbreak, but does not contrast contig specificity with unassembled reads. Papers 7\u20139 discuss assembly and its performance/limitations (e.g., Trinity performance, GC bias effects) without addressing specificity relative to unassembled data. Other papers are unrelated. Additionally, unassembled data are reads, not contigs, so the claimed comparison is not directly addressed by these studies."
    },
    "naive_doc_ids": [
      "6173523",
      "19140422",
      "11415809",
      "11419230",
      "1191830"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 1 (metagenomic outbreak sequencing using de novo assembly) and Paper 6 (GC bias effects on de novo assembly) relate to sequence assembly, but neither compares the number or specificity of contigs from de novo assembly to those from unassembled data. Unassembled sequence data do not contain contigs by definition. The remaining papers are unrelated. Therefore, the evidence does not address the claim."
    },
    "overthinking_doc_ids": [
      "6173523",
      "19140422",
      "11419230",
      "13256155",
      "15153602"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "Among the provided papers, only Paper 2 (GC bias effects on de novo assembly) and Paper 7 (Trinity de novo transcriptome assembly) address de novo assembly, focusing on completeness, fragmentation, and transcript recovery. They do not compare the number or specificity of contigs to unassembled reads. The remaining papers are unrelated to sequence assembly. Therefore, there is no direct evidence supporting or contradicting the claim about contig specificity versus unassembled sequence data."
    },
    "posthoc_doc_ids": [
      "4407385",
      "14464451",
      "143251",
      "1616661",
      "25041967"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.12,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "891",
    "claim": "Origin gross domestic product(GDP) is positively related to dengue virus (DENV-1) diffusion in air traffic shipments.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers analyze the relationship between origin GDP and DENV-1 diffusion via air traffic shipments. Only one paper (Paper 8) concerns dengue, focusing on village-level spatial-temporal clustering in Thailand, without mention of GDP or air transport. The remaining papers address unrelated topics (neuroimaging, Bayesian model metrics, glutamate physiology, circulating DNA, stem cells, gene delivery systems, zoonotic R estimation, newborn brain development, and socioeconomic lifestyle risks). Therefore, the evidence set does not inform the specific claim."
    },
    "naive_doc_ids": [
      "25789730",
      "70115",
      "2039912",
      "2841164",
      "2853291"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers analyze the relationship between origin GDP and dengue (DENV-1) diffusion via air traffic shipments. The only dengue-related paper (Paper 9) examines spatial and temporal clustering of dengue transmission within Thai villages and does not address GDP, air traffic, or specifically DENV-1. The remaining papers concern unrelated topics (cell biology, neuroscience, cancer, bacterial chromosome dynamics, zoonotic transmissibility estimation, WNV-mosquito interactions, HIV infection dynamics). Therefore, the evidence set provides no information relevant to the stated claim."
    },
    "overthinking_doc_ids": [
      "164189",
      "2039912",
      "2841164",
      "4422868",
      "5223817"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers analyze the relationship between origin GDP and DENV-1 diffusion via air traffic shipments. The dengue-related studies focus on local spatial-temporal clustering in Thai villages (Paper 1) and importation patterns into Guangzhou, China (Paper 4), without examining GDP or air cargo/traffic correlates. The remaining papers are unrelated to dengue transmission dynamics or air transport economics."
    },
    "posthoc_doc_ids": [
      "18816720",
      "4231060",
      "7485455",
      "8665891",
      "643765"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "390",
    "claim": "Ethanol stress increases the expression of PSP in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "None of the provided paper summaries report that ethanol stress increases expression of the phage shock protein (Psp) system in bacteria. Paper 6 notes increased PspA in a TolC mutant due to membrane stress/proton motive force loss, not ethanol. Paper 4 discusses ethanol stress during hydrolysate fermentation but does not mention Psp induction. The other papers are unrelated to Psp or ethanol stress. Therefore, the evidence given does not address the specific claim."
    },
    "naive_doc_ids": [
      "471735",
      "6669242",
      "45364685",
      "21602220",
      "26886351"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data showing that ethanol stress increases expression of the phage shock protein (Psp) system in bacteria. The only mention of Psp is in Paper 4, where PspA increases in a TolC mutant due to membrane stress and proton motive force dissipation, not ethanol exposure. Papers 3 and 10 discuss ethanol stress/tolerance but do not report Psp expression changes. Therefore, the claim is not supported or refuted by the given evidence."
    },
    "overthinking_doc_ids": [
      "471735",
      "6669242",
      "21602220",
      "26625002",
      "13135544"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "None of the provided papers present data on ethanol stress increasing expression of the bacterial PSP/Psp (phage shock protein) system. Paper 7 mentions increased PspA in a TolC knockout (membrane stress, not ethanol). Paper 6 discusses ethanol stress during hydrolysate fermentation but does not report Psp expression. The remaining papers address unrelated stress pathways or organisms. Therefore, the claim is not supported or refuted by these citations."
    },
    "posthoc_doc_ids": [
      "471735",
      "6669242",
      "9194077",
      "23305884",
      "24185667"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "890",
    "claim": "Origin gross domestic product(GDP) is negatively related to dengue virus (DENV-1) diffusion in air traffic shipments.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers analyze dengue virus (specifically DENV-1) diffusion via air traffic shipments or its relationship with origin GDP. The studies focus on local dengue transmission clustering, water supply and population density effects, specific outbreaks, mosquito biology, or unrelated diseases (HIV, HCV), and do not evaluate economic indicators or air traffic-mediated spread."
    },
    "naive_doc_ids": [
      "18816720",
      "10071552",
      "12885341",
      "17454301",
      "20996244"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers analyze the relationship between origin-country GDP and DENV-1 diffusion via air traffic shipments. The only dengue-related study (Paper 8) addresses local spatial-temporal clustering within Thai villages, not global diffusion or economic predictors. The remaining papers concern unrelated topics (chemotherapy access, sexual health, malaria prophylaxis, alcohol policies and homicides, p53 in breast cancer, zoonosis transmissibility estimation, influenza diagnostics, gene transfer systems, and HCV phylogeography)."
    },
    "overthinking_doc_ids": [
      "24575065",
      "3981244",
      "8593263",
      "8906858",
      "12762485"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers analyze the relationship between origin GDP and DENV-1 diffusion via air traffic shipments. While a few papers discuss dengue transmission patterns (Paper 6) and importation in China (Paper 9), they do not assess economic indicators or air traffic shipment networks. The remaining papers are unrelated to dengue diffusion. Therefore, the evidence set does not support or refute the claim."
    },
    "posthoc_doc_ids": [
      "2575938",
      "8318922",
      "12762485",
      "15833835",
      "20186814"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1197",
    "claim": "The availability of safe places to study is not effective at decreasing homelessness.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers evaluate the effect of providing safe places to study on homelessness. The only paper addressing homelessness (Paper 4) reviews impacts of homelessness on children and mediating factors but does not assess interventions aimed at reducing homelessness, let alone study-space availability. All other papers concern unrelated medical or public health topics."
    },
    "naive_doc_ids": [
      "21323758",
      "849771",
      "31208367",
      "33135135",
      "12122482"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Papers 6 and 7 address homelessness, focusing on its impacts on children and the progression from youth to adult homelessness and the value of long-term support. None of the papers evaluate or report outcomes on the availability of safe places to study as an intervention, nor do they measure its effectiveness in decreasing homelessness. Therefore, the evidence set does not contain relevant data to support or refute the claim."
    },
    "overthinking_doc_ids": [
      "11349166",
      "409280",
      "12009265",
      "15663829",
      "18340282"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate or report on the effectiveness of providing safe places to study as an intervention to reduce homelessness. The only homelessness-related paper (Paper 6) reviews impacts of homelessness on children but does not assess interventions or outcomes related to decreasing homelessness. The other papers address unrelated medical and public health topics."
    },
    "posthoc_doc_ids": [
      "21323758",
      "5151024",
      "13625993",
      "8756719",
      "11117498"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.02,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1052",
    "claim": "Rising temperatures caused by global warming increases risk of dengue fever transmission.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data linking rising temperatures to increased dengue transmission. Papers 2 and 3 analyze dengue transmission patterns and risk factors (clustering, water supply, population density) but do not address temperature or climate warming. Paper 1 concerns mosquito transcriptomics; Papers 4\u20135 address mosquito\u2013virus interactions unrelated to temperature or dengue; Paper 6 examines temperature-related all-cause mortality, not dengue; Paper 10 models temperature effects on tick populations (not dengue vectors). Other papers are unrelated. Therefore, the supplied evidence does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "13702924",
      "18816720",
      "2097256",
      "9539248",
      "12885341"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "Among the provided papers, none present data linking rising temperatures or global warming to increased dengue transmission risk. Paper 2 discusses dengue risk factors (population density and water supply) but not temperature. Paper 1 examines temperature-related mortality in general (not dengue), Paper 4 documents warming in Canada without infectious disease outcomes, and the remaining papers are unrelated to dengue or climate effects. Therefore, the claim is not addressed by the supplied evidence."
    },
    "overthinking_doc_ids": [
      "4810810",
      "2097256",
      "13702924",
      "129199129",
      "2665675"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, those on dengue (Papers 1, 3, 4) discuss determinants such as population density, water supply, spatial clustering, and global burden trends, but do not analyze temperature or global warming effects on dengue transmission risk. Other papers address unrelated topics (e.g., HCV vertical transmission, HIV modeling, general temperature-mortality, Canadian temperature trends, tick ecology, mosquito transcriptomics) without linking rising temperatures to dengue. Therefore, the set contains no direct evidence confirming or refuting the claim."
    },
    "posthoc_doc_ids": [
      "2097256",
      "13770184",
      "18816720",
      "3716075",
      "7647224"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "644",
    "claim": "Insulin increases risk of severe kidney failure.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 1 examines diabetes treatments (including insulin) and severe kidney failure, but the reported results in the excerpt only specify associations for glitazones and gliptins; no insulin-specific risk for severe kidney failure is presented. The remaining papers do not address insulin\u2019s effect on severe kidney failure. Therefore, the supplied evidence does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "13619127",
      "1974176",
      "33409100",
      "6157837",
      "13282296"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers assess whether insulin therapy increases the risk of severe kidney failure. The studies focus on antiplatelet therapy in diabetics (Paper 1), B-vitamin homocysteine lowering in CKD/ESRD (Paper 2), ACE inhibitor renal effects (Paper 3), arterial stiffness and mortality in ESRD (Paper 4), antihypertensive combinations and CKD progression (Paper 5), glycemic biomarkers (Paper 6), general diabetes complications (Paper 7), insulin pump effects on HbA1c (Paper 8), added sugars and insulin resistance in youth (Paper 9), and nuclear receptors in metabolism (Paper 10). None analyze insulin exposure with kidney failure outcomes."
    },
    "overthinking_doc_ids": [
      "6158879",
      "33409100",
      "6157837",
      "6525844",
      "40790033"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.85,
      "justification": "Among the provided papers, only Paper 9 examines diabetes treatments and severe kidney failure, but the reported results focus on gliptins and glitazones (and comparisons to metformin) without presenting findings for insulin. The other papers do not address insulin\u2019s association with severe kidney failure. Therefore, there is no direct evidence in the supplied excerpts to support or refute the claim that insulin increases the risk of severe kidney failure."
    },
    "posthoc_doc_ids": [
      "1711571",
      "19804204",
      "25816994",
      "27466734",
      "44624045"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "392",
    "claim": "Ethanol stress lowers the expression of PSP in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers report how ethanol stress affects expression of the phage shock protein (Psp) system in bacteria. The only direct mention of Psp (Paper 6) shows increased PspA under TolC-related membrane stress, not ethanol stress. Papers discussing ethanol stress (Papers 3 and 7) do not address Psp expression. Therefore, there is no evidence here to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "471735",
      "6669242",
      "21602220",
      "6493422",
      "22312627"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on PSP (e.g., phage shock protein) expression under ethanol stress in bacteria. Paper 5 discusses ethanol tolerance mechanisms in E. coli but does not report PSP expression. Paper 3 mentions the Pspac promoter in Bacillus subtilis (an IPTG-inducible promoter), which is unrelated to the phage shock protein system, and does not involve ethanol stress effects on PSP. The remaining papers focus on unrelated stress responses, regulatory systems, or different organisms/cell types. Therefore, the evidence set does not address the claim."
    },
    "overthinking_doc_ids": [
      "6669242",
      "471735",
      "34386619",
      "364522",
      "1148122"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data on PSP (e.g., phage shock protein) expression under ethanol stress in bacteria. Papers 6 and 7 discuss ethanol stress/tolerance in E. coli but do not mention PSP expression. The other papers are about different stress pathways (e.g., SoxRS oxidative stress, MAPK/JNK signaling in mammalian cells, replication stress in mice) or unrelated topics. Therefore, the evidence set does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "471735",
      "1554348",
      "6669242",
      "7875158",
      "24185667"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.12,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "326",
    "claim": "Deletion of ATM and Rad3 related protein leads to acute tissue loss.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.92,
      "justification": "Paper 1 directly shows that deleting ATR (Ataxia Telangiectasia and Rad3 related protein) in adult mice causes rapid defects in tissue homeostasis and acute cellular loss in tissues requiring continuous proliferation, with associated reductions in stem/progenitor cells. This aligns with the claim of acute tissue loss. The other papers do not contradict this and are largely unrelated to ATR deletion effects on tissue loss."
    },
    "naive_doc_ids": [
      "40349336",
      "19912367",
      "20418809",
      "28530299",
      "4311206"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.95,
      "justification": "Paper 1 directly tests deletion of ATR (ATM and Rad3 related protein) in adult mice and reports that ATR deletion causes acute cellular loss in tissues requiring continuous proliferation, along with rapid tissue-degenerative phenotypes (e.g., thymic involution, alopecia, hair graying) and marked loss of tissue-specific stem/progenitor cells. This aligns with the claim that deletion of ATR leads to acute tissue loss. The other papers do not address ATR and neither contradict this finding."
    },
    "overthinking_doc_ids": [
      "40349336",
      "20418809",
      "4311206",
      "11428884",
      "6492658"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.92,
      "justification": "Paper 1 directly examines deletion of ATR (ATM and Rad3-related protein) in adult mice and reports that ATR deletion causes acute cellular loss in tissues requiring continuous proliferation, alongside rapid age-related phenotypes. This aligns with the claim that ATR deletion leads to acute tissue loss. The other papers do not address ATR deletion or acute tissue loss and are not relevant to this claim."
    },
    "posthoc_doc_ids": [
      "40349336",
      "24917562",
      "10012166",
      "22281684",
      "35760786"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "870",
    "claim": "Obesity decreases life quality.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers directly assess health-related quality of life in individuals with obesity. Paper 1 shows impaired HRQoL in binge eating disorder (a distinct diagnosis), while the others address gestational diabetes risk, ADHD association, genetics of BMI, hypertension treatment effects on QoL, and mechanistic inflammation/obesity studies. No study provides direct evidence that obesity itself decreases quality of life."
    },
    "naive_doc_ids": [
      "40666943",
      "439670",
      "1831916",
      "11532028",
      "26199970"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Evidence indicates that higher body weight is associated with poorer quality of life and that weight loss improves it. Paper 9 reports significant improvements in depressive symptoms, the physical dimension of health-related quality of life (HRQoL), and self-esteem up to 4 years after bariatric surgery, with improvements correlating with the amount of weight lost\u2014implying obesity is linked to lower HRQoL. Paper 6 shows postoperative decreases in the prevalence and severity of depression among bariatric patients, supporting improvement in a key QoL domain with weight loss. Paper 7 documents substantial improvements in obesity-related comorbidities after weight loss, which, while not direct QoL measures, are consistent with enhanced life quality. Paper 1 shows binge eating disorder impairs HRQoL; although not obesity per se, it commonly co-occurs with severe obesity and aligns with the overall pattern. Collectively, the data support the claim that obesity decreases life quality."
    },
    "overthinking_doc_ids": [
      "40666943",
      "1831916",
      "26199970",
      "439670",
      "8298120"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "None of the provided papers directly assess quality of life in relation to obesity per se. The studies address QoL in glaucoma, ischemic heart disease with health literacy, effects of angiotensin system blockade, chronic diseases in general (without specifying obesity), pulmonary hypertension with exercise, binge eating disorder (which often co-occurs with obesity but is distinct), childhood leukemia, ADHD-obesity association, and obesity pharmacotherapy focusing on weight and cardiometabolic outcomes rather than QoL. Therefore, they do not provide direct evidence that obesity decreases quality of life."
    },
    "posthoc_doc_ids": [
      "31208367",
      "17693849",
      "26199970",
      "463533",
      "2820454"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "676",
    "claim": "LRBA prevents CTLA - 4 recycling.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers discuss LRBA or its role in CTLA-4 trafficking/recycling. The only CTLA-4\u2013related paper (Paper 6) addresses human CTLA4 mutations and their immunological consequences but does not mention LRBA or CTLA-4 recycling. The other papers focus on unrelated topics (ERK inhibition, synaptic vesicle recycling, Rac endocytic trafficking, autophagy of nuclear lamina, ubiquitin-mediated degradation, immune reconstitution post-transplant, T cell trafficking via ITK, B cell trafficking, and AP-1\u2013mediated vesicle recycling). Therefore, the evidence set does not contain information to support or refute the specific claim about LRBA preventing CTLA-4 recycling."
    },
    "naive_doc_ids": [
      "4920376",
      "14893425",
      "17017465",
      "4452659",
      "6422576"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers mention LRBA or CTLA-4, nor do they address CTLA-4 trafficking or recycling. The evidence focuses on unrelated topics such as ESCRT-mediated receptor degradation, DNA sensing, developmental patterning, PAR-2 signaling, lysosomal proteases in Alzheimer\u2019s, IL-17 in SIV infection, HDAC4 in ATM deficiency, HIV prophylaxis, IL6\u2013CXCR7 in ESCC, and autophagy/Fgf21. Therefore, the claim cannot be verified or refuted from these sources."
    },
    "overthinking_doc_ids": [
      "9680193",
      "13106686",
      "1031534",
      "1044552",
      "2194320"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers address LRBA (LPS-responsive beige-like anchor), CTLA-4, or CTLA-4 recycling/trafficking. The papers cover synaptic vesicle recycling, torsinA, mitochondrial redox biology, antibiotic-induced ROS, pleiotropy in social amoebae, FGF21 and atherosclerosis, NEMO/RIPK1 in intestinal inflammation, AIRE and melanoma immunity, L-serine deaminase in E. coli, and IL-15 in obesity. Therefore, they provide no relevant evidence to verify the claim about LRBA preventing CTLA-4 recycling."
    },
    "posthoc_doc_ids": [
      "11250124",
      "14893425",
      "797114",
      "1103795",
      "2140513"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "393",
    "claim": "Ethanol stress reduces the expression of SRL in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers examine the effect of ethanol stress on SRL expression in bacteria. Paper 2 mentions ethanol stress during fermentation but does not address SRL. The other papers cover unrelated regulons/genes (e.g., soxRS, yqhC/yqhD, AraC-mediated repression, acetylation) or non-bacterial systems. Therefore, there is no direct evidence here to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "471735",
      "21602220",
      "22312627",
      "15282056",
      "25519138"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine or mention SRL expression under ethanol stress. While several papers discuss ethanol stress responses in E. coli (e.g., physiological costs, tolerance evolution), and others cover unrelated topics (e.g., soxRS oxidative stress regulon, acetylation, TolC, viral genetics, glioblastoma HOX genes), there is no direct evidence about ethanol reducing expression of an SRL locus/regulon. Therefore, the evidence set does not support or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "471735",
      "21602220",
      "1148122",
      "6669242",
      "26625002"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine the effect of ethanol stress on SRL expression in bacteria. Papers 6 and 9 address ethanol-related stress and tolerance in E. coli but do not mention SRL or its expression. The remaining papers concern unrelated systems or stress pathways (e.g., SoxRS oxidative stress, vascular biology, neuronal hypoxia, heat shock in Bacillus). Therefore, there is no relevant evidence to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "471735",
      "6212802",
      "9194077",
      "22467585",
      "38944245"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.12,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "92",
    "claim": "Aged patients are more susceptible to ischaemia/reperfusion injury.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "Among the provided papers, only Paper 2 and Paper 3 address ischemia/reperfusion injury, but neither examines age-related differences in susceptibility. The remaining papers focus on unrelated topics (e.g., homocysteine lowering in CKD, ACE inhibitor renal effects, hypertension risk, alpha-synuclein, inflammasome/ROS, Nrf2, BAT metabolism, yeast aging). No study presents data comparing aged vs. younger subjects' responses to I/R injury. Therefore, the evidence does not inform whether aged patients are more susceptible to I/R injury."
    },
    "naive_doc_ids": [
      "33409100",
      "22281684",
      "33884866",
      "6157837",
      "12206390"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers analyze or report differences in ischemia/reperfusion injury susceptibility between aged and younger subjects. They address mechanisms, specific pathways (e.g., Sfrp5, proteasomes), treatments (abciximab, fingolimod), and related complications, but do not evaluate age as a factor. Therefore, the evidence does not inform the claim about increased susceptibility in aged patients."
    },
    "overthinking_doc_ids": [
      "6580081",
      "22281684",
      "6153754",
      "21868715",
      "1759213"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.89,
      "justification": "None of the provided papers present data comparing aged versus younger subjects in the context of ischemia/reperfusion (I/R) injury or outcomes. Papers 5, 6, and 9 discuss I/R mechanisms or modifiers but not age-related susceptibility. Papers 1\u20134, 7\u20138, and 10 address other clinical topics (ICU mortality, exercise/NO in elderly, drug safety/effects, fractures, spinal cord injury mechanisms, antihypertensives, antiplatelet therapy) without linking age to I/R injury susceptibility. Therefore, the evidence set does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "20606520",
      "32322418",
      "2492146",
      "4687948",
      "6580081"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.12,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1099",
    "claim": "Statins decrease blood cholesterol.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on the effect of statins on blood cholesterol levels. Paper 8 involves statins but evaluates hip fracture risk, not cholesterol outcomes. The other papers address different interventions (antipsychotics, bariatric surgery, antidiabetic drugs, blood pressure lowering, zinc, sterol biomarkers without statins, PI3K inhibitors, miRNA regulation, and PCSK9 inhibitors). Therefore, there is no direct evidence in the provided set to confirm that statins decrease blood cholesterol."
    },
    "naive_doc_ids": [
      "5402581",
      "7098463",
      "10430148",
      "202259",
      "4515975"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "Among the provided abstracts, none report measurements of blood cholesterol changes in response to statin therapy. Paper 2 examines clinical outcomes (mortality and cardiovascular events) with statins but does not present lipid level data. Paper 8 discusses statin use and hip fracture risk without lipid outcomes. Paper 4 shows that a low-saturated fat diet lowers serum cholesterol but does not involve statins. The remaining papers are unrelated to statins\u2019 effects on blood cholesterol. Therefore, the claim is not directly supported or refuted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "5402581",
      "5698494",
      "4515975",
      "10692948",
      "10430148"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided abstracts, none present direct data showing that statins decrease blood cholesterol levels. Paper 6 reports clinical outcome benefits from statins (reduced mortality and cardiovascular events) but does not report lipid changes. Paper 1 discusses LDL as a causal factor and mentions effective means to lower LDL exist but does not explicitly state or show that statins lower cholesterol. Other papers address LDL mechanisms (Paper 2), diet-induced cholesterol changes (Paper 9), or unrelated topics. Therefore, based on the provided evidence, the claim is not directly supported or refuted."
    },
    "posthoc_doc_ids": [
      "7662206",
      "9814332",
      "1958440",
      "9617381",
      "9899292"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "887",
    "claim": "Only a minority of cells survive development after differentiation into stress-resistant spores.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "Among the provided papers, only Paper 10 discusses sporulation (in Bacillus subtilis), focusing on gene discovery and functional roles in sporulation stages. It does not report population-level outcomes such as the fraction of cells that survive after differentiating into spores. The other papers address apoptosis, oxidative stress, autophagy, HIV infection of progenitors, microglial development, cancer resistance pathways, and stem cell senescence/differentiation\u2014none involve spores or quantify survival after sporulation. Therefore, there is no direct evidence here to confirm or refute the claim about only a minority of cells surviving development after differentiation into stress-resistant spores."
    },
    "naive_doc_ids": [
      "7875158",
      "10486817",
      "22890091",
      "2543135",
      "7224723"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers present data or discussion about differentiation into stress-resistant spores or the fraction of cells that survive such development. The only paper on Myxococcus xanthus addresses cooperative swarming, not sporulation or survival proportions. The remaining papers concern immune regulation, chromatin complexes, oxidative stress, drug side effects, cancer resistance, and stress physiology, none of which are relevant to spore formation or survival fractions."
    },
    "overthinking_doc_ids": [
      "4321295",
      "15635366",
      "10190778",
      "38502066",
      "279052"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address differentiation into stress\u2011resistant spores or the fraction of cells that survive development as spores. The studies focus on mammalian stem cell differentiation, microglia origin, stress responses, MAPK signaling, genomic imprinting, ILCs, and Myxococcus swarming behavior without discussing sporulation or survival proportions. Therefore, there is no relevant evidence to verify the claim."
    },
    "posthoc_doc_ids": [
      "1595617",
      "5085118",
      "17991818",
      "5633876",
      "16630060"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1111",
    "claim": "Sudden death can occur in patients with complex ventricular arrhythmias.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address complex ventricular arrhythmias or evaluate sudden death in patients with such arrhythmias. The studies focus on topics like alcohol drinking patterns, sudden infant death, biomarkers in chronic heart failure, ambient temperature and mortality, homocysteine and vascular events, vegetarian diet and ischemic heart disease, diabetes in unstable angina, and troponin-guided therapy in acute coronary syndromes. Therefore, they do not provide evidence to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "5939172",
      "21050357",
      "2613775",
      "4445629",
      "4810810"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers address sudden death in patients with complex ventricular arrhythmias. The articles focus on SIDS/SUID definitions and research priorities, predictors of cardiac death such as QT/QTc dispersion in diabetes, mortality with atypical antipsychotics in dementia, and various myocardial infarction and cardiac remodeling/regeneration topics. While Paper 4 links QT metrics to cardiac death risk, it does not specifically examine complex ventricular arrhythmias or sudden death attributable to them. Therefore, the supplied evidence does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "2613775",
      "21050357",
      "23117378",
      "43483151",
      "5402581"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate sudden death specifically in patients with complex ventricular arrhythmias. The studies focus on heart failure in congenital heart disease, sudden infant death syndrome, cardiac amyloidosis prognosis, research priorities for SUID, SIDS definitions, morphology of sudden coronary death, QT dispersion predicting cardiac death in diabetes, and antipsychotic-associated mortality. These do not present data linking complex ventricular arrhythmias in patients to sudden death."
    },
    "posthoc_doc_ids": [
      "24408040",
      "2613775",
      "13768432",
      "21050357",
      "23117378"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1014",
    "claim": "Rapamycin decreases the concentration of triacylglycerols in fruit flies.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the provided papers, only Paper 1 examines rapamycin in Drosophila, but it reports lifespan extension and stress resistance without presenting data on triacylglycerol levels. Paper 6 discusses triglyceride/lipid droplet regulation in Drosophila via the COPI complex, not rapamycin. The remaining papers are unrelated to rapamycin effects on triglycerides in fruit flies. Therefore, the supplied evidence does not address whether rapamycin decreases triacylglycerols in Drosophila."
    },
    "naive_doc_ids": [
      "6277638",
      "8646760",
      "25813706",
      "1286352",
      "13936152"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers report measurements of triacylglycerol (TAG) levels in Drosophila in response to rapamycin. Paper 1 examines rapamycin\u2019s lifespan effects and mechanisms in fruit flies but does not mention TAGs. The remaining papers concern other species, topics, or methods unrelated to TAG concentrations in Drosophila. Therefore, the evidence does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "6277638",
      "116792",
      "735130",
      "1227277",
      "1286352"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 1 examines rapamycin in Drosophila, but it discusses lifespan extension, stress resistance, and TORC1/autophagy/translation changes without reporting triacylglycerol levels. The remaining papers are unrelated to rapamycin\u2019s effects on lipid (triacylglycerol) concentrations in fruit flies. Therefore, there is no direct evidence here to confirm or refute the claim that rapamycin decreases triacylglycerols in Drosophila."
    },
    "posthoc_doc_ids": [
      "6277638",
      "8646760",
      "25813706",
      "1286352",
      "13936152"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "690",
    "claim": "Less than 10% of the gabonese children with Schimmelpenning-Feuerstein-Mims syndrome (SFM) had a plasma lactate of more than 5mmol/L.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers report data on Gabonese children with Schimmelpenning-Feuerstein-Mims syndrome or the proportion with plasma lactate >5 mmol/L. Some papers discuss lactic acidosis thresholds (>5 mmol/L) in metformin-treated patients, but they are unrelated to the specified population and condition."
    },
    "naive_doc_ids": [
      "13580614",
      "18218379",
      "25643818",
      "32587939",
      "23908217"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers address Schimmelpenning-Feuerstein-Mims syndrome, Gabonese children, or plasma lactate levels >5 mmol/L. The articles cover topics such as Down syndrome hematopoiesis, cardiac progenitor cells in HLHS, MOG antibodies in pediatric demyelination, growth hormone therapy, infant sleep cardiorespiratory control, bacteriuria screening, healthcare cost models, SIDS and bed sharing, psychiatric manifestations of mitochondrial disorders, and paraquat ingestion. Therefore, they provide no relevant data to verify or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "1145473",
      "9622258",
      "16737163",
      "21870716",
      "35521287"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers discuss Schimmelpenning-Feuerstein-Mims (SFM) syndrome or Gabonese children. While several papers address malaria (including lactate correlations) and other unrelated conditions (e.g., diabetes, Down syndrome, hypoplastic left heart syndrome), there is no data about plasma lactate levels in Gabonese children with SFM or proportions with lactate >5 mmol/L."
    },
    "posthoc_doc_ids": [
      "32587939",
      "1145473",
      "6000423",
      "9622258",
      "10692948"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "205",
    "claim": "CDK6 shows improved binding to loss-of-function variants of p18 INK4C.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers address CDK6, p18 INK4C (CDKN2C), or their binding interactions. The studies focus on unrelated receptors, enzymes, mutations, signaling pathways, and cancer biology topics (e.g., GLP-1R SNPs, INPP4A, mutant p53, Omi/HtrA2\u2013OPA1, TRPML1, PPM1D, TAMs in thyroid cancer, BCL9, ERK inhibition, HOX locus changes). Therefore, there is no relevant information to confirm or refute the claim about CDK6 binding to loss-of-function variants of p18 INK4C."
    },
    "naive_doc_ids": [
      "3127341",
      "6492658",
      "35684881",
      "10698739",
      "21114100"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers discuss CDK6, p18 INK4C (CDKN2C), or their binding interactions, nor do they address how loss-of-function variants of p18 affect binding to CDK6. The topics span bacterial two-component systems, dynein-microtubule interactions, KRAS inhibitors, integrin-collagen binding, HIF-1alpha\u2013p53 interactions, GLP-1 receptor polymorphisms, ZFP57 DNA binding, HCV immune escape, CTLA4 mutations, and PPM1D in gliomas\u2014none relevant to the specific claim."
    },
    "overthinking_doc_ids": [
      "1225513",
      "1546650",
      "4396105",
      "8219248",
      "10247314"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers address CDK6, p18 INK4C (CDKN2C), or their binding interactions. The evidence spans topics such as GLP-1R allosteric rescue, fungal virulence genes, T cell receptor binding strength, CuZnSOD and muscle function, mutant p53 gain-of-function, bacterial two-component systems, PRDM1 variants, TOLLIP variants in sepsis, ADAMTS7 in PAD, and GATA-Sp1 regulation. There is no data about CDK6 binding to p18 INK4C loss-of-function variants."
    },
    "posthoc_doc_ids": [
      "3127341",
      "7717468",
      "22874817",
      "25827024",
      "35684881"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "494",
    "claim": "HSCT-T dosage may not be diagnostic if the onset of symptoms occurs less than 3 hours before AMI.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.88,
      "justification": "Paper 1 directly evaluates high-sensitivity cardiac troponin T (hs-cTnT) for diagnosing AMI at presentation and concludes that a single baseline hs-cTnT measurement 'may not be appropriate for patients who present less than three hours after symptom onset.' This aligns with the claim that hs-cTnT levels may not be diagnostic when symptoms began <3 hours prior. The other papers do not address timing-dependent diagnostic performance of hs-cTnT."
    },
    "naive_doc_ids": [
      "34873974",
      "32159283",
      "44384384",
      "1905095",
      "29526125"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 (systematic review/meta-analysis of the Elecsys high-sensitivity troponin T assay) explicitly states that a single baseline hs-cTnT measurement to diagnose acute myocardial infarction may not be appropriate for patients who present less than three hours after symptom onset. This aligns with the claim that hs-cTnT dosage may not be diagnostic in very early presenters. The other papers are unrelated to hs-cTnT or AMI diagnosis."
    },
    "overthinking_doc_ids": [
      "34873974",
      "313394",
      "3444507",
      "3790895",
      "5151024"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 (systematic review/meta-analysis of hs-cTnT) explicitly concludes that a single baseline hs-cTnT measurement may not be appropriate for patients presenting less than three hours after symptom onset, due to reduced diagnostic accuracy at very early presentation. This directly supports the claim that hs-cTnT may not be diagnostic within <3 hours of AMI symptom onset. The other papers do not address this timing issue."
    },
    "posthoc_doc_ids": [
      "34873974",
      "29526125",
      "34054472",
      "1905095",
      "3984231"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1100",
    "claim": "Statins increase blood cholesterol.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "Among the provided papers, only Paper 2 involves statins, but it evaluates hip fracture risk and does not report effects on blood cholesterol. The other papers focus on diets, vitamins, zinc, PCSK9 inhibitors, nuclear receptors, immune modulators, or fibrates, none of which provide data on how statins affect blood cholesterol. Therefore, the evidence set does not contain relevant results to confirm or refute the claim that statins increase blood cholesterol."
    },
    "naive_doc_ids": [
      "10692948",
      "4687948",
      "11705328",
      "12009265",
      "4515975"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, those mentioning statins address cardiovascular outcomes (mortality and major events) and anti-inflammatory effects or in vitro anti-tumor effects, but none report data on changes in blood cholesterol levels with statin use. Therefore, the evidence given does not confirm or refute the claim that statins increase blood cholesterol."
    },
    "overthinking_doc_ids": [
      "5402581",
      "5698494",
      "12409683",
      "26199970",
      "4515975"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.78,
      "justification": "Paper 1 frames LDL cholesterol as the causative agent in coronary heart disease and emphasizes that lowering LDL should be the primary goal, with effective means currently available; given the paper\u2019s focus on statins, this indicates statins are used to lower LDL, not increase it. Paper 6 evaluates statins for primary prevention of cardiovascular disease and finds them beneficial and cost-effective, which is consistent with cholesterol-lowering effects rather than increases. No provided paper reports that statins increase blood cholesterol."
    },
    "posthoc_doc_ids": [
      "7662206",
      "169264",
      "7757997",
      "8137081",
      "9171913"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1395",
    "claim": "p16INK4A accumulation is  linked to an abnormal wound response caused by the microinvasive step of advanced Oral Potentially Malignant Lesions (OPMLs).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers directly link p16INK4A accumulation to an abnormal wound response specifically triggered by the microinvasive step of advanced oral potentially malignant lesions (OPMLs). Paper 7 mentions p16INK4A upregulation in fibroblast senescence, and Paper 2 discusses MAPK waves in epithelial wound healing (in kidney cells), but neither connects p16 to wound response in OPML microinvasion. Other papers focus on keratin changes, stromal/immune effects, EMT, or invasion in oral cancer without addressing p16INK4A or OPML microinvasion-related wound responses."
    },
    "naive_doc_ids": [
      "21063817",
      "6308416",
      "11721286",
      "1192458",
      "16532419"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address p16INK4A (CDKN2A) accumulation or link it to abnormal wound responses during the microinvasive step of advanced oral potentially malignant lesions. Papers 3 and 7 discuss keratin subtype expression in oral neoplasms; Papers 6 and 9 discuss wound healing mechanisms in general (MAPK waves, TG2) without reference to p16 or OPML microinvasion. The remaining papers cover unrelated topics (dietary fibers, vitamin D, LXR in immunity, microRNAs, HIV prophylaxis). Therefore, the evidence does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "1365188",
      "4483571",
      "9095394",
      "9784254",
      "12014458"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address p16INK4A accumulation, oral potentially malignant lesions (OPMLs), microinvasion, or an abnormal wound response linked to these factors. The studies cover unrelated topics (e.g., clinical trials of anticancer drugs, vitamin D metabolism, glycation end-products, wound healing enzymes like TG2, epithelial wound-healing dynamics, and metabolic effects of oligofructose). Therefore, there is no relevant evidence in the supplied papers to support or refute the specific claim."
    },
    "posthoc_doc_ids": [
      "5492542",
      "14626540",
      "3471191",
      "4483571",
      "4627816"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "896",
    "claim": "Overexpressing Cnp1 N-tail variants exacerbates the temperature-sensitive growth defect of scm3-139.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Papers 6 and 7 relate to fission yeast CENP-A (Cnp1) and its chaperone Scm3/HJURP, discussing their roles in centromere assembly and recruitment. However, none of the papers present data on overexpressing Cnp1 N-terminal tail variants or their genetic interaction with the temperature-sensitive scm3-139 allele. The remaining papers are unrelated to this specific claim. Therefore, the evidence set does not address whether Cnp1 N-tail overexpression exacerbates the scm3-139 temperature-sensitive growth defect."
    },
    "naive_doc_ids": [
      "36111909",
      "6766459",
      "12922760",
      "24307695",
      "20183360"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers present data about overexpressing Cnp1 N-tail variants or their effects on the temperature-sensitive growth defect of the scm3-139 allele. Paper 2 discusses Scm3 in fission yeast and its relationship with CENP-A(Cnp1) but does not mention scm3-139, Cnp1 N-tail variants, or temperature-sensitive growth phenotypes. The other papers are unrelated to Cnp1/Scm3 genetics."
    },
    "overthinking_doc_ids": [
      "6766459",
      "14338915",
      "980008",
      "2389574",
      "3078080"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 8 discusses Scm3 and CENP-A (Cnp1) in fission yeast, but it does not mention the scm3-139 temperature-sensitive allele, Cnp1 N-tail variants, or effects of overexpressing such variants on growth. The other papers address unrelated topics (fever miRNAs, fungal virulence, EGFR/PI3K signaling, cold-induced atherosclerosis, keratin/mTOR signaling, A20 in glioma, CTCF at H19/Igf2, condensin, and yeast aging). Therefore, there is no evidence here to confirm or refute the specific claim."
    },
    "posthoc_doc_ids": [
      "6766459",
      "7717468",
      "34016944",
      "970012",
      "4362729"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "587",
    "claim": "In transgenic mice harboring green florescent protein under the control of the Sox2 promoter, less than ten percent of the cells with green florescent colocalize with cell proliferation markers.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 1 directly studies Sox2-GFP transgenic mice in the adult hippocampal SGZ, noting that Sox2-GFP cells comprise two populations with different proliferation levels. However, the excerpt does not report quantitative co-localization with proliferation markers (e.g., Ki67, BrdU) or specify that it is less than 10%. The remaining papers do not address Sox2-GFP mice or provide relevant quantification. Therefore, the specific claim (<10% co-localization) is not supported or refuted by the provided evidence."
    },
    "naive_doc_ids": [
      "16999023",
      "23052989",
      "1630949",
      "23535770",
      "8318286"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Only Paper 3 discusses Sox2-GFP transgenic mice in the adult hippocampus, noting that Sox2-GFP cells comprise populations with differing proliferation levels. However, the provided excerpt does not report quantitative data on the fraction of GFP+ cells that co-localize with proliferation markers (e.g., Ki67, BrdU). None of the other papers address Sox2-GFP mice or provide relevant colocalization percentages. Therefore, the specific claim that fewer than 10% of GFP+ cells co-localize with proliferation markers is not verifiable from the supplied evidence."
    },
    "overthinking_doc_ids": [
      "30297355",
      "5395426",
      "16999023",
      "28441310",
      "36708463"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.76,
      "justification": "Only Paper 5 discusses Sox2-GFP transgenic mice in the adult hippocampus, noting that Sox2-GFP cells include populations with differing proliferation levels. However, the provided excerpt contains no quantitative data on the percentage of Sox2-GFP cells that co-localize with proliferation markers (e.g., Ki67, BrdU). The other papers are unrelated to Sox2-driven GFP or do not address proliferation colocalization. Therefore, the claim that less than 10% of GFP+ cells co-localize with proliferation markers is not supported or refuted by the given text."
    },
    "posthoc_doc_ids": [
      "5687200",
      "23124332",
      "28441310",
      "8133180",
      "16999023"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "139",
    "claim": "At least 85% of patients exposed to radiation have activated markers of myofibroblasts.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers report data on patients exposed to radiation or the proportion of such patients exhibiting activated myofibroblast markers. The studies address other contexts (e.g., cytokine-induced ET-1 in VSMCs, hiPSC to SMC differentiation, COPD airway inflammation, chromosome segregation, hepatitis C treatment, monocyte/macrophage roles in lung fibrosis, endothelial-myofibroblast transition in diabetic nephropathy, cancer exosome-induced myofibroblast differentiation, vascular injury responses, and mechanotransduction in skin fibrosis). Therefore, there is no evidence here to confirm or refute the specific claim about \u226585% of radiation-exposed patients."
    },
    "naive_doc_ids": [
      "6397191",
      "11840194",
      "6417632",
      "25041967",
      "26124606"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers assess patients exposed to radiation or report prevalence of activated myofibroblast markers in such patients. The closest mentions of myofibroblasts relate to diabetic renal fibrosis in mice and liver fibrosis/reprogramming in mice, not radiation exposure or human patient prevalence. Therefore, the evidence set does not address the claim."
    },
    "overthinking_doc_ids": [
      "1044552",
      "6397191",
      "11840194",
      "9164724",
      "26124606"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers report data on the proportion of patients exposed to radiation who exhibit activated myofibroblast markers. The only radiation-related studies involve mice (senescence markers, not myofibroblasts) or cell models (CHO cells), and the myofibroblast-related evidence pertains to diabetic mouse kidneys, not radiation exposure in patients. No paper provides an 85% figure or comparable statistic linking radiation exposure in patients to myofibroblast activation."
    },
    "posthoc_doc_ids": [
      "6417632",
      "2260571",
      "6397191",
      "11840194",
      "24640046"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "774",
    "claim": "Mice defective for deoxyribonucleic acid (DNA) polymerase I (polI) fail to reveal increased sensitivity to ionizing radiation (IR).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine mice defective for DNA polymerase I (Pol I) or their sensitivity to ionizing radiation. The only related study (Paper 1) concerns DNA polymerase beta (Pol \u03b2) overexpression in CHO cells, not Pol I deficiency in mice. Other papers address different genes, pathways, or phenotypes unrelated to Pol I and IR sensitivity."
    },
    "naive_doc_ids": [
      "11569583",
      "31293581",
      "52805891",
      "5572127",
      "10017612"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine mice defective for DNA polymerase I (Pol I) and their response to ionizing radiation. The closest related items are: (1) overexpression (not deficiency) of DNA polymerase \u03b2 in CHO cells increasing IR sensitivity (Paper 1), and (2) polymerase \u03b7-deficient mice showing UV (not IR) sensitivity and carcinogenesis (Paper 9). Other papers address IR effects without polymerase I/\u03b2 deficiency, or non-IR contexts. Therefore, there is no relevant evidence to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "11569583",
      "31293581",
      "52805891",
      "5572127",
      "10017612"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers investigate mice defective for DNA polymerase I (polI) or their sensitivity to ionizing radiation. Relevant polymerase studies address Pol \u03b2 (in CHO cells) and Pol \u03bb (in mammalian cells), not polI in mice. Therefore, the evidence set does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "31293581",
      "52805891",
      "5572127",
      "10017612",
      "11569583"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "312",
    "claim": "De novo assembly of sequence data has more specific contigs than unassembled sequence data.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers directly compare the specificity of contigs from de novo assemblies to unassembled reads. Paper 1 discusses how GC bias affects assembly completeness and accuracy but not specificity relative to unassembled data. Paper 8 demonstrates that de novo assembly can recover a draft genome in a metagenomic outbreak investigation but does not compare specificity of assembled contigs versus raw reads. The remaining papers address alignment, variant calling, phasing, or unrelated biological topics, and do not bear on the claim. Therefore, there is no direct evidence here to confirm or refute that de novo assembly yields more specific contigs than unassembled sequence data."
    },
    "naive_doc_ids": [
      "14464451",
      "15153602",
      "13914198",
      "1544804",
      "3662132"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, those relevant to sequencing and assembly (e.g., on BWA alignment, FreeBayes variant detection, GC bias effects on de novo assembly, Cufflinks, and Trinity) discuss methods, performance, and factors affecting assembly completeness/accuracy. However, none present data comparing the specificity of contigs produced by de novo assembly versus unassembled sequence data (raw reads). Therefore, the evidence does not address the specific claim that de novo assembly yields more specific contigs than unassembled sequence data."
    },
    "overthinking_doc_ids": [
      "11419230",
      "15153602",
      "3662132",
      "600808",
      "1191830"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "Among the provided papers, only Paper 1 (GC bias effects on de novo genome assembly) and Paper 3 (Trinity de novo transcriptome assembly) address de novo assembly, discussing completeness, fragmentation, and transcript recovery. Neither compares the specificity of assembled contigs to unassembled reads, and the notion of 'specific contigs' versus 'unassembled sequence data' is not evaluated. The remaining papers are unrelated to sequence assembly. Therefore, the evidence does not support or refute the specific claim."
    },
    "posthoc_doc_ids": [
      "14464451",
      "143251",
      "32770503",
      "2576811",
      "25041967"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "422",
    "claim": "Flexible molecules experience less steric hindrance in the tumor microenviroment than rigid molecules.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers assess or compare how molecular flexibility versus rigidity affects steric hindrance in the tumor microenvironment. The evidence discusses ECM remodeling, acidic pH signaling, CAF roles, stromal barriers (e.g., hyaluronan) to perfusion/diffusion, nanoparticle size\u2013dependent lymphatic transport, and transporters, but does not present data on flexibility vs. rigidity influencing steric hindrance."
    },
    "naive_doc_ids": [
      "4164929",
      "4583180",
      "27550580",
      "44640124",
      "952111"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers examine or compare steric hindrance experienced by flexible versus rigid molecules in the tumor microenvironment. The studies focus on ECM remodeling, acidic pH effects on SREBP2, fibroblast/MMP genotypes, integrin redox regulation, invadopodia dynamics, cancer-associated fibroblasts, matrix stiffness effects on drug response, thymic microenvironment development, nanoparticle vaccine adjuvancy, and macrophage roles. These do not provide data on molecular flexibility or steric hindrance in tumors."
    },
    "overthinking_doc_ids": [
      "4164929",
      "4583180",
      "13007205",
      "44640124",
      "6969753"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine or compare steric hindrance experienced by flexible versus rigid molecules in the tumor microenvironment. The articles focus on CAF biology, immune signaling, circulating tumor cells, stromal-epithelial metabolic coupling, tumor dormancy, skeletal muscle ECM, acidic pH effects on SREBP2, MMP genotypes in fibroblasts, redox regulation of integrins, and invadopodia dynamics. They do not provide data on molecular flexibility, steric effects, or penetration/transport differences between flexible and rigid molecules in tumors."
    },
    "posthoc_doc_ids": [
      "952111",
      "2734421",
      "21033230",
      "27647593",
      "30919024"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "91",
    "claim": "Aged patients are less susceptible to ischaemia/reperfusion injury.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers assess age-related differences in susceptibility to ischemia/reperfusion injury. While several studies address I/R mechanisms or interventions (e.g., proteasome activity in cold ischemia, Sfrp5 effects, hepatic I/R mechanisms, fingolimod neuroprotection), they do not compare aged versus younger patients/animals or evaluate age as a modifier of I/R injury."
    },
    "naive_doc_ids": [
      "17897801",
      "21868715",
      "22281684",
      "6580081",
      "6158879"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate age-related susceptibility to ischemia/reperfusion injury. The studies focus on molecular mediators (e.g., Sfrp5, TLR4), therapeutic agents (fingolimod), diagnostic assays (high-sensitivity troponin), pharmacologic safety (aliskiren combinations), genetics of atrial fibrillation, and unrelated clinical topics (smoking cessation in lung cancer, antiplatelet switching). No included evidence compares aged versus younger subjects/patients in the context of ischemia/reperfusion injury."
    },
    "overthinking_doc_ids": [
      "22281684",
      "6580081",
      "1759213",
      "33884866",
      "2481032"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers evaluate age-related susceptibility to ischemia/reperfusion (I/R) injury. The closest items address sex differences in acute coronary syndromes (Paper 1), molecular mediators of cardiac or hepatic I/R injury without age comparisons (Papers 2 and 6), and various unrelated topics (infection outcomes by gender, chemotherapy in elderly, statins and fractures, etc.). No study presents data comparing I/R injury severity or outcomes between aged and younger patients or animals."
    },
    "posthoc_doc_ids": [
      "29253460",
      "22281684",
      "14724693",
      "2488880",
      "2492146"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "527",
    "claim": "Homozygous deletion of murine Sbds gene from osterix-expressing mesenchymal stem and progenitor cells (MPCs) prevents oxidative stress.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.76,
      "justification": "Paper 1 reports that mesenchymal perturbation in a Shwachman-Diamond syndrome (SBDS-deficient) mouse model induces mitochondrial dysfunction and oxidative stress in hematopoietic stem/progenitor cells, indicating SBDS loss promotes\u2014not prevents\u2014oxidative stress. Paper 3 shows that deleting Sbds in mouse osteoprogenitors (osterix-lineage) causes bone marrow dysfunction and myelodysplasia; it does not indicate oxidative stress prevention. The other papers do not address Sbds in osterix-expressing mesenchymal cells. Therefore, the claim that homozygous Sbds deletion in these cells prevents oxidative stress is contradicted by available evidence."
    },
    "naive_doc_ids": [
      "3863543",
      "14972169",
      "1617327",
      "12240507",
      "39164524"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 1 reports that perturbation of mesenchymal cells in a Shwachman-Diamond syndrome (SDS) mouse model\u2014an SDS phenotype caused by Sbds deficiency\u2014induces mitochondrial dysfunction and oxidative stress in hematopoietic stem and progenitor cells. This indicates mesenchymal Sbds-related dysfunction drives, rather than prevents, oxidative stress. Paper 5 shows that deleting Sbds in osteoprogenitors (likely osterix-expressing cells) causes bone marrow dysfunction and myelodysplasia, but does not report any prevention of oxidative stress. The other papers are unrelated to Sbds in mesenchymal/osterix+ cells. Together, the evidence does not support the claim and, where relevant, suggests the opposite."
    },
    "overthinking_doc_ids": [
      "3863543",
      "14972169",
      "39164524",
      "471735",
      "1617327"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Paper 1 (SDS mouse model) shows that perturbation of mesenchymal cells associated with Sbds deficiency induces mitochondrial dysfunction and oxidative stress in hematopoietic stem/progenitor cells via a p53\u2013S100A8/9\u2013TLR inflammatory axis. This indicates mesenchymal Sbds loss drives, rather than prevents, oxidative stress. The other papers do not address Sbds deletion in osterix-expressing MPCs."
    },
    "posthoc_doc_ids": [
      "3863543",
      "7506409",
      "17682477",
      "4427392",
      "8790729"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "45",
    "claim": "A mutation in HNF4A leads to an increased risk of diabetes by the age of 14 years.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers discuss HNF4A or its mutations, nor do they address diabetes risk by age 14. The papers cover topics such as CABG outcomes in diabetes, diabetic complications, GLP-1R polymorphisms, MECP2/Rett syndrome, EGFR resistance in lung cancer, cardiovascular risk factors, metabolic syndrome, childhood risk factors for atherosclerosis, homocysteine and vascular events, and LXR/ABCA1 in cholesterol efflux. These are not relevant to HNF4A-related diabetes risk."
    },
    "naive_doc_ids": [
      "750781",
      "2138843",
      "3127341",
      "8698208",
      "9505402"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers discuss HNF4A (hepatocyte nuclear factor 4 alpha), its mutations, or age-specific diabetes risk related to HNF4A. The papers cover cancer-related inflammation, cell division in C. elegans, aging biomarkers, cytokines in depression, circulating tumor cells, hypoglycemia awareness in type 1 diabetes, dietary assessment, T-cell responses in type 1 diabetes, tamoxifen duration, and alternative glycemic markers. There is no evidence here addressing the claim about HNF4A mutations increasing diabetes risk by age 14."
    },
    "overthinking_doc_ids": [
      "4429118",
      "6333347",
      "7834603",
      "10029891",
      "21033230"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 6 mentions HNF4A mutations, focusing on macrosomia and neonatal hyperinsulinaemic hypoglycaemia, and a mouse model assessing fetal/neonatal insulin secretion. It does not report age-specific diabetes risk or penetrance by age 14. The other papers address unrelated topics (e.g., BMI and gestational diabetes, bone density in T2DM, CVD risk factors, pioglitazone and cancer, sleep and glucose metabolism, global disease burden, Alzheimer pathology, NF-\u03baB, dietary assessment). Therefore, the supplied evidence does not confirm or refute the specific claim about increased diabetes risk by age 14 in HNF4A mutation carriers."
    },
    "posthoc_doc_ids": [
      "439670",
      "1711571",
      "2138767",
      "3355397",
      "8868863"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "449",
    "claim": "Gastric lavage is an effective treatment for acute paraquat poisoning.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.78,
      "justification": "The most directly relevant evidence (Paper 3) compared paraquat-poisoned patients treated with only gastric lavage and symptomatic care versus those receiving hemoperfusion. Mortality was far higher in the gastric lavage group (92.1%) than in the hemoperfusion group (42.9%), indicating gastric lavage alone was not effective. A single case report (Paper 4) describes survival with early digestive decontamination plus hemodialysis and antioxidants, but cannot attribute benefit specifically to gastric lavage. Other papers either address different toxins (Paper 1) or different therapies (Papers 5, 10) and do not provide supportive evidence for lavage. Overall, the available evidence contradicts the claim that gastric lavage is an effective treatment for acute paraquat poisoning."
    },
    "naive_doc_ids": [
      "8447873",
      "22547508",
      "33203108",
      "40005757",
      "24097933"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "The only directly relevant comparative data (Paper 3) shows markedly higher mortality in paraquat-poisoned patients treated with only gastric lavage and supportive care (92.1%) compared with those receiving hemoperfusion (42.9%), indicating that gastric lavage alone is not an effective therapy. A single case report (Paper 9) mentions early digestive decontamination as part of a multimodal regimen in a survivor but does not isolate gastric lavage or establish its efficacy. Other papers either address different toxins (Paper 1 on organophosphorus pesticides) or focus on extracorporeal treatments/predictors and do not support gastric lavage effectiveness in paraquat poisoning. Overall, the evidence provided opposes the claim."
    },
    "overthinking_doc_ids": [
      "8447873",
      "22547508",
      "33203108",
      "3430789",
      "24097933"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Paper 2 (paraquat-specific) reports markedly higher mortality in patients who received only gastric lavage with symptomatic care compared to those receiving haemoperfusion (92.1% vs 42.9%), suggesting gastric lavage alone is not effective therapy for acute paraquat poisoning. No provided study demonstrates a clinical benefit of gastric lavage in paraquat poisoning. While Paper 1 addresses gastric lavage in organophosphorus pesticide poisoning (not paraquat), it also finds no high-quality evidence supporting effectiveness, further weakening the claim. Other paraquat papers focus on hemoperfusion/CVVH and do not support gastric lavage efficacy. Overall, the evidence refutes the claim that gastric lavage is an effective treatment for acute paraquat poisoning."
    },
    "posthoc_doc_ids": [
      "8447873",
      "33203108",
      "3430789",
      "22547508",
      "24097933"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "704",
    "claim": "Long - range chromatin interactions regulate transcription.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.92,
      "justification": "Multiple papers provide direct experimental evidence that long-range chromatin interactions regulate transcription. Paper 1 (Pol II ChIA-PET) maps widespread promoter-promoter and enhancer-promoter interactions and shows that genes engaged in these interactions are active, transcribed cooperatively, and exhibit cell-specific expression patterns linked to cell-specific chromatin contacts. Paper 2 (3C at the H19/Igf2 locus) demonstrates that CTCF-dependent looping on the maternal allele blocks distal enhancer access to Igf2, leading to its silencing, while paternal contacts permit activation; mutating CTCF sites disrupts this regulation. Paper 6 shows that the H19 ICR has methylation-sensitive, CTCF-mediated enhancer-blocking activity that determines Igf2 expression, a classic example of long-range regulatory control. Additional architectural context from Paper 4 supports a pervasive framework of CTCF/cohesin-mediated interactions within topological domains. Together, these findings confirm that long-range chromatin interactions can and do regulate transcription."
    },
    "naive_doc_ids": [
      "18276599",
      "140874",
      "4462139",
      "8494570",
      "3462075"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 3 directly shows that RNA polymerase II\u2013associated long-range, promoter-centered chromatin interactions correlate with active transcription, that interacting promoters can influence each other, and that cell-specific interaction patterns align with cell-specific transcription, indicating regulatory roles for long-range contacts. Paper 7 provides functional evidence: disrupting CTCF\u2013cohesin interactions (key mediators of chromatin looping/insulation) alters expression of the imprinted IGF2-H19 locus, demonstrating that long-range chromatin architecture modulates transcription. Paper 6 further links widespread CTCF/cohesin-mediated interactions within topological domains to genome organization underlying transcriptional regulation. Paper 8 reviews mechanistic models for CTCF/cohesin in genome folding and transcriptional control. Together, these support the claim that long-range chromatin interactions regulate transcription."
    },
    "overthinking_doc_ids": [
      "6455142",
      "9301606",
      "18276599",
      "27822315",
      "30933307"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Paper 1 (ChIA-PET in human cells) maps widespread long-range promoter-promoter and enhancer-promoter interactions associated with RNA polymerase II and shows that genes engaged in these interactions are generally active, can influence each other, and that cell-specific interactions provide structural frameworks for cell-specific transcription. Paper 6 demonstrates that distal p53-bound enhancers physically interact with multiple genes to mediate long-distance p53-dependent transcriptional regulation and that eRNAs from these enhancers are required for efficient transcriptional enhancement. These provide direct experimental evidence that long-range chromatin interactions regulate transcription. Other papers are less directly relevant to long-range interactions."
    },
    "posthoc_doc_ids": [
      "18276599",
      "40447899",
      "4305576",
      "4418582",
      "5519177"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1282",
    "claim": "Therapeutic use of the drug Dapsone to treat pyoderma gangrenous is based on anecdotal evidence.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers address dapsone or the treatment of pyoderma gangrenosum. The studies cover unrelated topics (e.g., cord blood and erythropoietin for cerebral palsy, antihypertensives and renal outcomes, asthma therapies, sildenafil for antidepressant-associated sexual dysfunction, acetylcysteine for contrast nephropathy, glaucoma prevalence, prenatal factors and breast cancer risk, blood pressure lowering in dialysis, sugar-sweetened beverages and weight gain, and antiretroviral therapy and tuberculosis). Therefore, they provide no evidence to confirm or refute the claim about dapsone\u2019s evidence base in pyoderma gangrenosum."
    },
    "naive_doc_ids": [
      "23073816",
      "25816994",
      "602760",
      "39281140",
      "4678846"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Paper 1 reports dapsone as an effective therapy for peristomal pyoderma gangrenosum within a small retrospective case series of 7 patients, alongside several other treatments. This constitutes low-level, non-randomized evidence consistent with anecdotal/case-series support rather than robust controlled trials. The other papers are unrelated to dapsone or pyoderma gangrenosum and provide no contrary evidence."
    },
    "overthinking_doc_ids": [
      "23649163",
      "26000593",
      "4886637",
      "14584755",
      "14831629"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "Paper 1 reports a small retrospective case series (n=7) of peristomal pyoderma gangrenosum in which oral dapsone was listed among effective therapies. This constitutes low-level, uncontrolled evidence (case series/anecdotal experience) rather than rigorous controlled trials. The remaining papers do not address dapsone or pyoderma gangrenosum. Therefore, the provided evidence aligns with the claim that therapeutic use of dapsone for pyoderma gangrenosum is based on anecdotal/low-level evidence."
    },
    "posthoc_doc_ids": [
      "23649163",
      "26150367",
      "2052720",
      "12869200",
      "15663829"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "26",
    "claim": "A 100g dose of chloroquine chemoprophylactic regimen results in retinal toxicity after 1 year of weekly intake.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate retinal toxicity from chloroquine, cumulative dosing thresholds, or outcomes after 1 year of weekly chloroquine chemoprophylaxis. Paper 1 reports general self-reported side effects with chloroquine-based prophylaxis but does not mention retinal toxicity. Papers 2 and 4 focus on tafenoquine vs mefloquine, not chloroquine. Paper 7 describes retinopathy due to severe malaria itself, not drug-induced toxicity. The remaining papers are unrelated to chloroquine retinopathy. Therefore, the evidence set does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "38410121",
      "8756719",
      "8593263",
      "17925632",
      "20999249"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers present data on chloroquine chemoprophylaxis dosing or retinal toxicity. Only Paper 3 mentions chloroquine, focusing on parasite resistance mechanisms, not human dosing or ocular adverse effects. The other papers address unrelated topics (radioiodine therapy, 6-mercaptopurine in ALL, physical activity, nanoparticle adjuvants, HIV PrEP, alendronate dosing, tafenoquine/mefloquine prophylaxis, RA criteria). Therefore, the evidence set does not inform the claim about retinal toxicity after 1 year of weekly chloroquine intake totaling 100 g."
    },
    "overthinking_doc_ids": [
      "37912677",
      "1373287",
      "4336849",
      "6647414",
      "8182950"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers evaluate retinal toxicity from chloroquine, cumulative dosing of ~100 g, or 1-year weekly chemoprophylaxis. The only chloroquine-related paper (Paper 7) reports self-reported side effects in travelers and focuses on general tolerability and CNS symptoms, without assessing retinal toxicity or long-term cumulative dose effects. All other papers concern unrelated drugs or topics (e.g., 6-mercaptopurine, alendronate, tafenoquine, HIV PrEP, polyglutamine toxicity, oleander toxicity, physical activity, TNF). Therefore, the evidence set does not contain relevant information to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "1373287",
      "3613041",
      "8756719",
      "14260013",
      "437924"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "173",
    "claim": "Bcp1 is a chaperone for Rpl23.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention Bcp1 or present data about its interaction with Rpl23. The evidence focuses on other ribosome biogenesis factors (e.g., Ria1, Yar1/Ltv1 with Rps3, exportins, and general ribosome assembly), but does not address Bcp1 or its role as a chaperone for Rpl23."
    },
    "naive_doc_ids": [
      "41087952",
      "15893330",
      "26596106",
      "365896",
      "1256116"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers discuss Bcp1 or its interaction with Rpl23. The articles focus on topics such as rDNA repeat expansion, condensin function, histone dynamics, stress signaling, yeast transformation, ribosome biogenesis factors unrelated to Bcp1 (e.g., Yar1, Ltv1, Rps3; Ria1; Tif6), human 60S export, RNA processing kinetics, and transcriptional regulatory databases. There is no evidence here addressing whether Bcp1 acts as a chaperone for Rpl23."
    },
    "overthinking_doc_ids": [
      "12086599",
      "335029",
      "406733",
      "418246",
      "463309"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers discuss Bcp1 or its interaction with Rpl23. While some papers address chaperones (ASF1, APLF, Hop, Hcp) and one mentions Rpl23 in the context of HDM2/p53 regulation, there is no evidence here about Bcp1 acting as a chaperone for Rpl23."
    },
    "posthoc_doc_ids": [
      "1084345",
      "12156187",
      "12428814",
      "13907427",
      "37164306"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1375",
    "claim": "Weighed food records (WFR) result in poor completion since they're costly to run and impose high participant burden.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 1 involves weighed food records (WFR) but focuses on validity (correlations with other methods). It notes 98/150 participants completed the overall multi-method protocol, without attributing non-completion to WFR specifically and without discussing cost or participant burden. Paper 3 evaluates WFR accuracy versus doubly labeled water but does not address completion rates, costs, or burden. The remaining papers are unrelated to dietary assessment methods. Therefore, there is no direct evidence here that WFRs have poor completion due to cost and participant burden."
    },
    "naive_doc_ids": [
      "21623140",
      "2048139",
      "21993510",
      "9244474",
      "10557471"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "Across the provided papers, none present direct evidence that weighed food records (WFR) have poor completion due to being costly and high-burden. Paper 1 includes WFR in a protocol but does not attribute completion rates to WFR burden or cost. Paper 8 discusses accuracy issues with WFR but not completion, burden, or cost. Other papers focus on different dietary assessment tools or unrelated health topics. Therefore, the supplied evidence does not confirm or refute the specific claim about WFR completion, cost, and participant burden."
    },
    "overthinking_doc_ids": [
      "21623140",
      "40666943",
      "8298120",
      "11748341",
      "16322674"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "None of the provided papers present data on completion rates, participant burden, or cost specifically for weighed food records (WFR). Paper 1 includes a weighed record within a broader protocol but does not attribute completion or attrition to WFR or discuss cost/burden. Paper 3 addresses accuracy/underreporting of WFR, not completion or cost. Papers 6\u20138 discuss alternative dietary assessment tools but do not compare completion or cost versus WFR. The remaining papers are unrelated to dietary assessment methods. Therefore, the evidence set does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "21623140",
      "2048139",
      "21993510",
      "11748341",
      "16322674"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1186",
    "claim": "The World Health Organization's (WHO) data collection process is biased downward by unequal selection of larger outbreaks.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers address WHO outbreak data collection or selection processes. The only paper mentioning WHO (Paper 6) concerns anthropometric reference data and recommendations, not surveillance bias or outbreak selection. The remaining papers focus on molecular biology, virology, epidemiologic methodology (without reference to WHO data systems), or health determinants, providing no evidence relevant to the claim about downward bias from unequal selection of larger outbreaks in WHO data."
    },
    "naive_doc_ids": [
      "1031534",
      "3868322",
      "11016410",
      "16172576",
      "24387017"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers analyze WHO data collection processes or biases in outbreak selection. The studies cover genetics, molecular biology, clinical trials, COPD spatial epidemiology, metagenomic outbreak diagnostics (without discussing WHO surveillance practices), dietary assessment in children, and developmental biology. There is no evidence addressing whether WHO\u2019s data are biased downward due to unequal selection of larger outbreaks."
    },
    "overthinking_doc_ids": [
      "1067605",
      "3580005",
      "5698494",
      "6173523",
      "7757997"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers analyze WHO\u2019s data collection practices or assess bias from unequal selection of larger outbreaks. Paper 7 discusses methods to correct surveillance biases in general and Paper 9 describes CDC (U.S.) foodborne outbreak surveillance, not WHO. The remaining papers are unrelated to outbreak surveillance. Therefore, the evidence does not address the specific claim about WHO."
    },
    "posthoc_doc_ids": [
      "25900857",
      "1542437",
      "3610282",
      "4561402",
      "6826100"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1244",
    "claim": "The number of unfertilized oocytes in mated hermaphrodites increases with age.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "None of the provided papers present data or explicit statements about the number of unfertilized oocytes in mated C. elegans hermaphrodites increasing with age. Paper 6 discusses reproductive aging and declines in oocyte quality and fertilizability, but does not report measurements of unfertilized oocytes in mated hermaphrodites across age. The remaining papers focus on unrelated topics (e.g., neural aging, polyglutamine toxicity, embryonic lineage, yeast aging, human arterial compliance)."
    },
    "naive_doc_ids": [
      "16267205",
      "7042304",
      "13072113",
      "5002665",
      "7834603"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers examines age-related changes in the number of unfertilized oocytes in mated C. elegans hermaphrodites. The relevant studies focus on endocrine regulation of lifespan (Paper 1), cell clearance (Paper 2), neuroendocrine secretion and metabolism (Paper 3), insulin-like signaling effects on fertility broadly (Paper 4), metabolomics with age (Paper 5), and unrelated human clinical topics (Papers 6\u201310). No paper presents data on unfertilized oocyte counts with age in mated hermaphrodites."
    },
    "overthinking_doc_ids": [
      "16267205",
      "1127562",
      "1281769",
      "1576955",
      "3270834"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers report data on the number of unfertilized oocytes in mated C. elegans hermaphrodites as a function of age. While Paper 9 discusses reproductive aging and declining oocyte quality/fertilizability, it does not quantify unfertilized oocytes or specifically analyze mated hermaphrodites. The remaining papers are unrelated to this specific claim."
    },
    "posthoc_doc_ids": [
      "4457834",
      "374902",
      "439670",
      "1412089",
      "1941721"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1226",
    "claim": "The loss of the TET protein functions may have dire biological consequences, such as myeloid cancers.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Paper 1 shows that miR-22 downregulates TET2, reduces 5-hmC, increases hematopoietic stem cell self-renewal, and causes mice to develop myelodysplastic syndrome and hematologic malignancies; re-expression of TET2 reverses these effects, and low TET2 correlates with poor outcomes in patients. Paper 4 (review) states that TET2 loss-of-function is common in myeloid malignancies and that Tet2 haploinsufficiency in mice initiates myeloid (and lymphoid) transformations, establishing TET2 as a tumor suppressor in hematopoiesis. These data directly support that loss of TET function can lead to myeloid cancers. Additional context from Papers 6 and 7 shows broader oncogenic and developmental consequences of reduced TET/5hmC, consistent with the claim."
    },
    "naive_doc_ids": [
      "33677323",
      "9478135",
      "27306942",
      "11951999",
      "28614776"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 directly links loss of TET function (specifically TET2 inactivation via loss-of-function mutations or deletion) to myeloid and lymphoid malignancies and shows that Tet2 haploinsufficiency in mice initiates myeloid transformations, indicating a tumor suppressor role. This supports the claim that loss of TET protein functions can have severe consequences, including myeloid cancers. The other papers do not address TET proteins and neither contradict this linkage."
    },
    "overthinking_doc_ids": [
      "11951999",
      "92308",
      "1145473",
      "1387104",
      "3127341"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 reports that TET2 inactivation (loss-of-function mutation, deletion, or via IDH1/2 mutations) is a common event in myeloid and lymphoid malignancies, and Tet2 knockout/heterozygous mice show that Tet2 acts as a tumor suppressor whose haploinsufficiency initiates myeloid transformations. This directly supports the claim that loss of TET protein function can lead to myeloid cancers. Paper 6 further shows reduced TET2 expression and 5hmC in cancers (melanoma), reinforcing that loss of TET function has serious biological consequences."
    },
    "posthoc_doc_ids": [
      "11951999",
      "92308",
      "1145473",
      "1387104",
      "3127341"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.8,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "389",
    "claim": "Ethanol stress increases the expression of IBP in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on IBP (e.g., IbpA/IbpB) expression under ethanol stress in bacteria. Several discuss stress responses (e.g., SoxRS oxidative stress in E. coli, heat shock regulation in Bacillus subtilis, general stress during ethanolic fermentation), but none measure or report IBP expression changes due to ethanol. Therefore, the claim is not verifiable from the given evidence."
    },
    "naive_doc_ids": [
      "471735",
      "6669242",
      "26886351",
      "34386619",
      "45364685"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data on IBP (e.g., E. coli small heat shock proteins IbpA/B or other proteins abbreviated IBP) expression under ethanol stress. The only paper mentioning ethanol (Paper 10) discusses aggregate stress costs (osmotic, lignotoxin, ethanol) during fermentation but does not report IBP expression changes. The remaining papers concern other stress pathways (e.g., SoxRS oxidative stress), heat shock regulation, or non-bacterial systems, and do not address ethanol-induced IBP expression."
    },
    "overthinking_doc_ids": [
      "471735",
      "45364685",
      "26886351",
      "34386619",
      "20524091"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data on IBP (e.g., E. coli small heat shock proteins IbpA/IbpB) expression under ethanol stress. Paper 3 discusses ethanol stress costs during fermentation in E. coli but does not report specific upregulation of IBP. The remaining papers address unrelated stress pathways, organisms, or topics (oxidative stress via SoxRS, protein acetylation, cancer signaling, transformation SSB proteins, immune responses). Therefore, the evidence set does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "471735",
      "20524091",
      "21602220",
      "6669242",
      "3730196"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "213",
    "claim": "CRP is not predictive of postoperative mortality following Coronary Artery Bypass Graft (CABG) surgery.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Paper 1 (CABG-only cohort, n=914) found that higher preoperative CRP predicted greater long-term, all-cause postoperative mortality after primary, nonemergent CABG: HR 2.50 (95% CI 1.22\u20135.16) for CRP 3\u201310 mg/L and HR 2.66 (1.21\u20135.80) for CRP >10 mg/L vs <1 mg/L. Paper 3 (cardiac surgery, including CABG) showed higher in-hospital postoperative mortality with elevated preoperative CRP (8.2% vs 3.4%; OR 2.61, p=0.02) and identified elevated CRP as an independent risk factor for mid-term survival. These findings indicate CRP is predictive of postoperative mortality following CABG/cardiac surgery, contradicting the claim. Other papers are not directly relevant to CABG postoperative mortality."
    },
    "naive_doc_ids": [
      "27054878",
      "750781",
      "20887554",
      "21048969",
      "25028913"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 1 (CABG-only cohort) shows preoperative CRP \u22653 mg/L independently predicts higher long-term, all-cause mortality after CABG (HR 2.50 for 3\u201310 mg/L; HR 2.66 for >10 mg/L). Paper 4 (cardiac surgery, including CABG) shows higher preoperative CRP is associated with increased in-hospital postoperative mortality (OR 2.61). These findings indicate CRP is predictive of mortality after CABG/cardiac surgery, contradicting the claim."
    },
    "overthinking_doc_ids": [
      "27054878",
      "25028913",
      "13625993",
      "20887554",
      "21048969"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Paper 2 directly shows that in primary, nonemergent CABG patients, higher preoperative CRP predicts greater postoperative (long-term) all-cause mortality: CRP 3\u201310 mg/L and >10 mg/L were associated with increased mortality (HR 2.50 [1.22\u20135.16], P=0.01; HR 2.66 [1.21\u20135.80], P=0.02). Paper 3 (cardiac surgery, including CABG) found higher preoperative CRP associated with higher in-hospital mortality (8.2% vs 3.4%; OR 2.61, P=0.02) and worse mid-term survival. These findings refute the claim that CRP is not predictive of postoperative mortality following CABG. Other papers are not specific to CABG mortality or are unrelated."
    },
    "posthoc_doc_ids": [
      "21048969",
      "27054878",
      "20887554",
      "72933407",
      "3878434"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1331",
    "claim": "Tumor development occurs in conjunction with upregulation of pro-inflammatory cytokines.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers directly assess cytokine expression during tumor development. Several discuss TNF-alpha or other cytokines in non-tumor contexts (atherosclerosis, metabolism, obesity) or viral modulation of TNF signaling, and others address cancer risk factors (adipokines, anthropometrics, drug exposures) without measuring pro-inflammatory cytokine upregulation accompanying tumorigenesis. Therefore, the evidence does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "2734421",
      "22889972",
      "36386637",
      "207972",
      "38023457"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 2 explicitly states that inflammatory mediators are integral to the tumor microenvironment and that oncogenic changes can induce an inflammatory microenvironment that promotes tumor development, implying elevated pro-inflammatory signaling during tumorigenesis. Paper 1 identifies NF-\u03baB as a key link between inflammation and cancer; NF-\u03baB is a master regulator of many pro-inflammatory cytokines and has a tumor-promoting role in many cancers, consistent with cytokine upregulation accompanying tumor development. Papers 4 and 6 further connect tumor progression with inflammatory components in the microenvironment (e.g., platelets and cancer-associated fibroblasts), which are known sources of cytokines. While these are largely reviews and not single experimental datasets, together they support the claim that tumor development occurs alongside upregulation of pro-inflammatory cytokines."
    },
    "overthinking_doc_ids": [
      "7046487",
      "4429118",
      "4886637",
      "5238341",
      "7639744"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 3 shows that in a lung cancer model, interactions with stromal cells increase tumor-cell secretion of inflammatory cytokines/chemokines (e.g., CXCL1 and IL-18), and that blocking these factors reduces proliferation and tumorigenicity\u2014directly linking upregulated pro-inflammatory mediators with tumor development. Paper 9 reports that higher pretreatment levels of the pro-inflammatory cytokine IL-6 are prognostic for worse outcomes in cervical cancer patients, indicating that elevated pro-inflammatory cytokines are associated with tumor progression. Other papers do not contradict this. Together, the evidence supports the claim that tumor development occurs in conjunction with upregulation of pro-inflammatory cytokines."
    },
    "posthoc_doc_ids": [
      "343052",
      "952111",
      "15727984",
      "24396137",
      "24726600"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "175",
    "claim": "Beta-band coherence is enhanced for visible stimuli over invisible stimuli.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.88,
      "justification": "Paper 1 directly reports that conscious (unmasked/visible) word processing shows increases in long-distance phase synchrony in the beta range, whereas nonconscious (masked/invisible) processing lacks coherent long-distance activity. This aligns with the claim that beta-band coherence is enhanced for visible over invisible stimuli. The other papers provided do not address visibility-related beta coherence."
    },
    "naive_doc_ids": [
      "1710116",
      "6955746",
      "6985854",
      "28910120",
      "45336190"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 6 reports that consciously perceived (unmasked/visible) words, compared to nonconscious (masked/invisible) words, show increased long-distance phase synchrony in the beta range, along with stronger long-range Granger causality\u2014consistent with enhanced beta-band coherence for visible stimuli. Paper 7, a review, converges on this finding by highlighting long-distance beta (and gamma) synchronization as a marker of conscious access. The other papers do not address visibility-related beta coherence."
    },
    "overthinking_doc_ids": [
      "79336156",
      "24523573",
      "313394",
      "6955746",
      "23929297"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 9 (intracranial EEG with masking) reports that conscious (unmasked/visible) stimuli show increases in long-distance phase synchrony in the beta range, whereas nonconscious (masked/invisible) stimuli lack coherent long-distance activity. Paper 10 (review) converges on the same point, noting long-distance cortico-cortical synchronization at beta (and gamma) frequencies as a marker of conscious access. These findings align with the claim that beta-band coherence is enhanced for visible over invisible stimuli. Other cited papers are not directly relevant to visibility or beta coherence."
    },
    "posthoc_doc_ids": [
      "79336156",
      "5137019",
      "6985854",
      "24523573",
      "2682997"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "244",
    "claim": "Certain immunomodulator-human dialyzable leukocyte extract (hDLE) peptides are recognized by toll-like receptors (TLRs) on macrophages and dendritic cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention human dialyzable leukocyte extract (hDLE) or show that hDLE-derived peptides are recognized by TLRs on macrophages or dendritic cells. While several papers discuss TLR signaling, ligand effects, expression on monocytes/DCs, and decoy peptides targeting TLR4, they do not provide data on hDLE peptides as TLR ligands."
    },
    "naive_doc_ids": [
      "56486733",
      "3127341",
      "24042363",
      "2603304",
      "3616843"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers investigate or report that human dialyzable leukocyte extract (hDLE) peptides are recognized by TLRs on macrophages or dendritic cells. The studies address TLR-driven differentiation (Paper 1), GM-CSF-driven DC generation (Paper 2), NOX2 and cross-presentation (Paper 3), ImmTAC-mediated cross-presentation (Paper 4), CD169+ macrophage antigen presentation to iNKT cells (Paper 5), modulation of TLR2/NLRP3 by PPAR\u03b3 agonist in asthma (Paper 6), TLR4 polymorphism and MI risk (Paper 7), TLR4 TIR domain decoy peptides inhibiting signaling (Paper 8), altered macrophage TLR responsiveness in schistosomiasis (Paper 9), and TLR4 expression on monocyte subsets related to plaque vulnerability (Paper 10). None mention hDLE or demonstrate its peptides binding to or being recognized by TLRs on these cells."
    },
    "overthinking_doc_ids": [
      "21498497",
      "188911",
      "12631182",
      "1196631",
      "1933281"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address human dialyzable leukocyte extract (hDLE) or its peptides, nor do they test or demonstrate recognition of such peptides by Toll-like receptors on macrophages or dendritic cells. While several papers discuss TLR activation, differentiation, or signaling in general, they do not involve hDLE or show that its peptides are TLR ligands. Therefore, the evidence does not speak to the specific claim."
    },
    "posthoc_doc_ids": [
      "12631182",
      "21498497",
      "4464565",
      "15425958",
      "26886351"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "294",
    "claim": "Crossover hot spots are not found within gene promoters in Saccharomyces cerevisiae.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data on the localization of meiotic crossover hot spots relative to gene promoters in Saccharomyces cerevisiae. Paper 1 maps Spo11-induced DSBs and shows their broader distribution but does not analyze promoter association or crossover hot spots specifically. Papers 2\u20139 address unrelated topics (splicing kinetics, transcriptional regulation resources, metabolism/aging, Ras signaling, RNA modifications, chromatin features in yeast or other species, and human promoter mapping). Paper 10 examines DSB repair on a plasmid, not genome-wide crossover hot spot locations. Therefore, the evidence set does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "10874408",
      "365896",
      "1256116",
      "4414481",
      "8210189"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers examine meiotic recombination or map crossover hotspots in Saccharomyces cerevisiae. The articles focus on transcriptional regulation, RNA processing, chromatin features at promoters, signaling, metabolism, domestication, polyploidy, and regulatory motif mapping. While some papers discuss promoter chromatin (e.g., H2A.Z localization), they do not address the location of crossover hotspots, so the evidence neither supports nor contradicts the claim."
    },
    "overthinking_doc_ids": [
      "365896",
      "1256116",
      "4414481",
      "8210189",
      "10300888"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on the genomic locations of meiotic crossover hotspots in Saccharomyces cerevisiae relative to promoters. Papers 6 and 8 discuss promoter architecture and nucleosome positioning but not recombination hotspots. Paper 4 addresses double-strand break repair on a plasmid system, not natural hotspot mapping. Paper 10 examines a meiotic recombination hotspot in Schizosaccharomyces pombe (not S. cerevisiae). Other papers concern lifespan, transcriptional/post-transcriptional regulation, or mouse hotspots. Therefore, the evidence set does not inform whether crossover hotspots occur within promoters in S. cerevisiae."
    },
    "posthoc_doc_ids": [
      "365896",
      "11527822",
      "23604601",
      "25462689",
      "26330861"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1032",
    "claim": "Reduction of purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpA in 2D BN-PAGE gels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers present data on 2D BN-PAGE analysis of cytoplasmic membrane preparations or report OmpA spot intensities as indicators of membrane purity. While OmpA is an outer membrane protein, the cited works do not discuss contamination of cytoplasmic membrane fractions from overexpressors or use BN-PAGE to assess purity."
    },
    "naive_doc_ids": [
      "6836086",
      "26625002",
      "7643848",
      "5914739",
      "46346525"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers discuss 2D BN-PAGE analyses of cytoplasmic membrane preparations from overexpressor strains or report stronger OmpA spots as an indicator of reduced purity. While OmpA is an E. coli outer membrane protein (Paper 1 context), there is no experimental evidence here linking OmpA spot intensity on 2D BN-PAGE to cytoplasmic membrane purity."
    },
    "overthinking_doc_ids": [
      "6836086",
      "26625002",
      "38528892",
      "797114",
      "5914739"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers discuss 2D BN-PAGE analyses, OmpA spot intensities, or the purity of cytoplasmic (inner) membrane preparations from overexpressor strains. The papers cover unrelated topics such as T-cell receptor membrane interactions, shrimp Dscam, antimicrobial peptide mechanisms, Gq localization in neurons, outer membrane biogenesis in general, TolC-related metabolism, chemotaxis receptor organization, oxidative stress regulation, and ethanol tolerance. Therefore, they do not provide evidence to confirm or refute the specific claim about OmpA indicating reduced purity in 2D BN-PAGE gels."
    },
    "posthoc_doc_ids": [
      "5914739",
      "8903143",
      "26117607",
      "350542",
      "13411519"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.03,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "481",
    "claim": "Guanine nucleotide dissociation inhibitor (Rho-GDI) interacts with the p75 NTR death domain",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention Rho-GDI, the p75 neurotrophin receptor, or its death domain. The studies focus on unrelated topics (TNF signaling, TCR membrane interactions, AMPA receptors, adenoviral proteins, MHC-CD4/CD8 interactions, PD-1/IL-10 in HIV, integrin mutations, class B GPCR activation, c-myc in T-cell apoptosis, and FGF21 in atherosclerosis). Therefore, they do not provide evidence to confirm or refute the claimed interaction."
    },
    "naive_doc_ids": [
      "41913714",
      "5914739",
      "18346333",
      "207972",
      "4270992"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers address interactions between Rho-GDI (Rho GDP dissociation inhibitor) and the p75 neurotrophin receptor (p75NTR) death domain. The cited studies cover unrelated topics such as ARF GEF structures, TNFR1\u2013TRADD interactions, adenoviral proteins, antibiotic-induced hydroxyl radicals, dynein\u2013microtubule binding, MHC\u2013CD4 interactions, HIF-1alpha\u2013p53 binding, CPEB/Orb2 in memory, ADAM13\u2013fibronectin binding, and TCR\u03b6 membrane association. Therefore, they do not provide evidence confirming or refuting the claim."
    },
    "overthinking_doc_ids": [
      "8093935",
      "41913714",
      "207972",
      "1103795",
      "1546650"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers address the p75 neurotrophin receptor (p75 NTR) death domain or Rho-GDI, nor do they examine interactions between them. The studies focus on unrelated systems (e.g., Sec7/ARF GEFs, adenoviral proteins, MHC-CD4, HIV Tat/CTIP2, p53 family in H. pylori infection, TNFR1-TRADD, TCR signaling components, AMPA receptors, and HIV cohort outcomes). Therefore, the evidence set does not contain information relevant to the claim."
    },
    "posthoc_doc_ids": [
      "8093935",
      "207972",
      "4270992",
      "22495397",
      "29367554"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1161",
    "claim": "The DEXI promoter region is bound by multiple transcription factors in a murine haematopoietic progenitor cell line.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided paper summaries mention DEXI or provide data showing transcription factor binding at the DEXI promoter in a murine hematopoietic progenitor cell line. While Paper 9 profiles genome-wide TF binding in blood stem/progenitor cells, the summary does not indicate binding at the DEXI promoter specifically. Therefore, the claim cannot be verified from the given evidence."
    },
    "naive_doc_ids": [
      "7155555",
      "18489989",
      "3052213",
      "8331432",
      "9724974"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data on the DEXI (Dexi) promoter or its transcription factor occupancy in a murine hematopoietic progenitor cell line. While Paper 6 profiles genome-wide binding of multiple transcription factors in blood stem/progenitor cells, the summary does not indicate binding at the DEXI promoter specifically. The remaining papers focus on other genes, cell types (e.g., adipocytes, yeast), or general mechanisms and do not address DEXI."
    },
    "overthinking_doc_ids": [
      "3052213",
      "8331432",
      "9724974",
      "5116145",
      "20179918"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention the DEXI gene or its promoter, nor do they present data on transcription factor binding at the DEXI promoter in murine hematopoietic progenitor cells. The studies address other genes, promoters, cell types, or species (e.g., yeast, human adipocytes, breast cancer cells) and general TF biology, but not the specific claim."
    },
    "posthoc_doc_ids": [
      "9724974",
      "16728949",
      "18489989",
      "23180075",
      "23269537"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1397",
    "claim": "p16INK4A degradation is  linked to an abnormal wound response caused by the microinvasive step of advanced Oral Potentially Malignant Lesions (OPMLs).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers examine p16INK4A (CDKN2A) degradation or link it to an abnormal wound response during the microinvasive step of advanced oral potentially malignant lesions (OPMLs). While several papers address related but distinct topics\u2014such as wound-healing signaling (MAPK/ROS), general wound-response enzymes (TG2), tumor\u2013stroma interactions, EMT, keratin and adhesion changes in OSCC/OED, and therapies in HNSCC\u2014none present data on p16INK4A status or its degradation in the context of OPML microinvasion and wound response."
    },
    "naive_doc_ids": [
      "21382907",
      "6308416",
      "11721286",
      "21063817",
      "26008462"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address p16INK4A degradation or directly link it to an abnormal wound response in the microinvasive step of advanced oral potentially malignant lesions (OPMLs). Some papers touch on wound healing (TG2, MAPK waves) or oral cancer invasion (miR-196), but they do not mention p16INK4A, its degradation, OPMLs, or a microinvasive wound-response mechanism. No paper provides supporting or contradicting data for the specific claim."
    },
    "overthinking_doc_ids": [
      "4483571",
      "26008462",
      "27260630",
      "16732790",
      "1471041"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers address p16INK4A degradation, Oral Potentially Malignant Lesions (OPMLs), or the microinvasive step linking to an abnormal wound response. Papers 6 and 7 discuss wound healing mechanisms (TG2, MAPK/ROS) in general but do not involve p16INK4A or OPMLs. The remaining papers cover unrelated topics (clinical trials in other cancers, metabolism, UPR, GLP-1R). Therefore, there is no relevant evidence to confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "5492542",
      "9956893",
      "14626540",
      "3471191",
      "4483571"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "848",
    "claim": "Nigerian physicians constitue the largest component of sub-Saharan Africa-trained physicians in the United States.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.76,
      "justification": "Only Paper 1 is relevant to sub-Saharan Africa-trained physicians in the US, but its abstract reports totals and recent increases (e.g., Nigeria +1,113) without stating which country constitutes the largest component of SSA-trained physicians in the US. The other papers are unrelated. Therefore, the provided evidence does not confirm or refute that Nigerian physicians are the largest group."
    },
    "naive_doc_ids": [
      "14500725",
      "3662510",
      "30844602",
      "641459",
      "3524352"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.6,
      "justification": "Only Paper 1 is directly relevant to physician migration from sub-Saharan Africa to the United States. It reports overall numbers and notes that migration from Nigeria increased by more than 50% (+1,113) from 2002 to 2011, but it does not provide country-by-country totals of SSA-trained physicians in the U.S. or state that Nigerians constitute the largest component. The other papers are unrelated. Therefore, the provided excerpts do not confirm or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "14500725",
      "3662510",
      "9547722",
      "30844602",
      "641459"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Only Paper 1 is relevant to the claim and discusses sub-Saharan Africa-trained physicians in the U.S. by source country trends, noting a substantial increase from Nigeria. However, the provided excerpt does not state which country constitutes the largest share of SSA-trained physicians in the U.S., nor does it provide a country-by-country breakdown of the total stock. The other papers are unrelated. Therefore, the claim cannot be confirmed or refuted from the given evidence."
    },
    "posthoc_doc_ids": [
      "14500725",
      "3662510",
      "30844602",
      "641459",
      "3524352"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "814",
    "claim": "Mutations in G-Beta protein GNB2 are present in many cancers, resulting in loss of interaction with G-alpha subunits and concomitant activation of AKT pathway.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers address mutations in the G-beta protein GNB2, their prevalence in cancers, effects on interaction with G-alpha subunits, or resulting AKT pathway activation. The evidence focuses on PI3K/mTOR inhibition, PTEN-related PI3K pathway activity, VEGF/EGFR signaling, BRAF/MEK dependence, epigenetic therapy and interferon signaling, inositol phosphatases, integrin beta3 mutations, adenoviral protein interactions, and AMPK beta subunit modifications. Therefore, there is no relevant information to support or contradict the specific GNB2 claim."
    },
    "naive_doc_ids": [
      "14241418",
      "15113221",
      "17844478",
      "85665741",
      "9767444"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers discuss mutations in GNB2 (a G\u03b2 subunit), their impact on interaction with G\u03b1 subunits, or resultant AKT pathway activation. The papers cover topics including pancreatic cancer genomics (without mentioning GNB2), PI3K/mTOR inhibition (not tied to GNB2), WNT/EGFR signaling, RB\u2013p16 pathway, EGFR mutation detection methodologies, adenoviral protein interactions, inflammation/cachexia, alternative splicing factors, and STIM1-dependent Ca2+ signaling. Therefore, the evidence set does not provide information relevant to the specific claim."
    },
    "overthinking_doc_ids": [
      "4325398",
      "14241418",
      "17648235",
      "46617075",
      "711256"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.65,
      "justification": "Among the provided papers, only Paper 6 addresses G protein beta subunits (GNB1 and GNB2). It reports recurrent mutations in both GNB1 and GNB2 across multiple cancers and shows that these mutations confer cytokine-independent growth and activate canonical G protein signaling. However, the mechanistic detail about disrupted interaction with G-alpha subunits is explicitly demonstrated for GNB1, not GNB2, in the provided excerpt. Likewise, activation of the AKT pathway is implied (via sensitivity to the PI3K-mTOR inhibitor BEZ235) for GNB1 but is not explicitly shown for GNB2 in the given text. The other papers are unrelated to GNB2. Therefore, the specific claim that GNB2 mutations cause loss of G-alpha interaction and concomitant AKT activation is not directly supported by the provided evidence."
    },
    "posthoc_doc_ids": [
      "14241418",
      "4414547",
      "16745747",
      "207972",
      "4889228"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "64",
    "claim": "ATM and Rad3 related protein have no role in sensing DNA damage.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.95,
      "justification": "Multiple papers show ATM and ATR (Rad3 related) function in sensing and signaling DNA damage. Paper 10 explicitly reviews how ATM/Tel1 and ATR/Mec1 sense and signal DNA double-strand breaks; Paper 1 notes replication stress triggers ATR activation leading to checkpoint signaling; Papers 2 and 4 show ATR-dependent Chk1 activation during replication stress; Paper 5 shows endogenous activation of ATM at replication-associated damage sites. These findings directly oppose the claim that ATM and ATR have no role in sensing DNA damage."
    },
    "naive_doc_ids": [
      "12909503",
      "11568270",
      "3173489",
      "21521236",
      "39225849"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 5 explicitly states that replication stress (a form of DNA damage/perturbation) triggers activation of ATR, leading to phosphorylation of RPA32 and Chk1-dependent checkpoint activation. Inhibition of ATR reproduces checkpoint defects, demonstrating ATR\u2019s upstream sensing/response role to DNA damage. Paper 6 (review) further supports that the DDR is activated by sensor kinases like ATM/ATR across the cell cycle. Therefore, the claim that ATR (ATM and Rad3 related protein) has no role in sensing DNA damage is refuted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "3173489",
      "4407318",
      "4899981",
      "5389523",
      "12909503"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 1 shows that DNA damage activates ATM via Cdk5-dependent phosphorylation, which is required for ATM autophosphorylation and kinase activation, driving DNA damage signaling (affecting p53 and H2AX). Paper 2 reports strong enrichment of phosphorylated ATM at telomeres concomitant with induction of a DNA damage response, indicating ATM engagement in damage signaling. These findings demonstrate a role for ATM in sensing/signaling DNA damage, contradicting the claim. While ATR (ATM and Rad3-related) is not directly addressed, the claim that both ATM and ATR have no role is falsified by the clear evidence for ATM."
    },
    "posthoc_doc_ids": [
      "21295300",
      "213017",
      "350542",
      "4320111",
      "4391817"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "622",
    "claim": "Individuals with low serum vitamin D concentrations have decreased risk of multiple sclerosis.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.8,
      "justification": "Paper 1 shows higher sun exposure (a proxy for higher vitamin D) in childhood/adolescence is associated with decreased MS risk, implying lower sun/likely lower vitamin D is linked to higher risk, the opposite of the claim. Paper 7 notes MS prevalence increases with latitude (lower UV/vitamin D) and discusses vitamin D\u2019s immunomodulatory role, suggesting lower vitamin D is associated with increased MS risk. No paper provides evidence that low serum vitamin D decreases MS risk."
    },
    "naive_doc_ids": [
      "17000834",
      "13831842",
      "25157790",
      "4462079",
      "13312471"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.87,
      "justification": "Paper 1 shows that higher sun exposure in childhood/adolescence is associated with a markedly reduced risk of multiple sclerosis, implying that greater UV-driven vitamin D synthesis (i.e., higher vitamin D) lowers MS risk; thus low vitamin D would not decrease risk. Paper 6 highlights the latitude gradient in MS prevalence and posits insufficient UV/vitamin D as a contributing environmental factor, again indicating that lower vitamin D is associated with higher, not lower, MS risk. Other papers are not directly relevant to vitamin D and MS. Therefore, the claim is contradicted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "17000834",
      "27466734",
      "1456068",
      "44624045",
      "829646"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 1 shows higher sun exposure in childhood/adolescence is associated with a reduced risk of multiple sclerosis; sun exposure raises vitamin D, implying lower vitamin D would be associated with higher (not lower) MS risk. Paper 3 links higher MS prevalence at higher latitudes (lower UV/vitamin D) and discusses vitamin D\u2019s immunomodulatory role, again implying that lower vitamin D increases risk. No paper presents data showing low serum vitamin D reduces MS risk; the rest are not directly relevant to MS risk from vitamin D levels."
    },
    "posthoc_doc_ids": [
      "17000834",
      "25599283",
      "22843838",
      "43226130",
      "4462079"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "898",
    "claim": "Oxidative DNA damage activates STING signalling.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Paper 1 shows that oxidized DNA containing 8-hydroxyguanosine (8-OHG) resists TREX1 degradation and thereby potentiates STING-dependent immune sensing, indicating that oxidative DNA damage enhances activation of the STING pathway. Paper 8 demonstrates that oxidized mitochondrial DNA released during NETosis is interferogenic and, when administered to mice, drives type I interferon signaling via a STING-dependent pathway. Together, these provide direct experimental evidence that oxidative DNA damage can activate STING signaling. Other papers either discuss DNA sensing mechanisms (Paper 2) or oxidative stress without linking to STING (Papers 3\u20137, 9\u201310) and do not contradict the claim."
    },
    "naive_doc_ids": [
      "13106686",
      "19688024",
      "5572127",
      "7875158",
      "18358026"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Multiple papers provide direct evidence that oxidatively damaged DNA engages the cGAS\u2013STING pathway. Paper 2 shows that oxidized mitochondrial DNA released in NETs triggers type I interferon responses in vitro and in vivo via a STING-dependent pathway. Paper 6 demonstrates that DNA containing the oxidative lesion 8-hydroxyguanosine resists TREX1 degradation and thereby potentiates STING-dependent cytosolic DNA sensing; oxidized DNA occurs physiologically during ROS exposure and NET formation and drives IFN-associated pathology. Other papers provide background on STING activation by DNA but are not essential to the claim. No provided paper contradicts this."
    },
    "overthinking_doc_ids": [
      "19688024",
      "1049501",
      "24721866",
      "4399311",
      "6501747"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 shows that oxidized DNA (marked by 8\u2011OHG) resists TREX1 degradation and potentiates STING-dependent immune sensing, indicating oxidative DNA damage enhances activation of the STING pathway. Paper 10 demonstrates that oxidized mitochondrial DNA released during NETosis is interferogenic and, when injected into mice, triggers type I interferon signaling via a STING-dependent mechanism. Together, these provide direct evidence that oxidative DNA damage activates STING signaling."
    },
    "posthoc_doc_ids": [
      "13106686",
      "21295300",
      "24185667",
      "213017",
      "1344498"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.65,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "575",
    "claim": "In domesticated populations of Saccharomyces cerevisiae, whole chromosome aneuploidy is very uncommon.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, none present data on the frequency of whole-chromosome aneuploidy in domesticated Saccharomyces cerevisiae. Paper 1 discusses domestication and divergence of industrial yeasts but the excerpt does not mention aneuploidy. The remaining papers address unrelated topics (RNA processing, chromosome segregation mechanisms, databases, human cancers, quality of life, calorie restriction, and Ras signaling) and do not provide evidence about aneuploidy prevalence in domesticated yeast populations."
    },
    "naive_doc_ids": [
      "10300888",
      "365896",
      "16686383",
      "1256116",
      "4457160"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided paper summaries present data or statements about the frequency of whole chromosome aneuploidy in domesticated Saccharomyces cerevisiae. Paper 1 discusses domestication, phenotypes, and selection but does not mention aneuploidy; the remaining papers address unrelated topics (gene induction, RNA processing, regulatory databases, lifespan under calorie restriction, and Ras signaling). Therefore, the evidence given does not confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "10300888",
      "42421723",
      "365896",
      "1256116",
      "4414481"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on the prevalence of whole-chromosome aneuploidy in domesticated Saccharomyces cerevisiae populations. Papers 1 and 9 address chromosome segregation mechanisms (Ipl1/Aurora B, kinetochore function) but not population-level aneuploidy rates. Paper 10 discusses domestication and divergence of industrial yeasts but, in the provided excerpt, does not mention aneuploidy frequency. The remaining papers are unrelated to yeast aneuploidy prevalence. Therefore, the evidence does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "16686383",
      "42421723",
      "365896",
      "1256116",
      "4414481"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1215",
    "claim": "The effect of Lipopolysaccharides on kidney barrier function is dependent on inflammation levels.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 2 directly links LPS to kidney barrier function, showing that LPS induces proteinuria via podocyte uPAR/\u03b1v\u03b23 integrin signaling. However, none of the papers assess how varying levels of inflammation modulate the LPS effect on kidney barrier function. Other papers discuss LPS-induced inflammatory pathways (Paper 1), kidney permeability mechanisms unrelated to LPS (Paper 4), or inflammation in other contexts (Papers 3, 5\u201310). Therefore, there is no evidence here that the LPS effect on kidney barrier function depends on inflammation levels."
    },
    "naive_doc_ids": [
      "9159125",
      "16355392",
      "31890716",
      "21369472",
      "26658659"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate how lipopolysaccharides (LPS) affect kidney (glomerular) barrier function or whether such effects depend on inflammation levels. Paper 6 discusses LPS-induced PGE2 production via TLR4/MyD88/NF-IL6 in macrophages but does not address kidney barrier function. Paper 2 concerns podocyte slit diaphragm function (TRPC6) without LPS, and Paper 1 links resistin to renal dysfunction without LPS. The remaining papers focus on other tissues or immune pathways. Therefore, the evidence set does not support or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "31890716",
      "21369472",
      "3761017",
      "4447055",
      "6945691"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Only Paper 1 directly examines lipopolysaccharide (LPS) effects on kidney barrier function, showing that LPS induces proteinuria via podocyte uPAR signaling and \u03b1v\u03b23 integrin activation. It does not assess or relate the magnitude of the LPS effect to levels of inflammation. The other papers address renal function, permeability, or inflammation in different contexts (e.g., resistin, ACE inhibitors, sepsis markers, intestinal or brain barriers) and do not test whether LPS effects on the renal filtration barrier vary with inflammation severity. Therefore, the provided evidence does not confirm or refute the claim that LPS effects on kidney barrier function depend on inflammation levels."
    },
    "posthoc_doc_ids": [
      "16355392",
      "31890716",
      "21369472",
      "3761017",
      "6157837"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "301",
    "claim": "Cytosolic proteins bind to iron-responsive elements on mRNAs coding for TFRC1.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data about iron-responsive elements (IREs) or iron regulatory proteins binding to the TFRC1 (transferrin receptor 1) mRNA. The papers focus on SREBP signaling, immune responses, general RNA\u2013protein interactions (e.g., YB-1, HuR), miRNA competition, and unrelated translational regulation. Therefore, they do not provide evidence to confirm or refute the specific claim."
    },
    "naive_doc_ids": [
      "4583180",
      "9315213",
      "7155555",
      "8065561",
      "13878643"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data about cytosolic proteins binding iron-responsive elements on TFRC1 (transferrin receptor 1) mRNA. The closest is Paper 4, which discusses IRP2 in COPD and mitochondrial iron regulation, but it does not demonstrate or mention IRP2 binding to IREs in TFRC1 mRNA. Other papers cover unrelated topics (SREBP2, FGF21, stress, VDR, general RNA-binding proteins, mitochondrial RNA regulation, and splicing) without referencing TFRC1 or IRE-IRP interactions."
    },
    "overthinking_doc_ids": [
      "4583180",
      "9315213",
      "2436602",
      "3553087",
      "3701541"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address iron-responsive elements (IREs), iron regulatory proteins (IRP1/IRP2), or binding to transferrin receptor 1 (TFRC/TFRC1) mRNA. The studies focus on unrelated topics such as stem cell transcription factors, yeast transcriptional maps, Rho GTPase regulation of synapses, hepcidin/ferroportin in lung iron overload, SREBP-mediated metabolic reprogramming, NAADP-binding proteins, nanoparticle protein coronas, p62/VDR in hepatic stellate cells, RNA-binding proteins in pluripotency (general), and acidic pH activation of SREBP2. Therefore, the claim is neither supported nor contradicted by the provided evidence."
    },
    "posthoc_doc_ids": [
      "6401675",
      "17240457",
      "24881307",
      "4421742",
      "13878643"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "698",
    "claim": "Lmna knock-in models are appropriate for testing therapeutic approaches against Hutchinson-Gilford progeria syndrome (HGPS).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, none describe or evaluate LMNA knock-in mouse models for HGPS or their use in therapeutic testing. The closest related evidence is a Zmpste24-deficient mouse model treated with a farnesyltransferase inhibitor (Paper 2), and in vitro correction of LMNA splicing in HGPS patient fibroblasts (Paper 3). Paper 1 reviews HGPS phenotype and genetics but does not address LMNA knock-in models. The remaining papers are unrelated to HGPS or LMNA modeling. Therefore, the claim about LMNA knock-in models being appropriate for therapeutic testing is not supported or refuted by the provided evidence."
    },
    "naive_doc_ids": [
      "15692098",
      "31324978",
      "22544171",
      "9767444",
      "118568"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on LMNA knock-in mouse models for HGPS or their use in testing therapies. Paper 1 reviews HGPS pathogenesis and mentions potential therapeutic strategies but does not address LMNA knock-in models. Paper 2 shows reversal of cellular HGPS phenotypes in patient fibroblasts via splice correction (in vitro). Paper 7 demonstrates therapeutic benefit of an FTI in a Zmpste24-deficient mouse model (a different progeria model, not an LMNA knock-in). The remaining papers are unrelated to HGPS models. Therefore, the evidence neither confirms nor refutes the appropriateness of LMNA knock-in models for testing therapies."
    },
    "overthinking_doc_ids": [
      "15692098",
      "22544171",
      "4462919",
      "13296399",
      "15981174"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Papers 6 and 7 address HGPS. Paper 6 is a phenotype review discussing LMNA mutations and potential therapeutic strategies but does not evaluate or mention Lmna knock-in animal models. Paper 7 demonstrates reversal of cellular defects in HGPS patient fibroblasts via splice correction, not in an in vivo Lmna knock-in model. The remaining papers concern other diseases or models (e.g., SCA1 knock-in, cancer, leukemia, Down syndrome). Therefore, there is no direct evidence here that Lmna knock-in models are appropriate for testing therapies against HGPS."
    },
    "posthoc_doc_ids": [
      "2565138",
      "10795340",
      "12240507",
      "13889962",
      "31884697"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.06,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1309",
    "claim": "Tonic signaling from the scFv prevents constitutive stimulation.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Paper 1 directly addresses tonic signaling originating from CAR scFv clustering and shows it triggers antigen-independent (constitutive) CD3\u03b6 phosphorylation and persistent signaling that leads to T cell exhaustion. It also notes that CD28 costimulation augments, while 4-1BB reduces, the exhaustion induced by this persistent signaling. This contradicts the claim that tonic signaling from the scFv prevents constitutive stimulation; instead, the scFv-driven tonic signaling is itself constitutive stimulation. The other papers do not provide relevant data on scFv-driven tonic signaling in CARs."
    },
    "naive_doc_ids": [
      "18231807",
      "5132358",
      "10906636",
      "36216395",
      "2714623"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Paper 1 directly shows that antigen-independent clustering of CAR scFv induces tonic CAR CD3-zeta phosphorylation, leading to persistent (constitutive) signaling and early T-cell exhaustion. It also notes that 4-1BB costimulation can mitigate exhaustion but does not indicate that tonic scFv signaling prevents constitutive stimulation. The other papers do not address scFv-driven tonic signaling in CARs. Therefore, the claim is contradicted by the relevant evidence."
    },
    "overthinking_doc_ids": [
      "18231807",
      "34016944",
      "20261352",
      "20568364",
      "25353658"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 4 shows that antigen-independent clustering of CAR scFvs triggers tonic CAR signaling (CD3\u03b6 phosphorylation), which constitutes persistent, antigen-independent activation and leads to T cell exhaustion. This is constitutive stimulation rather than prevention of it. No other provided papers support the idea that scFv-derived tonic signaling prevents constitutive activation."
    },
    "posthoc_doc_ids": [
      "4611267",
      "10576136",
      "14241418",
      "18231807",
      "34016944"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1207",
    "claim": "The composition of myosin-II isoform switches from the polarizable B isoform to the more homogenous A isoform during hematopoietic differentiation.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers discuss myosin-II isoform composition (IIA vs IIB) or a switch from B to A during hematopoietic differentiation. The references focus on TET2, microRNA regulation, differentiation protocols for smooth muscle cells, Polycomb components, general isoform switching in myoblasts, neurogenesis, osteoprogenitor signaling, metabolic control of HSCs, and protein expression noise, none of which provide data on myosin-II isoform switching in hematopoiesis."
    },
    "naive_doc_ids": [
      "11951999",
      "23727313",
      "11840194",
      "14581009",
      "27061085"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers present data on nonmuscle myosin-II isoform composition (NMIIA vs NMIIB) or an isoform switch during hematopoietic differentiation. Relevant mentions of myosin concern skeletal muscle myosin heavy chain isoforms in myoblast differentiation (Paper 4) and Drosophila myosin light chain regulation in oogenesis (Paper 5), which are not about hematopoietic cells or NMIIA/NMIIB. The remaining papers address HSC metabolism, regulation, niche interactions, miRNAs, and reprogramming without discussing myosin-II isoforms. Therefore, the claim is neither supported nor contradicted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "11289247",
      "13116880",
      "23727313",
      "344240",
      "735130"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Paper 3 directly addresses nonmuscle myosin-II isoforms in human hematopoiesis. It shows that MIIB (the B isoform) is a major, strongly polarized isoform in hematopoietic stem/progenitor cells and is downregulated in differentiated cells via asymmetric division. In contrast, MIIA (the A isoform) is constitutively present and becomes activated during cytokine-triggered differentiation. This implies a shift in isoform composition from polarized MIIB in early cells to predominant/active MIIA in differentiated cells, matching the claim of a switch from the polarizable B isoform to the more homogeneous A isoform during hematopoietic differentiation. Other provided papers do not contradict or materially inform this specific claim."
    },
    "posthoc_doc_ids": [
      "27061085",
      "14581009",
      "18909530",
      "9076196",
      "11289247"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.65,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "418",
    "claim": "Fibroblast Growth Factor is a ligand which signals through receptor tyrosine kinases.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.84,
      "justification": "Paper 3 explicitly identifies FGFR1 as a receptor tyrosine kinase (FGFR1TK) and uses a selective FGFR1 tyrosine kinase inhibitor (PD173074) to block signaling, demonstrating that fibroblast growth factor receptors are RTKs. This supports that fibroblast growth factors signal through receptor tyrosine kinases. Other papers discuss RTKs broadly but do not contradict this claim."
    },
    "naive_doc_ids": [
      "21931005",
      "16494316",
      "23420807",
      "34066665",
      "40710501"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.77,
      "justification": "Paper 3 explicitly identifies the fibroblast growth factor receptor (FGFR1) as a receptor tyrosine kinase (RTK) and studies selective inhibitors of FGFR1 tyrosine kinase activity (PD173074). Since FGFRs are the receptors for fibroblast growth factors (FGFs), this supports that FGF acts as a ligand that signals through RTKs. Other papers focus on different RTKs (EGFR, PDGFR, HER2) and do not contradict this, but Paper 3 provides the direct linkage via FGFR1 being an RTK."
    },
    "overthinking_doc_ids": [
      "40710501",
      "21931005",
      "23420807",
      "34066665",
      "1065627"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Among the provided papers, only Paper 4 mentions FGFR1 as a receptor tyrosine kinase target of inhibitors, but none of the papers explicitly state that fibroblast growth factor (FGF) is the ligand for FGFRs or that FGF signals through receptor tyrosine kinases. Other papers discuss RTKs (EGFR, PDGFR, VEGFR) and their signaling, but do not address FGF specifically. Therefore, the claim is not directly supported or refuted by the provided evidence."
    },
    "posthoc_doc_ids": [
      "34066665",
      "16494316",
      "21931005",
      "23420807",
      "40710501"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "4",
    "claim": "1-1% of colorectal cancer patients are diagnosed with regional or distant metastases.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Paper 6 reports that 19\u201323% of colorectal cancer patients in the Netherlands were diagnosed with synchronous distant metastases (stage IV) between 1996 and 2011\u2014far higher than 1%. Since regional metastases (stage III) would add further cases beyond distant disease, the proportion with regional or distant metastases is certainly well above 1%. Paper 1 also indicates only ~22\u201326% were stage I, implying many patients present beyond very early stage. Thus the claim that 1\u20131% are diagnosed with regional or distant metastases is contradicted by the evidence."
    },
    "naive_doc_ids": [
      "22942787",
      "2058909",
      "5641851",
      "7639744",
      "44562904"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "None of the provided papers report the proportion of colorectal cancer patients diagnosed with regional or distant metastases. Paper 1 only contrasts stage I versus stages II\u2013IV combined (without separating regional/distant). Paper 3 notes associations with stage 4 presentation but provides no absolute percentages. The other papers are about survival disparities, lung or breast cancer, prevention policy, or pulmonary nodules and do not quantify CRC stage distribution at diagnosis. Therefore, the claim cannot be verified or refuted from these sources."
    },
    "overthinking_doc_ids": [
      "22942787",
      "2058909",
      "5641851",
      "7639744",
      "27240667"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Paper 6 (nationwide, Netherlands, n=160,278) reports that 19\u201323% of colorectal cancer patients present with synchronous distant metastases (stage IV) at diagnosis\u2014far higher than 1%. Paper 1 (SEER-Medicare, 1992\u20132002) shows only 22.5\u201326.3% were stage I, implying the majority were stage II\u2013IV; even restricting to regional (stage III) and distant (stage IV), the proportion is well above 1%. Thus the claim that 1\u20131% are diagnosed with regional or distant metastases is contradicted by the evidence."
    },
    "posthoc_doc_ids": [
      "22942787",
      "2058909",
      "5641851",
      "7639744",
      "44562904"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1302",
    "claim": "Tirasemtiv has no effect on cardiac muscle.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "Only Paper 10 is about tirasemtiv (CK-2017357) and reports selective binding to the fast skeletal troponin complex with ensuing effects on skeletal muscle force. However, it does not present data or explicit results regarding effects (or lack thereof) on cardiac muscle. The other papers are unrelated to tirasemtiv. Therefore, the provided evidence does not directly confirm that tirasemtiv has no effect on cardiac muscle."
    },
    "naive_doc_ids": [
      "9622258",
      "13481731",
      "8509018",
      "25301182",
      "26341063"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "Only Paper 6 discusses tirasemtiv (CK-2017357), showing it selectively activates fast skeletal troponin and increases skeletal muscle force. It does not present data on cardiac muscle or cardiac troponin, nor report cardiac functional effects. All other papers are unrelated to tirasemtiv. Therefore, the provided evidence neither confirms nor refutes the claim that tirasemtiv has no effect on cardiac muscle."
    },
    "overthinking_doc_ids": [
      "31200375",
      "40156901",
      "106301",
      "1507222",
      "4164929"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Among the provided papers, only Paper 6 is about tirasemtiv (CK-2017357), describing it as a fast-skeletal-troponin activator with selective binding to the fast skeletal troponin complex. However, the excerpt does not present data on cardiac muscle or explicitly state lack of cardiac effects. The other papers are unrelated to tirasemtiv or cardiac muscle effects. Therefore, the evidence provided does not confirm or refute the claim that tirasemtiv has no effect on cardiac muscle."
    },
    "posthoc_doc_ids": [
      "31200375",
      "40156901",
      "106301",
      "1507222",
      "4164929"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "81",
    "claim": "Acute ablation of Snail in the embryonic cortex affects the proliferation and number of embryonic cortical precursors.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Paper 1 directly shows that Snail knockdown in embryonic murine cortical radial glial precursors reduces their proliferation and causes survival deficits (rescued by p53 knockdown), and that decreased proliferation/differentiation is rescued by Cdc25b coexpression. These findings indicate that acute loss of Snail affects both proliferation and the number (via survival/self-renewal) of embryonic cortical precursors. The other papers do not address Snail in embryonic cortex."
    },
    "naive_doc_ids": [
      "38919140",
      "6285534",
      "15833835",
      "29231620",
      "2356950"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 2 directly demonstrates that Snail knockdown in radial glial precursors of the embryonic murine cortex decreases their proliferation and survival, thereby reducing precursor numbers. Proliferation deficits are rescued by Cdc25b coexpression, and survival deficits are rescued by p53 knockdown, indicating specific pathways through which Snail controls precursor proliferation and number. The other papers do not address Snail in embryonic cortical precursors."
    },
    "overthinking_doc_ids": [
      "29231620",
      "38919140",
      "6285534",
      "15833835",
      "23901235"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 3 directly shows that Snail knockdown in embryonic murine cortical radial glial precursors decreases their proliferation and survival, with rescue by Cdc25b (for proliferation) and p53 knockdown (for survival), indicating reduced precursor numbers upon acute loss of Snail function. The other papers do not address Snail and are not relevant to this claim."
    },
    "posthoc_doc_ids": [
      "16964262",
      "33796570",
      "38919140",
      "2437807",
      "4679264"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1332",
    "claim": "Tumor necrosis factor alpha (TNF-\u03b1) and interleukin-1 (IL-1) are pro-inflammatory cytokines that inhibit IL-6 and IL-10.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "Across the provided papers, TNF-\u03b1 and IL-1\u03b2 are shown as pro-inflammatory (e.g., TNF-\u03b1 promoting atherosclerosis in Paper 3; IL-1\u03b2/TNF-\u03b1 as inflammatory mediators in arthritis context in Paper 7), but none present data showing that TNF-\u03b1 or IL-1 inhibit IL-6 or IL-10. Paper 10 shows CRP decreases IL-10, not TNF-\u03b1/IL-1. No study here reports TNF-\u03b1 or IL-1 suppressing IL-6 or IL-10, so the specific inhibitory part of the claim is unsupported by the provided evidence."
    },
    "naive_doc_ids": [
      "36386637",
      "207972",
      "22889972",
      "16066726",
      "35766603"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Across the provided papers, none present data showing that TNF-\u03b1 or IL-1 inhibit IL-6 or IL-10. The papers discuss assay technologies (Paper 1), apoptosis mechanisms (Paper 2), statin effects on inflammatory markers including IL-6 and TNF-\u03b1 (Paper 3), lifestyle effects on IVF (Paper 4), PGE2 regulation of TNF-\u03b1/IL-12 (Paper 5), TGR5-mediated anti-inflammatory effects (Paper 6), PD-1\u2013induced IL-10 production (Paper 7), \u03b1-synuclein-induced inflammation (Paper 8), HMGB1\u2013TLR4 pro-inflammatory signaling (Paper 9), and succinate-induced IL-1\u03b2 via HIF-1\u03b1 (Paper 10). None provide evidence that TNF-\u03b1 or IL-1 suppress IL-6 or IL-10; nor do they directly refute or confirm such inhibition."
    },
    "overthinking_doc_ids": [
      "159469",
      "238409",
      "2391552",
      "2787558",
      "9159125"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers present data about TNF-\u03b1 or IL-1 effects on IL-6 or IL-10. The studies focus on extracellular vesicles, RNAi and transcription, TRIM proteins and HBV, Th2 cytokines and autophagy, HCMV UL142 and NK cells, Notch/Numb in breast cancer, PPAR\u03b1 in melanoma, JMJD6 and p53, LXR\u03b1 and cholesterol efflux, and TDP43/SRSF3 in TNBC. They do not address cytokine interactions among TNF-\u03b1, IL-1, IL-6, or IL-10."
    },
    "posthoc_doc_ids": [
      "1905095",
      "4411760",
      "8692744",
      "30774694",
      "38747567"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "176",
    "claim": "BiP is a general endoplasmic reticulum stress marker.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.84,
      "justification": "Paper 1 explicitly identifies HSPA5 (BiP) as an ER chaperone and shows its increased expression/protein levels in multiple ER stress contexts: palmitate-treated beta cells, islets from db/db mice, and human type 2 diabetic pancreas. The study refers to upregulated \"marker genes of ER stress\" and includes HSPA5 among them, alongside CHOP, DNAJC3 and XBP1 splicing, supporting its use as a general ER stress marker. The other provided papers do not contradict this and largely do not address BiP."
    },
    "naive_doc_ids": [
      "25510546",
      "9752604",
      "35760786",
      "1554348",
      "6669242"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 1 explicitly identifies HSPA5/BiP as an ER chaperone whose expression is upregulated during ER stress and lists it among ER stress marker genes. It shows increased BiP/HSPA5 in palmitate-induced ER stress in MIN6 beta cells, in islets from db/db mice, and elevated BiP protein in human type 2 diabetic pancreas sections, supporting its use as an ER stress marker. The other papers do not provide relevant or contradictory information."
    },
    "overthinking_doc_ids": [
      "25510546",
      "8453819",
      "19561411",
      "29459383",
      "38477436"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.75,
      "justification": "Paper 1 explicitly identifies HSPA5 (BiP) as an ER chaperone and shows its upregulation under ER stress conditions: palmitate-treated beta cells, islets from db/db mice, and human type 2 diabetic islets all display increased HSPA5/BiP expression. The study also refers to HSPA5 among ER stress marker genes and demonstrates that modulating HSPA5 affects ER-stress\u2013linked apoptosis. This directly supports the use of BiP as an ER stress marker. The other papers do not provide additional direct evidence regarding BiP as a stress marker."
    },
    "posthoc_doc_ids": [
      "25510546",
      "8453819",
      "19561411",
      "29459383",
      "38477436"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "404",
    "claim": "Expression of oncolytic virus antigens as peptides permits additional protection against relapse.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers test or report that expressing oncolytic virus antigens as peptides confers additional protection against tumor relapse. The set covers topics such as stroke therapy (Paper 1), tumor recurrence driven by innate resistance without reference to oncolytic viral antigens or peptide vaccination (Paper 2), a bacterial peptide epitope and antigen presentation (Paper 3), syncope outcomes (Paper 4), CAR T-cell therapy outcomes in ALL (Paper 5), a proresolving peptide for atherosclerosis (Paper 6), Nrf2-mediated protection in influenza infection (Paper 7), pertussis vaccine transmission dynamics (Paper 8), Ang-1 vascular permeability mechanisms (Paper 9), and HSV-2 replication-defective vaccine protection against viral challenge (Paper 10). While Papers 3, 6, and 10 involve peptides or viral immunity, none address oncolytic viruses, peptide expression of oncolytic virus antigens, or demonstrate added protection against cancer relapse."
    },
    "naive_doc_ids": [
      "33884866",
      "1921218",
      "35612665",
      "323335",
      "3462075"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers evaluate or report that expressing oncolytic virus antigens as peptides confers additional protection against tumor relapse. The evidence includes epitope vaccines for Helicobacter pylori (Papers 1\u20132), a chikungunya vaccine platform (Paper 3), HSV-2 replication-defective strains conferring protection against viral challenge (Paper 4), tumor microenvironment myeloid cell effects (Paper 5), oncolytic adenoviruses armed with IL-24 (Paper 6) or selective replication in p53-deficient tumors (Paper 9), strategies for detecting/targeting relapse via innate resistance (Paper 8), and CAR T-cell therapy in ALL (Paper 10). None address peptide expression of oncolytic virus antigens or demonstrate added anti-relapse protection from such an approach."
    },
    "overthinking_doc_ids": [
      "2837758",
      "13965483",
      "24922825",
      "40584205",
      "219475"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address oncolytic viruses or strategies involving expression of oncolytic virus antigens as peptides to provide added protection against tumor relapse. The papers cover topics such as 2A peptide use in antibody production, EBV EBNA1 functions, T cell trafficking and PD-1 regulation, tumor relapse detection via innate resistance, EGFR in GBM, RET signaling, and keratin/Aire pathways\u2014none provide experimental evidence supporting or contradicting the specific claim."
    },
    "posthoc_doc_ids": [
      "26108767",
      "643765",
      "3765739",
      "11048759",
      "12100963"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "687",
    "claim": "Lamins are found within the inner layer of the nuclear membrane of all cells.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Papers 1 and 3 show lamins (e.g., lamin B1) are components of the nuclear lamina in mammalian cells, consistent with lamins being at the inner nuclear membrane. However, Paper 8 explicitly states that the yeast Saccharomyces cerevisiae lacks lamins, directly refuting the universality of the claim ('all cells'). Therefore, the claim is false as stated."
    },
    "naive_doc_ids": [
      "4452659",
      "4324278",
      "25036988",
      "25623469",
      "34747208"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "Among the provided papers, only Paper 1 discusses lamins (lamin B1) and confirms their involvement in the nuclear lamina in mammalian cells. None of the papers provide evidence that lamins are located at the inner nuclear membrane in all cells across taxa. Several papers are unrelated to lamins or nuclear lamina. Therefore, the evidence does not confirm the universality claimed."
    },
    "overthinking_doc_ids": [
      "4452659",
      "25623469",
      "5914739",
      "29422484",
      "43054703"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 1 shows that lamins (e.g., lamin B1) are nuclear lamina proteins associated with the nuclear envelope in mammalian cells. However, Paper 8 demonstrates that human red blood cells lack a nucleus entirely. Cells without a nucleus cannot have an inner nuclear membrane or lamins associated with it. Therefore, the universal claim that lamins are found in the inner layer of the nuclear membrane of all cells is false."
    },
    "posthoc_doc_ids": [
      "4452659",
      "25623469",
      "5914739",
      "29422484",
      "43054703"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "484",
    "claim": "H4 G94P proteins induce chromatin assembly, which increases free histones.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers mention the H4 G94P mutation or test its effects. While several papers discuss nucleosome/chromatin assembly and histone chaperones (e.g., H3K56 acetylation enhancing CAF-1/Rtt106-mediated assembly; roles of ASF1/Asf1 and nucleosome reassembly at PHO5), they do not address H4 G94P or report that chromatin assembly increases free histones. Therefore the claim cannot be verified from the supplied evidence."
    },
    "naive_doc_ids": [
      "12588500",
      "29877890",
      "20781656",
      "24311787",
      "175735"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention the H4 G94P mutation or provide data showing that H4 G94P proteins induce chromatin assembly or increase free histones. The papers cover topics such as SWR1-mediated H2A.Z exchange, H3K56 acetylation in replication-coupled nucleosome assembly, general roles of histone modifications, histone chaperones, promoter nucleosome reassembly, and other chromatin processes, but do not address H4 G94P. Therefore, the specific claim is not supported or refuted by the given evidence."
    },
    "overthinking_doc_ids": [
      "24311787",
      "12588500",
      "20630805",
      "29877890",
      "36831892"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers mention the H4 G94P mutation or examine whether H4 G94P proteins induce chromatin assembly or affect levels of free histones. The papers address other topics such as H2A.Z deposition (Paper 1), histone acetylation effects (Papers 2\u20133), general histone chaperone function and nucleosome assembly (Papers 4, 7), promoter reassembly dynamics (Paper 5), ALT induction via ASF1 depletion (Paper 6), H3.3 mutations in glioblastoma (Paper 8), CENP-A assembly (Paper 9), and condensin-mediated chromatin remodeling (Paper 10). Therefore, there is no direct evidence provided to confirm or refute the specific claim about H4 G94P."
    },
    "posthoc_doc_ids": [
      "24311787",
      "7137057",
      "12588500",
      "29877890",
      "406733"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1345",
    "claim": "Up-regulation of the p53 pathway and related molecular events speeds cancer progression.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address the p53 pathway or its up-regulation. The studies focus on PI3K/AKT/mTOR, Wnt/BCL9, Src, Arf6/VEGFR2, glutaminase dependence, and tumor microenvironment components (CAF-derived SDF-1, oxidative stress with Cav-1 loss, adipocytes, macrophages) in promoting tumor progression. Therefore, they neither support nor contradict the specific claim about p53 pathway up-regulation accelerating cancer progression."
    },
    "naive_doc_ids": [
      "13329980",
      "33638477",
      "45764440",
      "6944800",
      "9600826"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers evaluate whether up-regulation of the p53 pathway accelerates cancer progression. Most focus on unrelated pathways (e.g., Nrf2/HO-1, NF-\u03baB, STAT3, glutamine transport, immune modulation) or general antitumor effects. One paper (Paper 3) notes increased p53 expression in cyclosporine A\u2013treated renal cells leading to apoptosis, but this is not a cancer context and does not address tumor progression. Therefore, the set provides no relevant evidence for the specific claim."
    },
    "overthinking_doc_ids": [
      "27093166",
      "32852283",
      "238409",
      "1522336",
      "7869794"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.84,
      "justification": "None of the provided papers present data on up-regulation of the p53 pathway accelerating cancer progression. The studies focus on other pathways (PI3K/AKT/mTOR, SREBP2, Wnt/BCL9, integrin \u03b1v\u03b23/c-Src, IAP/NF-\u03baB/IFN, MAPK-Notch, miR-196/JNK, NRAGE). Paper 6 discusses senescence and regulation of p15/p21 (which can be p53-related effectors) in the context of tumor suppression via SASP, which does not support the claim and if anything trends opposite, but it does not directly address p53 pathway up-regulation promoting progression. Therefore, there is no direct evidence here to confirm or refute the specific claim."
    },
    "posthoc_doc_ids": [
      "13329980",
      "4583180",
      "33638477",
      "1782201",
      "3981033"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "617",
    "claim": "Increased mobility of retrotransposons is assosciated with mutation and higher tumorigenesis rates.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "The provided papers do not present data on endogenous retrotransposon (e.g., LINE-1/Alu) mobility or directly link increased retrotransposition to mutation burden and tumorigenesis. Paper 4 discusses insertional mutagenesis from exogenous retroviral gene therapy vectors, which is mechanistically related but not evidence about endogenous retrotransposon mobility in cancer. The remaining papers address chromosomal instability, microsatellite instability, KRAS alterations, epigenetic changes, p53 status, and ROS-induced DNA damage without mentioning retrotransposon activity."
    },
    "naive_doc_ids": [
      "7211056",
      "11271123",
      "1286352",
      "1944452",
      "3210545"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Paper 2 shows that highly active (\u201chot\u201d) LINE-1 retrotransposons are abundant and continue to generate new insertions, indicating ongoing retrotransposition as a major source of genetic variation (i.e., mutations). Paper 6 reports that lower methylation of LINE-1 repeats in blood leukocyte DNA\u2014consistent with derepression of LINE-1 and potential for increased activity\u2014is associated with higher risk of hepatocellular carcinoma. Together, these findings support an association between increased retrotransposon activity and both mutation and elevated tumorigenesis risk, although Paper 6 assesses LINE-1 hypomethylation as a surrogate rather than directly measuring mobility."
    },
    "overthinking_doc_ids": [
      "2608447",
      "13949015",
      "30369606",
      "4312169",
      "4378885"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers address retrotransposon mobility (e.g., LINE-1/Alu/SVA transposition) or its association with mutation burden or tumorigenesis. The studies focus on receptor polymorphisms, KRAS amplification/mutation, MECP2 knockout phenotypes, presenilin mutations and A\u03b2 dynamics, histone H3.3K27M-driven gliomagenesis, stromal oxidative stress and genomic instability, dasatinib response predictors, whole-genome doubling and chromosomal instability, glioblastoma genomic landscapes, and mismatch repair/MSI in endometrial cancer. These topics do not provide data about retrotransposon activity or its link to cancer risk."
    },
    "posthoc_doc_ids": [
      "3127341",
      "3210545",
      "8698208",
      "8892905",
      "12887068"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1405",
    "claim": "taa1 tar1 tar2 triple mutants in Arabidopsis do not make root meristem during embryogenesis.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "Among the provided papers, none present data on Arabidopsis taa1 tar1 tar2 triple mutants or explicitly assess root meristem formation during embryogenesis. Paper 3 discusses TAA1 (WEI8) and its paralogues in auxin biosynthesis and development broadly, but the excerpt does not mention triple mutants or embryonic root meristem phenotypes. The other papers are unrelated to this specific claim."
    },
    "naive_doc_ids": [
      "5849439",
      "7681810",
      "10504681",
      "40429879",
      "14308244"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers present data on Arabidopsis taa1 tar1 tar2 triple mutants or explicitly assess root meristem formation during embryogenesis. Paper 2 links TAA1 to auxin biosynthesis and development but does not address the triple mutant or embryonic root meristems. Paper 9 concerns a rice TAA ortholog (FIB) and general root defects, not Arabidopsis embryogenesis. The remaining papers are unrelated to TAA/TAR embryonic root meristem formation. Therefore, the evidence set does not confirm or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "5849439",
      "10504681",
      "14926162",
      "20402596",
      "20868160"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 2 discusses TAA1 and auxin biosynthesis in Arabidopsis, but it does not report embryonic root meristem formation phenotypes of taa1 tar1 tar2 triple mutants. The remaining papers address unrelated topics (e.g., pollen development, vesicle transport, rice crown roots, cellulose biosynthesis, DNA repair, mammalian and Drosophila embryogenesis, plant defense). There is no direct evidence here confirming or refuting that taa1 tar1 tar2 triple mutants fail to make a root meristem during embryogenesis."
    },
    "posthoc_doc_ids": [
      "5849439",
      "10504681",
      "14926162",
      "20402596",
      "20868160"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "398",
    "claim": "Exhaustion of B cells contributes to poor Ab response in HIV-infected individuals.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Paper 2 provides direct evidence that HIV infection is associated with B-cell dysfunction characterized by exhaustion (loss of CD21) and activation/apoptotic signaling (upregulation of CD95). The authors describe these as dysfunctional states within the B-cell compartment and note that progressive HIV infection is marked by B-cell anergy and exhaustion. Such exhaustion/anergy is mechanistically consistent with impaired, poor antibody responses. The other papers are not relevant to B-cell exhaustion in HIV and do not contradict this. While Paper 2 does not directly quantify antibody titers, it establishes B-cell exhaustion as a feature of HIV-associated B-cell dysfunction, supporting the claim that it contributes to poor antibody responses."
    },
    "naive_doc_ids": [
      "3155731",
      "20261352",
      "24879055",
      "9550981",
      "12966719"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers present data on B-cell exhaustion in HIV or its impact on antibody responses. The only HIV-focused study (Paper 2) addresses liver histology in HCV/HIV coinfection, not B-cell function. Other papers cover topics such as ES cells, tissue-resident T cells, CMV vIL-10 effects on myeloid cells, HSCT-related lung syndromes, and general B-cell migration mechanisms without reference to HIV or B-cell exhaustion."
    },
    "overthinking_doc_ids": [
      "10546779",
      "25134146",
      "26182390",
      "26873988",
      "30398773"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address B cell exhaustion in the context of HIV infection or its impact on antibody responses. Papers 1 and 10 discuss B cell migration and EBI2 in humoral responses, but not HIV or exhaustion. The remaining papers focus on unrelated topics (ATLL therapy, cancer prognosis, neutrophil ADCC, ovarian stimulation, iNKT cells, tissue-resident T cells, CpG nanoparticles). Therefore, there is no relevant evidence here to support or contradict the claim."
    },
    "posthoc_doc_ids": [
      "38587347",
      "39443128",
      "3899896",
      "7869794",
      "8642784"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1315",
    "claim": "Transcription rates in S. cerevisiae range between 7 and 12 kb/min.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.85,
      "justification": "Among the provided papers, only Paper 1 and Paper 3 address transcription elongation in S. cerevisiae, and neither abstract reports quantitative elongation rates. Paper 3 discusses factors affecting elongation rate and processivity but gives no numeric values. The remaining papers focus on different organisms (e.g., C. elegans, mammals, bacteria) or unrelated processes (replication, ribosome biogenesis, protein noise). Therefore, the evidence presented does not confirm or refute the specific claim that transcription rates in S. cerevisiae range between 7 and 12 kb/min."
    },
    "naive_doc_ids": [
      "29788648",
      "4411760",
      "13072112",
      "41087952",
      "23664875"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided paper excerpts report quantitative transcription elongation rates in S. cerevisiae. While some papers discuss elongation mechanisms or factors affecting rate/processivity, they do not provide numeric values that could confirm or refute the claimed 7\u201312 kb/min range."
    },
    "overthinking_doc_ids": [
      "13072112",
      "41087952",
      "29788648",
      "42421723",
      "365896"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 1 and Paper 3 discuss transcription elongation by RNA polymerase II in S. cerevisiae, but neither abstract reports absolute elongation rates or numeric values. Paper 1 states that Esa1 stimulates elongation, and Paper 3 distinguishes elongation rate from processivity and reports relative effects of mutations and drugs, but no kb/min values are given. The remaining papers are unrelated to Pol II elongation rates. Therefore, the evidence provided does not confirm or refute the specific range of 7\u201312 kb/min."
    },
    "posthoc_doc_ids": [
      "29788648",
      "4411760",
      "13072112",
      "41087952",
      "365896"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "411",
    "claim": "Febrile seizures reduce the threshold for development of epilepsy.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Only Paper 8 addresses febrile seizures, showing they produce long-lasting changes in neuronal excitability in limbic circuits and arguing against their benign nature. However, it does not directly measure epilepsy incidence, epileptogenesis, or a reduced threshold for developing epilepsy. The other papers are unrelated to febrile seizures and epileptogenesis. Therefore, the provided evidence does not directly confirm that febrile seizures reduce the threshold for development of epilepsy."
    },
    "naive_doc_ids": [
      "23136735",
      "5691302",
      "195680777",
      "6793674",
      "7552215"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers examine febrile seizures or their effect on later epilepsy risk or seizure threshold. Papers 6\u201310 address epileptogenesis mechanisms and genetics in temporal lobe epilepsy but do not involve febrile seizures, and the remaining papers concern unrelated topics (cardiovascular risk, dietary flavonols, bacterial meningitis sequelae, dengue risk factors, and smoking after lung cancer). Therefore, the evidence set does not contain relevant data to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "6793674",
      "12102963",
      "27866735",
      "2097256",
      "7639744"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Only Paper 1 addresses febrile seizures, showing long-lasting synaptic changes in hippocampal circuits after hyperthermia-induced seizures in immature rats and arguing against the strictly benign view. However, it does not demonstrate that febrile seizures lower the threshold for developing epilepsy or increase subsequent epilepsy incidence. The other papers concern unrelated topics (astrocyte-neuron dynamics in focal seizures, ketogenic diet efficacy, mTOR in epileptogenesis unrelated to febrile seizures, sepsis risk tools, comorbidities and febrile neutropenia, DVT after stroke, H. pylori and gastric cancer, adipokines and endometrial cancer, and yeast aging). Therefore, the provided evidence does not directly confirm or refute the specific claim."
    },
    "posthoc_doc_ids": [
      "14924526",
      "1410197",
      "23670644",
      "116792",
      "3878434"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.22,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "507",
    "claim": "Helminths interfere with immune system control of macrophages activated by IL-4 favor Mycobacterium tuberculosis replication.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Paper 1 shows that helminth infection (Nippostrongylus brasiliensis) increases M. tuberculosis burden via the IL-4R\u03b1 pathway, leading to accumulation of alternatively activated (IL-4\u2013driven) macrophages. IL-4R\u03b1-deficient mice are more resistant and have fewer AAMs, and adoptive transfer experiments implicate macrophage IL-4R signaling directly in heightened susceptibility. Paper 6 provides a mechanistic basis: IL-4/IL-13 inhibit autophagy-mediated killing of intracellular M. tuberculosis in macrophages, thereby favoring bacterial persistence/replication. Together, these data support the claim that helminth-induced IL-4\u2013activated macrophages impair immune control and promote M. tuberculosis replication."
    },
    "naive_doc_ids": [
      "7433668",
      "7970974",
      "22621251",
      "1386103",
      "16066726"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 directly shows that helminth infection (Nippostrongylus brasiliensis) induces an IL-4/IL-4R\u03b1\u2013driven Th2 environment in mice, leading to accumulation of alternatively activated (IL-4\u2013activated) macrophages in the lung and a higher Mycobacterium tuberculosis burden. Co-infected IL-4R\u03b1\u2212/\u2212 mice had reduced AAM accumulation and improved control of Mtb, and adoptive transfer of wild-type (IL-4R\u03b1\u2013competent) macrophages into IL-4R\u03b1\u2212/\u2212 mice increased Mtb burden, indicating a macrophage-intrinsic IL-4R pathway that favors Mtb persistence/replication. Other papers provided do not address helminth\u2013IL-4\u2013macrophage interactions with Mtb and do not contradict this finding."
    },
    "overthinking_doc_ids": [
      "7433668",
      "4319174",
      "11837657",
      "7230315",
      "19851614"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 5 shows that helminth infection (Nippostrongylus brasiliensis) induces a Th2 environment that engages the IL-4R\u03b1 pathway, accumulates alternatively activated (IL-4-driven) macrophages in the lung, and increases M. tuberculosis burden. Co-infected IL-4R\u03b1\u2212/\u2212 mice control Mtb better, and adoptive transfer of wild-type (IL-4R\u03b1+) macrophages into IL-4R\u03b1\u2212/\u2212 mice increases Mtb load, indicating a macrophage-intrinsic IL-4R effect. Paper 2 mechanistically supports this by showing IL-4/IL-13 inhibit autophagy and autophagy-mediated killing of intracellular M. tuberculosis in murine and human macrophages. Together, these data indicate helminth-induced IL-4 signaling in macrophages interferes with antimicrobial control and favors M. tuberculosis replication."
    },
    "posthoc_doc_ids": [
      "11837657",
      "30774694",
      "7230315",
      "33535222",
      "7433668"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.82,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "209",
    "claim": "CHOP is a general endoplasmic reticulum stress marker.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.85,
      "justification": "Paper 1 shows that ER stress induced by palmitate in beta cells leads to time-dependent increases in Ddit3 (CHOP) mRNA and protein, and elevated CHOP in islets from db/db mice and humans with type 2 diabetes\u2014consistent with CHOP being part of the ER stress/unfolded protein response. Paper 2 shows that disrupting ER lipid homeostasis (ARV1 deficiency) induces the UPR and specifically upregulates ATF4 and CHOP in murine macrophages, with further CHOP elevation upon cholesterol loading. Together these provide experimental evidence that CHOP is induced under ER stress conditions, supporting its use as a general ER stress marker. Other listed papers do not address CHOP/ER stress directly."
    },
    "naive_doc_ids": [
      "25510546",
      "35760786",
      "9752604",
      "1554348",
      "6669242"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Paper 1 shows that palmitate-induced ER stress in beta cells increases Ddit3 (CHOP) mRNA and protein, alongside other ER stress markers, and that ER stress is present in human T2D islets. Paper 2 reports that cyclosporine A induces expression of ER stress markers HERP, GRP78, and CHOP in renal cells. Across different cell types and stressors, CHOP is upregulated with ER stress, supporting its use as a general ER stress marker."
    },
    "overthinking_doc_ids": [
      "25510546",
      "238409",
      "2787558",
      "4951831",
      "7373453"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 shows that ER stress induced by palmitate in beta cells leads to time-dependent upregulation of Ddit3 (CHOP) alongside other ER stress markers, and increased CHOP protein is observed in human type 2 diabetic islets. They explicitly treat Ddit3/CHOP as an ER stress marker and confirm ER stress by XBP1 splicing. Paper 6 (systematic review) reports that cyclosporine A increases CHOP together with classic ER stress markers (GRP78/HSPA5, HERP) in renal cells. Together, these independent contexts (pancreatic beta cells and renal cells) support that CHOP is broadly used as an ER stress marker. Other provided papers do not address CHOP/ER stress and neither contradict this claim."
    },
    "posthoc_doc_ids": [
      "25510546",
      "8453819",
      "19561411",
      "29459383",
      "38477436"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1188",
    "claim": "The ability of activator E2Fs in preventing cell death is limited to terminally differentiated cells.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 8 directly addresses E2F1-3 and shows that in normal dividing progenitor cells, E2F1-3 are necessary for cell survival (i.e., they prevent cell death). In differentiating cells, E2F1-3 function as repressors with Rb to facilitate cell-cycle exit, not specifically to prevent death. Therefore, the anti-apoptotic function of activator E2Fs is present in progenitor cells and is not limited to terminally differentiated cells. Other papers do not provide relevant evidence regarding E2Fs."
    },
    "naive_doc_ids": [
      "22890091",
      "9197092",
      "25439264",
      "34436231",
      "33370"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 2 shows that in normal dividing progenitor cells, E2F1-3 act as transcriptional activators and are necessary for cell survival (i.e., prevent cell death). In differentiating cells, E2F1-3 function with Rb as repressors to facilitate cell-cycle exit. Thus, the anti-apoptotic/survival role of activator E2Fs is present in progenitor cells and is not limited to terminally differentiated cells. The other papers do not provide relevant evidence about E2F-mediated cell survival."
    },
    "overthinking_doc_ids": [
      "2452989",
      "4394817",
      "38502066",
      "20524091",
      "21439640"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.84,
      "justification": "Paper 7 reports that E2F1-3 are required for survival of normal dividing progenitor cells, demonstrating an anti-apoptotic role outside terminally differentiated cells. This directly opposes the claim that their ability to prevent cell death is limited to terminally differentiated cells. Additionally, Paper 6 shows E2F3 can promote apoptosis after DNA damage, indicating context-dependent pro-death activity rather than a general death-preventing role confined to terminal differentiation."
    },
    "posthoc_doc_ids": [
      "7224723",
      "10486817",
      "38502066",
      "3435889",
      "14060030"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1316",
    "claim": "Transferred UCB T cells acquire a memory-like phenotype in recipients.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers present data or findings on the phenotype of transferred umbilical cord blood (UCB) T cells in recipients. Paper 2 discusses immune reconstitution after UCB transplantation but, in the provided summary, does not address acquisition of a memory-like phenotype. The remaining papers focus on stem cells, leukemia, angiogenesis, iPSC generation, neural stem cells, or engineered T cells unrelated to UCB T-cell memory phenotype."
    },
    "naive_doc_ids": [
      "8790729",
      "27243019",
      "11344428",
      "12899612",
      "25985964"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers present data showing that transferred umbilical cord blood (UCB) T cells acquire a memory-like phenotype in recipients. Paper 1 discusses immune reconstitution after UCB transplantation in general but does not report phenotypic conversion of transferred UCB T cells. The remaining papers focus on unrelated topics (e.g., mesenchymal stem cells, donor cell leukemia, iPSC generation, general T cell memory biology in non-UCB contexts, and cerebral palsy therapy) and do not address the specific claim."
    },
    "overthinking_doc_ids": [
      "27243019",
      "8790729",
      "11344428",
      "25985964",
      "23073816"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on the phenotype of transferred umbilical cord blood (UCB) T cells in recipients. Paper 2 reviews immune reconstitution after UCB transplantation but does not report that transferred UCB T cells acquire a memory-like phenotype. The remaining papers address unrelated topics (e.g., MSC-derived islet-like cells, VSELs, donor cell leukemia, MSC microvesicles, HSC cycling, iPSC epigenetic memory, lncRNA in HCC, HIV TFH permissivity, and CD28 in mouse T cell memory). Therefore, there is no direct evidence here confirming or refuting the claim."
    },
    "posthoc_doc_ids": [
      "8790729",
      "27243019",
      "25985964",
      "11344428",
      "12899612"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "313",
    "claim": "De novo assembly of sequence data has shorter contigs than unassembled sequence data.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 2 shows that de novo assembly (Trinity) reconstructs full-length transcripts, which are much longer than raw sequencing reads (i.e., unassembled sequence data). This directly opposes the claim that de novo assembly yields shorter contigs than unassembled data. Paper 1 discusses assembly fragmentation under GC bias but does not compare assembled contig lengths to unassembled reads. Papers 3\u20136 are not relevant to contig length versus unassembled data."
    },
    "naive_doc_ids": [
      "14464451",
      "32770503",
      "143251",
      "11041152",
      "13123189"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the papers compare de novo assembly contig lengths to 'unassembled sequence data'. Unassembled data are reads and do not have contigs. Paper 1 discusses assembly fragmentation due to GC bias (shorter contigs under strong bias) but not relative to unassembled data. Papers 2 and 4 report de novo assemblies without such a comparison. Papers 3, 5, 6, and 7 are unrelated to contig length comparisons. The claim is also ill-posed because contigs arise only after assembly."
    },
    "overthinking_doc_ids": [
      "14464451",
      "32770503",
      "143251",
      "14185503",
      "13123189"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Paper 4 reports that de novo transcriptome assembly (Trinity) reconstructs many full-length transcripts, implying assembled sequences (contigs/transcripts) are longer than the short unassembled reads. Paper 1 notes factors that can fragment assemblies (e.g., GC bias) but also shows this can be rescued with more data, not that assembled contigs are shorter than unassembled reads. The remaining papers are unrelated to contig length or de novo sequence assembly. Thus, the claim that de novo assembly yields shorter contigs than unassembled sequence data is contradicted by the relevant evidence."
    },
    "posthoc_doc_ids": [
      "14464451",
      "143251",
      "25041967",
      "32770503",
      "600808"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.12,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "11",
    "claim": "4-PBA treatment raises endoplasmic reticulum stress in response to general endoplasmic reticulum stress markers.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers examine 4-phenylbutyric acid (4-PBA) or its effects on endoplasmic reticulum (ER) stress markers. While several papers discuss ER stress and unfolded protein response in other contexts (e.g., lipid-induced ER stress, ARV1 deficiency, AMPK-Nrf2 signaling), there is no experimental evidence here about 4-PBA increasing ER stress or ER stress marker expression."
    },
    "naive_doc_ids": [
      "25510546",
      "35760786",
      "6669242",
      "9752604",
      "1554348"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers investigate 4-phenylbutyrate (4-PBA) or its effects on endoplasmic reticulum stress. While Paper 5 discusses ER stress markers (ATF4, CHOP/DDIT3, DNAJC3, XBP1) in beta cells, it does not assess 4-PBA treatment. The other papers focus on diet, cryotherapy, psychological stress, oxidative stress, and immune responses, and are not relevant to 4-PBA or ER stress modulation by 4-PBA."
    },
    "overthinking_doc_ids": [
      "5687200",
      "7198295",
      "21093407",
      "22467585",
      "25510546"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers assess the effect of 4-phenylbutyrate (4-PBA) on endoplasmic reticulum stress or its markers. While some papers discuss ER stress induced by palmitate in beta cells, others address unrelated topics (diet, oxidative stress, protein acetylation, bone markers, lncRNAs, replication stress). There is no experimental data here about 4-PBA increasing ER stress."
    },
    "posthoc_doc_ids": [
      "25510546",
      "5687200",
      "6669242",
      "8037453",
      "13958154"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.06,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "606",
    "claim": "Increased conversion of PGE 2 to PPARy ligand 15-ket-PGE 2 causes accumulation of PGE.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 1 shows that 15-hydroxyprostaglandin dehydrogenase (15-PGDH) catalyzes the degradation of PGE2 to 15-keto-PGE2. When 15-PGDH is down-regulated, PGE2 degradation decreases and PGE2 accumulates in tissues. This implies the opposite of the claim: increased conversion to 15-keto-PGE2 would lower, not increase, PGE2 levels. Paper 3 identifies 15-keto-PGE2 as a PPAR\u03b3 ligand but does not support that increased conversion causes PGE accumulation."
    },
    "naive_doc_ids": [
      "21181273",
      "34101101",
      "712078",
      "9178310",
      "3882374"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Paper 1 shows that 15-hydroxyprostaglandin dehydrogenase (15-PGDH) enzymatically converts PGE2 to its metabolite 15-keto-PGE2 (a PPAR\u03b3 ligand), i.e., this conversion represents PGE2 degradation. Down-regulation or genetic disruption of 15-PGDH reduces this conversion and is associated with elevated PGE2 levels, indicating that decreased (not increased) conversion leads to PGE2 accumulation. Paper 6 identifies 15-keto-PGE2 as an endogenous PPAR\u03b3 ligand and reports reduced 15-keto-PGE2 in Cftr-deficient tissues, consistent with diminished conversion, but provides no evidence that increasing conversion causes PGE2 accumulation. Together, the evidence indicates that increased conversion to 15-keto-PGE2 would lower PGE2, contradicting the claim."
    },
    "overthinking_doc_ids": [
      "21181273",
      "33370",
      "9334631",
      "980008",
      "1686997"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Only Paper 1 is relevant to PGE2/15-keto-PGE2 and reports reduced amounts of the PPAR\u03b3 ligand 15-keto-PGE2 in Cftr-deficient tissues. It provides no data on increased conversion of PGE2 to 15-keto-PGE2 or on resulting accumulation of PGE2. The other papers do not address PGE2 metabolism or 15-keto-PGE2. Therefore, the provided evidence does not confirm or refute the specific claim."
    },
    "posthoc_doc_ids": [
      "712078",
      "3127341",
      "31564409",
      "327319",
      "994800"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "577",
    "claim": "In mice, P. chabaudi parasites are able to proliferate faster early in infection when inoculated at lower numbers than when inoculated at high numbers.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "Paper 7 (rodent malaria in mice) shows that the restriction of initial parasite growth by innate responses increases with inoculating dose and saturates, and that the effective propagation number is sensitive to inoculum size. This implies higher per\u2011capita early growth at lower inoculum compared to higher inoculum, aligning with the claim for P. chabaudi. The other papers are not relevant to inoculum-dependent early proliferation in rodent malaria."
    },
    "naive_doc_ids": [
      "2460304",
      "9513785",
      "24640046",
      "40473317",
      "40900567"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers address Plasmodium chabaudi infection dynamics in mice or compare early proliferation rates at different inoculum sizes. The topics cover cancer models, atherosclerosis, maternal diet effects, synaptic signaling, diabetic renal fibrosis, breast cancer prognostics, Epstein-Barr virus regulation, statins and AKI, olanzapine metabolic effects, and gender differences in infection outcomes, which are unrelated to rodent malaria parasite proliferation."
    },
    "overthinking_doc_ids": [
      "3419802",
      "970012",
      "9513785",
      "12932176",
      "24640046"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.97,
      "justification": "None of the provided papers address Plasmodium chabaudi, malaria infection, or the effect of inoculum size on early parasite proliferation in mice. The studies cover unrelated topics such as maternal protein restriction, diabetic renal fibrosis, exercise and tumor growth, Helicobacter pylori vaccination, humanized mouse models for plasma cells, adipose tissue cellularity, IL-7 receptor effects on lymphocytes, dietary fibers, mulberry leaf effects in obesity, and BPA exposure in IVF outcomes."
    },
    "posthoc_doc_ids": [
      "9513785",
      "24640046",
      "2242416",
      "2837758",
      "3419802"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.0,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1218",
    "claim": "The first MBT repeat of the four malignant brain tumor (4MBT) domain of Drosophila's Sfmbt and of the orthologous mammalian L3MBTL2 is required for the interaction with the spacer region of Drosophila's Pleiohomeotic (Pho) or its human ortholog YY1.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.98,
      "justification": "None of the provided papers discuss Sfmbt, L3MBTL2, MBT repeats, Pleiohomeotic (Pho), or YY1, nor do they address interactions between these proteins. The citations cover unrelated topics (e.g., MHC\u2013CD4 interactions, Hippo pathway, CTCF-mediated chromatin loops, mitochondrial dynamics, RNA-binding proteins, dynein\u2013microtubule binding). Therefore, they provide no relevant evidence for or against the specific claim."
    },
    "naive_doc_ids": [
      "4270992",
      "11822354",
      "13921783",
      "40721190",
      "10698739"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers present experimental data or discussion about Drosophila Sfmbt or mammalian L3MBTL2 interacting with the spacer region of Drosophila Pho or human YY1, nor about the requirement of the first MBT repeat for such interactions. Paper 1 concerns MBTD1 structure and histone methyl-lysine binding and only notes similarity to L3MBTL2 without discussing Pho/YY1 interactions. The remaining papers address unrelated proteins and systems."
    },
    "overthinking_doc_ids": [
      "3829232",
      "4387784",
      "4427060",
      "15121114",
      "46816158"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers present data about interactions between Drosophila Sfmbt or mammalian L3MBTL2 and Pho/YY1, nor about the specific requirement of the first MBT repeat for such interactions. Paper 3 discusses MBTD1 and mentions L3MBTL2 in the context of histone methyl-lysine binding and structure, but does not address Pho/YY1 binding. The remaining papers are unrelated to MBT-Pho/YY1 interactions."
    },
    "posthoc_doc_ids": [
      "8093935",
      "1546650",
      "3829232",
      "39929509",
      "207972"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.02,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1235",
    "claim": "The morphology change from large white adipocytes to small brown adipocytes is a sign of decreased energy expenditure potential in white adipose tissue.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.95,
      "justification": "Multiple papers show that the transition (browning) from white adipocytes to brown/beige adipocytes is associated with increased, not decreased, energy expenditure. Paper 1 reports WAT browning elevates UCP1 and increases energy expenditure in cachexia. Paper 2 demonstrates robust UCP1-independent thermogenesis in beige fat via SERCA2b-mediated Ca2+ cycling. Paper 4 shows activating human brown adipose tissue increases whole-body energy expenditure. Paper 6 reviews that brown fat activation/browning raises energy expenditure and improves metabolism. Paper 8 states brown adipocytes dissipate energy whereas white adipocytes store it. Collectively, these findings contradict the claim that the morphological change toward small brown adipocytes indicates decreased energy expenditure potential."
    },
    "naive_doc_ids": [
      "26902591",
      "19205437",
      "1507222",
      "1568684",
      "4319174"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.97,
      "justification": "Multiple papers show that the switch from white to brown/beige adipocytes (browning) increases thermogenic capacity and energy expenditure, not decreases it. Paper 1 explicitly reports that WAT browning with increased UCP1 expression leads to increased energy expenditure in cancer cachexia. Paper 2 shows activating human brown fat increases whole-body energy expenditure. Paper 3 reviews that brown fat activation and WAT browning raise energy expenditure and promote a negative energy balance. Paper 6 demonstrates robust thermogenesis in beige fat (even UCP1-independent), indicating higher energy expenditure potential. Thus, the morphological change toward brown/beige adipocytes signifies increased, not decreased, energy expenditure potential."
    },
    "overthinking_doc_ids": [
      "26902591",
      "1568684",
      "14865329",
      "20532591",
      "3621011"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.98,
      "justification": "Multiple papers show that the transition (browning) from white to brown/beige adipocytes increases thermogenic capacity and energy expenditure, not decreases it. Paper 1 demonstrates that WAT browning elevates UCP1 and energy expenditure in cachexia. Paper 2 shows activation of brown adipose tissue increases whole-body energy expenditure in humans. Paper 3 reviews that brown fat activation and WAT browning raise energy expenditure. Paper 4 states brown adipocytes dissipate energy whereas white store it, and browning is linked to thermogenic programs. Papers 5\u20137 further link catecholamine-driven browning to increased thermogenic gene expression and functional uncoupling. Therefore, the claimed morphology change indicates increased, not decreased, energy expenditure potential."
    },
    "posthoc_doc_ids": [
      "26902591",
      "1568684",
      "14865329",
      "29381091",
      "4319174"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.95,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "96",
    "claim": "Algerian physicians constitue the largest component of sub-Saharan Africa-trained physicians in the United States.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 1 analyzes sub-Saharan Africa (SSA)-trained physicians in the U.S. using data from 28 SSA countries. Algeria is not a sub-Saharan African country and is not included among SSA sources in the analysis. The paper highlights countries like Nigeria, South Africa, Ghana, Ethiopia, Sudan, and Liberia as key sources; Algeria is absent. Therefore, Algerian physicians cannot constitute the largest component of SSA-trained physicians in the U.S. The other papers are unrelated to this claim."
    },
    "naive_doc_ids": [
      "14500725",
      "8593263",
      "3662510",
      "10314816",
      "641459"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 1 analyzes physicians born or trained in sub-Saharan African (SSA) countries practicing in the US and identifies principal source countries within SSA (e.g., Nigeria, South Africa, Ghana, Ethiopia, Sudan). Algeria is not included because it is not an SSA country. Thus, Algerian physicians cannot constitute the largest component of SSA-trained physicians in the US. Paper 2 likewise focuses on SSA source countries (e.g., Nigeria, South Africa, Kenya, etc.) and does not include Algeria."
    },
    "overthinking_doc_ids": [
      "14500725",
      "3662510",
      "8593263",
      "30844602",
      "641459"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.88,
      "justification": "Paper 1 explicitly analyzes physicians trained in 28 sub-Saharan African (SSA) countries in the US workforce and lists principal source countries such as Nigeria, South Africa, Ghana, Ethiopia, Sudan, and Liberia. Algeria is not an SSA country and is not included among source countries in this analysis. Therefore, Algerian physicians cannot constitute the largest component of SSA-trained physicians in the United States."
    },
    "posthoc_doc_ids": [
      "14500725",
      "3662510",
      "30844602",
      "641459",
      "3524352"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.5,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "715",
    "claim": "Low expression of miR7a does represses target genes and exerts a biological function in ovaries.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers investigate miR-7a specifically, its expression level in ovaries, or whether low miR-7a represses targets and exerts ovarian biological functions. The evidence includes general miRNA regulatory principles (e.g., threshold effects), miRNAs in hematopoiesis, EBV infection, kidney disease, and ovarian cancer involving other miRNAs (miR-99a-5p, miR-551b-3p), but no data on miR-7a in ovaries."
    },
    "naive_doc_ids": [
      "2000038",
      "23727313",
      "53211308",
      "8247469",
      "9154703"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers investigate miR-7a or its expression/function in ovaries. The microRNA-related studies focus on other miRNAs (e.g., miR-205 in prostate cancer; miR-210, miR-132, miR-146a-3p in cardiac contexts). The remaining papers address unrelated topics (HDACs in yeast, cytokine signaling, transcription factors in erythropoiesis, Drosophila cell division and tissue repair, RNAi mechanism). Therefore, there is no relevant evidence to confirm or refute the specific claim about low miR-7a repressing targets and functioning in ovaries."
    },
    "overthinking_doc_ids": [
      "10024681",
      "43156471",
      "1905095",
      "2062382",
      "5774746"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers investigate miR-7a levels or function in ovaries. The set includes general microRNA regulatory behavior (Paper 1) and studies on other regulators or microRNAs in immune cells, endothelial cells, heart, kidney, and ovarian cancer (miR-21, miR-551b-3p), but no data on miR-7a or its low-level expression repressing targets in ovarian tissue. Therefore, the claim is not addressed by the supplied evidence."
    },
    "posthoc_doc_ids": [
      "2000038",
      "21363424",
      "5377642",
      "6690087",
      "9784254"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "876",
    "claim": "Obesity raises life quality.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "None of the provided papers directly evaluate whether obesity increases health-related quality of life (HRQoL). The closest related evidence suggests the opposite: binge eating disorder (often associated with obesity) impairs HRQoL (Paper 1), and multiple chronic conditions reduce HRQoL (Paper 8), but there is no direct comparison of HRQoL in obese vs. non-obese populations showing an increase. Other papers address comorbidities, treatments, or unrelated conditions. Therefore, the claim is not supported or refuted directly by the provided evidence."
    },
    "naive_doc_ids": [
      "40666943",
      "1831916",
      "26199970",
      "439670",
      "8298120"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "None of the provided papers directly assess whether obesity increases or decreases health-related quality of life (HRQoL). Paper 1 shows binge eating disorder impairs HRQoL, but BED is not equivalent to obesity. Paper 4 links higher BMI to greater gestational diabetes risk without HRQoL outcomes. Paper 10 examines HRQoL across chronic conditions but does not report obesity-specific results. The remaining papers do not address obesity or HRQoL. Therefore, the evidence provided does not directly verify the claim."
    },
    "overthinking_doc_ids": [
      "40666943",
      "1831916",
      "26199970",
      "439670",
      "8298120"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "None of the provided papers directly evaluate whether obesity increases (or decreases) quality of life. Several studies address quality of life in other conditions (cancer treatments, pulmonary hypertension, ischemic heart disease, heart failure), and one shows binge eating disorder impairs HRQoL, while others discuss obesity risk factors (dietary fat, soft drinks) without QoL outcomes. Therefore, the evidence set does not directly inform the claim that obesity raises life quality."
    },
    "posthoc_doc_ids": [
      "32421068",
      "463533",
      "41310252",
      "2820454",
      "17693849"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.06,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1402",
    "claim": "r-protein chaperones are found in complexes with their r-protein binding partners.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 shows that the ribosomal protein S3 (Rps3) is associated with its dedicated chaperone Yar1 during nuclear import and early 40S assembly, indicating they form a complex. Paper 6 provides genetic and biochemical evidence that Yar1 physically interacts with Rps3, further supporting that an r-protein chaperone is found in complex with its r-protein binding partner. These data confirm the claim."
    },
    "naive_doc_ids": [
      "15893330",
      "2582169",
      "11420613",
      "12428814",
      "22896970"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 3 provides direct experimental evidence that the ribosomal protein S3 associates with its specific chaperone Yar1 as an import complex, demonstrating a chaperone\u2013r-protein complex. Paper 5 shows an RNA-independent interaction between the chaperone B23/NPM and ribosomal protein S9, with B23 storing and protecting RPS9 in the nucleolus, further supporting that r-protein chaperones form complexes with their r-protein partners. Other papers are not directly relevant to this claim."
    },
    "overthinking_doc_ids": [
      "13915464",
      "8925851",
      "15893330",
      "20524091",
      "26495128"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 4 shows that the chaperone-like protein B23/NPM, described as a nucleoplasmin family (histone) chaperone, associates with a complex containing ribosomal proteins and directly binds ribosomal protein S9 (RPS9) in an RNA-independent manner. It facilitates nucleolar storage and protection of RPS9, implying a chaperoning role for a ribosomal protein and demonstrating that an r-protein chaperone is found in complex with its ribosomal protein binding partner. The other papers do not provide relevant counter-evidence."
    },
    "posthoc_doc_ids": [
      "30184745",
      "23342686",
      "18987782",
      "26495128",
      "41165286"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "739",
    "claim": "MT binding domain drives amyloid structure formation.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 6 shows that the amyloid filament core of tau in Alzheimer's disease is formed by residues 306\u2013378, which constitute part of tau\u2019s microtubule-binding repeat region (R3\u2013R4). These residues adopt the cross-\u03b2/\u03b2-helix structure that seeds aggregation, indicating that the microtubule-binding domain provides the core that drives amyloid structure formation. The other papers concern microtubule binding (dynein, LRRK2) or amyloid biology (A\u03b2, APOE, CD33) but do not link MT-binding domains to amyloid formation. Thus, based on Paper 6, the claim is supported."
    },
    "naive_doc_ids": [
      "1546650",
      "5914739",
      "7729656",
      "9638032",
      "15655418"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 6 shows that the cores of Alzheimer\u2019s disease tau filaments are formed by tau residues 306\u2013378, which adopt an amyloid cross-\u03b2/\u03b2-helix structure and define the seed for aggregation. These residues lie within tau\u2019s microtubule-binding repeat region, indicating that the microtubule-binding domain itself forms the amyloid core and drives aggregation in tau. The other papers do not address amyloid formation by microtubule-binding domains and do not contradict this. Thus, there is supportive evidence (in the tau system) for the claim."
    },
    "overthinking_doc_ids": [
      "1546650",
      "15655418",
      "35684881",
      "5914739",
      "7729656"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data linking a microtubule (MT) binding domain to amyloid structure formation. Paper 1 examines dynein\u2019s MT-binding residues and ATP-sensitive interactions without addressing amyloids. Papers 2\u20137 and 9 address unrelated ligand/receptor, membrane, chromatin, or nucleic acid binding topics. Paper 8 discusses Orb2A\u2019s glutamine-rich domain mediating complex formation (potentially amyloid-like) but not an MT-binding domain. Therefore, the claim is not evaluated by the supplied evidence."
    },
    "posthoc_doc_ids": [
      "1546650",
      "40383969",
      "5914739",
      "7729656",
      "9889151"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1085",
    "claim": "Side effects associated with antidepressants lower risk of myocardial infarction.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "Among the provided papers, only Paper 6 examines antidepressant use and cardiovascular outcomes, but its abstract does not report a reduction in myocardial infarction risk due to antidepressants or their side effects. It highlights increased risks for several other adverse outcomes (e.g., falls, hyponatraemia, stroke/TIA) and does not present evidence that antidepressant-related side effects lower MI risk. The remaining papers do not address antidepressants. Therefore, the supplied evidence does not provide relevant support or contradiction for the specific claim."
    },
    "naive_doc_ids": [
      "34873974",
      "202259",
      "1759213",
      "6158879",
      "6793674"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers evaluate myocardial infarction risk in relation to antidepressant side effects. Paper 3 reports adverse effects of tricyclic antidepressants (dry mouth, drowsiness, weight gain) but does not assess MI outcomes. Paper 5 discusses SSRI withdrawal symptoms without cardiovascular endpoints. The remaining papers address MI genetics, diagnostics, antiplatelet therapy, bariatric surgery, homocysteine, and unrelated exposures. Therefore, there is no relevant evidence here to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "22505190",
      "34873974",
      "14606752",
      "439670",
      "6112053"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Among the provided papers, only Paper 6 addresses antidepressant use and cardiovascular outcomes. It reports increased risks for several adverse outcomes (falls, hyponatraemia, all-cause mortality, stroke/TIA, fractures, epilepsy/seizures) with certain antidepressant classes in older adults, but it does not present evidence that antidepressant side effects lower myocardial infarction (MI) risk. The abstract does not report a reduction in MI risk, and the other papers are unrelated to antidepressants (they cover homocysteine, genetic polymorphisms, diagnostic assays, osteoporosis therapy, antiplatelet switching, corin levels, and antibiotics). Therefore, there is no presented evidence here that confirms the claim that side effects associated with antidepressants lower MI risk."
    },
    "posthoc_doc_ids": [
      "8595678",
      "22505190",
      "34873974",
      "37424881",
      "26000593"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "611",
    "claim": "Increased lipolysis leads to higher P38 phosphorylation in adipose tissue.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers report data on p38 MAPK phosphorylation in adipose tissue in relation to lipolysis. The studies focus on adipogenesis, adipose tissue inflammation/remodeling, mitochondrial respiration, Wnt/JNK signaling, ghrelin/adrenergic signaling, and yeast MAPK transport, but do not present findings linking increased lipolysis to higher p38 phosphorylation in adipose tissue."
    },
    "naive_doc_ids": [
      "3621011",
      "5106691",
      "23929297",
      "33063763",
      "3943235"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers examine the relationship between lipolysis and p38 MAPK phosphorylation in adipose tissue. The studies address other topics: adipocyte differentiation and insulin signaling (Paper 1), ER phosphorylation by MAPK in non-adipose contexts (Paper 2), cardiac CaMKII/Drp1 signaling (Paper 3), MAPK modulation in airway epithelial cells (Paper 4), yeast Hog1 (a p38 homolog) nuclear transport (Paper 5), adipose mitochondrial respiration (Papers 6 and 7), adipose microvascular function (Paper 8), BAT activation by bile acids (Paper 9), and bone marrow adipocyte effects on hematopoiesis (Paper 10). None provide data on p38 phosphorylation changes with increased lipolysis in adipose tissue."
    },
    "overthinking_doc_ids": [
      "3621011",
      "4662264",
      "14362678",
      "15381976",
      "33063763"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 9 shows in adipocytes that nicotine activates AMPK\u03b12, leading to MKP1 degradation and aberrant activation (phosphorylation) of p38 MAPK and JNK. This upstream p38 activation causes loss of insulin-mediated inhibition of lipolysis, resulting in increased lipolysis. Thus, the evidence indicates p38 phosphorylation leads to increased lipolysis, not that increased lipolysis drives p38 phosphorylation. The other provided papers do not address p38 phosphorylation in adipose tissue. Therefore, the claim's causal direction is opposed by the available evidence."
    },
    "posthoc_doc_ids": [
      "40232172",
      "1568684",
      "3621011",
      "9178310",
      "17933691"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "830",
    "claim": "NF2 (Merlin) causes phosphorylation and subsequent cytoplasmic sequestration of YAP in Drosophila by activating LATS1/2 kinases.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers present data on NF2/Merlin activating LATS1/2 (or Drosophila Warts) to phosphorylate and cytoplasmically sequester YAP/Yki in Drosophila. Hippo-related papers focus on mammalian interactomes (Paper 6), TEAD regulation by p38 independently of Hippo (Paper 7), or YAP in mouse intestinal regeneration (Paper 9). The remaining papers cover unrelated topics (embryogenesis timing, mismatch repair, myosin light chain phosphorylation, histone phosphorylation, HuR regulation, UV effects on replication, AMPK-JAK1). Therefore, the claim is not evaluated by the provided evidence."
    },
    "naive_doc_ids": [
      "25670099",
      "25813706",
      "735130",
      "20630805",
      "23634484"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on NF2 (Merlin) regulating YAP/Yorkie via LATS1/2 (Warts) in Drosophila. Papers 6\u20138 discuss aspects of Hippo signaling (TEAD translocation via p38, an LKB1\u2013MARK axis, and a mammalian Hippo interactome) but do not address Merlin/NF2 activating LATS to phosphorylate and sequester YAP, nor do they focus on Drosophila. The remaining papers are unrelated (myosin light chain in Drosophila oogenesis, syncytial embryo dynamics, MUC1\u2013NF-\u03baB, HOG1 nuclear transport, AMPK in bovine hepatocytes, TOR-controlled transcription factor localization, Notch signaling). Therefore, the evidence set does not contain information confirming or refuting the specific claim."
    },
    "overthinking_doc_ids": [
      "735130",
      "25670099",
      "23078022",
      "33063763",
      "7005276"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers present data about NF2/Merlin activating LATS1/2 (Warts) to phosphorylate and cytoplasmically sequester YAP/Yki in Drosophila. Relevant Hippo-related papers (3, 6, 7) discuss TEAD regulation by p38 (Hippo-independent), kinase\u2013phosphatase interactions in the Hippo network, or an LKB1\u2013MARK axis upstream of Hippo, but do not address NF2/Merlin\u2019s role or YAP/Yki phosphorylation and sequestration. The remaining papers are unrelated to Hippo/NF2/YAP."
    },
    "posthoc_doc_ids": [
      "25670099",
      "14719322",
      "52873726",
      "735130",
      "5107861"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1213",
    "claim": "The deregulated and prolonged activation of monocytes has deleterious effects in inflammatory diseases.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.84,
      "justification": "Paper 3 shows that reduced KLF2 (a negative regulator of monocyte activation) leads to increased recruitment and proinflammatory activation of monocytes, with more severe arthritis and greater cartilage/bone damage\u2014directly linking dysregulated monocyte activation to deleterious outcomes in an inflammatory disease. Paper 6 demonstrates that human monocytes can drive IL-1\u03b2-mediated immunopathology via an alternative inflammasome pathway, supporting a role for monocyte activation in harmful inflammation. Paper 9 indicates that genetic variants increasing expression of the TLR negative regulator TOLLIP reduce proinflammatory cytokines and sepsis risk, implying that insufficiently regulated innate (monocyte-related) activation worsens disease. Together, these findings support the claim that deregulated (and, in chronic models, prolonged) monocyte activation has deleterious effects in inflammatory diseases."
    },
    "naive_doc_ids": [
      "5572127",
      "11328820",
      "7948486",
      "21395936",
      "1191830"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.64,
      "justification": "Paper 2 shows that reduced KLF2, a brake on myeloid (including monocyte) proinflammatory activation, exacerbates responses in acute and subacute inflammatory models, and emphasizes that unchecked myeloid activation causes collateral tissue damage. Paper 9 identifies monocytes as key subsets recruited to inflamed tissues, underscoring their role in inflammatory pathology and as therapeutic targets. Paper 4 demonstrates that persistent immune activation worsens colitis severity, supporting the concept that prolonged immune activation is deleterious, though not monocyte-specific. Together, these data align with the claim that deregulated/prolonged monocyte-lineage activation contributes to harmful outcomes in inflammatory diseases."
    },
    "overthinking_doc_ids": [
      "21700295",
      "44724517",
      "4391121",
      "5572127",
      "9244474"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Across the provided papers, none present direct evidence that deregulated and prolonged activation of monocytes specifically causes deleterious effects in inflammatory diseases. Paper 2 shows KLF4 is essential for inflammatory monocyte differentiation but does not link prolonged monocyte activation to harm. Paper 6 implicates macrophages (monocyte-derived) in COPD pathogenesis but does not address prolonged monocyte activation per se. Paper 1 shows persistent immune activation worsens colitis, but focuses on T cells and general cytokines, not monocytes. Paper 3 indicates prolonged TLR3 activation in macrophages suppresses HIV replication, which is not deleterious. The remaining papers concern other inflammatory aspects without monocyte-specific prolonged activation data. Therefore, the specific claim is not directly supported or refuted by the provided evidence."
    },
    "posthoc_doc_ids": [
      "5572127",
      "25148216",
      "25606339",
      "54482327",
      "1265945"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.18,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "315",
    "claim": "Decrease of p62 in prostate tumor stroma results in defective autophagy.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Among the provided papers, only Paper 6 directly addresses p62 in the tumor stroma, showing that stromal p62 is reduced and that its loss in stromal fibroblasts promotes prostate tumorigenesis via mTORC1/c-Myc\u2013dependent metabolic and inflammatory reprogramming (e.g., increased IL-6). However, it does not report that decreased p62 causes defective autophagy. Other papers (1 and 3) discuss autophagy/mitophagy being induced in cancer-associated fibroblasts under oxidative stress, but they do not link this to p62 levels, nor do they demonstrate defective autophagy in the context of reduced p62. No provided paper presents experimental data tying decreased p62 in prostate tumor stroma specifically to defective autophagy."
    },
    "naive_doc_ids": [
      "24349992",
      "8702697",
      "27647593",
      "32742683",
      "3559136"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.58,
      "justification": "Among the provided papers, only Paper 6 directly addresses p62 in the tumor stroma, showing that p62 is reduced in stromal fibroblasts and that its loss promotes tumorigenesis via mTORC1/c-Myc\u2013driven metabolic reprogramming and IL-6 production. However, it does not assess or report autophagy status. Papers 2 and 3 discuss autophagy/mitophagy in cancer-associated fibroblasts, indicating increased autophagy induced by oxidative stress, but they do not link this to p62 levels or specifically to prostate stroma. Therefore, there is no direct evidence here that a decrease of p62 in prostate tumor stroma results in defective autophagy; if anything, the general CAF literature cited suggests active (not defective) autophagy, but without connecting it to p62. "
    },
    "overthinking_doc_ids": [
      "8702697",
      "24349992",
      "27647593",
      "308862",
      "1727493"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers address p62/SQSTM1 levels in prostate tumor stroma or link a decrease of p62 to defective autophagy in that context. The evidence discusses autophagy in adipose tissue, stromal oxidative stress and autophagy in general, tumor\u2013stroma interactions, and prostate cancer therapy, but does not mention p62 in prostate stroma or demonstrate that its decrease causes defective autophagy."
    },
    "posthoc_doc_ids": [
      "10463997",
      "24349992",
      "7228140",
      "27647593",
      "32766786"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "654",
    "claim": "Intra-cerebroventricular infusion of amyloid-\u03b2 oligomers increases expression of fibronectin type-III domain-containing protein 5 mRNA in mice hippocampi.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Paper 1 reports that FNDC5/irisin levels are reduced in Alzheimer\u2019s disease hippocampi and in experimental AD models, which implies a decrease rather than an increase. It does not provide data showing that intracerebroventricular infusion of amyloid-\u03b2 oligomers increases FNDC5 mRNA in mouse hippocampus. The other provided papers are unrelated to FNDC5/irisin expression in this context. Thus, the available evidence points against the claim\u2019s direction of effect."
    },
    "naive_doc_ids": [
      "57574395",
      "20943272",
      "39929509",
      "56486733",
      "20937018"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.61,
      "justification": "Among the provided papers, only Paper 1 discusses FNDC5/irisin in the context of Alzheimer\u2019s disease, reporting reduced FNDC5/irisin levels in AD hippocampi and experimental AD models. However, none of the abstracts explicitly examine the effect of intra-cerebroventricular infusion of amyloid-\u03b2 oligomers on FNDC5 mRNA expression in mouse hippocampus, nor do they report an increase in FNDC5 mRNA under that specific manipulation. The other papers are unrelated to FNDC5/irisin expression. Therefore, the specific claim is not supported or refuted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "57574395",
      "24989194",
      "2194320",
      "7221410",
      "15347087"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "None of the provided papers report on intra-cerebroventricular infusion of amyloid-\u03b2 oligomers and its effect on FNDC5 mRNA expression in mouse hippocampus. Paper 4 discusses FNDC5/irisin levels in Alzheimer\u2019s disease contexts and experimental AD models, generally noting reductions, but does not specifically examine mRNA changes in hippocampi following A\u03b2 oligomer infusion. The remaining papers are unrelated to the claim."
    },
    "posthoc_doc_ids": [
      "12658073",
      "14174055",
      "30351165",
      "57574395",
      "643765"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "269",
    "claim": "Cold exposure reduces BAT recruitment.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.95,
      "justification": "Multiple papers show that cold exposure increases, not reduces, BAT recruitment/activity. Paper 1 reports cold-induced upregulation of brown/brite genes in white fat, indicating browning and increased innervation. Paper 2 states prolonged cold exposure induces browning of white adipose tissue. Paper 5 demonstrates that during cold-induced browning, most beige adipocytes arise via de novo differentiation, i.e., recruitment. Paper 3 shows cold triggers UCP1-dependent processes consistent with BAT activation. Other papers are not directly about cold-induced BAT recruitment."
    },
    "naive_doc_ids": [
      "29381091",
      "14865329",
      "970012",
      "1568684",
      "20532591"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.88,
      "justification": "Paper 1 shows that cold exposure induces a brown/\u2018brite\u2019 transcriptional program in white adipose tissue, indicating increased browning/BAT recruitment rather than reduction. Paper 2 demonstrates that cold acclimation triggers UCP1-dependent thermogenic lipolysis, implicating activation of BAT; deletion of UCP1 abolishes cold-induced effects, consistent with increased BAT engagement under cold. The other papers do not address cold-induced BAT recruitment. No provided study reports a reduction of BAT recruitment with cold exposure."
    },
    "overthinking_doc_ids": [
      "29381091",
      "970012",
      "1568684",
      "40232172",
      "3621011"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Multiple papers show cold exposure increases, not reduces, BAT/beige recruitment and activity. Paper 1 reports cold-induced browning of white fat (a \"brite\" transcription signature), indicating recruitment toward a brown phenotype. Paper 4 shows cold-induced recruitment of beige adipocytes in WAT (with Pdgfr\u03b2+ mural cells contributing after prolonged cold). Paper 7 (review) states prolonged cold exposure induces browning of white adipose tissue and expands/activates brown fat. Paper 2 demonstrates cold-induced, UCP1-dependent thermogenesis, consistent with increased BAT activation. No provided paper reports a reduction of BAT recruitment with cold exposure."
    },
    "posthoc_doc_ids": [
      "29381091",
      "970012",
      "1568684",
      "32955023",
      "40232172"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "472",
    "claim": "Glucose restriction to 0.05% reduces RLS (replicative life span) by 20-40% in S. cerevisiae.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Multiple provided papers report that calorie or glucose restriction extends, not reduces, replicative lifespan (RLS) in Saccharomyces cerevisiae. Paper 1 shows lifespan extension by calorie restriction requiring SIR2/NAD. Paper 2 explicitly states that limiting glucose extends yeast lifespan, linking the effect to increased respiration. Paper 3 demonstrates that calorie restriction extends lifespan even independently of Sir2. None of the papers provide evidence that 0.05% glucose reduces RLS by 20\u201340%; most other papers are not directly about RLS under glucose restriction. Therefore, the claim is contradicted by the relevant evidence."
    },
    "naive_doc_ids": [
      "26330861",
      "4414481",
      "7185591",
      "13613916",
      "42421723"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Papers 5 and 7 report that calorie/glucose restriction in Saccharomyces cerevisiae extends replicative lifespan, not reduces it. Paper 5 shows lifespan extension by limiting glucose (via increased respiration), and Paper 7 shows lifespan extension by calorie restriction requiring SIR2 and NAD. None of the provided papers present data that 0.05% glucose reduces RLS by 20\u201340%; the direction of effect reported is opposite to the claim. Other papers listed are not directly about S. cerevisiae RLS under specific glucose percentages."
    },
    "overthinking_doc_ids": [
      "15975146",
      "9199796",
      "9696379",
      "16693950",
      "4414481"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Multiple provided papers report that calorie/glucose restriction extends (not reduces) replicative lifespan in Saccharomyces cerevisiae. Paper 1 shows lifespan is extended by limiting glucose and increasing respiration. Paper 7 explicitly demonstrates Sir2-independent life span extension by calorie restriction. Paper 10 shows life-span extension by calorie restriction requiring NAD/SIR2. None of the papers provide evidence of a 20\u201340% reduction in RLS at 0.05% glucose; instead they document extension under glucose restriction."
    },
    "posthoc_doc_ids": [
      "4414481",
      "13613916",
      "42421723",
      "23604601",
      "365896"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "391",
    "claim": "Ethanol stress increases the expression of SRL in bacteria.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers mention an SRL gene/regulon or report its expression under ethanol stress. Papers 3 and 4 discuss ethanol stress/tolerance in E. coli and associated gene expression changes, but do not reference SRL. The remaining papers address other stress responses or regulatory systems (e.g., soxRS, ctsR/clpC, KLF2) unrelated to SRL. Therefore, the evidence set does not contain information to confirm or refute the claim."
    },
    "naive_doc_ids": [
      "471735",
      "22312627",
      "21602220",
      "1148122",
      "6669242"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "None of the provided papers mention an SRL gene/locus or show data linking ethanol stress to increased SRL expression in bacteria. Papers 2 and 3 discuss ethanol stress/tolerance in E. coli but do not report SRL expression changes; Paper 1 addresses the SoxRS regulon under oxidative (superoxide) stress, not ethanol. The remaining papers are unrelated to bacterial ethanol stress or SRL."
    },
    "overthinking_doc_ids": [
      "471735",
      "21602220",
      "1148122",
      "6669242",
      "9194077"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data showing that ethanol stress increases expression of an SRL locus/regulon in bacteria. Paper 1 addresses soxRS induction by superoxide-generating agents (e.g., paraquat) but does not test ethanol. Papers 4 and 8 discuss ethanol stress/tolerance in E. coli, yet do not report SRL expression changes. The remaining papers are unrelated to bacterial ethanol stress or SRL expression. Therefore, there is no direct evidence here confirming or refuting the claim."
    },
    "posthoc_doc_ids": [
      "471735",
      "9194077",
      "38944245",
      "21602220",
      "22908536"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "775",
    "claim": "Mice defective for deoxyribonucleic acid (DNA) polymerase I (polI) reveal increased sensitivity to ionizing radiation (IR).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine mice defective for DNA polymerase I (polI) or their response to ionizing radiation. The references discuss other polymerases (pol eta, pol beta, pol mu, pol lambda) in contexts such as UV sensitivity, NHEJ-mediated DSB repair, or cell line responses to IR, but not polI in mice. Therefore, the evidence does not address the specific claim."
    },
    "naive_doc_ids": [
      "31293581",
      "43014661",
      "11569583",
      "9160947",
      "21878751"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers examine mice defective for DNA polymerase I (polI) or report their sensitivity to ionizing radiation. Relevant polymerases discussed include Pol \u03b2 (overexpression in CHO cells increases IR sensitivity) and Pol \u03bb (dominant-negative in mammalian cells increases IR sensitivity), but not Pol I in mice. Other papers address IR effects or DNA damage responses unrelated to Pol I. Therefore, the evidence does not address the specific claim."
    },
    "overthinking_doc_ids": [
      "11569583",
      "31293581",
      "52805891",
      "5572127",
      "10017612"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers examine mice defective for DNA polymerase I (Pol I) and their sensitivity to ionizing radiation. Paper 1 studies overexpression of DNA polymerase \u03b2 in CHO cells (not mice, not Pol I) and its effects on IR sensitivity. Paper 4 involves polymerase \u03b7-deficient mice and UV, not IR. Other papers address IR-induced senescence without polymerase defects, ATM deficiency, immune or metabolic topics, or unrelated behaviors. Therefore, there is no relevant evidence supporting or refuting the specific claim."
    },
    "posthoc_doc_ids": [
      "11569583",
      "31293581",
      "5572127",
      "43014661",
      "6961811"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1394",
    "claim": "miRNAs regulate a unique suite of mRNAs to maintain homeostasis in cells.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Multiple papers show that individual miRNAs bind specific sets of mRNAs and that this regulation underlies normal cellular function and stability. Paper 1 maps thousands of miRNA\u20133'UTR interactions in B cells, demonstrating that miRNAs (including viral and host) coordinately target suites of transcripts involved in immunity, survival, and proliferation. Paper 2 shows miR-21 directly represses IL-12p35, modulating immune balance. Paper 4 demonstrates miR-22 targets multiple pro-apoptotic and disease-related mRNAs to promote neuronal viability, consistent with homeostatic control. Paper 5 integrates miRNA and mRNA data in hematopoietic progenitors, validating that miRNAs hold differentiation programs in check\u2014key for cellular homeostasis\u2014and shows functional effects of miR-155. Paper 8 shows that loss of ADAR1 reduces global miRNA levels and alters target gene expression, indicating miRNA regulation is required for normal gene expression patterns. Paper 9 identifies a feedback loop where miR-71 modulates Argonaute and global miRNA abundance; disrupting it causes widespread mRNA dysregulation during aging, highlighting miRNA roles in maintaining expression homeostasis. Paper 10 links miRNA dysregulation with altered target protein levels in metastasis, reinforcing that miRNAs govern specific gene sets. Collectively, these findings support that miRNAs regulate distinct suites of mRNAs to sustain cellular homeostasis."
    },
    "naive_doc_ids": [
      "8247469",
      "7281161",
      "13290521",
      "16605494",
      "23727313"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.84,
      "justification": "Paper 5 explicitly proposes that each cell type has a unique miRNA milieu that dampens expression of thousands of mRNAs to achieve more uniform (homeostatic) gene levels within that cell type. Broad targeting is supported by Paper 6, which experimentally maps thousands of miRNA\u2013mRNA interactions in cellular 3'UTRs, and by Paper 9, which shows individual miRNAs can regulate multiple transcripts and are recycled for multiple-turnover regulation. Specific regulatory examples (e.g., miR-21 repressing IL-12p35; Paper 4) and correlations between miRNA dysregulation and target protein changes (Paper 2) further illustrate miRNA-directed control of mRNA suites. Essentiality of miRNA processing for normal function (Paper 3) and cell-type\u2013restricted miRNA expression (Paper 10) reinforce the role of miRNAs in maintaining cellular homeostasis via regulation of distinct mRNA sets."
    },
    "overthinking_doc_ids": [
      "9724974",
      "25523969",
      "5953485",
      "7281161",
      "12014458"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Paper 6 provides direct evidence that a specific miRNA (miR-92a) post-transcriptionally regulates the mRNA of KLF2, a key transcription factor for endothelial function, and that flow-dependent downregulation of miR-92a increases KLF2 to maintain endothelial homeostasis; in vivo delivery of miR-92a impairs flow-mediated vasodilation. This demonstrates miRNA-mediated regulation of a defined mRNA target to preserve cellular homeostasis. Paper 10 further supports miRNA specificity by showing miR-671 targets a circular antisense RNA to modulate CDR1 mRNA levels, illustrating miRNA-driven, target-selective control of gene expression. Paper 8 shows miRNA clusters can reprogram cell state by regulating broad gene networks, consistent with miRNAs controlling suites of mRNAs. Collectively, the evidence aligns with the claim."
    },
    "posthoc_doc_ids": [
      "3849194",
      "33569870",
      "42693833",
      "6828370",
      "2423940"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "474",
    "claim": "Glycan adaptation is rarely observed in the B-cell repertoire.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data on the frequency of glycan adaptation within the B-cell repertoire. Most papers address T-cell selection/tolerance (Paper 1, 9), transcriptional regulation and chromatin (Paper 2), neutrophil calcium signaling (Paper 3), vaccine-induced immunity broadly (Paper 4), bacterial TAL effectors (Paper 5), pre-BCR selection without glycan focus (Paper 6), antigen relay and affinity maturation mechanics (Paper 7), limited SHM in TG2-specific autoantibodies (Paper 8), and HIV viral glycan epitope evolution (Paper 10). The only glycan-related content (Paper 10) concerns viral glycan shifts and glycan-dependent antibody epitopes, not the prevalence of glycan adaptation in B-cell repertoires. Thus, the claim is not addressed by the evidence."
    },
    "naive_doc_ids": [
      "8354687",
      "4896726",
      "7869794",
      "18275697",
      "19099739"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers assess the frequency of glycan adaptation within the B\u2011cell repertoire. The most relevant articles (Papers 6, 7, and 9) discuss HIV Env glycan evolution and glycan-dependent antibody epitopes, focusing on viral adaptation and bnAb lineages, not on how often B cells adapt to glycans across the repertoire. The remaining papers address unrelated topics (centromeres, progenitors, Alzheimer\u2019s models, T-cell responses, antigen relay, infant cardiorespiratory control). Therefore, there is no direct evidence to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "25041967",
      "4427392",
      "4459491",
      "8325952",
      "8354687"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "None of the provided papers directly assess how often glycan adaptation occurs within the B-cell repertoire. Paper 9 discusses evolution of an HIV glycan-dependent epitope and the emergence of glycan-dependent broadly neutralizing antibodies in a minority of infected individuals, but this addresses viral glycan evolution and a specific antibody response rather than the general frequency of glycan adaptation within B-cell repertoires. Other papers focus on T-cell repertoire, dendritic cell glycan recognition, transcription factors, or non-glycan aspects of B-cell development and autoimmunity. Thus, the claim is not substantiated by the cited evidence."
    },
    "posthoc_doc_ids": [
      "4896726",
      "8354687",
      "21392223",
      "27910499",
      "34254203"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "560",
    "claim": "Immune responses result in the development of inflammatory Th17 cells and anti-inflammatory iTregs.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Multiple papers show that immune responses give rise to proinflammatory Th17 cells and anti-inflammatory induced Tregs (iTregs). Paper 3 explicitly defines Th17 as proinflammatory and FoxP3+ Tregs as anti-inflammatory, and demonstrates induction of FoxP3 (iTreg) while inhibiting Th17 differentiation in response to retinoic acid. Paper 1 shows in an autoimmune arthritis model that retinal reduces Th17 cells and increases FoxP3+ Tregs, indicating reciprocal development during immune responses. Paper 5 demonstrates that bacterial infection induces regulatory CD4+ T cells that suppress colitis via IL-10, consistent with anti-inflammatory iTregs arising in response to immune stimuli. Paper 8 further supports the inflammatory role of Th17 by showing TLR-activated B cells suppress Th17-driven inflammation in EAE. Together, these data support the claim."
    },
    "naive_doc_ids": [
      "22517564",
      "27588420",
      "18546584",
      "5633876",
      "5800138"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 1 states that during TCR activation in a cytokine milieu (i.e., an immune response), naive CD4+ T cells differentiate into Th17 and iTreg lineages. Paper 6 explicitly characterizes Th17 cells as proinflammatory IL-17\u2013producing cells and FoxP3+ Treg cells as anti-inflammatory, and shows immune-relevant modulation of their differentiation by retinoic acid. Paper 3 provides mechanistic evidence that the PI3K\u2013Akt\u2013mTORC1\u2013S6K axis controls Th17 differentiation, supporting their development during immune activation. Paper 9 notes ROR\u03b1 as a switch governing mutually exclusive Th17 vs Treg generation tied to harm/protection balance. Together, these data support that immune responses drive development of inflammatory Th17 cells and anti-inflammatory iTregs."
    },
    "overthinking_doc_ids": [
      "13798951",
      "18834078",
      "22174015",
      "24586989",
      "27588420"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 4 shows that IL-1R signaling via BCAP\u2013PI3K\u2013mTOR drives differentiation of pathogenic (inflammatory) Th17 cells. Paper 6 explicitly states Th17 cells are proinflammatory and FoxP3+ Tregs are anti-inflammatory, and demonstrates that retinoic acid induces FoxP3 in CD4+ T cells (iTreg induction) while inhibiting Th17 polarization. Paper 10 further confirms reciprocal regulation in vivo: retinal increases FoxP3+ Tregs and reduces IL-17\u2013producing T cells, ameliorating inflammatory arthritis. Together, these data support that immune responses can generate inflammatory Th17 cells and anti-inflammatory induced Tregs."
    },
    "posthoc_doc_ids": [
      "14474178",
      "5979056",
      "11328820",
      "51952430",
      "219475"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.58,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "826",
    "claim": "NAC destabilizes NO to increase the effect of contrast agents on renal functions.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "The evidence shows that N-acetylcysteine (NAC) does not destabilize nitric oxide (NO) nor increase the harmful effects of contrast agents on renal function. Instead, NAC attenuates contrast-induced intrarenal vasoconstriction and increases intrarenal NO and PGE2 (Paper 6), and multiple clinical trials demonstrate NAC reduces contrast-induced deterioration in renal function (Papers 9 and 10). None of the provided papers indicate NAC destabilizes NO; some even show NAC is protective. Therefore, the claim is contradicted by the evidence."
    },
    "naive_doc_ids": [
      "11459139",
      "22995164",
      "23100962",
      "2139357",
      "2533768"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "The provided evidence shows that N-acetylcysteine (NAC) mitigates, rather than enhances, contrast-induced renal dysfunction and is associated with increased, not destabilized, intrarenal nitric oxide (NO). In a rat model of contrast-induced nephropathy, NAC significantly attenuated intrarenal vasoconstriction and increased intrarenal NO and PGE2 levels (Paper 6). Clinically, prophylactic NAC reduced the incidence of contrast-induced rises in serum creatinine and even lowered mean creatinine post-contrast, indicating protection of renal function (Paper 8). No paper shows NAC destabilizing NO; the other papers address NO biology without linking NAC to NO destabilization. Thus, the claim that NAC destabilizes NO to increase the effect of contrast agents on renal functions is contradicted by the evidence."
    },
    "overthinking_doc_ids": [
      "22995164",
      "23100962",
      "2139357",
      "2533768",
      "5785219"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "The cited studies show NAC protects against, rather than enhances, contrast-induced renal dysfunction, and does not destabilize NO. Paper 1 and Paper 2 (randomized clinical trials) demonstrate NAC reduces the incidence of contrast-induced nephropathy and improves renal function metrics after contrast exposure. Paper 3 (rat model) shows NAC attenuates contrast-media\u2013induced renal vasoconstriction and increases intrarenal NO and PGE2, opposing the idea that NAC destabilizes NO. While Paper 9 shows thiols like NAC can quench HNO effects in cardiac cells, it is unrelated to renal contrast effects and does not support NO destabilization in this context. Overall, the evidence contradicts the claim."
    },
    "posthoc_doc_ids": [
      "140098548",
      "4678846",
      "26025370",
      "8536018",
      "5785219"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "90",
    "claim": "Adult tissue-resident macrophages stem from the embryonal yolk sac and fetal liver.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Multiple papers support embryonic origins of adult tissue-resident macrophages. Paper 10 provides direct experimental evidence that a lineage of tissue macrophages (including Kupffer cells, Langerhans cells, and microglia) derives from the yolk sac and persists independently of HSCs. Papers 1 and 3 show that major tissue-resident macrophage populations are established before birth and self-maintain during adulthood with minimal contribution from circulating monocytes, consistent with an embryonic (yolk sac/fetal) origin. Paper 2 specifically states Kupffer cells are of fetal origin. Paper 5 (review) summarizes that most adult tissue macrophages originate during embryonic development rather than from adult monocytes, aligning with yolk sac and fetal liver contributions. No papers provided contradict this; several unrelated papers do not affect the claim."
    },
    "naive_doc_ids": [
      "7521113",
      "5511240",
      "12827098",
      "1145473",
      "22406695"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.64,
      "justification": "Only Paper 1 notes that adult Kupffer cells are of fetal origin, and Paper 5 shows tissue-resident macrophages self-maintain with minimal monocyte input. However, none of the provided papers present direct lineage evidence tracing adult tissue-resident macrophages specifically to the embryonic yolk sac and fetal liver. The remaining papers are unrelated to macrophage ontogeny. Thus, the evidence here is insufficient to verify the specific claim."
    },
    "overthinking_doc_ids": [
      "5511240",
      "12966719",
      "1145473",
      "3155731",
      "12827098"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.47,
      "justification": "The provided papers collectively support that many adult tissue-resident macrophages are established before birth and self-maintain with minimal input from circulating monocytes (Papers 2, 3, 4) and that at least some (e.g., Kupffer cells) are of fetal origin (Paper 1). However, none of the excerpts explicitly identify the embryonal yolk sac or fetal liver as the specific progenitor sources for adult tissue-resident macrophages. Therefore, while the evidence aligns with an embryonic/fetal origin in general, it does not directly substantiate the specific claim that adult tissue-resident macrophages stem from the embryonal yolk sac and fetal liver."
    },
    "posthoc_doc_ids": [
      "5511240",
      "12827098",
      "22406695",
      "7521113",
      "12966719"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.55,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "684",
    "claim": "Lack of clpC does not affect sporulation efficiency in Bacillus subtilis cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, none present data on the effect of clpC deletion on sporulation efficiency in Bacillus subtilis. Paper 1 discusses identification of sporulation genes via Tn-seq but does not mention clpC specifically. Papers 2 and 3 focus on regulation and roles of clpC/Clp proteins in stress responses and proteolysis, not sporulation. Papers 4\u20137 address unrelated topics (motility, ABC transporter regulation, RecQ helicase, TatA structure). Therefore, the claim cannot be verified or refuted using the supplied evidence."
    },
    "naive_doc_ids": [
      "4942718",
      "34386619",
      "12881593",
      "12824568",
      "2851611"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, none directly assess the effect of a clpC deletion on sporulation efficiency in Bacillus subtilis. Paper 1 discusses genome-wide identification of sporulation genes but does not mention clpC or its impact on sporulation. Papers 2 and 3 focus on regulation and proteostasis of the clpC operon and Clp proteins under stress, not sporulation outcomes. Papers 4 and 5 address unrelated transport and helicase topics. Therefore, the evidence set does not provide information to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "4942718",
      "34386619",
      "12881593",
      "2851611",
      "2904102"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, none directly examine how deletion or absence of clpC affects sporulation efficiency in Bacillus subtilis. Paper 1 addresses sporulation genes broadly but does not mention clpC. Papers 2 and 3 discuss clpC regulation and Clp protease dynamics under stress, not sporulation outcomes. Papers 4\u20136 are unrelated to clpC or sporulation. Therefore, the claim cannot be verified or refuted from the given evidence."
    },
    "posthoc_doc_ids": [
      "4942718",
      "34386619",
      "12881593",
      "2851611",
      "2904102"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "514",
    "claim": "High dietary calcium intakes are unnecessary for prevention of secondary hyperparathyroidism in subjects with 25(OH)D levels above 75 nmol/liter.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Paper 1 directly links vitamin D status, calcium intake, and PTH: with adequate vitamin D status (their highest group >18 ng/mL \u2248 >45 nmol/L), higher calcium intakes (>800 mg/d) were unnecessary to maintain calcium metabolism and PTH was lowest, implying that high calcium is not required to prevent secondary hyperparathyroidism when vitamin D is sufficient. Paper 2 shows markedly better calcium absorption at 25(OH)D \u224886.5 nmol/L vs 50 nmol/L, suggesting that at >75 nmol/L individuals derive more calcium from usual intakes and are less likely to stimulate PTH. Paper 9 shows vitamin D deficiency\u2014not low calcium per se\u2014is associated with secondary hyperparathyroidism, reinforcing the primacy of vitamin D sufficiency. While none of the studies explicitly use the 75 nmol/L cutoff or diagnose secondary hyperparathyroidism as a categorical outcome, the evidence collectively supports the claim\u2019s direction."
    },
    "naive_doc_ids": [
      "16256507",
      "3034412",
      "19278208",
      "21199527",
      "3758260"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.64,
      "justification": "Paper 1 directly links vitamin D status, calcium intake, and PTH. It found that serum PTH was lowest with higher 25(OH)D and concluded that, when vitamin D status is ensured, calcium intakes above ~800 mg/day may be unnecessary for maintaining calcium metabolism. Although their vitamin D sufficiency threshold (>18 ng/mL \u2248 >45 nmol/L) is lower than 75 nmol/L, this supports the claim\u2019s direction that with adequate 25(OH)D, high calcium intake is not needed to prevent elevated PTH. Paper 3 shows an inverse correlation between 25(OH)D and PTH and an association of vitamin D deficiency with secondary hyperparathyroidism, reinforcing that vitamin D sufficiency suppresses PTH. While neither paper uses the exact 75 nmol/L cutoff nor directly tests high vs. low calcium at that threshold, the available evidence aligns with the claim."
    },
    "overthinking_doc_ids": [
      "16256507",
      "3222187",
      "9555784",
      "13312471",
      "21199527"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Paper 6 directly shows that when vitamin D status is adequate, higher calcium intakes (>800 mg/day) are unnecessary to maintain calcium metabolism, with serum intact PTH lowest at higher 25(OH)D and relatively unresponsive to higher calcium intake. Although their sufficiency cutoff (>18 ng/mL \u2248 >45 nmol/L) is below the claim\u2019s threshold (75 nmol/L \u2248 30 ng/mL), this implies that individuals above 75 nmol/L would likewise not require high calcium intake to prevent secondary hyperparathyroidism. Paper 7 supports that low 25(OH)D is associated with elevated PTH (secondary hyperparathyroidism), underscoring vitamin D\u2019s primary role over calcium intake. Paper 9 shows better calcium absorption at ~86.5 nmol/L versus 50 nmol/L, consistent with less need for high calcium intake when vitamin D is sufficient. Other papers are not relevant to this claim."
    },
    "posthoc_doc_ids": [
      "28617573",
      "11071351",
      "27166444",
      "40790033",
      "7454794"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1310",
    "claim": "Traditional reviews are biased in their interpretations.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "All listed papers are systematic reviews/meta-analyses on diverse clinical topics and do not address or compare the interpretive bias of traditional (narrative) reviews. None present data or commentary evaluating whether traditional reviews are biased, so they provide no direct evidence for or against the claim."
    },
    "naive_doc_ids": [
      "202259",
      "1759213",
      "2425364",
      "3770750",
      "6793674"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 3 notes that traditional narrative review articles failed to mention advances identified by an updated systematic review (Antman et al.), illustrating selective and potentially biased interpretation in traditional reviews. Paper 1 provides empirical evidence that reviews/meta-analyses can be biased, showing funnel plot asymmetry in a substantial proportion of published meta-analyses and that discordant cases overestimated effects compared with large trials. Paper 2 further supports the presence of publication bias in meta-analyses and shows that adjusting for missing studies alters effect estimates. Together, these findings support the claim that traditional (non-systematic) reviews are prone to biased interpretations."
    },
    "overthinking_doc_ids": [
      "22711954",
      "39652608",
      "8042158",
      "14361849",
      "15048300"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 1 explicitly emphasizes the need to make explicit efforts to limit bias in literature reviews and cites evidence (Antman et al.) showing that traditional review articles failed to mention advances detected by updated systematic reviews, implying that traditional (narrative) reviews are prone to biased or incomplete interpretation. This directly supports the claim. Other papers are not directly about interpretive bias in traditional reviews; none contradict the claim."
    },
    "posthoc_doc_ids": [
      "8042158",
      "13515165",
      "14464451",
      "22711954",
      "439670"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "437",
    "claim": "Functional consequences of genomic alterations due to Myelodysplastic syndrome (MDS) are poorly understood due to the lack of an animal model.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Paper 7 reports a functional MDS mouse model: hematopoietic-specific miR-22 overexpression in transgenic mice leads to MDS and hematologic malignancies, with mechanistic linkage to TET2 suppression and reduced 5-hmC; ectopic TET2 rescues phenotypes. This directly shows animal models exist and are used to study functional consequences of genomic/epigenetic alterations relevant to MDS. Paper 10 further uses a mouse model of a pre-leukemic syndrome to uncover a p53\u2013S100A8/9\u2013TLR inflammatory signaling axis that predicts MDS evolution in humans, demonstrating animal-model-driven mechanistic insight into MDS pathogenesis. Therefore, the claim that functional consequences are poorly understood due to lack of an animal model is contradicted by the provided evidence."
    },
    "naive_doc_ids": [
      "2359152",
      "10795340",
      "12240507",
      "31884697",
      "13889962"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 2 explicitly states that animal models have enabled interrogation of the hematopoietic niche in MDS and have furthered insights, contradicting the claim of a lack of animal models. Paper 9 describes and utilizes a two-step mouse model (mutant NRAS/BCL2) to uncover mechanistic links between genomic abnormalities, ROS, DNA damage, and error-prone repair during MDS progression, directly demonstrating functional consequences in an animal system. These findings refute the assertion that functional understanding is poor because animal models are lacking."
    },
    "overthinking_doc_ids": [
      "2359152",
      "3391547",
      "7239105",
      "19185192",
      "39776978"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.87,
      "justification": "Among the provided papers, only one (Paper 5) addresses myelodysplastic syndromes, and it focuses on human bone marrow mesenchymal stem cells\u2019 properties, not on animal models or the functional consequences of genomic alterations. The other papers pertain to unrelated topics (e.g., AML mouse models, metabolomics, enhancer transcription, adipocyte lineage, pleural effusion, podocyte imaging, monocyte differentiation, uterine artery ligation). None provide evidence about the existence or absence of MDS animal models or link the understanding of MDS genomic alterations to a lack of such models."
    },
    "posthoc_doc_ids": [
      "31070360",
      "37328025",
      "18104691",
      "39281166",
      "39851630"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1308",
    "claim": "Tonic signaling from the scFv is amplified by MyD88/CD40.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "Among the provided papers, only Paper 1 addresses tonic signaling from CAR scFvs, showing that CD28 costimulation augments and 4-1BB reduces exhaustion from persistent signaling. None of the papers mention or evaluate MyD88/CD40 signaling modules in CARs, nor do they assess whether MyD88/CD40 amplifies tonic scFv signaling. Paper 6 discusses an engineered CD40 receptor in dendritic cells without MyD88 and not in the context of scFv-driven tonic signaling. Therefore, the specific claim that scFv tonic signaling is amplified by MyD88/CD40 is not supported or contradicted by the provided evidence."
    },
    "naive_doc_ids": [
      "18231807",
      "5132358",
      "20311968",
      "22210434",
      "36216395"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "Among the provided papers, only Paper 1 addresses tonic signaling from CAR scFvs, showing that CD28 augments and 4-1BB reduces exhaustion due to tonic CAR signaling. None of the papers examine or demonstrate that MyD88 and/or CD40 amplify tonic scFv-driven signaling in CARs. The other papers discuss MyD88 or CD40 in unrelated contexts (e.g., innate immunity, thymic epithelial cell development, adjuvant effects, engineered CD40 in dendritic cells) without linking them to scFv tonic signaling. Therefore, the provided evidence does not support or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "18231807",
      "2734421",
      "6270720",
      "6767271",
      "9159125"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "Among the provided papers, only Paper 1 addresses tonic signaling from CAR scFvs, showing that CD28 augments and 4-1BB reduces exhaustion driven by tonic signaling. None of the papers present data on MyD88 and/or CD40 amplifying tonic signaling from an scFv. Papers mentioning CD40 (Paper 2) or MyD88 (Papers 3, 5, 10) discuss these molecules in unrelated biological contexts (thymic epithelial development, cardiac fibrosis, adjuvant/Th17 responses, and LPS-induced PGE2), not CAR tonic signaling. Therefore, the evidence provided does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "18231807",
      "2734421",
      "6270720",
      "6550579",
      "6767271"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "969",
    "claim": "PrimPol degrades short DNA replication intermediates on the leading strand during DNA replication.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "None of the provided papers present data showing PrimPol degrading short DNA replication intermediates on the leading strand. Paper 6 addresses PrimPol\u2019s function and demonstrates that it acts as a primase/TLS polymerase to repriming DNA synthesis downstream of lesions, facilitating fork progression, but does not report nuclease or degradative activity. The remaining papers discuss other proteins or processes (e.g., BLM, RAD52, MRE11, EXO1, topoisomerases) and do not pertain to PrimPol-mediated degradation."
    },
    "naive_doc_ids": [
      "41314611",
      "2758012",
      "4444861",
      "7151961",
      "11401602"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "The provided papers that mention PrimPol (Papers 1 and 8) show it functions as a primase/TLS polymerase that reprimes DNA synthesis and facilitates replication fork progression, especially after UV damage or dNTP depletion. None of the papers present evidence that PrimPol degrades short DNA replication intermediates, on the leading strand or otherwise. Degradation of nascent DNA at stalled forks is instead linked to nucleases such as MRE11 (Paper 5). Other papers address different proteins/processes (BLM at telomeres, ZRANB3 and PCNA polyubiquitination, ERCC1/MUS81 at fragile sites) and do not involve PrimPol-mediated degradation. Therefore, there is no relevant evidence supporting or refuting the specific degradation claim."
    },
    "overthinking_doc_ids": [
      "28904104",
      "2758012",
      "41314611",
      "2543135",
      "4444861"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Among the provided papers, the ones addressing PrimPol (Papers 4 and 5) show that PrimPol facilitates replication fork progression by translesion synthesis and repriming downstream of lesions, enabling bypass and continuation of DNA synthesis. They do not report any nuclease or degradative activity by PrimPol on replication intermediates. Paper 6 attributes degradation of nascent DNA at stalled forks to the MRE11 nuclease (regulated by PTIP), not PrimPol. The remaining papers are unrelated to PrimPol\u2019s activity. Therefore, there is no evidence here that PrimPol degrades short leading-strand replication intermediates."
    },
    "posthoc_doc_ids": [
      "2758012",
      "41314611",
      "7151961",
      "15077696",
      "28904104"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "900",
    "claim": "Oxidative phosphorylation is one of the primary glycometabolic pathways in cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Multiple papers indicate that oxidative mitochondrial metabolism, including the electron transport chain/oxidative phosphorylation, is a central pathway for cellular energy generation and tightly linked to glucose metabolism. Paper 4 shows macrophage phenotypes depend on glycolysis vs oxidative metabolism (implying reliance on OXPHOS for M2). Paper 6 demonstrates increased dependence on oxidative mitochondrial metabolism and sensitivity to electron transport chain inhibition in IDH1-mutant cells. Paper 10 shows nitric oxide inhibits TCA and electron transport chain enzymes, reshaping glucose metabolic fluxes, underscoring the central role of OXPHOS in glycometabolic control. Paper 2 reports high activities of TCA enzymes in macrophages, suggesting importance of oxidative metabolism for energy generation. Together, these data support that oxidative phosphorylation is a primary, core pathway connected to cellular carbohydrate metabolism."
    },
    "naive_doc_ids": [
      "7005276",
      "20672596",
      "293661",
      "8477699",
      "14827874"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 2 states that oxidative phosphorylation (OXPHOS) is the major pathway for ATP production in humans, and Paper 3 explains that the bulk of cellular ATP is generated by OXPHOS via mitochondrial complexes I\u2013V, underscoring its central role in cellular energy metabolism. Paper 4 further shows contexts where cells become particularly dependent on oxidative mitochondrial metabolism. Together, these findings support that OXPHOS is a primary pathway in cellular energy metabolism linked to glucose oxidation, aligning with the claim."
    },
    "overthinking_doc_ids": [
      "3973445",
      "19957813",
      "37362689",
      "14663842",
      "23895668"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 1 explicitly states that oxidative phosphorylation (OXPHOS) is the major pathway for ATP production in humans, establishing it as a core energy-producing pathway. Papers 6 and 8 link glucose metabolism to mitochondrial oxidative metabolism: Paper 6 shows that nitric oxide modulates glucose metabolic routing by inhibiting TCA cycle and electron transport chain enzymes (integral to OXPHOS), shifting cells toward glycolysis and the pentose phosphate pathway; Paper 8 highlights active TCA cycle enzymes in macrophages, implying coupling to OXPHOS during glucose utilization. Together, these data support that OXPHOS is a primary pathway involved in cellular energy generation from glucose (i.e., a key component of glycometabolism), even though it also oxidizes substrates from fats and amino acids."
    },
    "posthoc_doc_ids": [
      "19957813",
      "2686003",
      "4795303",
      "4820792",
      "24349430"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "820",
    "claim": "N-terminal cleavage increases success identifying transcription start sites.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.92,
      "justification": "Across the provided papers, none evaluate whether N-terminal cleavage affects the success of identifying transcription start sites (TSS). One study (Paper 4) discusses N-terminal truncation of A\u03b2 peptides due to APP cleavage, which is unrelated to TSS mapping. Another study (Paper 6) identifies multiple TSSs in the Golli-MBP locus, but not via N-terminal cleavage-based methods. The remaining papers focus on transcription regulation, gene expression profiling, or chromatin interactions without addressing N-terminal cleavage or its impact on TSS identification. Therefore, there is no relevant evidence to support or refute the claim."
    },
    "naive_doc_ids": [
      "8692744",
      "6532806",
      "8331432",
      "10207180",
      "16398049"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "None of the provided papers present data showing that N-terminal cleavage improves the identification of transcription start sites (TSS). Paper 1 uses N-terminal protein sequencing to assign translation initiation sites (TIS), not TSS. Other papers discuss translation initiation mechanisms, epigenetic marks at TSS, transcription factor binding, and gene structure, but do not link N-terminal cleavage to enhanced TSS identification. Therefore, the claim is not supported or refuted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "39729277",
      "2479538",
      "16927286",
      "9505448",
      "24521894"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers discuss N-terminal cleavage or evaluate its impact on success in identifying transcription start sites. While several papers mention transcription start sites, promoter architecture, or transcriptional regulation, they do not address any cleavage-based method (protein N-termini or otherwise) affecting TSS identification. Therefore, the evidence does not support or refute the claim."
    },
    "posthoc_doc_ids": [
      "3346812",
      "3052213",
      "19238",
      "4411760",
      "5116145"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "908",
    "claim": "PGE 2 suppresss intestinal tumor growth by altering the expression of tumor suppressing and DNA repair genes.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.95,
      "justification": "Paper 3 reports that prostaglandin E2 (PGE2) promotes intestinal tumor growth by silencing tumor-suppressor and DNA-repair genes via DNA methylation. This directly opposes the claim that PGE2 suppresses intestinal tumor growth. The other papers do not address PGE2\u2019s effect on intestinal tumors."
    },
    "naive_doc_ids": [
      "11271123",
      "15113221",
      "6923961",
      "470625",
      "7028976"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Paper 1 directly reports that PGE2 silences tumor-suppressor and DNA-repair genes via DNA methylation to promote intestinal tumor growth, which is the opposite of the claim that PGE2 suppresses tumor growth. The other papers provided do not address PGE2's role in intestinal tumors and thus do not counter this contradiction."
    },
    "overthinking_doc_ids": [
      "6923961",
      "8677721",
      "31311495",
      "22401720",
      "33638477"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.95,
      "justification": "Paper 1 directly shows that PGE2 promotes (not suppresses) intestinal tumor growth by silencing tumor-suppressor and DNA-repair genes via DNA methylation. This is the opposite of the claim. Additionally, Paper 5 indicates PGE2 supports tumor growth by suppressing antitumor immunity, further contradicting the claim. The other papers are not directly relevant to PGE2\u2019s effect on intestinal tumors."
    },
    "posthoc_doc_ids": [
      "6923961",
      "2242416",
      "33370",
      "470625",
      "7975937"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.92,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "74",
    "claim": "Active H. pylori urease has a polymeric structure consisting of five distinct subunits.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.8,
      "justification": "The provided papers indicate that Helicobacter pylori urease comprises two structural subunits, UreA and UreB. Paper 3 explicitly targets an epitope from the H. pylori urease A subunit (UreA), and Paper 5 uses epitopes from UreB, implying a two-subunit enzyme. Papers 9 and 10 discuss accessory proteins (UreD, UreE, UreF, UreG) required for nickel-center assembly in bacterial ureases, but these are not subunits of the active enzyme. No paper presents evidence that active H. pylori urease has five distinct subunits; the evidence points to two, contradicting the claim."
    },
    "naive_doc_ids": [
      "4387784",
      "25657127",
      "13965483",
      "22896970",
      "2837758"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Papers 2 and 3 explicitly reference Helicobacter pylori urease as comprising subunits UreA and UreB (e.g., epitopes from the urease A subunit UreA and the B subunit UreB were used for vaccines), consistent with the well-known two-subunit composition of the active enzyme. None of the provided papers report five distinct subunits for H. pylori urease. Other papers are about the urea channel (not urease) or unrelated proteins. Thus, the claim of five distinct subunits is contradicted by the evidence indicating two subunits (UreA and UreB)."
    },
    "overthinking_doc_ids": [
      "4387784",
      "13965483",
      "2837758",
      "25657127",
      "2052720"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "The provided evidence referring to Helicobacter pylori urease identifies two subunits, UreA and UreB, not five distinct subunits. Paper 3 explicitly mentions the urease A subunit (UreA), and Papers 2 and 3 focus on epitopes from UreA and UreB, consistent with the well-known two-subunit composition of H. pylori urease. None of the papers report or support a five-subunit urease; other papers are about different proteins (e.g., the UreI urea channel) or unrelated systems. Therefore, the claim of five distinct subunits is contradicted by the evidence presented."
    },
    "posthoc_doc_ids": [
      "4387784",
      "2837758",
      "13965483",
      "2052720",
      "2099400"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1025",
    "claim": "Reduced levels of lipolysis leads to higher P38 phosphorylation in adipose tissue.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Paper 8 shows that in adipocytes nicotine activates AMPK\u03b12, which degrades MKP1 and aberrantly activates p38 MAPK and JNK. This leads to impaired insulin signaling and a loss of insulin-mediated inhibition of lipolysis, thereby increasing lipolysis. Thus, higher p38 phosphorylation is associated with increased (not reduced) lipolysis in adipose tissue. The other cited papers do not provide direct data linking reduced lipolysis to increased p38 phosphorylation in adipose tissue."
    },
    "naive_doc_ids": [
      "40232172",
      "79447",
      "1568684",
      "3621011",
      "9178310"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers present data on the relationship between lipolysis levels and p38 MAPK phosphorylation in adipose tissue. The studies cover unrelated topics such as yeast HOG1 transport, beta-adrenergic effects on immune function and ghrelin secretion, cardiovascular genetics, cancer signaling, adipose microvascular function, NO-mediated S-nitrosylation, tenomodulin in adipogenesis, and AMPK-JAK1 signaling. No paper measures p38 phosphorylation in adipose tissue in the context of altered lipolysis."
    },
    "overthinking_doc_ids": [
      "33063763",
      "3943235",
      "23929297",
      "24586989",
      "31311495"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.8,
      "justification": "Paper 6 shows in adipocytes that nicotine activates AMPK\u03b12, which promotes MKP1 degradation, leading to activation (increased phosphorylation) of p38 MAPK and JNK. This activation causes IRS1 Ser307 phosphorylation, IRS1 degradation, and loss of insulin-mediated inhibition of lipolysis, resulting in increased lipolysis. Thus, higher p38 phosphorylation is associated with increased, not reduced, lipolysis. The other papers do not address p38 phosphorylation in adipose tissue in relation to lipolysis."
    },
    "posthoc_doc_ids": [
      "79447",
      "3621011",
      "39187170",
      "40232172",
      "1568684"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "63",
    "claim": "ATM and Rad3 related protein are critical for sensing DNA damage.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Multiple papers show that ATR (Ataxia Telangiectasia and Rad3-related) and ATM are activated by DNA damage/replication stress and are required to initiate checkpoint signaling, consistent with a critical role in sensing and responding to DNA damage. Paper 1 shows replication stress with ssDNA\u2013RPA triggers ATR activation leading to Chk1 activation, and ATR inhibition phenocopies checkpoint defects. Paper 2 shows MDC1 facilitates ATR-dependent Chk1 activation at stalled forks, linking damage recognition machinery to ATR signaling. Paper 5 indicates ATR and Rad17 require RPA for DNA association, consistent with ATR engagement at damage-associated ssDNA. For ATM, Paper 3 shows endogenous activation of ATM (pS1981), \u03b3-H2AX, and Chk2 at replication foci in BLM-deficient cells, and Paper 7 identifies ATM as a central coordinator of DDR whose activation is required for downstream signaling to p53 and H2AX. Paper 8 shows ATM phosphorylation is enriched at telomeres within APBs, indicating damage signaling at altered telomeres. Although Paper 1 notes ATM is not required for certain replication-stress-specific events, the broader evidence supports ATM and ATR as key initiators of damage signaling, aligning with the claim."
    },
    "naive_doc_ids": [
      "12909503",
      "11568270",
      "39225849",
      "164189",
      "34105878"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Multiple provided papers explicitly identify ATM and ATR (Ataxia Telangiectasia and Rad3 related) as key sensors in the DNA damage response. Paper 10 states that DNA damage checkpoints employ damage sensor proteins such as ATM and ATR to detect DNA damage and initiate signaling. Paper 9 reviews how ATM/Tel1 and ATR/Mec1 sense and signal DNA double-strand breaks as master regulators, detailing activation by distinct DNA-end structures. Paper 6 describes ATM as a DNA double-strand break recognition and response protein in vivo. Paper 4 further supports ATR\u2019s role in sensing replication stress (RPA-ssDNA) and initiating checkpoint signaling. While Paper 4 notes ATM is not required for a specific replication-stress outcome, it does not contradict the broader role of ATM in sensing DNA damage. Collectively, the evidence supports the claim."
    },
    "overthinking_doc_ids": [
      "42267740",
      "10015292",
      "10704438",
      "12909503",
      "36831892"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.9,
      "justification": "Paper 5 explicitly identifies ATM and ATR as DNA damage checkpoint damage sensor proteins that detect DNA damage and initiate signaling. Paper 10 describes ATM as a DNA double-strand break recognition and response protein and shows functional consequences of its loss, consistent with a sensing role. Paper 6 shows ATR activation upon replication stress and its necessity in checkpoint signaling, supporting its role in detecting replication-associated DNA damage. Together, these align with the claim that ATM and ATR are critical for sensing DNA damage."
    },
    "posthoc_doc_ids": [
      "4530659",
      "10012166",
      "13106686",
      "16605494",
      "38131471"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1330",
    "claim": "Tumor development occurs in conjunction with suppression of pro-inflammatory cytokines.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Multiple cited studies indicate that pro-inflammatory cytokines can promote, not be suppressed during, tumor development. Paper 3 shows IL-17 (a pro-inflammatory cytokine) promotes tumor growth and MDSC accumulation; neutralizing IL-17 inhibits tumors. Paper 4 shows NLRP3 inflammasome activity (generating pro-inflammatory IL-1\u03b2/IL-18) impedes antitumor immunity by enhancing tumor-associated MDSCs. Paper 6 demonstrates that inhibiting IL-6 (pro-inflammatory) trans-signaling suppresses colon tumor progression, implying IL-6 promotes progression. While other papers (2,5) describe MDSC-driven immunosuppression and inhibitory cytokines (IL-10, TGF-\u03b2), they do not provide evidence that pro-inflammatory cytokines are suppressed during tumor development. Overall, the evidence contradicts the claim."
    },
    "naive_doc_ids": [
      "2014909",
      "2030623",
      "25726838",
      "15435343",
      "5836"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.88,
      "justification": "Key cancer-focused papers indicate that tumor development is commonly associated with the presence and promotion of inflammation, not suppression of pro-inflammatory cytokines. Paper 6 describes NF-\u03baB-driven inflammatory signaling as a tumor-promoting factor. Paper 7 (Hallmarks of Cancer) explicitly states that inflammation fosters multiple hallmark functions of tumors. Paper 8 details 'smouldering' cancer-related inflammation in the tumor microenvironment that promotes proliferation, survival, angiogenesis, metastasis, and immune subversion. These collectively contradict the claim that tumor development occurs with suppression of pro-inflammatory cytokines. The other papers are not directly relevant to this specific claim."
    },
    "overthinking_doc_ids": [
      "952111",
      "2391552",
      "11233339",
      "25315295",
      "1522336"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.88,
      "justification": "Paper 9 shows that colon tumor progression is driven by IL-6 trans-signaling and that suppressing this pro-inflammatory pathway via TGF-\u03b2 inhibits tumor progression, implying pro-inflammatory cytokine activity promotes, not accompanies suppression during, tumor development. Paper 8 finds elevated IL-6 levels in cervical cancer patients are associated with poorer overall survival, again indicating pro-inflammatory cytokines are elevated rather than suppressed in cancer. The other papers do not provide evidence that tumor development occurs with suppression of pro-inflammatory cytokines."
    },
    "posthoc_doc_ids": [
      "22889972",
      "7898952",
      "8133180",
      "9559146",
      "11233339"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.18,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1398",
    "claim": "p16INK4A degradation is encoded by CDKN2A.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.94,
      "justification": "None of the provided papers discuss p16INK4A or the CDKN2A gene, nor do they address mechanisms of p16INK4A degradation or its genetic encoding. While several papers cover ubiquitin-dependent degradation and specific E3 ligases (e.g., Neuralized/Mind bomb, FBW7) in other contexts, they do not mention CDKN2A or p16INK4A. Therefore, the evidence set does not confirm or refute the claim."
    },
    "naive_doc_ids": [
      "3067015",
      "5403286",
      "159469",
      "202259",
      "238409"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers mention CDKN2A or p16INK4A, nor do they address mechanisms specific to p16INK4A degradation. The articles focus on topics such as image analysis (Fiji), mesenchymal stem cells and HSC niches, endothelial-to-mesenchymal transition, ovarian surface epithelium stem cells, LepR+ stromal cells, Notch signaling and ubiquitin ligases (Neuralized/Mind bomb), general ubiquitin-dependent degradation pathways, viral ubiquitin ligases targeting BST2, ERAD via RHBDL4, and nonlysine ubiquitination by viral E3 ligases. Therefore, the evidence set does not provide information to confirm or refute the claim about p16INK4A degradation being encoded by CDKN2A."
    },
    "overthinking_doc_ids": [
      "1283401",
      "2853291",
      "6807122",
      "9997636",
      "10078024"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers present data on p16INK4A (the protein product of the CDKN2A gene) degradation or link its degradation mechanism to CDKN2A. The evidence discusses ubiquitin-dependent degradation in general and specific substrates (e.g., KLF2, RhoA, Mcl-1, catalase), and one paper mentions p16 reactivation under ERK inhibition, but none address p16INK4A degradation or its encoding by CDKN2A. Therefore, the claim is not supported or refuted by the provided evidence."
    },
    "posthoc_doc_ids": [
      "6422576",
      "33068577",
      "2988714",
      "23513818",
      "4920376"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1206",
    "claim": "The composition of myosin-II isoform switches from the A isoform to the B isoform during hematopoietic differentiation.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data on myosin-II isoform (A vs B; e.g., MYH9 vs MYH10) composition or its switching during hematopoietic differentiation. Relevant mentions include general miRNA regulation in hematopoietic progenitors (Paper 1), isoform switching in myoblast differentiation (Paper 2), signaling and epigenetic regulators of pluripotency/hematopoiesis (Papers 3, 5, 8\u201310), T-cell-specific phosphatase expression (Paper 6), neural stem cell regulation (Paper 7), and mitochondrial control of HSC differentiation (Paper 9). Paper 4 discusses myosin heavy chain II in smooth muscle cells, not hematopoietic differentiation. Therefore, the evidence set does not address the specific myosin-II A-to-B isoform switch in hematopoiesis."
    },
    "naive_doc_ids": [
      "23727313",
      "27061085",
      "42787108",
      "11840194",
      "11951999"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 1 directly examines nonmuscle myosin II isoforms in human hematopoiesis and finds MIIB is the major isoform in hematopoietic stem/progenitor cells and is downregulated upon differentiation, while MIIA is constitutively expressed and activated during differentiation under certain matrix conditions. This pattern opposes a switch from MIIA to MIIB during hematopoietic differentiation. The other papers do not provide relevant data on MIIA\u2194MIIB changes in hematopoiesis."
    },
    "overthinking_doc_ids": [
      "18909530",
      "14581009",
      "27061085",
      "344240",
      "735130"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.9,
      "justification": "Paper 6 reports that MIIB (myosin-II B) is the major isoform in hematopoietic stem/progenitor cells and is downregulated upon differentiation, while MIIA (myosin-II A) is constitutively present and becomes activated during differentiation. This indicates a shift from B-dominant in stem/progenitors toward A activity in differentiated cells\u2014the opposite of the claim that isoform composition switches from A to B during hematopoietic differentiation. The other papers do not provide relevant isoform-switching data for myosin-II in hematopoiesis."
    },
    "posthoc_doc_ids": [
      "11289247",
      "13116880",
      "14581009",
      "23727313",
      "344240"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "502",
    "claim": "Healthcare delivery efficiency in crowded delivery centers is impaired by improving structural, logistical, and interpersonal elements.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "The claim states that improving structural, logistical, and interpersonal elements impairs healthcare delivery efficiency. Multiple provided studies show the opposite\u2014such improvements enhance efficiency and outcomes. Tele-ICU reengineering (Paper 7) increased best-practice adherence, reduced preventable complications, and shortened hospital length of stay, indicating improved efficiency. Pharmacist participation on ICU rounds (Paper 10) reduced preventable adverse drug events by 66%, a process improvement consistent with greater efficiency and safety. Additionally, Paper 1 suggests that making hospitals safer, more comfortable, and culturally sensitive would increase timely use of services, not impair it. While none focus specifically on crowded delivery centers, the direction of effect contradicts the claim."
    },
    "naive_doc_ids": [
      "17626822",
      "2425364",
      "8842332",
      "11360768",
      "25182647"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine healthcare delivery efficiency in crowded delivery centers or the effect of improving structural, logistical, and interpersonal elements in that specific context. The closest related studies (e.g., IV drug administration errors and pharmacist participation in ICU rounds) address different settings and, if anything, suggest that such improvements reduce errors and improve outcomes, not impair efficiency. However, they do not directly test the claim in crowded delivery centers, so there is no relevant evidence here to confirm or refute the claim."
    },
    "overthinking_doc_ids": [
      "2097256",
      "6477536",
      "8909176",
      "12824568",
      "16495649"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers examine efficiency in crowded delivery centers or assess whether improving structural, logistical, or interpersonal elements impairs efficiency in that setting. Relevant healthcare studies (e.g., ICU staffing changes and RICU vs ICU for COPD) address different contexts and generally show improvements enhance efficiency (reduced costs/length of stay), but they are not about crowded delivery centers. Therefore, the evidence does not directly inform this specific claim."
    },
    "posthoc_doc_ids": [
      "432261",
      "2211868",
      "2565138",
      "3829232",
      "3981729"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "813",
    "claim": "Mutations in G-Beta protein GNB1 are present in many cancers, resulting in loss of interaction with G-alpha subunits and concomitant activation of AKT pathway.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.95,
      "justification": "None of the provided papers discuss GNB1 (G-beta) mutations, their effects on G-alpha interactions, or direct linkage of such mutations to AKT pathway activation. The evidence focuses on PI3K/mTOR pathway modulation (e.g., PIK3CA mutations, PTEN loss), PPM1D truncations, and unrelated topics (e.g., PKC phosphorylation of p53, GLP-1R variants, HP1 phosphorylation). Therefore, the claim about GNB1 mutations is not addressed by these papers."
    },
    "naive_doc_ids": [
      "14241418",
      "15113221",
      "32721137",
      "4414547",
      "5403286"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 8 directly shows that recurrent mutations in the G\u03b2 proteins GNB1 and GNB2 occur across a range of human tumors and that multiple GNB1 mutations affect the G\u03b1-binding interface, disrupting G\u03b1\u2013G\u03b2\u03b3 interactions. It also demonstrates that these mutations activate signaling that is suppressible by the dual PI3K\u2013mTOR inhibitor BEZ235, implying activation of the PI3K/AKT/mTOR axis. Paper 1 independently establishes that BEZ235 inhibits PI3K/mTOR signaling and downstream AKT activation, supporting the interpretation that GNB1-driven signaling includes AKT pathway activation. Other papers are not relevant. Thus, the evidence supports the claim."
    },
    "overthinking_doc_ids": [
      "14241418",
      "207972",
      "711256",
      "4414547",
      "7736860"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 6 reports recurrent mutations in GNB1 (and GNB2) across multiple human tumor types, including myeloid and B-cell neoplasms, indicating presence in many cancers. It shows that several GNB1 mutations disrupt the G\u03b1\u2013G\u03b2\u03b3 interface, leading to loss of interaction with G\u03b1 subunits and activation of canonical G protein signaling. Moreover, GNB1-driven signaling was suppressed in vivo by the dual PI3K\u2013mTOR inhibitor BEZ235, implying involvement of the PI3K/AKT pathway. Paper 3 establishes that BEZ235 inhibits PI3K/mTOR signaling and downstream Akt activation, supporting the interpretation that GNB1 mutations concomitantly activate the AKT pathway. Other provided papers are not directly relevant."
    },
    "posthoc_doc_ids": [
      "16745747",
      "7736860",
      "14241418",
      "25479072",
      "25915873"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "350",
    "claim": "Discrimination between the initiator and elongation tRNAs depends on the translation initiation factor IF3.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.61,
      "justification": "Among the provided papers, only Paper 1 addresses bacterial translation initiation factors (IF1\u2013IF3) and shows, via cryo-EM, that IF3 undergoes conformational changes that facilitate accommodation of initiator fMet-tRNA in the P site, implying a role in initiator tRNA selection. However, it does not explicitly demonstrate or state that discrimination between initiator and elongator tRNAs depends on IF3 (e.g., by showing prevention of elongator tRNA binding or necessity of IF3 for this discrimination). The remaining papers are unrelated to bacterial IF3-mediated tRNA discrimination. Therefore, the claim is not directly supported or refuted by the provided evidence."
    },
    "naive_doc_ids": [
      "16927286",
      "22896970",
      "6826100",
      "8331432",
      "9505448"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Only Paper 1 is tangentially relevant; it shows that IF3 participates in initiation and undergoes conformational changes that facilitate accommodation of fMet-tRNAfMet and that IFs 1\u20133 enable selection of the initiator tRNA. However, it does not present direct experimental evidence that discrimination between initiator and elongator tRNAs specifically depends on IF3 or that IF3 is necessary for excluding elongator tRNAs. The remaining papers are unrelated to bacterial IF3-mediated tRNA discrimination."
    },
    "overthinking_doc_ids": [
      "16927286",
      "2479538",
      "2319305",
      "8698857",
      "30261663"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 10 directly addresses bacterial translation initiation and shows that initiation factors (IF1\u2013IF3) enable the selection of initiator tRNA and the start codon in the 30S P site. It specifically reports that IF3 undergoes large conformational changes with tRNA to facilitate the proper accommodation of fMet-tRNAfMet into the P site, consistent with a role in discriminating initiator tRNA from elongator tRNAs. The other provided papers do not present relevant data on IF3\u2019s role in tRNA discrimination. Thus, the evidence supports the claim that discrimination between initiator and elongation tRNAs depends on IF3."
    },
    "posthoc_doc_ids": [
      "8698857",
      "9505448",
      "24521894",
      "2479538",
      "6985854"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "899",
    "claim": "Oxidative DNA damage inhibits STING signalling.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.97,
      "justification": "Paper 1 shows that oxidative DNA damage (8-hydroxyguanosine-modified DNA) potentiates, rather than inhibits, STING-dependent immune sensing by reducing TREX1-mediated degradation. Paper 9 demonstrates that oxidized mitochondrial DNA released in NETs is interferogenic and triggers type I interferon signaling via a STING-dependent pathway. Other papers provide context on STING/cGAS signaling but do not indicate inhibition by oxidative DNA damage. Together, the relevant evidence indicates oxidative DNA damage activates/enhances STING signaling, contradicting the claim."
    },
    "naive_doc_ids": [
      "13106686",
      "18358026",
      "19688024",
      "22059387",
      "44693226"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Paper 2 shows that oxidized mitochondrial DNA released in NETs is proinflammatory and, when injected into mice, activates type I interferon signaling through a STING-dependent pathway. Paper 3 demonstrates that oxidative DNA damage (8-oxoguanine) makes DNA resistant to TREX1 degradation and thereby potentiates STING-dependent immune sensing. These findings indicate oxidative DNA damage enhances, not inhibits, STING signaling. Other papers are background or not directly relevant."
    },
    "overthinking_doc_ids": [
      "19688024",
      "1049501",
      "13106686",
      "164189",
      "888896"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.93,
      "justification": "Paper 1 reports that oxidative DNA damage (8-hydroxyguanosine in DNA) enhances, rather than inhibits, STING-dependent immune sensing by reducing TREX1-mediated degradation of cytosolic DNA, thereby potentiating type I IFN responses. The other papers do not provide direct evidence about STING signaling in the context of oxidative DNA damage. Therefore, the claim that oxidative DNA damage inhibits STING signaling is contradicted by the provided evidence."
    },
    "posthoc_doc_ids": [
      "13106686",
      "18358026",
      "22059387",
      "44693226",
      "1686997"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1026",
    "claim": "Reduced phosphorylation of PP2A increases HDAC4 dephosphorylation by enhancing PP2A-HDAC4 interaction.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "Paper 4 shows that ATM-mediated phosphorylation downregulates PP2A activity; in ATM deficiency, PP2A activity increases, leading to HDAC4 dephosphorylation and nuclear accumulation. This supports that reduced phosphorylation of PP2A can increase HDAC4 dephosphorylation. However, none of the provided papers present data that this effect occurs via enhanced PP2A\u2013HDAC4 interaction. Paper 1 discusses phosphorylation-dependent phosphatase interactions in the Hippo pathway generally, but not PP2A\u2013HDAC4 specifically. No direct evidence links decreased PP2A phosphorylation to increased PP2A\u2013HDAC4 binding. Therefore, the mechanism stated in the claim is not supported by the provided evidence."
    },
    "naive_doc_ids": [
      "26019505",
      "207972",
      "1554348",
      "3113630",
      "11256632"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Paper 2 shows that ATM-mediated phosphorylation downregulates PP2A activity, and in ATM deficiency (i.e., with reduced PP2A phosphorylation), PP2A activity increases, leading to HDAC4 dephosphorylation and nuclear accumulation. However, none of the provided excerpts present evidence that this occurs specifically by enhancing PP2A\u2013HDAC4 interaction. The other papers are unrelated to PP2A\u2013HDAC4. Thus, while increased HDAC4 dephosphorylation with reduced PP2A phosphorylation is supported, the mechanism of enhanced PP2A\u2013HDAC4 interaction is not evidenced in the provided texts."
    },
    "overthinking_doc_ids": [
      "22185730",
      "3113630",
      "3973445",
      "6157371",
      "8417211"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Paper 2 shows that ATM-mediated phosphorylation downregulates PP2A activity and that ATM deficiency (reduced PP2A phosphorylation) enhances PP2A activity, leading to HDAC4 dephosphorylation and nuclear accumulation. However, none of the provided papers present evidence that this occurs specifically by enhancing PP2A\u2013HDAC4 interaction. The other papers are unrelated to PP2A\u2013HDAC4 binding. Therefore, the interaction-based mechanism in the claim is not supported by the given evidence."
    },
    "posthoc_doc_ids": [
      "22185730",
      "3113630",
      "3973445",
      "6157371",
      "8417211"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "755",
    "claim": "Many cytokines that are produced by cancer cells also contribute to carcinogenesis.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.88,
      "justification": "Multiple papers show that cytokines produced by tumor cells actively promote carcinogenesis. Paper 3 demonstrates that tumor cell\u2013derived VEGF drives autocrine proliferation and is required for tumorigenesis, with genetic deletion delaying tumor development. Paper 9 shows TGF\u03b2, secreted by tumor (and stromal) cells, induces fascin and promotes invasion and metastasis, with correlations in patient tumors. Paper 4 finds breast tumors express high levels of VEGF and TGF-\u03b21, with high VEGF linked to poorer prognosis, consistent with pro-tumor roles. Paper 7 further indicates that tumor-cell VEGF expression (regulated by BCL9) enhances angiogenesis and tumor progression, and its reduction curtails these processes. Paper 5 adds that tumor-derived HMGB1 (a cytokine-like alarmin) in exosomes reprograms neutrophils to a pro-tumor state that enhances cancer cell migration. Together, these data support that several cytokines produced by cancer cells contribute directly to cancer development and progression."
    },
    "naive_doc_ids": [
      "22049489",
      "14664424",
      "17844478",
      "22401720",
      "52925737"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.88,
      "justification": "Multiple papers show tumor cell\u2013derived cytokines actively drive carcinogenic processes. Paper 4 demonstrates that cancer cell mTOR signaling increases G-CSF production, which recruits pro-tumorigenic MDSCs and promotes tumor initiation; blocking this axis inhibits progression and restoring G-CSF rescues it, indicating causality. Paper 6 shows that VEGF produced by tumor cells acts autocrinely via VEGFR/EGFR synergy to promote tumor cell proliferation and tumorigenesis independently of angiogenesis. Paper 1 further supports the concept by showing tumor-derived exosomal HMGB1 (a cytokine-like alarmin) polarizes neutrophils to a pro-tumor state that enhances cancer cell migration. Paper 5 associates higher serum cytokines (IL-6, VEGF) with worse prognosis in cervical cancer, consistent with pro-tumor roles. Together, these findings support the claim that cytokines produced by cancer cells contribute to carcinogenesis."
    },
    "overthinking_doc_ids": [
      "52925737",
      "1522336",
      "22049489",
      "2014909",
      "14664424"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 4 provides direct evidence that a cytokine produced by cancer cells (G-CSF, induced by oncogenic mTOR signaling) promotes tumor initiation by recruiting myeloid-derived suppressor cells and creating a pro-tumorigenic feedforward loop. This aligns with the claim that cytokines made by cancer cells can contribute to carcinogenesis. Additional papers reinforce that cytokine signaling drives tumor progression and poor outcomes (e.g., IL-6/VEGF prognostic associations in Paper 5; IL-6-driven progression and chemoresistance in Papers 9 and 10), though their sources may include stromal/immune cells. Paper 8 shows that some tumor cell\u2013derived cytokines (type I IFNs) can be anti-tumor, indicating not all such cytokines are carcinogenic; however, this does not negate the claim that many are. Overall, the evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "1522336",
      "15435343",
      "22049489",
      "2014909",
      "14664424"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1001",
    "claim": "R2D2 stops miRNA production by increasing the selectivity of Dcr2 for long dsRNA.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.84,
      "justification": "Paper 1 directly shows that while purified Drosophila Dicer-2 (Dcr-2) can cleave pre-miRNA, the partner protein R2D2 (and inorganic phosphate) inhibits pre-miRNA cleavage, thereby restricting Dcr-2 substrate specificity to long dsRNA. This indicates R2D2 prevents Dcr-2 from processing miRNA precursors and promotes selectivity for long dsRNA, aligning with the claim\u2019s mechanism. Paper 2 is consistent in placing R2D2 in the Dcr-2 complex (though it does not enhance activity), without contradicting the selectivity effect. The other papers are not relevant to R2D2\u2019s effect on Dcr-2 substrate choice. Thus, the provided evidence supports the claim that R2D2 limits miRNA production by increasing Dcr-2 selectivity for long dsRNA."
    },
    "naive_doc_ids": [
      "5702790",
      "23913146",
      "5953485",
      "9091863",
      "236204"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.8,
      "justification": "Paper 1 directly shows that purified Drosophila Dicer-2 can cleave pre-miRNA but that its partner R2D2 (and inorganic phosphate) inhibits pre-miRNA cleavage, thereby restricting Dicer-2 substrate specificity. Since Dicer-2 requires ATP to process long dsRNA and R2D2 blocks pre-miRNA processing, R2D2 functionally increases Dicer-2 selectivity for long dsRNA over pre-miRNA, effectively preventing miRNA production by Dicer-2. Paper 2 is consistent with R2D2 being part of the Dicer-2 complex and does not contradict this role (it notes Loqs-PD, not R2D2, enhances activity). Other papers are not relevant to this specific claim."
    },
    "overthinking_doc_ids": [
      "5702790",
      "23913146",
      "5953485",
      "25515662",
      "30379039"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 1 shows that purified Drosophila Dicer-2 can cleave pre-miRNA unless inorganic phosphate and its partner R2D2 are present; R2D2 inhibits pre-miRNA cleavage and thereby restricts Dicer-2 substrate specificity to long dsRNA. This directly supports the mechanism that R2D2 increases Dicer-2 selectivity for long dsRNA and suppresses Dicer-2\u2013mediated miRNA processing. Paper 3 further places R2D2 in the Dicer-2 complex specialized for si/esiRNA production, consistent with promoting long dsRNA processing. Note that in vivo miRNAs are primarily produced by Dicer-1 in Drosophila, so R2D2\u2019s effect is to prevent Dicer-2 from processing pre-miRNA rather than globally stopping miRNA production."
    },
    "posthoc_doc_ids": [
      "5702790",
      "15590539",
      "23913146",
      "2460304",
      "5953485"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.55,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "978",
    "claim": "Pro-inflammatory cytokines are up repressed during tumor development.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Multiple papers show pro-inflammatory cytokines are active/elevated and promote tumor progression, not repressed. Paper 5: Lung cancer patients exhibit systemic inflammation with increased IL-6 and TNF-related markers. Paper 8: NLRP3-driven activation of IL-1\u03b2/IL-18 impedes antitumor immunity by enhancing tumor-associated MDSC accumulation. Paper 9: IL-17 promotes tumor growth; its deficiency or neutralization reduces tumors and MDSCs. Paper 7: Oncogenic mTOR upregulates G-CSF to recruit pro-tumorigenic MDSCs. These findings indicate pro-inflammatory cytokines are upregulated/functional during tumor development, contradicting the claim that they are repressed."
    },
    "naive_doc_ids": [
      "22889972",
      "36386637",
      "2734421",
      "6270720",
      "24917562"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "The provided cancer-focused papers indicate that inflammatory cytokines are elevated and actively promote tumor development, not repressed. Paper 8 shows oncogenic mTOR signaling increases G-CSF (a pro-inflammatory cytokine), which recruits myeloid-derived suppressor cells and enhances tumor initiation; inhibiting this pathway impairs progression and can be rescued by restoring G-CSF. Paper 10 describes how macrophages create an inflammatory milieu during tumor initiation and progression, implying active pro-inflammatory cytokine signaling. Other tumor papers (e.g., Paper 9, Paper 5) note upregulation of cytokines/growth factors within the tumor microenvironment. Thus, the evidence contradicts the claim that pro-inflammatory cytokines are repressed during tumor development."
    },
    "overthinking_doc_ids": [
      "11233339",
      "22889972",
      "25315295",
      "2391552",
      "17844478"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Several papers indicate pro-inflammatory or tumor-promoting cytokines are present/increased during cancer, not repressed. Paper 5 shows elevated IL-6 is a prognostic biomarker in cervical cancer, implying higher levels associate with worse outcomes. Paper 7 describes macrophages creating an inflammatory milieu that promotes tumor initiation and progression. Paper 9 finds increased exosomal cytokine cargo (e.g., TGF-\u03b21) in ovarian cancer patients, increasing with advanced stage. Paper 10 notes upregulation of cytokines involved in angiogenesis in tumors. Together, these oppose the claim that pro-inflammatory cytokines are repressed during tumor development."
    },
    "posthoc_doc_ids": [
      "21258863",
      "22889972",
      "11233339",
      "11328820",
      "14664424"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "410",
    "claim": "Febrile seizures increase the threshold for development of epilepsy.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.63,
      "justification": "Only Paper 2 directly addresses febrile seizures. It shows that hyperthermia-induced (febrile) seizures in immature rats produce long-lasting modifications in hippocampal neuronal excitability, including a selective presynaptic increase in inhibitory transmission, and explicitly states these findings do not support the view that early-life febrile seizures are benign. While it does not directly measure epilepsy incidence or an epileptogenesis threshold, the authors' conclusion argues against a protective effect. The other papers do not examine febrile seizures or their impact on epileptogenesis."
    },
    "naive_doc_ids": [
      "116792",
      "14924526",
      "1410197",
      "35520219",
      "643765"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Only Paper 6 is relevant to febrile seizures, reporting long-lasting changes in hippocampal synaptic transmission after hyperthermia-induced seizures in immature rats. It does not assess or conclude whether febrile seizures increase the threshold for developing epilepsy (i.e., a protective effect). The other papers are unrelated to febrile seizures or epilepsy risk. Therefore, the provided evidence does not directly support or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "5691302",
      "23136735",
      "4828631",
      "20321154",
      "14682243"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Only Paper 3 is relevant to febrile seizures and epileptogenesis. It shows that early-life febrile seizures induce persistent alterations in hippocampal synaptic transmission that last into adulthood and argues against the benign nature of febrile convulsions, implying a potential facilitation of epileptogenesis (i.e., effectively lowering rather than increasing the threshold for developing epilepsy). The other papers do not address febrile seizures or epilepsy risk."
    },
    "posthoc_doc_ids": [
      "439670",
      "6793674",
      "14924526",
      "17450673",
      "23557241"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1214",
    "claim": "The deregulated and prolonged activation of monocytes improves inflammatory disease outcomes.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 4 directly shows that reduced inflammatory responses in monocytes (via a FOXO3-driven pathway that lowers TNF\u03b1 and increases IL-10) are associated with a milder course of Crohn's disease and rheumatoid arthritis. This indicates that dampening\u2014not deregulating or prolonging\u2014monocyte activation improves inflammatory disease outcomes. Paper 1 further shows that persistent immune activation worsens DSS-induced colitis in mice (higher disease activity and mortality), arguing against prolonged activation being beneficial. Although Papers 2 and 3 focus on neutrophils, they demonstrate that deregulated innate cell activation exacerbates autoimmune disease, consistent with the notion that sustained innate activation is detrimental. Paper 5 links higher systemic inflammation with worse functional outcomes in COPD. Together, the evidence contradicts the claim that deregulated and prolonged monocyte activation improves outcomes."
    },
    "naive_doc_ids": [
      "5572127",
      "1049501",
      "11328820",
      "13905670",
      "26107000"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Multiple papers indicate that prolonged or dysregulated inflammatory activation is associated with worse, not improved, outcomes. Paper 2 shows chronic stress-induced glucocorticoid receptor resistance leads to failure to down-regulate inflammation, higher risk of developing colds, and increased local proinflammatory cytokines. Paper 3 identifies chronic low-grade inflammation (inflammaging) as a major risk factor for morbidity and mortality in aging. In autoimmune/inflammatory contexts, excessive innate/adaptive activation worsens disease: Paper 7 links enhanced NETosis with amplified inflammatory responses in rheumatoid arthritis; Papers 8 and 10 show expansion/activation of IL-23\u2013responsive ILCs and upregulated IL-17F in IBD correlating with inflammation. No paper demonstrates that deregulated and prolonged monocyte activation improves inflammatory disease outcomes. Paper 5\u2019s prolonged TLR3 activation in macrophages reduces HIV replication, but this is not an inflammatory disease outcome and does not support the claim."
    },
    "overthinking_doc_ids": [
      "2787558",
      "3083927",
      "5035827",
      "21700295",
      "25606339"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.84,
      "justification": "Multiple papers indicate that improved outcomes in inflammatory diseases are associated with limiting or appropriately regulating monocyte/macrophage inflammatory activity, not with deregulated or prolonged activation. Paper 1 shows a FOXO3A variant that dampens monocyte proinflammatory cytokines (via TGF\u03b21) is linked to milder Crohn's disease and rheumatoid arthritis, indicating reduced activation improves outcomes. Paper 3 implicates increased neutrophil and macrophage activation in COPD pathogenesis, suggesting such activation worsens disease rather than improves it. Paper 8 emphasizes that defective resolution and chronic/excess inflammation are features of lung diseases, and pro-resolving pathways are required for recovery, again opposing the idea that prolonged activation is beneficial. Other papers either show benefits of anti-inflammatory or alternative activation states (Papers 2 and 7) or are not directly relevant to monocyte activation and inflammatory disease outcomes (Papers 4, 5, 9, 10). Overall, the evidence contradicts the claim."
    },
    "posthoc_doc_ids": [
      "13905670",
      "7735859",
      "21395936",
      "24396137",
      "25606339"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1098",
    "claim": "Stacking is more stable when a purine is present in the +5 position (C1698).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address base-stacking interactions involving rRNA nucleotide C1698 or how the mRNA +5 position identity (purine vs pyrimidine) affects stacking stability. The citations focus on ribosome biogenesis factors, nucleolar stress, translational GTPase\u2013ribosome complexes without nucleotide-specific stacking details, mRNA modifications (pseudouridine) broadly, YB-1 binding to 3' UTR motifs, and unrelated viral protein interactions. Therefore, the claim about enhanced stacking stability with a purine at +5 (C1698) is neither supported nor refuted by the provided evidence."
    },
    "naive_doc_ids": [
      "18467982",
      "26112624",
      "6670101",
      "7487927",
      "13552682"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.96,
      "justification": "None of the provided papers present data on nucleotide stacking stability at a specific rRNA position or analyze the effect of a purine at the +5 position (C1698). The papers focus on pre-rRNA processing, enzyme kinetics, plant transformation methods, microtubule dynamics, brown adipose tissue activation, neuronal Sirt1, EMT in lung cancer, and replication fork stability\u2014topics unrelated to the specific stacking claim."
    },
    "overthinking_doc_ids": [
      "18467982",
      "26112624",
      "393001",
      "410286",
      "3033830"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers address nucleotide stacking stability as a function of having a purine at the +5 position or specifically discuss residue C1698. The cited works focus on DNA methylation, replication fork protection, atherosclerotic plaque biology, SIRT1 chromatin dynamics, sequence alignment gap penalties, ribosome\u2013GTPase structures, ribosome-mediated translational specificity, and pre-rRNA processing/mitochondrial RNA granules. While a few papers relate to ribosome structure and RNA processing, they do not present data about base-stacking energetics or sequence-dependent stability at the specified position."
    },
    "posthoc_doc_ids": [
      "3174305",
      "4444861",
      "4890578",
      "5824955",
      "7260461"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.05,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "43",
    "claim": "A low percentage of hematopoietic progenitor cells are susceptible to HIV-1 infection ex vivo.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.93,
      "justification": "None of the provided papers present data on HIV-1 infection of hematopoietic progenitor cells ex vivo or report the percentage susceptible. Several papers discuss hematopoietic stem/progenitor cell biology (e.g., bcl-2-mediated chemoresistance, miRNA regulation, HES-1 effects, mobilization, cell cycle) and others address unrelated viruses (HCMV, MCMV, SIV) or microbial infections. While one paper examines SIV coreceptor usage in human cells and another discusses HCMV latency in myeloid progenitors, they do not assess HIV-1 infection of HSPCs or quantify susceptibility ex vivo."
    },
    "naive_doc_ids": [
      "11900630",
      "23727313",
      "40234452",
      "13509809",
      "18374364"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Only Paper 3 addresses HIV-1 infection of hematopoietic progenitor cells (CD34+ HPCs), showing that these cells can be infected and may harbor latent virus. However, it does not provide quantitative data indicating that only a low percentage are susceptible ex vivo. The other papers are unrelated to HIV susceptibility in progenitors. Therefore, the provided evidence does not confirm the 'low percentage' aspect of the claim."
    },
    "overthinking_doc_ids": [
      "23727313",
      "40234452",
      "7224723",
      "11900630",
      "13509809"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Among the provided papers, only Paper 7 directly addresses HIV-1 infection of hematopoietic progenitor cells (CD34+ HPCs), demonstrating that these cells can be infected and can harbor latent infection ex vivo/in vitro. However, it does not quantify the fraction of HPCs that are susceptible. The other papers concern HSC/HSPC biology, mobilization, expansion, mechanics, or HIV permissivity in T cells, not the percentage of progenitors infected. Therefore, the evidence does not specifically support the claim that only a low percentage are susceptible ex vivo."
    },
    "posthoc_doc_ids": [
      "11900630",
      "13509809",
      "18374364",
      "19583924",
      "40234452"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.4,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1002",
    "claim": "RA activation of DIF2 and NB4 cells induces hallmarks of transcriptionally active promoters.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "Among the provided papers, only Paper 2 examines retinoic acid effects in NB4 cells and shows rapid RA-induced transcription of the IEX-1 gene via RA-response elements, but it does not measure promoter-associated chromatin hallmarks such as histone acetylation, H3K4me3, or RNA polymerase II occupancy. None of the papers mention DIF2 cells or assess RA-induced promoter chromatin marks in NB4. The remaining papers address unrelated systems (T cells, PPAR/RXR signaling, other cancers, general chromatin regulation) without providing direct evidence for RA inducing hallmarks of transcriptionally active promoters in DIF2 or NB4 cells."
    },
    "naive_doc_ids": [
      "18546584",
      "24624992",
      "8458567",
      "14116046",
      "23269537"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers directly assess retinoic acid (RA) activation in DIF2 cells, and only one paper (Paper 7) examines RA effects in NB4 cells, focusing on rapid induction of IEX-1 expression via RA-response elements without reporting promoter chromatin hallmarks (e.g., histone acetylation, H3K4me3, RNAPII recruitment). Other papers address unrelated systems (e.g., B-cell malignancies, ESCs, Trypanosoma, T cells) or structural/algorithmic topics and do not provide experimental evidence linking RA activation in NB4 or DIF2 to hallmarks of transcriptionally active promoters."
    },
    "overthinking_doc_ids": [
      "23269537",
      "175735",
      "7416873",
      "12149169",
      "13777706"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "Among the provided papers, only Paper 9 addresses RA responses in NB4 cells, showing rapid RA-induced transcription of the IEX-1 gene and identifying RA-response elements in its promoter. However, it does not report promoter-level chromatin hallmarks (e.g., H3K4me3, H3/H4 acetylation, Pol II Ser5 phosphorylation) or other canonical features of transcriptionally active promoters. None of the papers mention DIF2 cells at all. The remaining papers discuss RA/RAR-RXR mechanisms or unrelated cell systems, without demonstrating promoter hallmarks in DIF2 or NB4 following RA activation. Therefore, the evidence provided does not confirm the specific claim."
    },
    "posthoc_doc_ids": [
      "17997584",
      "23985464",
      "25050969",
      "25328476",
      "43419566"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "268",
    "claim": "Cold exposure increases BAT recruitment.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.82,
      "justification": "Multiple papers provide experimental evidence that cold exposure recruits thermogenic (brown/beige) adipocytes. Paper 4 shows that cold exposure induces a browning program in white adipose tissue in mice, consistent with recruitment of brown-like adipocytes. Paper 7, using lineage tracing, demonstrates that prolonged cold exposure drives Pdgfr\u03b2+ mural preadipocytes to differentiate into beige adipocytes, indicating cold-induced recruitment of new thermogenic adipocytes. Paper 9 shows that during cold-induced browning of subcutaneous fat, most beige adipocytes arise via de novo adipogenesis, again supporting recruitment. Together, these findings support the claim that cold exposure increases BAT (thermogenic adipocyte) recruitment."
    },
    "naive_doc_ids": [
      "1568684",
      "3621011",
      "79447",
      "29381091",
      "40232172"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Multiple papers indicate that cold exposure induces browning/recruitment of thermogenic adipocytes. Paper 2 shows that cold exposure drives white adipose tissue toward a brown (brite/beige) phenotype in mice, identifying cold-induced gene programs underlying this transition\u2014i.e., recruitment of BAT-like cells. Paper 4 (review) explicitly states that prolonged cold exposure induces browning of white adipose tissue, increasing overall brown fat activity. Paper 3 demonstrates that cold acclimation engages UCP1-dependent thermogenesis, consistent with functional BAT activation during cold. Together, these support the claim that cold exposure increases BAT recruitment."
    },
    "overthinking_doc_ids": [
      "1568684",
      "29381091",
      "970012",
      "14865329",
      "2014909"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.87,
      "justification": "Multiple papers show cold exposure induces recruitment of thermogenic adipocytes. Paper 5 directly states that cold exposure causes an initial recruitment of beige adipocytes in WAT and that prolonged cold drives Pdgfr\u03b2+ mural cells to differentiate into beige adipocytes, demonstrating cold-driven adipocyte recruitment. Paper 1 shows cold exposure triggers 'browning' of white fat (acquisition of brown/brite features and gene programs), consistent with recruitment of brown-like adipocytes. Paper 4 shows cold activates UCP1-dependent thermogenesis in BAT, consistent with cold-driven BAT engagement. Together, these support that cold exposure increases recruitment of brown/beige adipocytes (BAT-related recruitment)."
    },
    "posthoc_doc_ids": [
      "29381091",
      "1568684",
      "40232172",
      "970012",
      "32955023"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1037",
    "claim": "Replacement of OCT4 and SOX2 genes with GATA3 has the ability to reprogram human cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.77,
      "justification": "The provided papers document human cell reprogramming using canonical pluripotency factors such as OCT4, SOX2, NANOG, LIN28, KLF4, and MYC, as well as nuclear transfer approaches. None of the papers present data showing that GATA3 can replace OCT4 and SOX2 to reprogram human cells. Several papers emphasize the central roles of OCT4 and SOX2 in pluripotency regulation, but there is no experimental evidence here about substituting them with GATA3 for reprogramming."
    },
    "naive_doc_ids": [
      "86129154",
      "4457834",
      "10273147",
      "10786948",
      "27588420"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.71,
      "justification": "Among the provided abstracts, only Paper 4 states that lineage specifiers can replace OCT4 and SOX2 in reprogramming human fibroblasts, but it does not identify specific factors in the provided text. None of the other papers mention GATA3 or demonstrate that GATA3 specifically can replace OCT4 and SOX2 to reprogram human cells. Therefore, based on the given evidence, there is insufficient information to confirm this specific claim."
    },
    "overthinking_doc_ids": [
      "6054657",
      "4380451",
      "2853685",
      "16287725",
      "1630949"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 4 discusses replacing OCT4 and SOX2 with lineage specifiers in human fibroblast reprogramming, but it does not specify which factors were used. None of the excerpts explicitly mention GATA3 or demonstrate that GATA3 can replace OCT4 and SOX2 to reprogram human cells. The remaining papers focus on standard Yamanaka factors, alternative factors (e.g., NANOG, LIN28), miRNAs, lincRNAs, and epigenetic considerations without referencing GATA3. Therefore, the supplied evidence does not confirm or refute the specific claim about GATA3."
    },
    "posthoc_doc_ids": [
      "6054657",
      "4380451",
      "2853685",
      "16287725",
      "1630949"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "89",
    "claim": "Adult tissue-resident macrophages stem from the embryonal yolk sac and fetal liver.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Multiple papers indicate that many adult tissue-resident macrophages are seeded before birth and maintained independently of adult blood monocytes, consistent with embryonic origins. Paper 1 shows major tissue-resident macrophages (e.g., Kupffer cells, alveolar, splenic, peritoneal) are established prenatally and self-maintain. Paper 2 provides direct evidence that a lineage of adult tissue macrophages (including Kupffer cells, Langerhans cells, microglia) derives from the embryonic yolk sac and is independent of HSCs. Paper 3 explicitly states Kupffer cells are of fetal origin. Paper 4 shows steady-state self-maintenance with minimal monocyte contribution, aligning with embryonic seeding. Paper 5 documents active fetal liver myelopoiesis, supporting the fetal liver as a source of embryonic myeloid progenitors. Together, these findings support the claim that adult tissue-resident macrophages stem from embryonal yolk sac and fetal liver, though the provided excerpts offer more direct evidence for yolk sac origins and prenatal establishment than explicit lineage tracing from the fetal liver."
    },
    "naive_doc_ids": [
      "7521113",
      "22973574",
      "5511240",
      "12827098",
      "1145473"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Multiple papers provide evidence that adult tissue-resident macrophages are established during embryonic development and persist independently of circulating monocytes. Paper 5 shows a yolk sac\u2013derived lineage (e.g., Kupffer cells, Langerhans cells, microglia) that persists into adulthood, directly supporting yolk sac origin. Papers 2 and 4 report that major tissue-resident macrophage populations are established before birth and self-maintain in adulthood, consistent with embryonic origins that include yolk sac and fetal liver waves. Paper 3 shows self-maintenance with minimal monocyte contribution, aligning with embryonic seeding. Paper 1 notes Kupffer cells are of fetal origin. Together, these findings support the claim, though explicit mention of fetal liver as the specific embryonic source is implicit rather than directly stated in the excerpts."
    },
    "overthinking_doc_ids": [
      "5511240",
      "22406695",
      "12827098",
      "7521113",
      "22973574"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Multiple papers show that adult tissue-resident macrophages are established prenatally and self-maintain without significant input from adult circulating monocytes, consistent with embryonic (yolk sac/fetal liver) origins. Paper 2 (fate mapping) demonstrates major tissue-resident macrophages, including Kupffer cells, are established before birth and persist independently of blood monocytes. Paper 3 shows tissue-resident macrophages self-maintain locally throughout adult life with minimal monocyte contribution. Paper 1 explicitly notes Kupffer cells are of fetal origin. Paper 5 (review) synthesizes that most adult tissue macrophages originate during embryonic development. While the excerpts do not explicitly name the yolk sac and fetal liver as sources, the prenatal establishment and fetal origin findings align with the claim."
    },
    "posthoc_doc_ids": [
      "5511240",
      "7521113",
      "12827098",
      "12966719",
      "22406695"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "551",
    "claim": "ITAM phosphorylation prevents the transfer of the T cell receptor (TCR) signal from the echo-domain to the cytoplasmic tail of the T cell receptor (TCR).",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.86,
      "justification": "Paper 3 shows that phosphorylation of the TCR\u03b6 ITAMs by Lck is required for TCR\u03b6 dissociation from the plasma membrane following TCR engagement, and that disrupting this membrane association attenuates signaling. Thus, ITAM phosphorylation facilitates cytoplasmic tail rearrangements that support signaling rather than preventing signal transfer. Paper 1 further indicates that ligand binding induces a conformational change in CD3\u03b5 that exposes a proline-rich sequence and recruits Nck independently of tyrosine kinase activation, meaning phosphorylation does not block the initial transmission of signal from the ectodomain to the cytoplasmic domain. Paper 10 supports a model where cytoplasmic tail membrane association/dissociation modulates signaling but does not indicate that ITAM phosphorylation prevents signal transfer. Collectively, the evidence opposes the claim."
    },
    "naive_doc_ids": [
      "2714623",
      "34498093",
      "8903143",
      "13578199",
      "21164071"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.8,
      "justification": "Paper 6 shows that phosphorylation of the TCR\u03b6 ITAMs by Lck drives dissociation of the \u03b6 cytoplasmic tail from the plasma membrane and that this regulation is important for downstream signaling. This indicates that ITAM phosphorylation facilitates, rather than prevents, propagation of the TCR signal to the cytoplasmic tail. Paper 9 further demonstrates that TCR ligation induces a conformational change in CD3\u03b5 that initiates intracellular adaptor recruitment (Nck) independently of tyrosine kinase activation, consistent with signal transmission rather than prevention by phosphorylation. Paper 10 shows rapid formation of phosphotyrosine-rich signaling assemblies after TCR ligation, again consistent with phosphorylation enabling signaling. The other papers are not relevant to the specific ITAM/TCR signal transfer question."
    },
    "overthinking_doc_ids": [
      "20630805",
      "159469",
      "202259",
      "238409",
      "439670"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.78,
      "justification": "Paper 4 shows that phosphorylation of the TCR\u03b6 ITAMs by Lck is required for dissociation of the TCR\u03b6 cytoplasmic tail from the plasma membrane following TCR engagement, and that this process modulates and supports downstream signaling. This indicates ITAM phosphorylation facilitates, rather than prevents, transmission of the activation signal from the ectodomain to the cytoplasmic tail. The other papers do not provide relevant data on TCR ITAM signaling."
    },
    "posthoc_doc_ids": [
      "26117607",
      "21931005",
      "34498093",
      "8903143",
      "14405193"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.1,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "407",
    "claim": "FACT and other histone chaperone(s) compensate for Histone 2A (H2A)-histone 2B (H2B) dimer eviction during the histone exchange process.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.8,
      "justification": "Papers 1, 2, and 4 demonstrate SWR1-mediated H2A-to-H2A.Z exchange and associated H2A-H2B dimer eviction, and identify SWR1 subunits (e.g., Swc2) that bind H2A.Z-H2B, but they do not show FACT or other chaperones compensating for the evicted H2A-H2B during this exchange. Paper 3 shows that FACT binds H2A-H2B and can disrupt nucleosomes, indicating capacity to chaperone H2A-H2B, but it does not provide evidence that FACT functions specifically to compensate for dimer eviction during the SWR1-driven histone exchange process. The remaining papers are not directly relevant to this claim. Therefore, the provided evidence does not confirm the claim."
    },
    "naive_doc_ids": [
      "9451052",
      "9881829",
      "9889151",
      "27274441",
      "43156471"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.88,
      "justification": "Among the provided papers, several address histone exchange (SWR1- and INO80-mediated H2A/H2A.Z swapping; Papers 4, 7, 10) and histone chaperones (ASF1 and APLF; Papers 1, 5). However, none present data on FACT, nor do they show that FACT or other histone chaperones compensate for H2A\u2013H2B dimer eviction during exchange. The cited chaperones (ASF1, APLF) are primarily H3/H4-focused, and the exchange studies attribute eviction/replacement to remodeling complexes rather than chaperone compensation. Therefore, the evidence provided does not address the specific claim."
    },
    "overthinking_doc_ids": [
      "12156187",
      "4455466",
      "8331432",
      "9881829",
      "13907427"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "The provided papers show that SWR1 catalyzes stepwise eviction of H2A\u2013H2B during H2A.Z exchange (Papers 1, 3) and that FACT is an H2A\u2013H2B histone chaperone capable of binding H2A\u2013H2B dimers and disrupting/reorganizing nucleosomes (Paper 4). However, none of the cited studies present direct experimental evidence that FACT or other chaperones specifically compensate for, sequester, or redeposit the evicted H2A\u2013H2B dimers during the histone exchange reaction. The remaining papers discuss histone variant structure or other chaperone functions unrelated to H2A\u2013H2B eviction in exchange. Thus, the claim is not directly supported or refuted by the provided evidence."
    },
    "posthoc_doc_ids": [
      "9451052",
      "5966635",
      "9881829",
      "9889151",
      "20781656"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1275",
    "claim": "The tip of the inner tube of the toxic type VI secretion system (T6SS) antibacterial effector in Escherichia coli (E. coli) is decorated with VgrG and PAAR proteins.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Paper 1 provides experimental evidence that PAAR proteins form a conical extension on the VgrG spike, defining the T6SS tip in Vibrio cholerae and Acinetobacter baylyi, but it does not address Escherichia coli. Paper 5 is a general review of T6SS without specific mention of VgrG/PAAR in E. coli in the provided excerpt. The other papers are unrelated to T6SS spike composition or focus on different organisms. Thus, there is no direct evidence in the provided texts confirming this architecture specifically in E. coli."
    },
    "naive_doc_ids": [
      "4406819",
      "26625002",
      "5223817",
      "24896957",
      "27731651"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.76,
      "justification": "Paper 1 provides direct structural and functional evidence that PAAR-repeat proteins form a sharp conical extension on the VgrG spike, creating a VgrG\u2013PAAR complex that decorates the tip of the Type VI secretion system (T6SS) spike and attaches effectors. Paper 2 (a review) is consistent with this architecture. Although the experimental demonstrations in Paper 1 are in Vibrio cholerae and Acinetobacter baylyi rather than E. coli, the T6SS spike/tube architecture (Hcp tube tipped by VgrG and PAAR) is conserved across Gram-negative bacteria, supporting the claim\u2019s mechanistic assertion about the tip being decorated with VgrG and PAAR proteins."
    },
    "overthinking_doc_ids": [
      "4406819",
      "27731651",
      "7145763",
      "7481159",
      "23423230"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 1 shows that PAAR-repeat proteins form a sharp conical extension on the VgrG spike of the T6SS and that the VgrG\u2013PAAR complex decorates the spike tip, which is at the end of the inner Hcp tube. Paper 8 (review) further describes the conserved T6SS architecture in which the VgrG spike sits at the tip of the inner tube and is associated with PAAR proteins to deliver effectors. Although Paper 1\u2019s primary experimental systems are Vibrio cholerae and Acinetobacter baylyi, the structural organization is conserved across Gram-negative bacteria, including E. coli, supporting the claim."
    },
    "posthoc_doc_ids": [
      "4406819",
      "17208742",
      "5223817",
      "7643848",
      "6669242"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.58,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "758",
    "claim": "Marmosets have a brain region homologous to Broca's area.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 2 reports that the ventrolateral prefrontal cortex (the region that comprises Broca\u2019s area in humans) shows increased Egr-1 expression during vocal production in marmosets, indicating engagement of a Broca-analogue region. Paper 5 further shows vocal-motor related activity in marmoset frontal cortex during natural communication, consistent with a Broca-like frontal contribution to vocal behavior. Although Paper 1 focuses on macaques, it establishes that nonhuman primates possess homologues of Broca\u2019s areas 44/45, supporting the broader primate homology framework. Other papers are not relevant. Together, the evidence supports the claim that marmosets have a brain region homologous to Broca\u2019s area."
    },
    "naive_doc_ids": [
      "3095620",
      "1391126",
      "602760",
      "2291922",
      "14195528"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 2 shows that in marmosets the ventrolateral prefrontal cortex\u2014the region that comprises Broca\u2019s area in humans\u2014is specifically engaged during vocal production (Egr-1 activation), implying the presence of a homologous frontal region involved in vocal control. Paper 4 further demonstrates vocal-motor related activity in marmoset frontal cortex during natural communication, consistent with Broca-like functions. Paper 1 establishes homologues of Broca\u2019s areas (44/45) in macaques, supporting primate-wide homology of this ventrolateral frontal region. Other papers are not relevant. Together, the evidence aligns with marmosets having a brain region homologous to Broca\u2019s area."
    },
    "overthinking_doc_ids": [
      "3095620",
      "1391126",
      "8122346",
      "14195528",
      "22107641"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.76,
      "justification": "Paper 2 reports that the ventrolateral prefrontal cortex (the region that comprises Broca\u2019s area in humans) is engaged during vocal output in marmosets, implying a homologous frontal region involved in vocal control. Paper 6 further shows motor-related activity in marmoset frontal cortex during natural vocal communication, consistent with Broca-related functions. While Paper 1 focuses on macaques, it establishes homologues of areas 44/45 and prelinguistic precursor circuits in nonhuman primates, supporting the broader notion of such homologies across primates. Other papers are not relevant. Together, the evidence supports that marmosets possess a brain region homologous to Broca\u2019s area."
    },
    "posthoc_doc_ids": [
      "3095620",
      "1391126",
      "7548577",
      "11884867",
      "12885341"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "19",
    "claim": "7-day-old adult Caenorhabditis elegans exhibit approximately 5% of the learning capacity seen in 1-day old adults.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "Among the provided papers, only Paper 4 directly addresses learning and memory decline with age in C. elegans, showing that learning and memory decrease over time and are modulated by genetic backgrounds (e.g., daf-2, eat-2). However, none of the excerpts provide a quantitative comparison stating that 7-day-old adults have ~5% of the learning capacity of 1-day-old adults. The remaining papers focus on neuronal morphology, protein aggregation, endocrinology, transcriptional profiles, or studies in mice, and do not quantify learning capacity across these specific ages. Therefore, the specific 5% figure is not supported or refuted by the provided text."
    },
    "naive_doc_ids": [
      "13072113",
      "7042304",
      "16267205",
      "3202143",
      "7834603"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.82,
      "justification": "Only Paper 2 addresses age-related learning and memory in C. elegans and reports that learning ability declines with age and is modulated by insulin signaling and dietary restriction. However, the provided excerpt contains no quantitative data comparing 7-day-old to 1-day-old adults, nor any percentage such as ~5%. The other papers focus on rodents, metabolism, development, or aging markers without measuring C. elegans learning performance. Therefore, the specific claim about a ~5% learning capacity at day 7 versus day 1 is not supported or refuted by the provided text."
    },
    "overthinking_doc_ids": [
      "16284655",
      "3202143",
      "10765888",
      "11992632",
      "12805683"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 10 addresses age-related changes in learning and memory in C. elegans, reporting that learning declines with age and is differentially affected by longevity pathways. However, the excerpt does not provide quantitative data comparing 7-day-old adults to 1-day-old adults, nor does it state an approximate 5% residual learning capacity. The other papers are unrelated to C. elegans learning decline with age. Therefore, the specific quantitative claim (\u22485% at day 7 vs day 1) is not supported or refuted by the provided evidence."
    },
    "posthoc_doc_ids": [
      "1127562",
      "1576955",
      "5002665",
      "6333347",
      "7036529"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "545",
    "claim": "IFIT1 speeds viral replication by allowing for the proliferation of mis-capped viral RNAs.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.84,
      "justification": "Paper 3 shows that viral RNAs lacking 2'-O methylation (i.e., mis-capped) are recognized by host innate immunity and are restricted by IFIT proteins, leading to attenuation of viral replication. The attenuation phenotype of methylation-defective Japanese encephalitis virus was attributed to enhanced sensitivity to interferon and IFIT proteins. This indicates IFITs, including IFIT1, inhibit rather than promote proliferation of mis-capped viral RNAs, contradicting the claim. Other provided papers do not address IFIT1 or cap recognition."
    },
    "naive_doc_ids": [
      "5633957",
      "42065070",
      "1970884",
      "5137019",
      "7137057"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.8,
      "justification": "Paper 1 shows that viral RNAs lacking 2'-O methylation (mis-capped) are recognized by the host and that the resulting attenuation is due to enhanced sensitivity to interferon and IFIT proteins. This indicates IFIT proteins restrict, rather than promote, replication of mis-capped viral RNAs. The other papers do not address IFIT1 or cap-methylation effects on viral replication. Therefore, the claim that IFIT1 speeds viral replication by allowing proliferation of mis-capped viral RNAs is contradicted by the provided evidence."
    },
    "overthinking_doc_ids": [
      "1970884",
      "2460304",
      "9278263",
      "22495397",
      "1695604"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.84,
      "justification": "Paper 1 shows that viruses lacking 2'-O cap methylation (i.e., mis-capped RNAs) are attenuated because they are more sensitive to interferon and IFIT proteins, which restrict their replication rather than promote it. Paper 8 further supports that lack of 2'-O-methylation marks viral RNA for innate sensing and increased interferon responses, making such viruses highly sensitive to host defenses. Together, these findings indicate IFIT proteins (which include IFIT1) act as antiviral restriction factors against mis-capped viral RNAs, contradicting the claim that IFIT1 speeds viral replication or allows proliferation of mis-capped viral RNAs."
    },
    "posthoc_doc_ids": [
      "1970884",
      "5633957",
      "8300657",
      "42065070",
      "92308"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "316",
    "claim": "Decreased conversion of PGE 2 to PPARy ligand 15-ket-PGE 2 causes accumulation of PGE.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.83,
      "justification": "Paper 1 shows that 15-hydroxyprostaglandin dehydrogenase (15-PGDH), the enzyme that converts PGE2 to its first catabolic product 15-keto-PGE2, is down-regulated or disrupted, which blocks production of downstream PGE2 metabolites. This indicates reduced conversion/degradation of PGE2 and implies accumulation of PGE2. Paper 8 identifies 15-keto-PGE2 as an endogenous PPAR\u03b3 ligand and shows its reduction in a disease setting, confirming the product identity in the pathway. Together, these data support that decreased conversion of PGE2 to 15-keto-PGE2 (a PPAR\u03b3 ligand) leads to increased PGE2 levels."
    },
    "naive_doc_ids": [
      "21181273",
      "5775033",
      "35760786",
      "56486733",
      "1686997"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Paper 1 shows that PGE2 is degraded by 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and that downregulation or disruption of 15-PGDH markedly reduces production of PGE2 metabolites, implying decreased conversion of PGE2 and hence its accumulation when this pathway is impaired. Paper 8 identifies 15-keto-PGE2 as an endogenous PPAR\u03b3 ligand and reports reduced levels of 15-keto-PGE2 in Cftr-deficient tissues, consistent with impaired conversion from PGE2. Together, these data support that decreased conversion of PGE2 to 15-keto-PGE2 lowers the PPAR\u03b3 ligand and would favor accumulation of PGE2. Other papers are not relevant to this pathway and do not contradict it."
    },
    "overthinking_doc_ids": [
      "21181273",
      "16086778",
      "25050364",
      "25817686",
      "344240"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Paper 6 shows that 15-hydroxyprostaglandin dehydrogenase (15-PGDH), the enzyme that oxidizes PGE2 to 15-keto-PGE2, is downregulated in colorectal cancer, with enzymatic activity tracking expression and genetic disruption blocking formation of the downstream urinary PGE2 metabolite. This demonstrates decreased conversion/degradation of PGE2, which would raise steady-state PGE2 levels (i.e., accumulation). Paper 3 identifies 15-keto-PGE2 as an endogenous PPAR\u03b3 ligand and shows reduced 15-keto-PGE2 in Cftr-deficient tissues, linking the conversion product to PPAR\u03b3 signaling. Together, these data support that decreased conversion of PGE2 to 15-keto-PGE2 reduces PPAR\u03b3 ligand levels and is consistent with accumulation of PGE2."
    },
    "posthoc_doc_ids": [
      "22478394",
      "24150328",
      "712078",
      "3127341",
      "5775033"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "365",
    "claim": "ER-localized phosphatase Sac1 processes PI4P through coordination with OSBP and the endosome-localized protein sorting nexin 2.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Among the provided papers, only Paper 1 is relevant to endosomal PI4P regulation and mentions VAP, OSBP, and the retromer subunit SNX2 at ER\u2013endosome contact sites. However, none of the excerpts explicitly mention the ER-localized phosphatase Sac1 or demonstrate that Sac1 processes PI4P through coordination with OSBP and SNX2. The remaining papers are unrelated to PI4P metabolism or these proteins. Therefore, the specific involvement of Sac1 in this coordination is not supported or refuted by the provided evidence."
    },
    "naive_doc_ids": [
      "600437",
      "36464673",
      "35231675",
      "35747505",
      "799586"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "Paper 1 shows that VAP is recruited to endosomes via SNX2 and that OSBP participates in VAP-dependent ER\u2013endosome contacts to regulate endosomal PI4P levels. However, none of the provided papers mention Sac1 or provide data showing that Sac1 processes PI4P in coordination with OSBP and SNX2. The remaining papers are unrelated to this pathway. Therefore, the specific involvement of Sac1 is not supported by the provided evidence."
    },
    "overthinking_doc_ids": [
      "600437",
      "7093809",
      "35231675",
      "38043606",
      "43390777"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Paper 1 shows that VAP (ER-anchored) is recruited to endosomes via SNX2 and that OSBP participates in VAP-dependent ER\u2013endosome tethers to regulate endosomal PI4P levels. However, none of the provided papers explicitly mention Sac1 or demonstrate that Sac1 is the phosphatase processing PI4P in this context. Papers 2\u201310 are unrelated to PI4P/Sac1/OSBP/SNX2. Thus, the specific involvement of Sac1 is not supported by the provided evidence."
    },
    "posthoc_doc_ids": [
      "600437",
      "1554348",
      "1676568",
      "5254463",
      "6123924"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "550",
    "claim": "ITAM phosphorylation allows for the transfer of the T cell receptor (TCR) signal from the echo-domain to the cytoplasmic tail of the T cell receptor (TCR).",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.64,
      "justification": "Paper 1 shows that TCR engagement (an event at the ectodomain) leads to Lck-mediated phosphorylation of ITAMs in the TCR\u03b6 cytoplasmic tail, which in turn causes the cytoplasmic tail to dissociate from the plasma membrane and modulates downstream signaling. This demonstrates a phosphorylation-dependent linkage between extracellular triggering and cytoplasmic tail signaling behavior, consistent with the claim. Paper 6 indicates an additional, earlier conformational change that is phosphorylation-independent, but it does not negate the role of ITAM phosphorylation in conveying/propagating the signal to the cytoplasmic tail and downstream effectors. Other papers are not relevant to TCR ITAM signaling."
    },
    "naive_doc_ids": [
      "8903143",
      "9612317",
      "21931005",
      "6363093",
      "10607877"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.78,
      "justification": "Paper 1 shows that ligand engagement induces a conformational change in CD3\u03b5 that exposes a proline-rich sequence and recruits Nck earlier than and independently of tyrosine kinase activation, indicating that the initial transmembrane transfer of the TCR signal does not require ITAM phosphorylation. Paper 5 shows that ITAM phosphorylation by Lck regulates TCR\u03b6 membrane association after engagement and modulates downstream signaling, implying phosphorylation is a subsequent step rather than the mechanism that transfers the signal from the ectodomain to the cytoplasmic tail. The other papers are not relevant to this specific claim."
    },
    "overthinking_doc_ids": [
      "2714623",
      "3701541",
      "6163801",
      "7370282",
      "8903143"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Paper 4 shows that upon TCR engagement, Lck phosphorylates the ITAMs within the TCR\u03b6 cytoplasmic tail, which triggers dissociation of the tail from the inner leaflet of the plasma membrane and modulates downstream signaling. This indicates that ITAM phosphorylation is a key step that enables the cytoplasmic tail to propagate the signal initiated by extracellular ligand binding, consistent with transfer of the TCR signal from the ectodomain to the cytoplasmic domain. The other papers do not directly address ITAMs in TCR signaling."
    },
    "posthoc_doc_ids": [
      "26117607",
      "21931005",
      "34498093",
      "8903143",
      "14405193"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "434",
    "claim": "Foxp3 enables the expression of transcriptional regulators implicated in memory T cell development.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "None of the provided papers present data showing that Foxp3 enables or promotes expression of transcriptional regulators involved in memory T cell development. The relevant Foxp3-focused study (Paper 7) shows Foxo1 programs in Treg cells are largely independent of direct Foxp3 regulation, but does not test Foxp3 enabling expression of memory-related regulators. Other papers address memory T cell transcription factors (e.g., Blimp-1, Bcl6) or unrelated systems without linking them to Foxp3-driven expression."
    },
    "naive_doc_ids": [
      "5508750",
      "20179918",
      "21363424",
      "5979056",
      "12580014"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.9,
      "justification": "None of the provided papers present data showing that Foxp3 enables expression of transcriptional regulators implicated in memory T cell development. Papers 3, 6, and 7 discuss Foxp3 in regulatory T cells (identification, expansion, function) but do not link Foxp3 to inducing transcription factors for memory T cell programs. Paper 2 covers cytokine control (IL-7/IL-15) of memory CD8+ T cells without Foxp3 involvement. Paper 5 addresses CD4 help and T-bet in lung Trm cells, not Foxp3. Paper 1 and 8 involve KLF2 in dendritic cells or endothelial cells, not Foxp3-driven regulation in T cells. The remaining papers are unrelated. Therefore, the evidence set does not support or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "5979056",
      "13636631",
      "266641",
      "643765",
      "3835423"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "None of the provided papers present evidence that Foxp3 induces or enables the expression of transcriptional regulators implicated in memory T cell development. Papers 1\u20133 and 5 discuss cytokine control, lineage, and transcriptional regulation of memory T cells without linking Foxp3 to activating those regulators. Paper 4 shows Foxo1-dependent programs in Treg cells largely independent of Foxp3, not enabled by it. Papers 6\u201310 focus on Treg function, biomarkers, exosome-mediated suppression, or effects on non\u2013T cells (e.g., endothelial KLF2), but do not demonstrate Foxp3 driving expression of memory-related transcription factors in T cells."
    },
    "posthoc_doc_ids": [
      "13636631",
      "991137",
      "3835423",
      "4418070",
      "5508750"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.15,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1280",
    "claim": "The ureABIEFGH gene cluster encodes urease maturation proteins : UreD/UreH, UreE, UreF, and UreG.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Papers 1\u20133 provide direct experimental evidence that UreD (or its functional counterpart), UreE, UreF, and UreG are accessory urease maturation proteins required for nickel metallocenter assembly and in vivo activation of urease. Paper 1 shows deletions in ureD/E/F/G impair activity in a manner correlating with nickel incorporation, demonstrating their roles in metallocenter biosynthesis. Papers 2 and 3 show formation of UreD/UreF/UreG\u2013urease apoprotein complexes essential for activation. While Paper 6 focuses on UreI as a proton-gated urea channel (not a maturation protein), it is consistent with the gene cluster context in organisms like H. pylori. Together, the evidence supports that the ureABIEFGH cluster includes and encodes the maturation proteins UreD/UreH, UreE, UreF, and UreG."
    },
    "naive_doc_ids": [
      "29214508",
      "37768883",
      "36233757",
      "18467982",
      "34386619"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.86,
      "justification": "Paper 1 provides direct experimental evidence that ureD, ureE, ureF, and ureG are accessory genes required for nickel metallocenter biosynthesis and thus for urease activation (maturation). Papers 6 and 7 further show that UreD, UreF, and UreG form activation-competent complexes with urease apoprotein, reinforcing their roles in maturation. Paper 9 characterizes UreG as an essential chaperone for Ni2+ insertion into urease. While Paper 2 shows UreI is a urea channel (not a maturation protein), this does not contradict the claim; it supports that within the ureABIEFGH locus, the maturation proteins are UreD/UreH, UreE, UreF, and UreG. Overall, the cited studies align with the claim that these genes encode urease maturation proteins."
    },
    "overthinking_doc_ids": [
      "29214508",
      "4387784",
      "8654183",
      "13965483",
      "15425958"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.81,
      "justification": "Papers 1\u20133 provide direct experimental evidence that the accessory genes ureD, ureE, ureF, and ureG\u2014located in the urease gene cluster\u2014are required for nickel metallocenter assembly and in vivo activation of urease, establishing them as maturation proteins. Paper 1 shows deletions in ureD/E/F/G disrupt nickel incorporation and activity; Papers 2\u20133 identify UreD/UreF/UreG-containing apoprotein complexes essential for activation. Paper 7 further supports UreG\u2019s conserved role as a maturation/activation chaperone. While UreH is not explicitly discussed, UreH is a known UreD homolog in some organisms, consistent with the claim\u2019s UreD/UreH designation."
    },
    "posthoc_doc_ids": [
      "29214508",
      "37768883",
      "36233757",
      "18467982",
      "1964163"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "946",
    "claim": "Physical activity level is associated with the difference in maximal oxygen consumption between black and white youth.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 3 directly examined whether differences in activity levels explain the Black\u2013White gap in VO2max using objective doubly labeled water measures of total and activity energy expenditure (TEE, AEE). The approximately 15% lower VO2max in African-American children persisted after adjustment for TEE and AEE, indicating the racial difference was independent of physical activity level. Paper 1 measured activity by questionnaire and suggested the VO2max difference could be partly due to a more sedentary lifestyle, but this is inferential and less definitive. Papers 5 and 6 show Black youth report lower activity and more inactivity, but they do not link these patterns to VO2max differences. Overall, the strongest direct evidence (Paper 3) contradicts the claim that physical activity level is associated with the VO2max difference between Black and White youth."
    },
    "naive_doc_ids": [
      "18537148",
      "13230773",
      "26112696",
      "25135304",
      "8428935"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.84,
      "justification": "Paper 1 directly compares VO2max in black vs white children and, after assessing activity by questionnaire, concludes the lower VO2max in black youth could be attributed at least in part to a more sedentary lifestyle (and lower hemoglobin), indicating an association between physical activity level and the racial VO2max difference. Paper 3 shows non-Hispanic black children engage in less vigorous activity and more TV, and Paper 5 reports lower moderate-to-vigorous physical activity among non-Hispanic black adolescents, supporting that activity patterns differ by race in youth. Paper 7 further notes lower fitness among non-Hispanic blacks. Together, these findings support that differences in physical activity are associated with the VO2max disparity between black and white youth."
    },
    "overthinking_doc_ids": [
      "18537148",
      "4449524",
      "8428935",
      "12205576",
      "13083189"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.58,
      "justification": "Evidence is mixed, but the most rigorous study contradicts the claim. Paper 8 found African-American children had ~15% lower VO2max than Caucasian peers, and this difference persisted after adjusting for objectively measured total and activity energy expenditure (TEE/AEE), indicating the VO2max gap was independent of physical activity level. Paper 1 reported lower VO2max in black children and suggested it could be partly attributable to a more sedentary lifestyle based on questionnaires, but this inference is weaker and is not supported when activity is measured objectively. Paper 2 shows black youth report lower vigorous activity nationally but does not link this to VO2max. Overall, the best evidence provided does not support that physical activity level is associated with the racial difference in VO2max."
    },
    "posthoc_doc_ids": [
      "18537148",
      "8428935",
      "11201004",
      "13083189",
      "1941721"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "555",
    "claim": "Immune complex triggered cell death leads to extracellular release of nuclear DNA.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Papers 1, 3, and 5 show that neutrophil extracellular traps (NETs) can release nuclear chromatin/DNA, but they are not specifically linked to immune-complex triggering in the provided evidence. Paper 2 demonstrates that ribonucleoprotein immune complexes induce NETosis with extracellular DNA enriched in oxidized mitochondrial (not explicitly nuclear) DNA. Paper 6 shows immune-complex-induced apoptosis signaling in neutrophils but does not report extracellular DNA release. Therefore, the supplied papers do not directly show that immune-complex-triggered cell death leads to extracellular release of nuclear DNA."
    },
    "naive_doc_ids": [
      "14853989",
      "1049501",
      "43054703",
      "9878167",
      "29399239"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "Paper 1 shows that immune complexes induce apoptosis in human neutrophils, but it does not report extracellular release of nuclear DNA. Papers 2, 4, and 5 document extracellular release of nuclear chromatin (NETs), but in contexts such as infection, PMA stimulation, or general NETosis, not specifically triggered by immune complexes. Paper 10 shows NETs can contain mitochondrial (not nuclear) DNA from viable neutrophils, indicating DNA release need not follow cell death. None of the provided papers directly link immune complex\u2013triggered cell death to extracellular release of nuclear DNA."
    },
    "overthinking_doc_ids": [
      "9225850",
      "2236768",
      "2714623",
      "14853989",
      "30041340"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 1 shows that immune complexes induce apoptosis in human neutrophils, but it provides no evidence of extracellular nuclear DNA release. Critically, Paper 7 demonstrates that ribonucleoprotein immune complexes stimulate NETosis characterized by extracellular release of oxidized mitochondrial DNA, not nuclear DNA. Paper 6 further shows that NETs can be formed by viable neutrophils and contain mitochondrial, but no nuclear, DNA, indicating that cell death is not required for extracellular DNA release and that the DNA can be non-nuclear. Together, these findings contradict the specific claim that immune complex\u2013triggered cell death leads to extracellular nuclear DNA release."
    },
    "posthoc_doc_ids": [
      "9225850",
      "9977329",
      "14848619",
      "34436231",
      "42873134"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1344",
    "claim": "Up-regulation of the p53 pathway and related molecular events casues cancer resistance and results in a significantly shortened lifespan marked by senescent cells and accelerated organismal aging.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 1 (review) states that p53 activation contributes to tumor suppression via induction of senescence and also modulates cellular senescence and organismal aging, discussing its impact on lifespan. Paper 2 (review) explicitly describes p53/RB-controlled cellular senescence as a potent anticancer mechanism that, through accumulation of senescent cells, contributes to aging and can limit longevity (antagonistic pleiotropy). Paper 4 provides experimental evidence that aging muscle shows increased p53/p16/pRB and senescence, linking heightened pathway activity to aging phenotypes. Together, these align with the claim that up-regulation of the p53 pathway enhances cancer resistance but is associated with increased senescence and shortened lifespan. While the provided excerpts do not include a direct lifespan experiment with p53 up-regulation, the mechanistic and conceptual evidence supports the claim."
    },
    "naive_doc_ids": [
      "6896063",
      "9559146",
      "38243984",
      "4653837",
      "4920376"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Paper 6 directly links the p53/RB-controlled senescence program to potent tumor suppression (i.e., cancer resistance) and to aging-related phenotypes that can limit longevity, aligning with the claim\u2019s core mechanism and outcomes. Although it is largely conceptual, it supports the idea that up-regulation of p53 pathway activity and related senescence-associated events can protect against cancer while promoting organismal aging. Other papers are largely unrelated to this claim. Paper 4 indicates that some persistent senescence markers after irradiation can be p53-independent, which does not refute the broader relationship but tempers certainty."
    },
    "overthinking_doc_ids": [
      "4920376",
      "38243984",
      "13350374",
      "31293581",
      "1921218"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.62,
      "justification": "Among the provided papers, only a review (Paper 3) broadly discusses p53\u2019s roles in senescence, aging, and tumor suppression, without presenting specific experimental results demonstrating that up-regulation of the p53 pathway causes both increased cancer resistance and shortened lifespan with senescent cell accumulation. Paper 5 shows that long-term senescence markers after ionizing radiation occur independent of p53, indicating such aging phenotypes can arise without p53 activation, which does not support the claim\u2019s p53-centric causality. The remaining papers are unrelated to p53-driven aging or lifespan outcomes. Therefore, the set lacks direct experimental evidence confirming the claim."
    },
    "posthoc_doc_ids": [
      "38243984",
      "2466614",
      "6896063",
      "9513785",
      "31293581"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.3,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "557",
    "claim": "Immune complex triggered cell death leads to sequestration of oxidized mitochondrial DNA.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.76,
      "justification": "Paper 2 shows that ribonucleoprotein immune complexes (RNP ICs) trigger NETosis in neutrophils with mitochondrial hypopolarization and extracellular release of oxidized mitochondrial DNA, which is interferogenic via STING. This indicates release, not sequestration, of oxidized mtDNA. Papers 6 and 7 further support that immune complex\u2013induced NETs externalize DNA and activate pDCs, again pointing to extracellular exposure rather than sequestration. Paper 8 shows that mitochondrial DNA can be released in NETs even from viable neutrophils, reinforcing the release concept. Other papers provide general cell death context but do not support sequestration of oxidized mtDNA. Therefore, the claim that immune complex\u2013triggered cell death leads to sequestration of oxidized mitochondrial DNA is contradicted by the evidence showing extracellular release and interferogenic activity."
    },
    "naive_doc_ids": [
      "33667484",
      "1049501",
      "13651792",
      "25251625",
      "935034"
    ],
    "overthinking_label": "CONTRADICT",
    "overthinking_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Paper 1 shows that ribonucleoprotein immune complexes induce NETosis that depends on mitochondrial ROS and leads to extracellular release of oxidized mitochondrial DNA, which is interferogenic via STING. This is the opposite of sequestration. Paper 4 further shows neutrophils can release mitochondrial DNA to form NETs without cell death, again indicating release rather than sequestration. Paper 2 demonstrates immune-complex-induced apoptosis in neutrophils but provides no evidence of oxidized mitochondrial DNA sequestration. Other papers are not directly relevant. Therefore, the claim that immune complex\u2013triggered cell death leads to sequestration of oxidized mitochondrial DNA is contradicted by the provided evidence, which indicates release."
    },
    "overthinking_doc_ids": [
      "1049501",
      "9225850",
      "9164724",
      "9878167",
      "14692646"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.8,
      "justification": "Paper 2 shows that ribonucleoprotein immune complexes trigger NETosis in neutrophils and cause extracellular release of oxidized mitochondrial DNA, which is proinflammatory and activates STING/type I IFN signaling in vivo. This indicates release rather than sequestration. Paper 10 demonstrates immune-complex-induced apoptosis in neutrophils but provides no evidence of sequestration of oxidized mitochondrial DNA. The remaining papers are not relevant to this specific claim."
    },
    "posthoc_doc_ids": [
      "9977329",
      "1049501",
      "12641252",
      "13380011",
      "25251625"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.35,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "866",
    "claim": "Nuclear transfer from adult human fibroblasts to human oocytes can give rise to blastocysts containing expandable pluripotent cells.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.93,
      "justification": "Multiple papers directly show that SCNT using adult human somatic cells\u2014specifically adult dermal fibroblasts\u2014into human oocytes yields blastocysts from which expandable pluripotent stem cell lines can be derived. Paper 5 explicitly reports successful human SCNT using adult dermal fibroblasts (35- and 75-year-old males) to generate hESC lines, implying blastocyst formation and expansion of pluripotent cells. Paper 2 demonstrates improved blastocyst formation and efficient derivation of SCNT-ESCs from adult patient somatic nuclei via KDM4A overexpression. Paper 3 shows optimized protocols yielding blastocysts and derivation of diploid pluripotent stem cell lines from adult somatic cells (a type 1 diabetic). Paper 1 reports a pluripotent ES cell line from a cloned human blastocyst, with long-term expansion, further supporting the concept. Other papers (4, 6\u20139) are not directly about SCNT. Overall, the evidence supports the claim."
    },
    "naive_doc_ids": [
      "10546779",
      "15803282",
      "4457834",
      "86129154",
      "37822406"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.95,
      "justification": "Multiple papers report that somatic cell nuclear transfer (SCNT) from adult human fibroblasts into human oocytes yields blastocysts from which expandable pluripotent stem cell lines can be derived. Paper 3 explicitly used dermal fibroblasts from 35- and 75-year-old adults to generate human ESCs via SCNT, demonstrating applicability to adult fibroblasts. Paper 1 shows that adult somatic nuclei (from a type 1 diabetic, using modified activation protocols) develop to blastocysts and yield diploid pluripotent stem-cell lines. Paper 2 further shows enhanced blastocyst formation and efficient derivation of SCNT-ESCs using adult patient somatic nuclei via KDM4A overexpression. Together, these align with the claim that adult human fibroblast nuclear transfer to oocytes can produce blastocysts containing expandable pluripotent cells."
    },
    "overthinking_doc_ids": [
      "4457834",
      "15803282",
      "37822406",
      "86129154",
      "22490293"
    ],
    "posthoc_label": "SUPPORT",
    "posthoc_result": {
      "label": "SUPPORT",
      "confidence": 0.92,
      "justification": "Multiple papers show that somatic cell nuclear transfer (SCNT) from adult human fibroblasts into human oocytes can produce blastocysts and yield expandable pluripotent stem cell lines. Paper 2 explicitly reports successful SCNT using dermal fibroblasts from 35- and 75-year-old adults, with derivation of human ESCs (which implies blastocyst formation and expandable pluripotent cells). Paper 1 demonstrates blastocyst development and derivation of diploid pluripotent stem-cell lines from an adult donor (type 1 diabetic), consistent with adult fibroblast donors commonly used in such studies. Paper 3 shows improved blastocyst formation and efficient derivation of SCNT-ESCs using adult patient somatic nuclei via KDM4A overexpression. Together, these directly support the claim."
    },
    "posthoc_doc_ids": [
      "4457834",
      "37822406",
      "15803282",
      "22490293",
      "10786948"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.95,
      "need_refinement": false,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "357",
    "claim": "During non-homologous end joining, the ligation step is not as tolerant of disrepairs and other distortions when joining 3' of strand breaks as compared to 5' strand breaks.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.78,
      "justification": "Paper 2 provides direct mechanistic evidence of an asymmetry: Ku\u2019s 5\u2032-dRP/AP lyase efficiently excises abasic damage on short 5\u2032 overhangs to make them ligatable, but is less active near 3\u2032 termini because excision would generate a ligation-blocking \u03b1,\u03b2-unsaturated aldehyde. This implies the NHEJ ligation step is more easily obstructed by distortions/damage near 3\u2032 ends than near 5\u2032 ends. Paper 5 is consistent with this asymmetry at the functional level: DSBs with 3\u2032 overhangs and gaps strongly require Pol4 for repair, whereas analogous 5\u2032 overhangs do not, indicating additional processing is needed before ligation at 3\u2032 ends. Other papers do not contradict this and are largely unrelated to 3\u2032 vs 5\u2032 tolerance at ligation."
    },
    "naive_doc_ids": [
      "18111172",
      "20821402",
      "17768946",
      "27635177",
      "41403996"
    ],
    "overthinking_label": "SUPPORT",
    "overthinking_result": {
      "label": "SUPPORT",
      "confidence": 0.8,
      "justification": "Paper 6 shows that NHEJ ligation is differentially impacted by damage near 5' versus 3' termini. Ku\u2019s 5'-dRP/AP lyase efficiently excises abasic sites in short 5' overhangs to prepare them for ligation, but is less active near 3' termini because excision there would create a ligation-blocking \u03b1,\u03b2-unsaturated aldehyde. This indicates ligation is less tolerant of lesions/distortions at 3' ends than at 5' ends. Paper 3 further supports that the ligation step\u2019s tolerance dictates processing choices, consistent with differential end tolerance."
    },
    "overthinking_doc_ids": [
      "27635177",
      "17768946",
      "18111172",
      "21561474",
      "26059876"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Paper 2 provides direct, mechanism-based evidence of asymmetric tolerance at the ligation step. Ku\u2019s 5\u2032-dRP/AP lyase efficiently processes abasic sites in short 5\u2032 overhangs to prepare them for ligation, whereas near 3\u2032 termini, excision would generate a ligation-blocking \u03b1,\u03b2-unsaturated aldehyde, so the activity is suppressed. This implies that the ligation step is less permissive/tolerant of certain distortions at 3\u2032 ends than at 5\u2032 ends. Paper 1 supports the broader principle that the ligase\u2019s requirements dictate processing to generate ligatable ends, though it does not explicitly address 3\u2032 versus 5\u2032 asymmetry. Other papers are not directly relevant to this claim."
    },
    "posthoc_doc_ids": [
      "18111172",
      "20821402",
      "13791206",
      "2734421",
      "16644043"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.45,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "361",
    "claim": "During the primary early antibody response activated B cells migrate toward the inner-and outer follicular areas where oxysterol accumulation is generated by stromal cells.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.82,
      "justification": "Papers 1 and 2 show that during the early (primary) antibody response, activated B cells upregulate EBI2 and migrate to inter- and outer-follicular or extrafollicular sites. Entry into the follicle center (inner follicular area) requires downregulation of EBI2 and is associated with germinal center formation, not the early phase. Thus the claim that early activated B cells migrate to inner-and outer follicular areas is inconsistent with the evidence. Additionally, while Paper 8 identifies 7\u03b1,25-dihydroxycholesterol as the EBI2 ligand and mentions in vivo gradients, the provided excerpts do not demonstrate that stromal cells generate oxysterol accumulation in those zones. Overall, the localization aspect is contradicted and the stromal oxysterol source is unsupported by the provided text."
    },
    "naive_doc_ids": [
      "38587347",
      "15488881",
      "35256900",
      "1071991",
      "1933281"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.78,
      "justification": "The provided papers (notably Papers 1 and 5) support that, during early T-dependent antibody responses, activated B cells use EBI2 to migrate to inter- and outer-follicular/extrafollicular niches and that downregulation of EBI2 is needed for germinal center entry. However, none of the abstracts mention oxysterols as the guiding ligands or identify stromal cells as the source of oxysterol accumulation in these regions. Therefore, the specific mechanistic detail about stromal cell\u2013generated oxysterol accumulation is not supported by the provided evidence."
    },
    "overthinking_doc_ids": [
      "38587347",
      "11721286",
      "30369606",
      "6163801",
      "15488881"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.67,
      "justification": "The papers support that, during early antibody responses, EBI2 guides activated B cells to inter- and outer-follicular niches (Papers 1 and 7). Paper 6 identifies the oxysterol 7\u03b1,25-dihydroxycholesterol as the EBI2 ligand and notes that in vivo gradients regulate B cell migration, but the provided text does not specify that stromal cells generate the oxysterol accumulation in those areas. None of the abstracts explicitly state stromal cell production of oxysterols in inter/outer follicular regions. Thus, the evidence is insufficient to confirm the full claim."
    },
    "posthoc_doc_ids": [
      "38587347",
      "30369606",
      "15128866",
      "40473317",
      "928281"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.5,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "651",
    "claim": "Interferon stimulated genes (ISGs) Irf1, Irg1, Ifi27, and Rsad2 encourage West Nile virus replication in cortical neurons.",
    "gold": "NOINFO",
    "naive_label": "CONTRADICT",
    "naive_result": {
      "label": "CONTRADICT",
      "confidence": 0.87,
      "justification": "Paper 2 shows that transducing cortical neurons with the interferon-stimulated genes Ifi27, Irg1, and Rsad2 (Viperin) confers antiviral activity against neurotropic positive-stranded RNA viruses, in the context of differential neuronal susceptibility that includes West Nile virus. Thus, these ISGs restrict rather than encourage viral replication in cortical neurons. Paper 1 further supports the antiviral role of type I interferon signaling against WNV (though it notes limited effect in cortical neurons for IFN-\u03b2 deficiency), and provides no evidence that these ISGs promote replication. No paper supports the claim that Irf1, Irg1, Ifi27, or Rsad2 encourage WNV replication; the available data for three of these genes contradict it."
    },
    "naive_doc_ids": [
      "10559501",
      "9433958",
      "12885341",
      "34287602",
      "38376189"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.83,
      "justification": "None of the provided papers examine the roles of the specific ISGs (Irf1, Irg1, Ifi27, Rsad2) in West Nile virus replication in cortical neurons. Paper 1 discusses IFN-\u03b2\u2019s role in controlling WNV and notes no difference in replication in cortical neurons from IFN-\u03b2 knockout vs wild-type mice, but it does not test or implicate these ISGs as promoting replication. The other papers focus on mosquito factors, viral genetic diversity, vaccination, JC virus, and HIV, which are unrelated to the claim. Therefore, the evidence set does not support or refute the specific claim."
    },
    "overthinking_doc_ids": [
      "10559501",
      "12885341",
      "34287602",
      "38376189",
      "13322804"
    ],
    "posthoc_label": "CONTRADICT",
    "posthoc_result": {
      "label": "CONTRADICT",
      "confidence": 0.88,
      "justification": "Paper 6 shows that the interferon-stimulated genes Ifi27, Irg1, and Rsad2 (Viperin) mediate antiviral effects in neurons and, when expressed in cortical neurons, reduce replication of neurotropic positive-strand RNA viruses, which is opposite to 'encouraging' West Nile virus replication. Paper 1 further supports that type I interferon signaling restricts WNV replication in multiple cell types, consistent with an antiviral role of ISGs. None of the provided papers present evidence that Irf1, Irg1, Ifi27, or Rsad2 promote WNV replication in cortical neurons."
    },
    "posthoc_doc_ids": [
      "10559501",
      "12885341",
      "34287602",
      "38376189",
      "40584205"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.2,
      "need_refinement": true,
      "refinement_triggered": true
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "362",
    "claim": "During the primary early antibody response activated B cells migrate toward the inner-and outer paracortical areas where oxysterol accumulation is generated by stromal cells.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.69,
      "justification": "The provided excerpts do not explicitly state that, during the early antibody response, activated B cells migrate to inner and outer paracortical areas where stromal cells generate oxysterol accumulation. Paper 1 (review) notes EBI2 guides activated B cells to inter and outer follicular niches (not specifically paracortical areas). Paper 3 shows B cells can migrate to the T zone after antigen encounter but does not mention oxysterols or stromal production. Paper 4 (review) identifies 7\u03b1,25-dihydroxycholesterol as the EBI2 ligand and mentions in vivo gradients but does not specify stromal cell sources or paracortical localization in the excerpt. Other papers are unrelated. Therefore, the specific claim is not directly supported or refuted by the provided text."
    },
    "naive_doc_ids": [
      "38587347",
      "11020556",
      "35256900",
      "15058155",
      "1071991"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.7,
      "justification": "The provided papers collectively show that activated B cells migrate to T zone\u2013related/extrafollicular areas during early responses (e.g., Paper 1) and that EBI2 guides activated B cells to inter- and outer-follicular niches (Papers 5 and 8), with 7\u03b1,25-dihydroxycholesterol acting as the EBI2 ligand that forms in vivo gradients (Paper 3). However, none of the excerpts explicitly state that oxysterol accumulation is generated by stromal cells specifically in the inner and outer paracortical areas. Thus, the specific claim about oxysterol accumulation by stromal cells in those precise regions is not directly supported by the provided text."
    },
    "overthinking_doc_ids": [
      "35256900",
      "11020556",
      "15058155",
      "1071991",
      "15488881"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.55,
      "justification": "The provided excerpts indicate that EBI2 guides activated B cells to inter- and outer-follicular/extrafollicular sites (Papers 1 and 5) and that the oxysterol 7\u03b1,25-dihydroxycholesterol serves as the EBI2 ligand and forms in vivo gradients (Paper 4). However, the excerpts do not state that activated B cells migrate specifically to inner and outer paracortical (T-zone) areas, nor do they specify that stromal cells generate oxysterol accumulation in those areas. Thus, the specific spatial claim and stromal cell source are not directly supported by the provided text."
    },
    "posthoc_doc_ids": [
      "38587347",
      "7736860",
      "14768471",
      "15058155",
      "15488881"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.6,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1342",
    "claim": "Understanding epigenetic regulation of replication is essential for the reational design of episomally replicating vectors.",
    "gold": "NOINFO",
    "naive_label": "SUPPORT",
    "naive_result": {
      "label": "SUPPORT",
      "confidence": 0.88,
      "justification": "Paper 8 provides direct experimental evidence that replication of an episomal replicon (HBV cccDNA minichromosome) is regulated by the acetylation status of cccDNA-bound histones H3/H4; HDAC inhibition increases histone acetylation and HBV replication, while hypoacetylation correlates with lower viremia in patients. This shows epigenetic regulation is a key determinant of episomal replication, implying that understanding it is essential for rational vector design. Additional supportive context comes from Paper 4 (replication timing linked to chromatin state and nuclear organization) and Paper 10 (H3K56 acetylation regulates replication-coupled nucleosome assembly), reinforcing that chromatin modifications broadly influence DNA replication processes relevant to episomal vector behavior."
    },
    "naive_doc_ids": [
      "8267678",
      "2613813",
      "2888272",
      "8759633",
      "18037805"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.66,
      "justification": "The cited papers discuss (a) epigenetic influences on DNA replication timing and chromatin organization (e.g., Polycomb retention during replication, INO80/H2A.Z dynamics), and (b) episomally replicating vectors based on EBV (EBNA1/FR and human origin) that support long-term maintenance. However, none of the papers provide direct evidence that understanding epigenetic regulation of replication is essential for the rational design of episomal vectors. The EBV hybrid vector study demonstrates design and function without explicitly tying success or optimization to epigenetic replication mechanisms. Thus, the specific necessity claim is not substantiated by the provided evidence."
    },
    "overthinking_doc_ids": [
      "8759633",
      "24512417",
      "2356950",
      "4037034",
      "6948886"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.86,
      "justification": "The papers include evidence about epigenetic regulation of chromatin and replication timing (e.g., Papers 2, 7\u201310) and about episomally replicating EBV-based vectors (Paper 3). However, none of the studies demonstrate or test that understanding epigenetic regulation of replication is essential for the rational design of episomal vectors, nor do they link epigenetic replication control to vector design outcomes. Therefore, the provided evidence does not confirm or refute the claim."
    },
    "posthoc_doc_ids": [
      "8006440",
      "8759633",
      "4037034",
      "18924534",
      "28243325"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.28,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "1075",
    "claim": "Sequence conservation in gene regulatory regions between species is a poor predictor of conserved functionality.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Multiple papers show that regulatory function (e.g., transcription factor occupancy) often diverges between species regardless of sequence alignment, indicating that sequence conservation poorly predicts conserved regulatory function. Paper 9 reports that only ~5% of OCT4 and NANOG binding sites are shared at homologous regions between human and mouse embryonic stem cells, with species-specific transposable elements creating many functional binding sites, rewiring the regulatory network. Paper 6 finds substantial differences between C/EBP\u03b1 targets in mouse 3T3-L1 versus human adipocytes and emphasizes the need for species-specific regulatory maps. Together, these results show that cross-species sequence similarity in regulatory regions is not a reliable predictor of conserved functionality."
    },
    "naive_doc_ids": [
      "38805486",
      "6259170",
      "8646760",
      "10766688",
      "18346333"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.73,
      "justification": "Most cited papers do not directly test whether interspecies sequence conservation of regulatory DNA predicts conserved regulatory function. Paper 1 shows rapid enhancer evolution across mammals and promoter conservation, but does not assess the predictive value of sequence conservation for conserved function across species. Paper 3 concerns conservation of protein function despite poor sequence conservation (not regulatory DNA). Paper 6 examines p53-bound enhancers and eRNAs largely within a species and notes conserved binding sites, but does not evaluate cross-species functional conservation. Papers 2, 4, 5, and 7 are unrelated to regulatory sequence-function conservation. Therefore the provided evidence does not directly support or refute the claim."
    },
    "overthinking_doc_ids": [
      "14658685",
      "3823862",
      "23244529",
      "6202834",
      "29334259"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.72,
      "justification": "Paper 2 shows that liver enhancers evolve rapidly across 20 mammals, with many being lineage-specific, implying low sequence conservation despite regulatory activity; therefore sequence conservation is not a reliable predictor of conserved enhancer function. Paper 7 finds that only ~5% of OCT4/NANOG sites are homologously occupied between human and mouse and that species-specific transposable elements rewired the pluripotency network, indicating conserved cellular function despite divergent regulatory sequences. While Paper 10 notes conserved CTCF anchor regions (an exception for insulators), the broader evidence, especially for enhancers, supports that sequence conservation is a poor predictor of conserved regulatory functionality."
    },
    "posthoc_doc_ids": [
      "23244529",
      "14658685",
      "8502193",
      "29334259",
      "2754534"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.55,
      "need_refinement": true,
      "refinement_triggered": false
    }
  },
  {
    "model": "gpt-5",
    "claim_id": "975",
    "claim": "Primary pro-inflammatory cytokines induce secondary pro- and anti-inflammatory mediators.",
    "gold": "NOINFO",
    "naive_label": "NOINFO",
    "naive_result": {
      "label": "NOINFO",
      "confidence": 0.68,
      "justification": "Among the provided papers, there is evidence that a primary pro-inflammatory cytokine (TNF-alpha) induces secondary pro-inflammatory mediators: Paper 3 shows TNF-alpha upregulates ICAM-1, VCAM-1, and MCP-1. Paper 2 shows TNF-alpha induces expression of a cellular protein (FIP-2), but its role is not clearly anti-inflammatory. However, none of the papers provide data that primary pro-inflammatory cytokines (e.g., TNF-alpha, IL-1) induce anti-inflammatory mediators (such as TGF-beta or IL-10). Therefore, the evidence does not substantiate the full claim that they induce both pro- and anti-inflammatory mediators."
    },
    "naive_doc_ids": [
      "36386637",
      "207972",
      "22889972",
      "35766603",
      "38023457"
    ],
    "overthinking_label": "NOINFO",
    "overthinking_result": {
      "label": "NOINFO",
      "confidence": 0.56,
      "justification": "Among the provided papers, only Paper 6 presents direct evidence that a primary pro-inflammatory cytokine (IL-1\u03b2) induces secondary pro-inflammatory mediators (PGE2, COX-2, MMPs) in synovial fibroblasts. None of the papers demonstrate that primary pro-inflammatory cytokines induce secondary anti-inflammatory mediators. Therefore, the evidence set does not fully support the claim that primary pro-inflammatory cytokines induce both pro- and anti-inflammatory mediators."
    },
    "overthinking_doc_ids": [
      "238409",
      "1871230",
      "12672066",
      "12705056",
      "22908536"
    ],
    "posthoc_label": "NOINFO",
    "posthoc_result": {
      "label": "NOINFO",
      "confidence": 0.74,
      "justification": "Paper 6 shows a clear example of a primary pro-inflammatory cytokine inducing a secondary anti-inflammatory mediator: IFN-\u03b3 induces inducible nitric oxide synthase (iNOS) and nitric oxide in the heart, which then downregulates T-cell responses and limits myocarditis; blocking iNOS worsens disease. Paper 1 indicates that factors from activated T cells (a source of pro-inflammatory cytokines) up-regulate both RANK (pro-osteoclastogenic/pro-resorptive mediator) and osteoprotegerin (OPG; an anti-osteoclastogenic decoy receptor), demonstrating induction of both pro- and anti-mediators by a primary inflammatory cytokine milieu. Other papers are tangential and do not contradict this. Overall, the evidence supports the claim."
    },
    "posthoc_doc_ids": [
      "43619625",
      "2391552",
      "9956893",
      "25315295",
      "11233339"
    ],
    "posthoc_metadata": {
      "initial_confidence": 0.25,
      "need_refinement": true,
      "refinement_triggered": false
    }
  }
]